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Worldwide,	  many	  animals	  are	  used	  in	  regulatory	  and	  academic	  studies	  to	  determine	  the	  
environmental	   fate	   and	   impact	  of	   xenobiotic	   compounds	   that	  may	  be	   released	   into	   the	  
environment.	   Fish	   are	   commonly	   used	   in	   these	   tests	   as	   they	   inhabit	   the	   aquatic	  
environment,	  the	  sink	  into	  which	  many	  pharmaceuticals	  eventually	  enter.	  Fish	  gills	  are	  the	  
primary	  site	  of	  xenobiotic	  uptake.	  In	  line	  with	  the	  replacement,	  reduction	  and	  refinement	  
(3Rs)	  of	  the	  use	  of	  animals	  in	  scientific	  practices,	  alternative	  methods	  to	  in	  vivo	  fish	  testing	  
are	   required.	   For	   rainbow	   trout	   (Oncorhynchus	   mykiss),	   a	   commonly	   used	   species	   in	  
European	   and	   American	   in	   vivo	   regulatory	   testing,	   two	   gill	   epithelial	   models	   exist	   –	  
primary	   gill	   cells	   cultured	   in	   a	   two	   compartment	   model	   (termed	   DSI	   –	   double	   seeded	  
inserts)	  and	  the	  immortalised	  gill	  cell	  line	  RTgill-­‐W1.	  This	  work	  uses	  these	  gill	  cell	  models	  
to	  characterise	  the	  physiology	  of	  the	  in	  vitro	  gill	  epithelium	  and	  assess	  their	  suitability	  as	  
epithelial	  gill	  surrogates.	  DSI	  cultures	  were	  found	  to	  have	  characteristics	  similar	  to	  the	  in	  
tact	  gill,	  whilst	  experiments	  investigating	  the	  co-­‐culture	  of	  RTgill-­‐W1	  with	  primary	  gill	  cells	  
failed	   to	   produce	   epithelia	   with	   such	   features,	   like	   high	   TER	   and	   low	   paracellular	  
permeability.	  The	  DSI	  cell	  culture	  system	  was	  used	  to	  investigate	  the	  uptake	  and	  efflux	  of	  
pharmaceuticals	   over	   the	   gill	   and	   found	   that	   for	   some,	   active	   uptake	   plays	   a	   small	   but	  
significant	  role.	  This	  work	   further	   investigates	  the	  metabolism	  of	  pharmaceuticals	  at	   the	  
gill	  and	  shows	  the	  relevance	  of	  the	  primary	  gill	  cell	  DSI	  technique	  as	  an	  appropriate	  in	  vitro	  
model,	   as	   the	   metabolite	   hydroxypropranolol	   was	   detected,	   which	   in	   single-­‐seeded	  
primary	  cultures	  (SSI)	  and	  RTgill-­‐W1,	  it	  was	  not.	  This	  work	  is	  an	  important	  step	  forward	  in	  
the	  development	  of	  alternative	  in	  vitro	  methods	  to	  assess	  the	  ecotoxicology	  of	  xenobiotic	  
compounds	  in	  fish	  and	  provides	  evidence	  that	  the	  primary	  gill	  cell	  DSI	  technique	  provides	  
the	  most	  accurate	  in	  vitro	  gill	  model.	  Experimental	  information	  obtained	  from	  DSI	  uptake,	  
efflux	  and	  metabolism	  assays	  has	  the	  potential	  to	  be	  incorporated	  into	  and	  supplement	  in	  
vivo	  regulatory	  studies,	  therefore	  reducing	  the	  numbers	  of	  fish	  used	  in	  such	  tests.	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1.1	   Introduction	  
The	   objectives	   of	   this	   work	   are	   to	   develop	   and	   assess	   the	   suitability	   of	   a	   primary	   fish	   gill	   cell	  
culture	   system	   for	   characterising	   the	   transport	   and	   metabolism	   of	   xenobiotics,	   namely	  
pharmaceuticals,	   at	   the	   rainbow	   trout	   (Oncorhynchus	  mykiss)	   gill.	   Through	   the	   development	   of	  
this	  in	  vitro	  gill	  model	  there	  is	  the	  potential	  to	  replace	  fish	  in	  toxicological	  studies,	  which	  fulfils	  the	  
UK	  government’s	  current	  aims	  to	  reduce,	  replace	  and	  refine	  (3Rs)	  the	  use	  of	  animals	  in	  scientific	  
research	  (Gov.UK,	  2014).	  The	  freshwater	  teleost	  fish	  gill	  is	  a	  multifunctional	  organ.	  It	  is	  the	  primary	  
site	   of	   respiratory	   gas	   exchange,	   ionic	   and	   osmotic	   regulation	   and	   nitrogenous	  waste	   excretion	  
(Evans	  et	  al.,	  2005).	  The	  gill	   is	   adapted	   to	  maximise	  diffusive	  gas	  exchange	  whilst	   regulating	   the	  
influx	   and	   efflux	   of	   water,	   ions	   and	   compounds	   and	   because	   of	   its	   constant	   contact	   with	   the	  
aquatic	  environment,	  it	  is	  also	  the	  primary	  site	  of	  xenobiotic	  uptake	  from	  water	  (Bury	  et	  al.,	  2014).	  
1.2	   Gill	  physiology	  and	  anatomy	  
Four	  gill	   arches	   lie	  beneath	   the	  operculum	  on	  either	   lateral	   side	  of	   the	   rainbow	  trout	  head.	  The	  
filament	   abductor	   and	   adductor	   muscles	   control	   the	   positioning	   of	   the	   arches	   dependent	   on	  
oxygen	  requirement	  from	  exercise,	  stress	  or	  hypoxia.	  Each	  gill	  arch	  bears	  hundreds	  of	  gill	  filaments	  
lined	  in	  two	  hemibranch	  rows,	  each	  possessing	  thousands	  of	  leaf-­‐like	  respiratory	  lamellae	  (Fig	  1.1).	  
The	  positioning	  of	  the	  lamellae	  with	  respect	  to	  the	  flow	  of	  water	  through	  the	  mouth	  and	  over	  the	  
gills	  (Fig	  1.2A)	  creates	  a	  counter-­‐current	  flow	  system	  whereby	  blood	  flow	  through	  the	  lamellae	  is	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opposite	  to	  that	  of	  the	  water	  over	  the	  gills	  (Fig	  1.2B).	  This	  maintains	  a	  high	  oxygen	  concentration	  
gradient	  between	  the	  blood	  and	  the	  water,	  even	  to	  near-­‐fully	  oxygenated	  blood,	  maximising	  the	  
efficiency	  of	  blood	  oxygenation	  (Wood,	  2001).	  
	  
Fig	  1.1	  The	  gill	  filaments	  are	  made	  up	  of	  thousands	  of	  finger-­‐like	  structures	  called	  lamellae.	  Bar	  =	  0.5	  mm.	  
The	  osmotic	  concentration	  of	  freshwater	  trout	  blood	  is	  in	  the	  range	  of	  260-­‐330	  mOsm	  Kg-­‐1,	  whilst	  
that	  of	   freshwater	   is	   typically	   less	   than	  20	  mOsm	  Kg-­‐1	   (Jobling,	  1995).	   This	  osmotic	   gradient	  has	  
profound	  effects	   on	   the	   fish’s	   ability	   to	  maintain	   ionic	   homeostasis.	   Firstly,	   it	  means	   freshwater	  
teleosts	  will	   absorb	  water	  across	   the	  gills,	  which	   is	   then	  excreted	  via	   the	  kidney	  as	  dilute	  urine.	  
Secondly,	  fish	  will	  lose	  ions	  across	  the	  gill,	  which	  is	  compensated	  for	  by	  active	  ion	  uptake	  at	  the	  gill	  
and	  intestine	  and	  efficient	  ionic	  reabsorption	  from	  the	  urine	  by	  the	  kidneys.	  Ions	  taken	  up	  at	  the	  
gill	   and	   via	   food	   are	   reabsorbed	   in	   the	   kidney	  nephrons	   to	   counteract	   the	  high	  water	   excretion	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Fig	  1.2	  The	  counter	  current	  of	  blood	  flow	  to	  water	  flow	  in	  the	  teleost	  gill.	  Water	  flows	  between	  the	  gill	  filaments	  
attached	  to	  the	  gill	  arch	  (A).	  Each	  filament	  possesses	  many	  leaf-­‐like	  processes	  called	  lamellae,	  in	  which	  the	  blood	  flows	  
in	  the	  opposite	  direction	  to	  the	  water	  flowing	  between	  them	  (B).	  
Nitrogen	  excretion	   in	  rainbow	  trout	   is	  mostly	  through	  the	  elimination	  of	  ammonium	  ions	  (NH4+),	  
which	   constitute	   around	   90%	   of	   nitrogenous	   waste	   in	   freshwater	   rainbow	   trout	   (McDonald	   &	  
Wood,	   2004).	   Oxygen	   crosses	   the	   branchial	   epithelium	   by	   diffusion	   and	   is	   used	   in	   cellular	  
metabolism,	   producing	  water	   and	   carbon	   dioxide.	   These	   are	   diffusively	   excreted	   via	   the	   partial	  
pressure	  gradient	  set	  up	  at	  the	  gill.	  Carbonic	  anhydrase	  may	  also	  convert	  carbon	  dioxide	  (CO2)	  and	  
water	  to	  bicarbonate	  ions	  (HCO3-­‐)	  (excreted	  by	  a	  chloride,	  Cl-­‐/HCO3-­‐	  exchanger)	  and	  hydrogen	  ions	  
(H+),	   which	   form	   ammonium	   ions	   (NH4+)	   that	   are	   excreted	   via	   a	   sodium/ammonium	   (Na+/NH4+)	  
exchanger	   (Wood,	   2001).	   Ammonia	   (NH3)	   may	   also	   be	   excreted	   via	   Rhesus	   (Rh)	   ammonia	  
transport	  proteins	  (Wright	  &	  Wood,	  2009).	  In	  the	  water	  most	  adjacent	  to	  the	  branchial	  epithelium,	  
termed	   the	   unstirred	   water	   layer	   (UWL;	   a	   boundary	   layer),	   ions	   excreted	   undergo	   further	  
reactions,	  such	  as	  the	  conversion	  of	  CO2	  back	  to	  HCO3-­‐	  and	  H+,	  which	  further	  maintains	  the	  partial	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Fig	  1.3	  Scanning	  electron	  micrograph	  of	  the	  apical	  gill	  cell	  surface	  in	  vitro.	  The	  irregularly	  shaped	  epithelial	  cells	  with	  
microridges	  (mr)	  and	  plasma	  membrane	  (pm)	  can	  be	  observed.	  Bar	  =	  20	  μm.	  Reproduced	  with	  permission	  from	  Dr	  
Sabine	  Schnell.	  
The	   branchial	   epithelium	   is	   composed	   of	   four	   differentiated	   cell	   types:	   pavement	   cells	   (PVCs),	  
mitochondria-­‐rich	   cells	   (MRCs),	  mucous	   cells	   and	  neuro-­‐epithelial	   cells	   (Wood,	  2001).	   Internally,	  
collagen	  and	  pillar	  cells	  channel	  blood	  flow	  from	  afferent	  lamellar	  arterioles	  to	  efferent	  along	  the	  
leading	  margin	  of	  each	  filament	  (Penrice	  &	  Eddy,	  1993).	  
PVCs	  are	  polygonal	  cells,	  comprising	  at	  least	  80%	  of	  the	  trout	  gill	  epithelium	  and	  are	  thought	  to	  be	  
responsible	   for	   diffusive	   gas	   exchange	   (Leguen	   et	   al.,	   2001;	   Wood,	   2001).	   Microridges	   can	   be	  
observed	  on	  the	  apical	  surface	  (Fig	  1.3)	  and	  function	  to	  increase	  the	  surface	  area	  and	  maintain	  the	  
UWL	  (Wood,	  2001).	  A	  glycocalyx	  mucus	  layer	  produced	  by	  the	  mucous	  cells	  covers	  this.	  MRCs	  are	  
fewer,	  covering	  less	  than	  15%	  of	  the	  epithelium	  and	  were	  first	  documented	  by	  Keys	  and	  Willmer	  
(1932)	  when	  describing	  the	  cells	  responsible	  for	  chloride	  ion	  excretion	  in	  seawater	  teleosts;	  hence	  
their	  initial	  terming	  as	  chloride	  cells	  (CCs).	  MRCs	  are	  the	  main	  site	  of	  active	  Cl-­‐,	  calcium	  ion	  (Ca2+)	  
and	  Na+	   exchange	   (Wood,	   2001),	   and	   so	   possess	  many	  mitochondria	   to	   provide	   the	   energy	   for	  
these	   processes	   to	   occur	   (Perry,	   1997).	   Histology	   shows	   that	   the	  MRCs	   are	   indented	   and	  more	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rounded	   due	   to	   their	   partial	   covering	   by	   PVCs,	   with	   deep	   tight	   junctions	   and	   desmosomes	  
between	  cells	  (Evans	  et	  al.,	  2005;	  Wood,	  2001).	  
	  
Fig	  1.4	  The	  tight	  junction	  complex	  of	  the	  teleost	  fish	  gill.	  Claudins	  and	  occludins	  constitute	  a	  network	  of	  proteins	  that	  act	  
to	  gate	  keep	  the	  paracellular	  transport	  pathway.	  ZO-­‐1	  proteins	  link	  the	  external	  TJ	  complex	  to	  the	  internal	  actin	  
cytoskeleton,	  whilst	  also	  acting	  to	  transduce	  signals	  to	  the	  nucleus	  about	  TJ	  formation	  and	  cell	  proliferation.	  
Tight	   junctions	   (TJs)	   and	   interconnecting	   desmosomes	   are	   present	   in	   the	   gill	   epithelium;	   their	  
formation	   and	   relative	   impermeability	   are	   integral	   to	   the	   proper	   barrier	   functioning	   of	   the	   gill	  
epithelium	   and	   its	   physiological	   pathways	   (Chasiotis	   &	   Kelly,	   2011;	   Sandbichler	   et	   al.,	   2011a).	  
Transmembrane	  proteins	  are	  held	  by	  cytoplasmic	  protein	  networks	  at	  the	  sides	  of	  epithelial	  cells	  
(Fig	  1.4)	  and	  act	  to	   limit	   the	  paracellular	  movement	  of	  water	  and	   ions.	  Communication	  between	  
exposed	   transmembrane	   proteins	   and	   the	   internal	   actin	   cytoskeleton	   allows	   information	   about	  
the	   external	   environment	   to	   be	   relayed	   to	   inside	   the	   cell,	   affecting	   transcriptional	   pathways	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1.3	   Requirement	  for	  in	  vitro	  methods	  
Whole	   animal	   studies	   using	   rainbow	   trout	   provide	   information	   about	   the	   effects	   of	  
pharmaceuticals	   and	   other	   chemicals	   on	   fish	   at	   the	   organism	   level.	   In	   order	   to	   understand	  
individual	   organ	   functionality	   and	   physiology,	   it	   is	   necessary	   to	   develop	   an	   in	   vitro	   cell	   system	  
(Baron	  et	  al.,	  2012;	  Murer	  &	  Kinne,	  1980;	  Uchea	  et	  al.,	  2013).	  In	  vitro	  gill	  cell	  cultures	  offer	  a	  more	  
detailed	  description	  of	  the	  transport	  properties	  of	  the	  gill,	  and	  to	  date	  there	  has	  been	  no	  gill	  cell	  
culture	   model	   for	   assessing	   pharmaceutical	   uptake,	   efflux	   and	   metabolism	   by	   this	   organ.	  
Furthermore,	   an	   in	   vitro	  method	   offers	   a	   reduction	   in	   the	   number	   of	   animals	   used	   in	   scientific	  
research,	  as	  the	  gill	  cells	  obtained	  from	  two	  organisms	  can	  be	  used	  to	  create	  many	  individual	  gill	  
epithelia	   for	   assaying,	   thus	   providing	   an	   alternative	   to	   whole-­‐animal	   methods	   in	   line	   with	   the	  
replacement,	  reduction	  and	  refinement	  (3Rs)	  of	  the	  use	  of	  animals	  in	  scientific	  research.	  
The	  gill	  cell	   line,	  RTgill-­‐W1,	  offers	  an	  alternative	  model	  to	  whole-­‐animal	  experiments	  and	  studies	  
using	  cells	  obtained	  from	  live	  fish,	  that	  can	  be	  supplied	  conveniently	  and	  maintained	  in	  long-­‐term	  
culture	  (Bols	  et	  al.,	  1994).	  This	  cell	  line	  exhibits	  the	  PVC,	  MRC	  and	  goblet	  cells	  present	  in	  primary	  
cells	   (Lee	   et	   al.,	   2009)	   but	   fails	   to	   form	   a	   tight	   epithelium	   (Trubitt	   et	   al.,	   2015)	   and	   enzymes	  
essential	  for	  xenobiotic	  metabolism	  such	  as	  CYP1A	  are	  absent	  (Schirmer	  et	  al.,	  1998).	  
Other	  alternative	  freshwater	  gill	  surrogates	  have	  been	  identified,	  such	  as	  flat	  opercula	  or	  jaw	  skin	  
preparations	  of	  freshwater	  adapted	  killifish	  (Wood	  &	  Marshall,	  1994)	  or	  Nile	  tilapia	  (Burgess	  et	  al.,	  
1998)	   that	   contain	   freshwater	   type	  MRCs	  and	  can	  be	  used	   to	  assess	   ion	   transport	   (Wood	  et	  al.,	  
2002).	  However,	  these	  preparations	  very	  slowly,	  or	  completely	  lack	  the	  ability	  to,	  take	  up	  Cl-­‐	  or	  Na+	  
when	   exposed	   to	   apical	   freshwater.	   This	   initiated	   the	   development	   of	   a	   suitable	   reconstructed	  
freshwater	  gill	  epithelial	  model.	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Fig	  1.5	  Permeable	  membrane	  cell	  culture	  inserts	  in	  a	  companion	  well	  plate.	  
Pärt	  et	  al.	   (1993)	   first	  documented	  the	  success	  of	  primary	  cell	  cultures	  of	   isolated	  rainbow	  trout	  
epithelial	   cells	   on	   plates	   and	   demonstrated	   the	   best	   conditions	   for	   cell	   growth	   and	   attachment	  
efficiency.	   This	   was	   later	   developed	   through	   the	   seeding	   of	   primary	   cells	   onto	   permeable	  
membrane	   supports,	   termed	   single	   seeded	   inserts	   (SSI)	   (Fig	   1.5)	   (Wood	   &	   Pärt,	   1997).	   For	   SSI	  
preparations,	  cells	  were	  grown	  in	  cell	  culture	  medium	  supplemented	  with	  fetal	  bovine	  serum	  (FBS)	  
and	   formed	   an	   epithelial	   sheet	   on	   inserts	   (Fig	   1.6A).	   SSI	   epithelia	   showed	   a	   gradual	   rise	   in	  
transepithelial	   resistance	   (TER),	   which	   was	   indicative	   of	   the	   formation	   of	   intercellular	   tight	  
junctions	   and	   a	   tight	   epithelium	   (Wood	  &	   Pärt,	   1997).	   Epithelia	   could	   sustain	   apical	   freshwater	  
exposure	  whilst	  cells	  remained	  bathed	  in	  the	  body	  fluid-­‐like	  cell	  culture	  medium	  in	  the	  basolateral	  
compartment	   (Fig	   1.6B).	   Apical	   water	   exposure	   showed	   a	   6-­‐11	   fold	   increase	   in	   TER	   and	   the	  
creation	   of	   a	   basolaterally	   negative	   transepithelial	   potential	   (TEP),	   owing	   to	   the	   differential	  
permeability	  of	  the	  epithelium	  to	  ions,	  which	  is	  similar	  to	  the	  TEP	  observed	  in	  vivo	  (Wood,	  2001).	  
Despite	  showing	  a	  developed	  apical	  glycocalyx	  and	  abundant	  rough	  endoplasmic	  reticulum,	  the	  SSI	  
primary	  cultured	  cells	  showed	  no	  differentiation,	  and	  DASPEI	  staining	  revealed	  low	  mitochondrial	  
activity	  indicating	  the	  presence	  of	  only	  PVCs	  (Wood	  et	  al.,	  1998).	  
Insert 
Well 
Companion	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  plate 
Lid 
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Fig	  1.6	  Representation	  of	  the	  in	  vitro	  gill	  in	  (A)	  symmetrical	  conditions	  with	  cell	  culture	  medium	  (orange;	  L-­‐15)	  with	  FBS	  
and	  with	  or	  without	  antibiotics	  both	  sides	  of	  the	  epithelium,	  (B)	  asymmetrical	  conditions	  with	  freshwater	  (blue;	  FW)	  in	  
the	  apical	  chamber	  whilst	  the	  basolateral	  remains	  bathed	  in	  L-­‐15	  and	  (C)	  the	  gill	  epithelium	  growing	  multiple	  cell	  types	  
(PVCs	  and	  an	  MRC)	  in	  layers	  on	  the	  permeable	  membrane	  cell	  culture	  inserts.	  
Fletcher	  et	  al.	   (2000)	   later	  employed	   the	  double	   seeded	   insert	   (DSI)	   technique	  whereby	  primary	  
cells	  were	  seeded	  over	  two	  consecutive	  days.	  This	  provided	  a	  carpet	  of	  PVCs	  on	  the	  first	  day	  that	  
enables	  MRCs	  to	  attach	  during	  the	  second	  seed	  on	  day	  2	  (Fig	  1.6C)	  (Wood	  et	  al.,	  2002).	  Using	  the	  
DSI	   technique	   produced	   epithelia	   with	   greater	   numbers	   of	   MRCs	   of	   around	   15%	   of	   total	   cell	  
numbers,	  similar	  to	  the	  proportion	  observed	  in	  vivo,	  and	  higher	  TER	  values	  of	  up	  to	  34,000	  Ω	  cm2,	  
typical	   of	   an	   electrically	   tight	   epithelium	   (Kelly	   et	   al.,	   2000).	   Furthermore,	   this	   reconstructed	  
epithelium	  exhibited	   transport	   properties	   of	   the	   intact	   freshwater	   gill	   such	   as	   active	  Cl-­‐	   and	  Ca+	  
uptake,	  and	  responded	  to	  hormone	  treatments	  such	  as	  cortisol	  and	  thyroid	  hormone	  (Wood	  et	  al.,	  
2002).	   However,	   despite	   the	   presence	   of	   active	   Na+/K+ATPase,	   the	   cell	   cultures	   did	   not	  
demonstrate	  discernible	  Na+	  or	  Cl-­‐	  net	  uptake	  to	  values	  seen	  in	  vivo	  (Wood	  et	  al.,	  2002).	  
The	   development	   of	   a	   suitable	   in	   vitro	   gill	   epithelial	  model	   has	   allowed	   for	   the	   investigation	   of	  
other	  transport	  properties	  of	  this	  organ.	  The	  potential	  uses	  for	  this	  system	  are	  many	  (Wood	  et	  al.,	  
2002)	  particularly	  in	  the	  field	  of	  aquatic	  toxicology	  (Bury	  et	  al.,	  2014).	  This	  model	  has	  been	  used	  as	  
an	   in	   vitro	  method	   to	   assess	   the	   toxicity	   of	  waterborne	  metals	   to	   fish	   (Walker	   et	   al.,	   2008),	   for	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the	  uptake,	  efflux	   (Stott	  et	   al.,	   2015)	   and	  metabolism	  of	   xenobiotics	   such	  as	  pharmaceuticals	   at	  
the	  gill.	  
Owing	  to	  its	  intimate	  contact	  with	  the	  water,	  the	  gill	  is	  the	  first	  point	  of	  contact	  of	  the	  organism	  to	  
xenobiotics	   in	   the	   aquatic	   environment	   (Laurent	   &	   Perry,	   1991;	  McKim	   &	   Erickson,	   1991).	   The	  
most	  common	  initial	  lesions	  at	  the	  gill	  after	  exposure	  to	  high	  concentrations	  of	  toxicants	  are	  lifting	  
of	   the	  PVCs	   (causing	  TJ	  disruption),	  PVC	  and	  MRC	  hypertrophy,	  necrosis	  or	  apoptosis),	   fusion	  of	  
neighbouring	  lamellae	  (reducing	  surface	  area)	  and	  PVC,	  MRC	  and	  mucous	  cell	  proliferation	  (Wood,	  
2001).	  
1.4	   Pharmaceuticals	  in	  the	  aquatic	  environment	  
Pharmaceuticals	  are	  used	   in	   the	  therapy	  and	  treatment	  of	  numerous	  diseases	  and	   include	  many	  
thousands	  of	  compounds,	  which	  are	  derived	  from	  natural	  sources	  or	  are	  synthetically	  produced.	  
Recently,	   the	   production,	   availability	   and	   use	   of	   pharmaceuticals	   have	   increased,	   and	   so	  
understanding	   the	   fate	   and	   implications	   of	   these	   compounds	   in	   the	   environment	   is	   necessary	  
(Kümmerer,	   2008).	   Moreover,	   all	   chemical	   products	   manufactured	   or	   imported	   into	   the	   EU	   in	  
quantities	  of	  1	  tonne	  or	  more	  per	  year	  require	  environmental	  risk	  assessment	  to	  determine	  their	  
safety	  (REACH,	  2009).	  
Pharmaceuticals	  have	  become	  a	  class	  of	  contaminants	  of	  emerging	  concern	  (CECs)	  (Ashton	  et	  al.,	  
2004;	   Kümmerer,	   2008).	   This	   is	   owing	   to	   their	   specific	   design;	   their	   ability	   to	   cross	   biological	  
membranes	   and	   remain	   stable	  makes	   them	  well	   designed	   for	   their	   desired	   use,	   but	   biologically	  
detrimental	   when	   exposed	   to	   non-­‐target	   organisms	   (Gunnarsson	   et	   al.,	   2008).	   Pharmaceuticals	  
present	  in	  the	  environment	  include	  anti-­‐depressants,	  antibiotics,	  anti-­‐cancer	  drugs,	  beta-­‐blockers,	  
lipid	  regulators	  and	  oral	  contraceptives	  (Daughton	  &	  Ternes,	  1999).	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Wastewater	  treatment	  plants	  (WWTPs)	  process	  sewage	  water	  that	  contains	  unmetabolised	  active	  
pharmaceutical	  ingredients	  (APIs)	  and	  their	  conjugate	  metabolites	  excreted	  from	  human	  drug	  use.	  
Here,	  they	  may	  not	  be	  fully	  removed	  or	  degraded,	  or	  are	  further	  transformed	  by	  sewage	  microbial	  
systems	   to	   other	   compounds	   that	   may	   ultimately	   enter	   environmental	   water	   systems.	   For	  
example,	   the	   effect	   of	   increased	   environmental	   levels	   of	   synthetic	   oestrogens	   and	   their	  
metabolites	   from	   excreted	   human	   usage	   not	   adequately	   removed	   by	   WWTPs	   has	   caused	  
feminised	   male	   fish	   and	   altered	   sexual	   behaviours	   (Sumpter	   &	   Jobling,	   2013).	   Veterinary	  
medicines	  may	  enter	  ecosystems	  by	  excretion	  directly	  onto	  pastures	  used	  for	  animal	  husbandry	  or	  
through	  the	  spreading	  of	  manure	  containing	  APIs	  and	  their	  metabolites	  on	  agricultural	  land,	  which	  
will	   eventually	  enter	   surface	  and	  ground	  waters.	   Environmental	   levels	  of	  pharmaceuticals	   are	   in	  
the	  ng-­‐μg	  L-­‐1	  range.	  Their	  effect	  on	  human	  health	  specifically	  is	  unlikely	  because	  therapeutic	  doses	  
are	  many	  orders	  of	  magnitude	  higher	   (Thomas	  &	  Klaper,	  2012),	   although	   these	   low	  doses	  are	  a	  
cause	  for	  concern	  for	  early	  life	  stages	  (i.e.	  pregnant	  women)	  and	  for	  chemicals	  with	  carcinogenic	  
or	  chemotherapeutic	  properties.	  
Despite	  the	  detection	  of	  many	  types	  of	  pharmaceutical	  compounds	  in	  the	  environment,	  research	  
into	  the	  effects	  to	  aquatic	  organisms	  has	  focused	  predominantly	  on	  single-­‐substance	  exposures.	  In	  
reality,	   wild	   organisms	   are	   probably	   exposed	   to	   mixtures	   of	   compounds	   and	   their	   metabolites	  
(Khetan	  &	  Collins,	   2007),	   thus	   risk	   assessments	   are	   therefore	   likely	   to	   underestimate	   the	   actual	  
environmental	   impact	   imposed	  by	   the	  presence	  of	  many	  active	  pharmaceutical	   ingredients	  with	  
similar	  or	  much	  different	  modes	  of	  action	  to	  one	  another.	  
The	  octanol-­‐water	  partitioning	  coefficient	  (Kow)	  is	  used	  as	  an	  indicator	  to	  predict	  the	  behaviour	  of	  
compounds	   in	   the	   environment,	   based	   on	   the	   way	   it	   partitions	   between	   the	   phases	   of	   two	  
immiscible	   liquids	   (Hermens	   et	   al.,	   2013).	   It	   is	   the	   ratio	   of	   the	   concentration	   of	   a	   chemical	   in	  
octanol	   to	  water,	   often	   logged	   to	   create	   a	   Log	  Kow	   scale	   for	  which	   different	   compounds	   can	   be	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compared	   in	   terms	   of	   lipophilicity	   (the	   octanol	   phase)	   or	   hydrophilicity	   (the	   water	   phase),	   as	  
shown	  in	  the	  following	  equation	  
𝐾!" =    [𝑠𝑜𝑙𝑢𝑡𝑒]!"#$%!&[𝑠𝑜𝑙𝑢𝑡𝑒]!"#$"#%&'  !"#$% 	  
The	  partition	  coefficient	  is	  calculated	  experimentally	  using	  the	  shake-­‐flask	  method	  (OECD107,	  1995)	  
or	  predicted	  using	  Quantitative	   Structure	  Activity	  Relationship	   algorithms	   (QSAR)	   (Hansch	  et	   al.,	  
1995).	   Computer-­‐based	   models	   (e.g.	   Parameter	   Client,	   Tetko	   et	   al.,	   2005)	   can	   make	   an	  
interpretation	  of	  Kow	  from	  the	  apparent	  functional	  groups	  within	  a	  chemical,	  based	  on	  those	  from	  
a	  fixed	  set	  of	  known	  compounds.	  The	  values	  modelled	   in	  this	  way	  may	  therefore	  be	  different	  to	  
figures	  obtained	  experimentally.	  
Log	   Kow	   assumes	   a	   compound	   is	   non-­‐ionisable	   and	   at	   constant	   temperature	   and	   pressure.	   For	  
pharmaceuticals,	   many	   of	   which	   are	   ionisable	   and	   polar,	   the	   pH-­‐corrected	   octanol-­‐water	  
distribution	   coefficient	  Dow	   is	   preferred	   (Hermens	   et	   al.,	   2013).	   For	   both	   Log	  Kow	   and	   Log	  Dow	   a	  
value	  of	  more	  than	  3	  indicates	  the	  likelihood	  that	  a	  compound	  will	  partition	  into	  the	  hydrophobic	  
phase	  and	  accumulate	   in	  organisms,	  whilst	  a	  value	  of	   less	   than	  1	  predicts	   that	  a	   compound	  will	  
remain	  in	  the	  environment	  or	  in	  the	  water	  phase.	  However,	  both	  these	  coefficients	  fail	  to	  take	  into	  
account	   other	   interactions	   such	   as	   hydrogen	   bonding	   and	   van	   der	  Waals	   forces,	   or	   uptake	   via	  
carrier-­‐mediated	  processes	  (Dobson	  &	  Kell,	  2008;	  Sugano	  et	  al.,	  2010).	  
The	  bioconcentration	  factor	  (BCF)	  is	  a	  measure	  of	  the	  ability	  of	  a	  compound	  to	  accumulate	  into	  an	  
organism	   from	   the	   aquatic	   environment	   (i.e.	   the	   hydrophobic	   phase)	   or	   remain	   in	   the	  
environment	  (i.e.	  the	  aqueous	  phase).	  It	  is	  calculated	  at	  steady	  state	  using	  the	  following	  equation	  
𝐵𝐶𝐹 =    [𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑]!"#$%&'([𝑐𝑜𝑚𝑝𝑜𝑢𝑛𝑑]!"#$%&"'!"(	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The	  determination	  of	  fish	  BCF	  follows	  guidelines	  standardised	  by	  the	  Organisation	  of	  Economic	  Co-­‐
operation	   and	   Development	   (OECD),	   using	   test	   guideline	   OECD305,	   ‘Bioaccumulation	   in	   Fish:	  
Aqueous	  and	  Dietary	  Exposure’	  (OECD305,	  2012).	  During	  the	  uptake	  phase,	  fish	  are	  exposed	  to	  at	  
least	  two	  concentrations	  and	  a	  water	  control	  (and	  a	  solvent	  control	  if	  required)	  of	  test	  compound.	  
The	   internal	   compound	  concentrations	  are	  monitored	   throughout	   the	  exposure	   (for	  28-­‐60	  days,	  
depending	  on	  how	   long	   it	   takes	   for	   internal	   steady-­‐state	   concentrations	   to	  be	   reached)	  and	   the	  
depuration	  phase	  in	  substance-­‐free	  conditions.	  BCF	  is	  then	  expressed	  normalised	  to	  a	  fish	  with	  a	  
5%	  lipid	  content	  (based	  on	  wet	  weight).	  The	  OECD305	  guidelines	  have	  recently	  been	  modified	  and	  
for	  highly	  lipophilic	  (Log	  Kow	  >	  5	  and	  solubility	  below	  0.1	  mg	  L-­‐1)	  compounds,	  fish	  are	  exposed	  via	  
the	  diet	  in	  a	  different	  test	  protocol.	  
As	  well	   as	  OECD305,	  BCF	   formulations	   for	   less	  hydrophobic	   compounds	   (Log	  Kow	   <	  5)	   can	  also	  be	  
calculated	   using	   fish	   compartment	   models	   that	   incorporate	   the	   absorption,	   distribution,	  
metabolism	   and	   excretion	   (ADME)	   of	   a	   compound,	   as	   represented	   by	   the	   following	   equation	  
(Gobas,	  1993;	  Gomez	  et	  al.,	  2010)	  
𝐵𝐶𝐹 = 𝑘! +   𝑘!𝑘! + 𝑘! + 𝑘! + 𝑘! 	  
where	   k1	   is	   the	   uptake	   across	   gills,	   kU	   is	   dietary	   ingestion,	   and	   k2,	   kG,	   kM,	   kE	   are	   rate	   constants	  
representing	  elimination	   from	  across	   the	  gills	   (k2),	  growth	   (kG),	  metabolic	  biotransformation	   (kM)	  
and	   faecal	  egestion	   (kE).	  Using	   this,	   in	   vitro	   assays	   could	  provide	   the	   inputs	   required	   in	  order	   to	  
calculate	  the	  BCF	  of	  a	  compound,	  thus	  complementing	  information	  obtained	  from	  in	  vivo	  studies.	  
There	   are	   currently	   over	   140,000	   compounds	   registered	   with	   The	   European	   Chemicals	   Agency	  
(ECHA),	  of	  which	  30,000	  compounds	  are	  being	  reassessed	  for	  their	  bioconcentrative	  properties	  as	  
part	  of	  the	  EU	  Registration,	  Evaluation,	  Authorisation	  &	  restriction	  of	  Chemicals	  (REACH)	  (REACH,	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2009).	  REACH	  aims	  to	  provide	  the	  protection	  of	  human	  health	  and	  the	  environment	  through	  the	  
controlling	  of	  chemicals,	  and	  promotes	  the	  minimisation	  of	  animal	  testing.	  
Typically,	  each	  compound	  evaluated	  by	  OECD305	  uses	  at	  least	  108	  fish,	  and	  many	  thousands	  of	  fish	  
are	   used	  worldwide	   for	   this	   test	   every	   year	   (Scholz	   et	   al.,	   2013).	   There	   is	   currently	   a	   desire	   to	  
develop	  alternative	  methods	  to	  reduce,	  refine	  and	  replace	  (3Rs)	  the	  use	  of	  whole-­‐animal	  studies	  
such	  as	  OECD305	  to	  recognise	  and	  classify	  environmental	  hazards	  (Creton	  et	  al.,	  2013;	  Wolf	  et	  al.,	  
2007).	   This	   requires	   the	   identification	   and	   validation	   of	   appropriate	   in	   vitro	   systems	   that	   could	  
replace	   such	  studies	   (Stott	  et	  al.,	  2015).	  To	   find	  alternatives	   to	   the	  OECD305	  water	  exposure	   it	   is	  
necessary	  to	  identify	  a	  suitable	  fish	  gill	  model	  that	  mimics	  the	  intact	  organ	  because	  the	  gill,	  being	  
constantly	   and	   continuously	   exposed	   to	   substances	   in	   water,	   is	   the	   principle	   site	   of	   xenobiotic	  
uptake	  (Bury	  et	  al.,	  2014).	  
1.5	   Xenobiotic	  uptake	  
Entry	   into	   a	   biological	   system	   involves	   movement	   across	   cell	   membranes.	   In	   rainbow	   trout	   gill	  
cells,	  this	  will	  firstly	  involve	  the	  influx	  of	  water	  into	  the	  buccal	  cavity	  by	  depression	  of	  the	  jaw,	  then	  
over	  the	  gills	  as	  the	  operculum	  opens.	  Other	  routes	  of	  xenobiotic	  uptake	  are	  by	  ingestion	  or	  over	  
the	   dermis.	   At	   the	   gill	   surface,	   xenobiotic	   compounds	   will	   come	   into	   contact	   with	   the	   plasma	  
membranes	   of	   the	   gill	   epithelial	   cells	   (McKim	   &	   Erickson,	   1991).	   The	   cell	   membranes	   of	   gill	  
epithelial	   cells	   are	   amphiphilic	   phospholipid	   bilayers	   5	   nm	   thick,	   with	   a	   hydrophobic	   internal	  
compartment	   composed	   of	   fatty	   acid	   tails	   lined	   by	   hydrophilic	   polar	   phospholipid	   heads.	  
Cholesterol	   and	   membrane	   anchored	   proteins	   determine	   membrane	   fluidity.	   The	   main	   driving	  
force	  dictating	  how	  a	  compound	  transfers	  from	  the	  aquatic	  environment	  into	  gill	  epithelial	  cells	  is	  
determined	  by	   its	   lipophilicity	   (Log	  Kow)	   (Huggett	   et	   al.,	   2003).	   This	   transport	   can	  be	   via	   passive	  
diffusion	   across	   the	   lipid	   bilayer	   or	   by	   carrier-­‐mediated	   transport	   using	   membrane	   protein	  
transporters.	  It	  is	  thought	  that	  the	  two	  processes	  coexist	  together	  by	  an	  interplay	  of	  mechanisms	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allowing	  for	  the	  transport	  of	  xenobiotics	  such	  as	  pharmaceuticals	  (Dobson	  &	  Kell,	  2008;	  Sugano	  et	  
al.,	  2010).	  
The	  transport	  of	  molecules	  at	  the	  apical	  surface	  of	  cells	  assumes	  free	  diffusion	  through	  the	  water	  
most	   adjacent	   to	   the	   cell	   membrane	   (Fig	   1.7)	   (Dobson	   &	   Kell,	   2008).	   The	   chemistry	   of	   this	  
unstirred	  water	  layer	  (UWL)	  may	  be	  altered	  from	  that	  of	  the	  rest	  of	  the	  bulk	  water	  due	  to	  cellular	  
processes	  occurring	  at	  the	  gill	  cell	  apical	  surface	  such	  as	  ionic	  efflux	  of	  HCO3-­‐,	  OH-­‐	  and	  H+	  and	  NH3	  
excretion	   (Wood,	   2001),	  which	   affects	   how	   xenobiotic	   compounds	  permeate	   this	   layer.	  Mucous	  
produced	   by	  mucous	   cells	   to	   form	   the	   glycocalyx	   further	   presents	   another	   boundary	   layer	   that	  
affects	  gas	  diffusion	  (Laurent	  &	  Perry,	  1991)	  and	  therefore	  xenobiotic	  uptake.	  Mucus	  cells	  produce	  
the	  glycoprotein	  mucin,	  which	  is	  thought	  to	  aid	  defense	  at	  the	  gill	  by	  reducing	  metal	  bioavailability	  
via	   complexation	   or	   increasing	  Na+,	   K+,	   and	   Ca2+	   concentrations,	   thereby	   increasing	   competition	  
between	   these	   cations	   and	  metal	   uptake	   routes	   (Wood,	   2001).	   The	   pH	   and	   chemistry	   of	   these	  
boundary	   layers	   will	   affect	   the	   ionisation	   of	   pharmaceutical	   compounds	   and	   influence	   their	  
transport	  across	  the	  gill.	  
Paracellular	  diffusion	  describes	  the	  transport	  of	  compounds	  between	  gill	  epithelial	  cells	  (Fig	  1.7A),	  
which	  depends	  on	  the	  formation	  of	  tight	  junctions	  (TJs).	  These	  are	  a	  vital	  feature	  of	  gill	  epithelia	  as	  
they	  constitute	  the	  main	  barrier	  required	  between	  the	  freshwater	  and	  organism,	  and	  control	  the	  
passage	  of	  water	  and	  ions	  via	  the	  paracellular	  transport	  pathway	  in	  fish	  (González-­‐Mariscal	  et	  al.,	  
2003).	   In	   general,	   the	   tighter	   and	   deeper	   the	   TJ,	   the	   less	   paracellular	   transport	   can	   occur.	  
Transmembrane	  and	  cytosolic	  proteins	  constitute	  TJs	  and	  appear	  to	  ‘stitch’	  cells	  together	  (Fig	  1.3),	  
whilst	   being	   anchored	   to	   the	   internal	   cytoskeleton	   of	   cells.	   This	   forms	   a	   belt	   at	   which	   the	  
movement	  of	  apical	  membrane	  bound	  proteins	  and	  channels	  cannot	  pass	  to	  basolateral,	  and	  vice	  
versa	  (Fig	  1.4)	  (Chasiotis	  et	  al.,	  2012).	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Fig	  1.7	  Transport	  processes	  at	  the	  apical	  gill	  epithelium.	  Xenobiotics	  in	  the	  water	  first	  penetrate	  the	  mucus	  layer	  and	  the	  
unstirred	  water	  layer	  (UWL).	  Uptake	  may	  occur	  via	  the	  paracellular	  route	  between	  epithelial	  cells	  (A)	  or	  transcellularly	  
through	  the	  phospholipid	  bilayer	  (B).	  ATP-­‐binding	  cassette	  (ABC)	  transporters	  may	  be	  present	  on	  the	  cell	  membrane	  (C)	  
as	  well	  as	  members	  of	  the	  solute	  carrier	  (SLC)	  superfamily	  (D).	  Inside	  the	  cells	  of	  the	  gill	  epithelium,	  xenobiotics	  may	  
undergo	  metabolism	  by	  cytochrome	  P450	  enzymes	  (E).	  
The	  TJs	  of	  freshwater	  teleosts	  are	  deeper	  and	  more	  complex	  than	  the	  more	  leaky	  TJs	  of	  seawater	  
fish,	  owing	  to	  the	  differences	  in	  osmotic	  gradient	  between	  the	  blood	  and	  external	  water	  that	  has	  
to	  be	  maintained.	  Furthermore,	  accessory	  cells	  with	  leakier	  cell	  junctions	  are	  absent	  in	  freshwater	  
fish	  species	  (Chasiotis	  et	  al.,	  2012).	  Therefore,	  the	  TJs	  of	  freshwater	  teleosts	  render	  the	  epithelium	  
more	   impermeable	   to	   paracellular	   transport.	   Cortisol	   plays	   an	   important	   role	   in	   regulating	   tight	  
junction	   formation,	   decreasing	   paracellular	   permeability	   and	   passive	   ion	   efflux	   in	   rainbow	   trout	  
gills	   (Chasiotis	   et	   al.,	   2010;	   Sandbichler	   et	   al.,	   2011b)	   and	   increasing	   cultured	   gill	   cell	   epithelial	  
tightening	  (Wood	  et	  al.,	  2002).	  
Over	  40	  vertebrate	  TJ	  proteins	  involved	  in	  the	  paracellular	  transport	  pathway	  have	  been	  identified	  
(González-­‐Mariscal	  et	  al.,	  2003).	  The	  proteins	  occludin	  and	  claudin	  are	  integral	  to	  the	  TJ	  backbone	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(González-­‐Mariscal	  et	  al.,	  2003),	  as	  well	  as	  cadherins,	  zonula	  occludin	  (ZO-­‐1)	  and	  junction	  adhesion	  
molecules	  (JAMs)	  (Chasiotis	  et	  al.,	  2012).	  Occludin	  is	  a	  tetraspan	  protein	  involved	  specifically	  in	  the	  
external	  TJ	  formation.	  It	  is	  anchored	  in	  the	  cell	  membrane	  by	  4	  transmembrane	  domains	  (Fig	  1.4)	  
and	  has	  been	  fully	  characterised	  in	  rainbow	  trout	  (Chasiotis	  &	  Kelly,	  2011;	  Chasiotis	  et	  al.,	  2010).	  
Claudins	   are	   a	   superfamily	   of	   tetraspan	   proteins,	   likewise	   anchored	   in	   the	   cell	   membrane,	   but	  
appearing	  to	  be	  more	  associated	  with	  the	  facilitation	  of	  paracellular	  transport.	  Different	  subtypes	  
aid	   the	  movement	  of	  different	   solutes	   in	   specific	   tissue	   regions,	   therefore	   acting	   as	  paracellular	  
gatekeepers	  (Chasiotis	  et	  al.,	  2012).	  Many	  claudins	  have	  been	  identified	  in	  fish	  species	  –	  more	  so	  
than	   in	  mammalian,	  and	  claudin	  expression	   is	  elevated	   in	   freshwater	  acclimatised	   fish,	  as	  would	  
be	  expected	  in	  ‘tighter’	  freshwater	  epithelia.	  In	  rainbow	  trout,	  claudin-­‐12,	  -­‐28b,	  -­‐30	  and	  -­‐31	  have	  
been	   identified	   in	  whole	   gill	   tissue	   samples	   and	   PVCs	   (Chasiotis	   et	   al.,	   2012).	   Other	   TJ	   proteins	  
include	  the	  ZO-­‐1	  proteins	  that	  are	  present	  inside	  gill	  cells	  (Fig	  1.4),	  linking	  the	  external	  TJ	  proteins	  
such	   as	   claudin	   and	  occludins	   to	   the	   internal	   actin	   cytoskeleton,	  whilst	   also	   acting	   to	   transduce	  
signals	  to	  the	  nucleus	  about	  TJ	  formation	  and	  cell	  proliferation	  (Bauer	  et	  al.,	  2010).	  	  
In	   cultured	   rainbow	   trout	   epithelial	   cell	   cultures,	   5	   genes	   encoding	   for	   proteins	   involved	   in	   TJ	  
formation,	   including	   claudin	   28b,	   were	   identified	   when	   cells	   were	   exposed	   to	   freshwater	  
(Sandbichler	  et	  al.,	  2011a).	  Occludin	  is	  expressed	  in	  whole	  gill	  tissue	  samples,	  as	  well	  as	  in	  PVCs	  in	  
culture	   (Chasiotis	   et	   al.,	   2010).	   Staining	   of	   ZO-­‐1	   shows	   its	   location	   on	   the	   periphery	   of	   cultured	  
rainbow	  trout	  PVCs	  (Walker	  et	  al.,	  2007).	  
Transcellular	   diffusion	   involves	   the	   movement	   of	   molecules	   into	   cells	   by	   permeating	   the	  
phospholipid	   membrane	   down	   a	   concentration	   gradient	   (Fig	   1.7B)	   (Sugano	   et	   al.,	   2010).	   This	  
process	  will	  not	  reach	  saturation	  or	  be	  subject	  to	  inhibition	  and	  is	  concentration	  dependent.	  It	   is	  
mainly	  driven	  by	  how	  easily	  a	  compound	  can	  permeate	  the	  hydrophobic	  region	  of	  the	  membrane	  
and	   it	   being	   uncharged	   (Sugano	   et	   al.,	   2010).	   Therefore	   passive	   diffusion	   is	   governed	   by	   a	  
compounds	   charge	   and	   lipophilicity,	   Log	   Kow	   and	   Log	   Dow.	   The	   characteristics	   of	   a	   compounds	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passive	  transcellular	  transport	  can	  be	  assessed	  using	  octanol-­‐water	  partitioning	  (OECD107,	  1995)	  or	  
artificial	   membranes	   without	   transporters,	   such	   as	   black	   lipid	   membranes	   and	   liposomes,	   and	  
parallel	   artificial	  membrane	   permeability	   assays	   (PAMPA)	   (Sugano	   et	   al.,	   2010).	   PAMPA	   studies	  
have	   been	   shown	   to	   provide	   accurate	   information	   about	   drug	   partitioning	   across	   biological	  
membranes	  in	  line	  with	  Log	  Dow	  values	  (Galinis-­‐Luciani	  et	  al.,	  2007),	  although	  others	  dispute	  this,	  
due	   to	   their	   lacking	   the	   true	   structure	   of	   a	   biological	   membrane	   that	   performs	   paracellular	   or	  
facilitated	  transport	  with	  proteins	  (Sugano	  et	  al.,	  2010).	  
Facilitated	   transport	   uses	   membrane	   bound	   protein	   carriers	   that	   act	   as	   gatekeepers	   to	   a	   cell,	  
controlling	   the	   movement	   of	   water,	   ions,	   solutes	   and	   xenobiotics	   by	   passive	   (down	   a	  
concentration	   gradient)	   or	   active	   (requiring	   energy)	   processes	   (Fig	   1.7)	   (Hediger	   et	   al.,	   2004).	  
Active	  transporters	  move	  substrates	  using	  energy	  obtained	  directly	  from	  the	  hydrolysis	  of	  ATP	  in	  
primary	   active	   transport	   or	   indirectly	   in	   secondary	   active	   transport	   through	   the	   electrochemical	  
gradient	   set	   up	  by	  pumping	  hydrogen	   ions	   into	  or	   out	   of	   cells	   (Hediger	   et	   al.,	   2004).	   Facilitated	  
transporters	   include	   water,	   ion	   and	   solute	   channels	   (Fig	   1.7),	   that	   allow	   passive	   movement	   by	  
osmosis	   or	   down	   the	   electrochemical	   or	   concentration	   gradient,	   and	   that	  may	   open	   via	   gating	  
mechanisms	  or	  changes	  in	  membrane	  conductance	  (Hediger	  et	  al.,	  2004).	  Ion	  pumps	  use	  energy	  to	  
actively	  pump	  out	  ions	  such	  as	  Na+,	  K+,	  H+	  and	  Ca2+	  to	  create	  electrochemical	  gradients	  that	  other	  
secondary	  active	  transporters	  can	  use.	  Other	  carriers	  such	  as	  the	  efflux	  ATP-­‐binding	  cassette	  (ABC)	  
transporters	  also	  require	  energy	  to	  move	  substrates	  out	  of	  cells	  (Fig	  1.7C).	  
The	   solute	   carrier	   (SLC)	   group	   of	   membrane	   transporters	   is	   a	   superfamily	   of	   carrier	   proteins	  
involved	   in	   the	  movement	  of	  endogenous	  and	  exogenous	   substrates.	  SLCs	  are	  expressed	  on	   the	  
apical,	   basolateral	   and	   organelle	   membrane	   of	   cells	   as	   passive	   transporters	   (uniporters),	  
cotransporters	  (symporters)	  and	  exchangers	  (antiporters)	  (Fig	  1.7D)	  (Dobson	  &	  Kell,	  2008;	  Hediger	  
et	  al.,	  2004).	  Symporters	  and	  exchangers	  are	   likely	   to	  utilise	  electrochemical	  gradients	  set	  up	  by	  
the	   primary	   active	   transport	   of	   ions	   by	   pumps,	   and	   hence	   are	   termed	   secondary	   active	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transporters	   (Sugano	  et	  al.,	  2010).	   In	  humans,	  398	  SLC	  genes	  have	  been	  grouped	   into	  one	  of	  52	  
families	   (Bioparadigms,	   2015).	   Certain	   carriers	   of	   SLC15	   (the	   proton	   oligopeptide	   cotransporter	  
family),	   SLCO	   (the	   organic	   anion	   transporter	   family),	   SLC22	   (the	   organic	   cation/anion/zwitterion	  
transporter	  family)	  and	  SLC47	  (the	  multidrug	  and	  toxin	  extrusion	  family)	  appear	  to	  be	  involved	  in	  
the	   uptake	   of	   xenobiotics	   (Daniel	   &	   Kottra,	   2004;	   Dobson	  &	   Kell,	   2008;	   Giacomini	   et	   al.,	   2010;	  
Hagenbuch	  &	  Meier,	  2003;	  Koepsell	  &	  Endou,	  2004).	  
The	  SLC15	  family	  contains	  4	  members	  including	  the	  PEPT1	  and	  PEPT2	  transporters,	  which	  mediate	  
peptide	  substrate	  uptake	  through	  proton	  cotransport.	  They	  transport	  charged	  and	  uncharged	  di-­‐	  
and	   tri-­‐	  peptides	  based	  on	   their	   stereospecificity,	  and	  because	  of	   this,	  will	   transport	   xenobiotics	  
with	  similar	  structures	  (Daniel	  &	  Kottra,	  2004).	  The	  SLCO	  family	  of	  carriers	  is	  named	  so	  due	  to	  their	  
ability	   to	   transport	   organic	   anions	   (organic	   anion	   transporting	   proteins,	   OATPs),	   and	   is	   further	  
divided	  into	  species-­‐specific	  subfamilies	  (Hagenbuch	  &	  Meier,	  2003).	  A	  total	  of	  52	  members	  have	  
so	  far	  been	  identified,	  and	  in	  general	  they	  comprise	  12	  transmembrane	  domains.	  They	  transport	  
by	   an	   anion	   exchange	   system,	   whereby	   the	   substrate	   is	   transported	   during	   the	   efflux	   of	   an	  
endogenous	   substance	   in	   an	   electroneutral	   process	   (Giacomini	   et	   al.,	   2010).	   The	   SLC22	   family	  
comprises	  carriers	   concerned	  with	   the	   transport	  of	  organic	  cations	  and	  anions,	  with	   the	  general	  
structure	   of	   12	   transmembrane	   domains	   (Koepsell	   &	   Endou,	   2004).	   SLC22A1	   (Organic	   cation	  
transporter	   1;	   OCT1)	   and	   SLC22A2	   (OCT2)	   are	   uniporters	   that	   transport	   substrates	   in	   either	  
direction	   with	   wide	   and	   overlapping	   substrate	   specificities,	   whilst	   SLC22A6	   (Organic	   anion	  
transporter	   1;	   OAT1)	   and	   SLC22A8	   (OAT3)	   are	   anion	   (or	   dicarboxylate)	   exchangers	   utilising	  
electrochemical	  membrane	  gradients	  to	  drive	  transport	  (Koepsell	  &	  Endou,	  2004).	  
Currently,	  representatives	  of	  50	  of	  the	  52	  human	  SLC	  families	  have	  been	  established	  in	  teleost	  fish	  
(SLC28	  remains	  undetected	  and	  SLC52	  is	  newly	  identified;	  Yonezawa	  &	  Inui,	  2013)	  comprising	  338	  
members,	  most	  extensively	  so	  in	  zebrafish	  (Dario	  rerio)	  (Romano	  et	  al.,	  2014;	  Verri	  et	  al.,	  2012).	  In	  
this	  species	  304	  out	  of	  338	  SLC	  genes	  have	  been	  identified,	  whilst	  in	  rainbow	  trout,	  this	  totals	  22	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(Verri	  et	  al.,	  2012).	  The	  difference	  is	  likely	  due	  to	  zebrafish	  being	  a	  popular	  teleost	  fish	  model	  used	  
for	  functional	  studies,	  probably	  due	  to	  the	  annotation	  of	  its	  genes	  and	  genome	  and	  it	  is	  regarded	  
as	  the	  reference	  teleost	  fish	  model	  in	  the	  solute	  carriers	  field	  to	  date	  (Romano	  et	  al.,	  2014).	  
Transporters	  analogous	  to	  human	  SLC15A1	  and	  2,	  peptide	  transporter	  1	  and	  2	  (PEPT1	  and	  PEPT2)	  
(slc15a1b	  and	  slc15a2)	  as	  well	  as	  another	  novel	  peptide	  transporter	  (zgc:63767)	  were	  identified	  in	  
zebrafish,	   and	   their	   function	   has	   been	   tested	   through	   the	   transport	   of	   di-­‐	   and	   tripeptides	   in	   a	  
number	   of	   species	   (Verri	   et	   al.,	   2012).	   Of	   the	   SLCO	   family	   of	   solute	   carriers,	   14	   organic	   anion-­‐
transporting	  polypeptides	   (Oatps)	  have	  been	   identified	   in	   zebrafish	   (Popovic	  et	  al.,	  2010).	   In	   the	  
gills	  of	   zebrafish,	  Oatp2b1	  expression	   is	  highest,	   followed	  by	  Oatp3a1,	  Oatp1d1	  and	  Oatp2a1.	   In	  
humans,	   the	   SLCO2B1	   (analogous	   to	   Oatp2b1	   in	   fish)	   transports	   various	   drug	   types	   and	   is	  
concerned	  with	  drug-­‐drug	  interactions	  (Giacomini	  et	  al.,	  2010).	  
Eight	   members	   of	   the	   SLC22	   family	   have	   been	   discovered	   in	   teleosts,	   mostly	   in	   zebrafish	   and	  
Atlantic	   salmon	   (Salmo	  salar),	  but	  none	  so	   far	   in	   rainbow	  trout	   (Verri	  et	  al.,	  2012).	  Transporters	  
analogous	  to	  mammalian	  SLC22A1	  and	  2	  (OAT1	  and	  OAT3)	  have	  been	  suggested	  in	  winter	  flounder	  
(Pseudopleuronectes	   americanus)	   (fOat),	   zebrafish	   (zfOat)	   and	   puffer	   fish	   (pfOat)	   (Aslamkhan	   et	  
al.,	  2006).	  The	  flounder	  SLC22	  (Oat)	  transporter	  was	  tested	  for	  functionality	  and	  found	  to	  have	  the	  
same	  substrates	  as	  mammalian	  OAT1	  and	  OAT3	   (Aslamkhan	  et	  al.,	  2006).	  Proteins	  analogous	   to	  
mammalian	  SLC22A6	  and	  7	  (OCT1	  and	  OCT2)	  transporters	  that	  are	   involved	  in	  xenobiotic	  uptake	  
are	  yet	   to	  be	  confirmed	   in	   teleost	   fish	   (Giacomini	  et	  al.,	  2010).	   slc47a1	  and	  slc47a2	  are	   the	   two	  
members	   akin	   to	   the	  multidrug	   and	   toxin	   extrusion	   family	   in	  mammals,	   SLC47.	  Messenger	   RNA	  
transcripts	   of	   both	  proteins	   have	  been	   identified	   in	   zebrafish,	   yet	   testing	   of	   the	   functionality	   of	  
these	  transporters	  is	  yet	  to	  be	  confirmed	  (Giacomini	  et	  al.,	  2010).	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1.6	   Xenobiotic	  metabolism	  
Trout	   possess	   a	   suite	   of	   biotransformation	   enzymes	   that	   detoxify	   xenobiotics	   through	   phase	   I	  
metabolism,	   and	   then	   conjugate	   these	   functional	   groups	   by	   further	   addition	   of	   endogenous	  
molecules	   to	   add	   polarity	   in	   phase	   II.	   These	   compounds	   may	   then	   be	   excreted	   or	   further	  
catabolised	   and	   broken	   down	   into	   smaller	   products	   involving	   enzymes	   such	   as	   proteases	   and	  
hydrolases	  (Xu	  et	  al.,	  2005).	  
Phase	   I	   of	   xenobiotic	   metabolism	   involves	   the	   reduction,	   oxidation	   or	   hydrolysis	   of	   lipophilic	  
compounds	   to	   more	   water-­‐soluble	   by	   the	   mixed-­‐function	   oxidase	   (MFO)	   or	   microsomal	  
monooxygenase	  (MO)	  enzymes,	  which	  include	  the	  cytochrome	  P450	  (CYP)	  superfamily	  of	  enzymes	  
(Meunier	  et	  al.,	  2004).	  These	  are	  a	  collection	  of	  isoenzymes	  possessing	  an	  iron	  protoporphyrin	  IX	  
prosthetic	  group	  and	  classified	   into	   families	  based	  on	   their	  primary	  amino	  acid	   sequences.	  They	  
are	   termed	  microsomal	  due	   to	  suspension	   in	   the	  microsomal	   fraction	  after	  cell	  homogenisation,	  
and	   are	  membrane	  bound	   in	   large	  numbers	   in	   the	   rough	   and	   smooth	   endoplasmic	   reticulum	   in	  
cells,	  especially	  in	  the	  liver	  but	  also	  intestinal	  tract	  and	  gills	  of	  rainbow	  trout	  (Andersson	  &	  Förlin,	  
1992).	  
CYP	  proteins	  are	  induced	  in	  response	  to	  xenobiotic	  exposure.	  Xenobiotics	  that	  have	  entered	  cells	  
bind	   to	   cytosolic	   aryl	   hydrocarbon	   receptors	   (AhR),	   which	   cause	   the	   release	   of	   bound	   proteins	  
involved	  in	  a	  signal	  transduction	  cascade.	  The	  AhR-­‐ligand	  complex	  enters	  the	  nucleus	  and	  binds	  to	  
the	   aryl	   hydrocarbon	   nuclear	   translocation	   (ARNT)	   protein	   forming	   an	   activated	   transcription	  
factor	   which	   is	   able	   to	   bind	   to	   certain	   segments	   of	   DNA	   resulting	   in	   the	   transcription	   of	   CYP	  
proteins	  in	  the	  cell	  (Whyte	  et	  al.,	  2000).	  
CYP	   enzymes	   are	   closely	   associated	   with	   other	   MO	   enzymes	   present	   within	   the	   endoplasmic	  
reticulum	   involved	   in	   metabolism,	   chiefly	   the	   flavoprotein	   nicotinamide	   adenine	   di-­‐nucleotide	  
phosphate	   (NADPH)	   and	   cytochrome	   P450	   reductase,	   which	   transfers	   electrons	   to	   cytochrome	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P450	  during	  the	  step-­‐by-­‐step	  sequence	  of	  reactions.	  A	  substrate	  will	  bind	  to	  the	  hydrophobic	  site	  
on	   P450	  when	   the	   iron	   present	   in	   the	   enzyme	   is	   oxidised,	   ferric	   and	   in	   the	   low	   spin	   state.	   The	  
binding	   site	   is	   close	   enough	   to	   the	   haem	   group	   present	   on	   the	   CYP	   molecule	   to	   interact	   with	  
oxygen,	  causing	  a	  conformational	  change	  to	  the	  high	  spin	  state.	  This	  causes	  the	  first	  reduction	  of	  
iron	   from	   its	   ferric	   to	   ferrous	   state,	   by	   an	   electron	   transfer	   from	   NADPH	   via	   cytochrome	   P450	  
reductase.	  The	  addition	  of	  molecular	  oxygen	  follows,	  before	  adding	  another	  electron	  via	  the	  same	  
pathway	   to	   create	   a	   short	   term	   intermediate	   complex.	   This	   is	   rapidly	   protonated,	   releasing	   a	  
molecule	  of	  water,	  whilst	  the	  other	  oxygen	  atom	  is	  inserted	  into	  the	  substrate	  complex	  to	  make	  it	  
hydroxylated.	  After	  the	  product	  is	  released,	  the	  P450	  enzyme	  returns	  to	  its	  active	  state	  (Meunier	  
et	  al.,	  2004;	  Timbrell,	  2000;	  van	  der	  Oost	  et	  al.,	  2003).	  
The	   families	   of	   Cytochrome	   P450	   associated	   with	   xenobiotic	   metabolism	   in	   humans	   are	   CYP1,	  
CYP2,	  CYP3	  and	  CYP4	  (Timbrell,	  2000).	  They	  have	  broad	  and	  overlapping	  substrate	  specificity	  and	  
different	   CYPs	   may	   metabolise	   the	   same	   substrate	   differently.	   For	   example	   propranolol	   is	  
metabolised	   to	   4-­‐hydroxypropranolol	   by	   CYP2D6	   and	   to	   napthoxylacetic	   acid	   by	   CYP2C19	  
(Timbrell,	  2000).	  
In	  fish,	  137	  genes	  have	  been	  identified	  that	  are	  classified	  into	  18	  CYP	  families	  (Uno	  et	  al.,	  2012).	  In	  
rainbow	  trout	  the	  CYP	  isoforms	  identified	  are	  CYP1A,	  CYP2K	  CYP2M,	  CYP3A27,	  CYP3A45,	  CYP4T1,	  
CYP11A,	  CYP11B,	  CYP17	  and	  CYP19,	  and	  these	  are	  mostly	  associated	  with	  xenobiotic	  metabolism	  
(Hasselberg	  et	  al.,	  2008;	  Uno	  et	  al.,	  2012).	  
The	  CYP1A	   family	   is	   analogous	   to	  mammalian	  CYPs,	  with	   similar	   substrate	   specificity	   in	   rainbow	  
trout,	  and	  is	  involved	  in	  phase	  I	  metabolism	  of	  xenobiotics	  by	  exposing	  or	  adding	  a	  polar	  group	  to	  
aid	   solubility	   (Whyte	   et	   al.,	   2000).	   In	   rainbow	   trout,	   CYP1A	   is	   induced	  by	   exposure	   to	  polycyclic	  
aromatic	  hydrocarbons	  (PAHs),	  polychlorinated	  biphenols	  (PCBs),	  tetrachlorodibenzodioxin	  (TCDD)	  
and	  other	   dioxins,	   polychlorinated	  dibenzofurans	   (PCDFs)	   and	  other	   pesticides	   (Buhler	  &	  Wang-­‐
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Buhler,	  1998).	  Catalytic	  measurements	  of	  CYP1A	  induction	  and	  inhibition	  in	  fish	  can	  be	  quantified	  
using	  an	  ethoxyresorufin-­‐O-­‐deethly-­‐ase	   (EROD)	  assay	  whereby	  7-­‐ethoxyresorufin	   is	   converted	   to	  
fluorescent	   resorufin.	   CYP1A	   can	   be	   induced	   in	   vitro	   in	   gill	   cells	   by	   beta-­‐naphthoflavone	   (BnF)	  
(Carlsson	  &	  Pärt,	  2001;	  Carlsson	  et	  al.,	  1999)	  and	  inhibited	  by	  alpha-­‐naphthoflavone	  (AnF)	  (Thibaut	  
et	  al.,	  2006).	  In	  rainbow	  trout,	  propranolol	  induces	  CYP1A	  activity	  in	  the	  liver	  and	  gills	  both	  in	  vivo	  
and	  in	  vitro	  (Bartram	  et	  al.,	  2011).	  
Benzyloxy-­‐4-­‐trifluoromethylcoumarin-­‐O-­‐debenzyloxylase	   (BFCOD)	   activity	   is	   used	   to	   measure	  
CYP3A-­‐like	   enzymatic	   activity	   in	   fish	   (Hasselberg	   et	   al.,	   2008;	   Thibaut	   et	   al.,	   2006).	   Known	  
mammalian	  inducers	  and	  inhibitors	  of	  CYP3	  enzymes	  give	  inconsistent	  results	  in	  fish.	  Ketoconazole	  
has	   been	   shown	   to	   increase	   CYP3A	   protein	   levels	   1.5-­‐fold	   and	   decrease	   BFCOD	   activities	   in	  
rainbow	  trout	   in	  vivo	   (Hasselberg	  et	  al.,	  2008).	  Clotrimazole,	  omeprazole	  and	  rifampicin,	  but	  not	  
dexamethasone	   or	   lithocholic	   acid,	   decrease	   the	   activity	   of	   BFCOD	   in	   rainbow	   trout	   liver	  
microsomes	  (Burkina	  et	  al.,	  2013;	  Wassmur	  et	  al.,	  2010).	  
1.7	   Xenobiotic	  efflux	  
Research	  into	  the	  occurrence	  of	  multi-­‐drug	  resistance	  (MDR)	  using	  cancerous	  cell	  lines	  has	  led	  to	  
the	  better	  understanding	  of	   the	  cellular	  efflux	  of	  drugs	   (Cole	  &	  Deeley,	  1998;	  Leslie	  et	  al.,	  2005)	  
and	  the	  mediation	  of	   the	  MDR	  phenotype.	  For	  example,	   intrinsic	  or	  acquired	  over	  expression	  of	  
the	  membrane	  transporter	  P-­‐glycoprotein	  (Pgp)	  is	  associated	  with	  the	  rapid	  and	  unspecific	  efflux	  
of	   cancer	   drugs	   and	   results	   in	   the	   decreased	   success	   of	   chemotherapy	   treatment	   in	   cancer	  
patients	   (Takara	   et	   al.,	   2006).	   This	   is	   known	   as	   phase	   0	   of	   cellular	   defense,	   as	   the	   drug	   is	  
eliminated	  from	  cells	  before	  it	  can	  affect	  the	  body.	  Pgp	  is	  also	  present	  in	  aquatic	  organisms	  (Bard,	  
2000).	   Kurelec	   (1992)	   coined	   the	   term	   ‘multixenobiotic	   resistance’	   (MXR)	   when	   describing	   the	  
occurrence	  of	  populations	  of	  aquatic	  organisms	  in	  polluted	  water	  systems,	  as	  they	  are	  capable	  of	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rapidly	   pumping	   out	   harmful	   xenobiotics	   by	   Pgp	   transporters	   and	   thus	   inhabiting	   toxic	  
environments.	  
Pgp	   is	   part	   of	   the	   adenosine	   triphosphate	   (ATP)	   binding	   cassette	   (ABC)	   superfamily	   of	   ATP	  
requiring	  membrane	  proteins	  involved	  in	  the	  transport	  (Fig	  1.7C),	  primarily	  efflux	  (Zolnerciks	  et	  al.,	  
2011),	   of	   peptides,	   ions,	   sterols	   and	   other	   endogenous	   solutes	   and	   metabolites	   as	   well	   as	  
exogenous	  hydrophobic	  molecules	   such	  as	   xenobiotics	   (Dean	  &	  Annilo,	   2005;	  Dean	  et	   al.,	   2001;	  
Deeley	   et	   al.,	   2006).	   In	   humans,	   7	   subfamilies	   are	   encoded	   by	   the	   genes	   ABCA-­‐ABCG,	   which	  
transcribe	   49	   proteins	   that	   are	   highly	   conserved	   between	   species	   (Dean	   et	   al.,	   2001).	   Each	  
transporter	  typically	  consists	  of	  1-­‐3	  hydrophobic	  transmembrane	  domains	  (TMDs)	  made	  up	  of	  6-­‐
11	  alpha	  helices,	  which	   transport	   the	   solute,	   and	  1-­‐3	  nucleotide	  binding	  domains	   (NBDs),	  which	  
bind	  and	  hydrolyse	  ATP	  providing	  the	  energy	  for	  transport	  to	  occur	  (Dean	  &	  Annilo,	  2005).	  Studies	  
isolating	   and	   crystallising	   NBDs	   have	   determined	   the	   amino	   acid	   sequence	   and	   binding	   site	   of	  
nucleotides.	  This	  region	  is	  very	  highly	  conserved	  amongst	  the	  ABC	  transporters	  (Zolnerciks	  et	  al.,	  
2011),	  and	  is	  composed	  of	  Walker	  A	  and	  B	  motifs	  separated	  by	  90-­‐120	  amino	  acids	  which	  contain	  
the	  C	  motif	  upstream	  from	  Walker	  B	  (Deeley	  et	  al.,	  2006;	  Sturm	  &	  Segner,	  2005).	  ABC	  genes	  can	  
code	   for	   full	   transporters,	   or	   two	   ABC	   genes	   are	   required	   for	   the	   expression	   of	   two	   half	  
transporters	  that	  together	  form	  a	  functional	  unit	  (Dean	  et	  al.,	  2001).	  
The	  main	  ABC	  transporters	  involved	  in	  the	  efflux	  of	  xenobiotics	  and	  MXR	  in	  aquatic	  organisms	  are	  
Pgp	   and	   BSEP	   (ABCB1	   and	   ABCB11),	   the	   MRPs	   (ABCCs)	   and	   BCRP	   (ABCG2)	   (Dean	   et	   al.,	   2001;	  
Fischer	   et	   al.,	   2011;	   Lončar	   et	   al.,	   2010).	   Whilst	   Pgp	   is	   mainly	   associated	   with	   the	   efflux	   of	  
unmetabolised	  xenobiotics	  (phase	  0),	  others	  move	  biotransformed	  xenobiotics	  out	  of	  cells,	  such	  as	  
the	  MRPs	   (ABCCs)	   that	   transport	  phase	   I	  and	   II	  metabolised	  xenobiotics,	  particularly	  glutathione	  
and	   sulphate	   conjugates.	   This	   is	   therefore	   termed	   phase	   III	   of	   cellular	   defense	   (Fischer	   et	   al.,	  
2011).	   The	   two	   transporters	   of	   the	   SLC47	   family,	   SLC471	   and	   SLC474,	   MATE1	   and	   MATE2	  
(multidrug	  and	  toxin	  extrusion	  1	  and	  2),	  export	  toxic	  endogenous	  and	  exogenous	  substrates	  out	  of	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cells	  by	  H+-­‐coupled	  electroneutral	  exchange	  (Otsuka	  et	  al.,	  2005)	  in	  humans,	  primarily	  in	  the	  liver	  
to	  aid	  excretion	  of	  toxins	  into	  bile	  (Giacomini	  et	  al.,	  2010).	  
ABC	  transporters	  in	  aquatic	  species	  have	  been	  documented	  in	  sponges,	  aquatic	  molluscs,	  marine	  
worms	   and	   bivalves	   (Bard,	   2000;	   Luckenbach	   &	   Epel,	   2008;	   Sturm	   &	   Segner,	   2005).	   After	  
preliminary	  work	  suggesting	  the	  presence	  of	  Pgp	  like	  proteins	  in	  teleosts,	  Sturm	  et	  al.	  (2001)	  used	  
primary	  hepatocyte	  cells	  isolated	  from	  perfused	  livers	  of	  O.	  mykiss	  to	  demonstrate	  the	  presence	  of	  
MDR	  (ABCB)	  proteins	  such	  as	  Pgp	   (ABCB1)	   through	  the	  accumulation	  of	   fluorescent	  Rhodamine-­‐
123	   in	   hepatocytes	   preloaded	   with	   Pgp	   inhibitors,	   such	   as	   verapamil.	   Pgp	   and	   MRP3	   (ABCC3)	  
sequences	  have	  been	  characterised	   to	  a	  high	  degree	  of	  homogeny	   in	   the	   topminnow	  hepatoma	  
cell	  line	  PLHC-­‐1	  (Zaja	  et	  al.,	  2007).	  The	  ABC	  transporters	  Pgp,	  BSEP	  (bile	  salt	  export	  pump;	  ABCB11)	  
and	  MRP2	  (ABCC2)	  are	  present	  in	  primary	  O.	  mykiss	  hepatocytes,	  and	  their	  presence	  and	  function	  
was	   confirmed	  using	   fluorescent	   substrate	   accumulation	   assays	   in	   the	   presence	   and	   absence	   of	  
inhibitors	  (Zaja	  et	  al.,	  2008).	  
Lončar	  et	  al.	  (2010)	  presented	  the	  first	  thorough	  insight	  into	  the	  whole	  body	  distribution	  of	  the	  8	  
MXR	  ABC	  transporters	  in	  rainbow	  trout	  using	  qRT-­‐PCR.	  mRNA	  from	  whole	  bodies	  was	  isolated	  and	  
reverse	  transcribed	  and	  specific	  ABC	  transporter	  primers	  provided	  the	  detailed	  expression	  levels	  in	  
the	   liver,	   brain,	   kidney,	   gills,	   gonads	   and	   proximal	   and	   distal	   intestine.	   All	   8	   of	   the	   MXR	   ABC	  
transporters	   were	   detected,	   with	   Pgp	   (ABCB1)	   being	   expressed	   ubiquitously	   in	   all	   tissues	   apart	  
from	  the	  gills.	  However,	  a	  study	  using	  the	  rainbow	  trout	  gill	  cell	   line	  RTgill-­‐W1	  opposed	  this	  and	  
found	  its	  expression	  (Fischer	  et	  al.,	  2011).	  Other	  MXR	  ABC	  transporters	  expressed	  preferentially	  in	  
organs	   of	   rainbow	   trout	   included	   BSEP	   in	   the	   liver	   (like	   in	   mammals),	   MRP1	   and	  MRP2	   in	   the	  
kidney	  (supporting	  their	  role	   localised	   in	  cells	   for	  apical	  cellular	  transport),	  MRP3	  in	  most	  tissues	  
(but	  mainly	  intestinal	  in	  mammals),	  MRP4	  and	  MRP5	  in	  gonads	  and	  kidneys	  (similar	  to	  mammals)	  
and	  BCRP	   in	  most	   tissues	  and	   the	   liver	   (as	   supported	  by	  Zaja	  et	  al.,	  2008).	  MRP1	  and	  MRP3	  are	  
present	   in	   the	   rainbow	   trout	   gill	   cell	   line,	   RTgill-­‐W1,	   (Fischer	   et	   al.,	   2010).	   A	   study	   using	   7	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permanent	  cell	  lines	  derived	  from	  different	  rainbow	  trout	  tissues	  showed	  the	  expression	  of	  9	  ABC	  
efflux	   transporters	   related	   to	   phase	   0	   and	   III	   metabolism	   associated	   with	   MXR	   (Fischer	   et	   al.,	  
2011).	   However,	   differences	   in	   transcription	   levels	   between	   cell	   lines	   and	   live	   tissues	   are	  
commonly	  reported	  (Zaja	  et	  al.,	  2008).	  
1.8	   Xenobiotic	  excretion	   	  
The	  excretion	  of	  pharmaceuticals	   involves	  the	  removal	  of	  parent	  and	  conjugated	  pharmaceutical	  
compounds,	   made	   more	   soluble	   and	   with	   greater	   molecular	   weights	   from	   phase	   I	   and	   II	  
metabolism,	  via	  the	  urine	  and	  faeces.	  
In	   fish,	  parent	  compounds	  and	   their	  hydroxylated	   forms	  are	  made	  more	  soluble	  and	  conjugated	  
typically	  through	  glucuronidation	  to	  increase	  their	  molecular	  weight	  (Togunde	  et	  al.,	  2012),	  which	  
allows	   concentration	   into	   fish	   bile	   from	   the	   plasma	   (Ferreira-­‐Leach	   &	   Hill,	   2001),	   along	   with	  
inorganic	   ions	   and	  bile	   acids.	   Xenobiotics	   can	  be	   concentrated	   in	   the	  bile	   to	  many	   times	   higher	  
than	  in	  that	  of	  the	  plasma	  (Statham	  et	  al.,	  1976;	  Förlin	  &	  Haux,	  1985),	  and	  this	  bile	  enters	  the	  gut	  
lumen	   and	   is	   excreted	   in	   faeces.	   Pharmaceuticals	   and	   their	   metabolites	   in	   fish	   bile	   act	   as	  
biomarkers	  of	  the	  uptake	  and	  metabolism	  of	  drugs	  in	  fish	  (Vuorinen	  et	  al.,	  2006;	  Lahti	  et	  al.,	  2011),	  
and	   these	   can	  be	  used	   to	   assess	   excretion	   rates.	   The	  perfused	   trout	   liver	   has	   also	  provided	   the	  
study	  of	  biliary	  excretion	  (Nichols	  et	  al.,	  2009).	  In	  the	  bile	  of	  wild	  bream	  and	  roach,	  the	  presence	  of	  
17	   different	   pharmaceuticals,	   including	   naproxen,	   diclofenac	   and	   ibuprofen,	   and	   six	   different	  
phase	  I	  metabolites	  were	  identified	  (Brozinski	  et	  al.,	  2013).	  In	  vitro,	  primary	  cells	  of	  rainbow	  trout	  
liver	   S9	   fractions	   and	  microsomes	   are	  metabolically	   active	   (Conners	   et	   al.,	   2013;	   Gomez	   et	   al.,	  
2011)	  and	  have	  been	  used	  to	  generate	  metabolism	  data	  for	  fish	  (Nichols	  et	  al.,	  2007).	  Primary	  liver	  
cells	  in	  2D	  monoculture	  and	  3D	  spheroid	  culture	  have	  been	  shown	  to	  be	  more	  metabolically	  active	  
than	  microsomal	  fractions	  (Uchea	  et	  al.,	  2013)	  the	  latter	  being	  a	  more	  representative	  model	  of	  the	  
liver	  in	  terms	  of	  morphology	  and	  biochemical	  activity	  (Baron	  et	  al.,	  2012).	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1.9	   Xenobiotic	  drug	  targets	  
Much	  drug	  research	  focuses	  on	  the	  development	  of	  compounds	  with	  mammalian	  drug	  targets	  in	  
mind.	   Many	   of	   these	   systems	   are	   highly	   conserved	   in	   rainbow	   trout	   with	   high	   levels	   of	  
homogeneity	   (Huggett	   et	   al.,	   2003;	   Fischer	   et	   al.,	   2011;	  Madigou	   et	   al.,	   2000;	   Nickerson	   et	   al.,	  
2001;	  Zaja	  et	  al.,	  2008;	  Zou	  et	  al.,	  1999).	  Therefore,	  mammalian	  pharmacology	  data	  can	  be	  used	  to	  
assess	  the	  potential	  chronic	  receptor	  mediated	  responses	  in	  fish	  (Bartram	  et	  al.,	  2011;	  Daughton	  &	  
Brooks,	  2011;	  Huggett	  et	  al.,	  2003;	  Owen	  et	  al.,	  2007).	  
Beta-­‐adrenoceptors	   are	   7-­‐transmembrane	   receptors	   coupled	   with	   G	   proteins,	   involved	   in	   the	  
activation	   of	   the	   sympathetic	   nervous	   system.	   The	   endogenous	   catecholamines,	   adrenaline	   and	  
noradrenaline,	  are	  synthesised	  in	  the	  medulla	  of	  the	  adrenal	  glands	  and	  are	  released	  in	  response	  
to	  stress.	  They	  bind	  to	  β-­‐adrenoceptors	  of	  which	  there	  are	  three	  types	  in	  humans,	  β1-­‐3.	  Binding	  of	  
adrenalin	  or	  noradrenaline	  causes	  activation	  of	  the	  associated	  G	  protein,	  which	  in	  turn	  stimulates	  
the	  membrane-­‐bound	   enzyme	   adenylyl	   cyclase.	   This	   catalyses	   the	   synthesis	   of	   cyclic	   adenosine	  
monophosphate	   (cAMP),	  which	  activates	   target	  proteins	  such	  as	  protein	  kinase	  A,	  and	  enhances	  
the	   phosphorylation	   of	   other	   membrane	   channels.	   In	   general	   this	   increases	   the	   likelihood	   of	  
cellular	  depolarisation,	  which	   in	  the	  heart	  (β1	  receptors)	  causes	   increased	  speed	  and	  strength	  of	  
contraction,	  in	  the	  lungs	  (β2	  receptors)	  causes	  increased	  bronchodilation	  and	  in	  adipose	  tissue	  (β3	  
receptors),	   increased	  lipolysis	  to	   increase	  energy	  availability.	  These	  are	  required	  for	  the	  ‘flight	  or	  
flight’	   response,	   but	   can	   have	   adverse	   effects	   when	   there	   is	   a	   cardiac	   problem	   (Black	   &	  
Stephenson,	   1962).	   Activation	   of	   β-­‐adrenoceptors	   in	   these	   cases	   cause	   adverse	   strain	   on	   the	  
cardiac	   system,	   hence	   the	   development	   of	   the	   beta-­‐adrenergic	   receptor	   antagonist	   drugs	   (β-­‐
blockers)	   that	   treat	   conditions	   such	   as	   angina,	   high	   blood	   pressure	   and	   glaucoma,	   through	  
selective	  inhibition	  of	  one	  or	  more	  of	  the	  β	  receptors.	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β-­‐blockers	   are	   often	   detected	   in	   WWTP	   effluents	   and	   the	   environment	   in	   the	   ng-­‐μg	   L-­‐1	   range	  
(Johnson	  et	  al.,	  2007;	  Owen	  et	  al.,	  2007;	  Owen	  et	  al.,	  2009).	  As	  in	  mammals,	  the	  adrenergic	  system	  
in	  fish	  functions	  using	  adrenalin	  and	  noradrenalin,	  and	  the	  associated	  β-­‐adrenoceptors,	  which	  are	  
highly	   conserved	   amongst	   vertebrates	   (Owen	   et	   al.,	   2007).	   Activation	   of	   the	   adrenergic	   system	  
results	   in	   a	   range	   of	   outcomes	   in	   fish	   due	   to	   the	   wide	   distribution	   of	   receptor	   types.	   The	  
physiological	   outcomes	   of	   this	   result	   in	   the	   preparation	   for	   the	   fight	   or	   flight	   response,	   such	   as	  
changes	   in	   cardiac	   performance	   and	   ventilation	   rates,	   metabolic	   regulation,	   skeletal	   muscle	  
performance	  and	  melanophore	  regulation	  (Owen	  et	  al.,	  2007).	  
After	   a	   40-­‐day	   exposure	   to	   10	   mg	   L-­‐1	   of	   the	   β-­‐blocker	   propranolol,	   the	   concentration	   of	  
propranolol	  in	  rainbow	  trout	  blood	  plasma	  reached	  5200	  ng	  mL-­‐1	  (Owen	  et	  al.,	  2009).	  In	  rainbow	  
trout,	  the	  expression	  of	  β2	  receptors	  is	  high	  in	  the	  liver	  and	  red	  and	  white	  muscle,	  and	  less	  so	  in	  
the	  gills,	  heart,	  kidney	  and	  spleen	  (Nickerson	  et	  al.,	  2001).	  
	  
1.10	   Aims	  and	  objectives	  
The	  present	  study	  aims	  to	   investigate	  the	  suitability	  of	  the	   in	  vitro	   rainbow	  trout	  gill	  as	  a	  tool	  to	  
assess	   the	   uptake,	   efflux	   and	   metabolism	   of	   xenobiotics	   such	   as	   pharmaceuticals.	   The	   study	  
therefore	  aimed	  to	  complete	  the	  following	  objectives	  
I. The	   development,	   optimisation	   and	   standardisation	   of	   rainbow	   trout	   primary	   gill	   cell	  
culture.	  
II. The	  characterisation	  of	  SSI	  and	  DSI	  primary	  gill	  cell	  epithelia,	  as	  well	  as	  epithelia	  cultured	  
using	   the	   rainbow	   trout	   gill	   cell	   line	   RTgill-­‐W1.	   This	   involves	   the	   monitoring	   of	  
transepithelial	   resistance	   (TER)	   and	   potential	   (TEP)	   during	   epithelial	   development	   and	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during	   apical	   freshwater	   exposure	   and	   the	   quantification	   of	   epithelial	   paracellular	  
permeability.	  
III. The	  investigation	  into	  the	  improvement	  of	  RTgill-­‐W1	  epithelial	  preparations	  by	  increasing	  
TER	  and	  decreasing	  paracellular	  permeability	  through	  the	  supplement	  of	  culture	  medium	  
and	  the	  co-­‐culture	  with	  primary	  gill	  cells.	  
IV. The	   investigation	   into	   the	   uptake	   and	   efflux	   of	   7	   pharmaceuticals	   across	   the	   in	   vitro	  
primary	  gill	  cell	  system,	  including	  bidirectional,	  concentration	  equilibrated,	  pH-­‐dependent,	  
and	   concentration-­‐dependent	   transport	   assays,	   as	   well	   as	   membrane	   channel	   inhibitor	  
studies.	  The	  uptake	  rates	  were	  compared	  to	  in	  silico	  (Fitzsimmons	  et	  al.,	  2001;	  Huggett	  et	  
al.,	  2003)	  and	  in	  vivo	  data	  (Owen	  et	  al.,	  2009).	  
V. The	  assessment	  of	  the	  metabolism	  of	  pharmaceuticals	  by	  the	  gill	  epithelia	  cultured	  using	  
SSI,	  DSI	  techniques,	  and	  the	  cell	  line	  RTgill-­‐W1	  through	  metabolic	  enzyme	  assays	  and	  HPLC	  
analysis	  of	  parent	  compounds	  and	  a	  metabolite.	  
	  
It	   is	  hypothesised	   that	   the	  DSI	  primary	  cell	   culture	  will	  most	  accurately	   resemble	   the	  gill	   in	   situ.	  
Uptake	   and	   efflux	   experiments	   using	   DSI	   are	   hypothesised	   to	   show	   that	   a	   combination	   of	   both	  
passive	   and	   carrier-­‐mediated	   transport	   of	   pharmaceuticals	   exists	   at	   the	   gill.	   Furthermore,	   it	   is	  
hypothesised	   that	   the	   DSI	   primary	   cell	   cultures	   will	   produce	  metabolic	   products	   whilst	   SSI	   and	  
RTgill-­‐W1	  gill	  cell	  cultures	  may	  not.	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Chapter	  2	  
General	  Materials	  and	  Methods	  
	  
The	  body	  of	  this	  chapter	  is	  also	  presented	  as	  a	  film	  produced	  as	  part	  of	  the	  BBSRC	  Sparking	  Impact	  
prize	  awarded	  to	  this	  project,	  on	  a	  DVD	  at	  the	  back	  of	  this	  thesis.	  
2.1	  Materials	  
2.1.1	   Reagents	  and	  suppliers	  
Leibovitz’s	   L-­‐15	   cell	   culture	   medium	   with	   L-­‐glutamine	   (2	   mM)	   and	   without	   phenol	   red	   (L-­‐15),	  
penicillin-­‐streptomycin	  (5000	  units	  mL-­‐1	  penicillin,	  5	  mg	  mL-­‐1	  streptomycin),	  gentamicin	  (5	  mg	  mL-­‐1)	  
and	  10x	  0.5%	  trypsin-­‐EDTA	  were	  purchased	  from	  Invitrogen	  Life	  Technologies.	  Fetal	  bovine	  serum	  
(FBS),	   amphotericin	  B	  and	  Trypan	  blue	  were	  purchased	   from	  Sigma	  Aldrich.	  Phosphate	  buffered	  
saline	  tablets	  were	  purchased	  from	  Thermo	  Scientific.	  Ethanol	  absolute	  was	  purchased	  from	  VWR.	  
2.1.2	   Equipment	  and	  suppliers	  
The	   laminar	   flow	   hood	  was	  model	   number	  M51424/2	   produced	   by	  Microflow	  Biological	   Safety.	  
The	  refrigerated	  centrifuge	  was	  model	  number	  5810R,	  with	  rotor	  A-­‐4-­‐62	  by	  Eppendorf.	  The	  vortex	  
was	  model	  number	  F20220176	  by	  VELP	  Scientifica.	  The	  dissecting	  equipment	  used	  included	  a	  large	  
sharp	  knife,	  forceps	  purchased	  from	  SLS,	  scissors	  from	  VWR	  and	  scalpels	  from	  Swann-­‐Morton.	  The	  
portable	  gyratory	  shaker	  was	  model	  IKA-­‐VIBRAX-­‐VXR.	  Pipettes	  used	  were	  adjustable	  Gilson;	  P-­‐20,	  
P-­‐200	  and	  P-­‐1000	  with	  disposable	  pipette	   tips	   from	  Starlab.	   The	  5,	   10	   and	  25	  mL	   tissue	   culture	  
pipettes	   were	   purchased	   from	   Corning.	   The	   inverted	   phase	   contrast	   microscope	   was	   model	  
number	  TE200	  by	  Nikon	  Eclipse.	  The	  cells	  were	  cultured	  in	  a	  cell	  culture	  cooling	  incubator	  model	  
number	   MIR-­‐1554	   by	   Sanyo	   set	   to	   18°C,	   without	   CO2	   atmosphere.	   The	   haemocytometer	   was	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purchased	  from	  Neubauer.	  The	  EVOM™	  epithelial	  voltohmmeter	  was	  modified	  to	  read	  TER	  up	  to	  
100,000	   Ω	   cm2	   and	   purchased	   from	   World	   Precision	   Instruments	   with	   EVOM™	   ‘chopstick’	  
electrodes	   number	   STX-­‐2.	   Twelve	   well	   cell	   culture	   inserts	   with	   0.4	   μm	   pore,	   0.9	   cm2	   effective	  
growth	  area	  and	  made	  of	  polyethylene	  terephthalate	   (PET)	  membrane	  were	  purchased	   from	  BD	  
Falcon.	  The	  companion	  cell	  culture	  plates,	  12	  well	  with	   low	  (notched)	  evaporation	   lid,	  were	  also	  
purchased	  from	  BD	  Falcon.	  25	  and	  75	  cm2	  cell	  culture	  flasks	  were	  purchased	  from	  Nunc.	  0.2	  μm	  
sterile	  syringe	  filters	  and	  sterile	  Petri	  dishes	  were	  purchased	  from	  VWR	  and	  the	  cell	  strainers	  (100	  
μm,	  nylon)	  and	  50	  and	  14	  mL	  conical	  tubes	  were	  purchased	  from	  BD	  Falcon.	  
2.1.3	   Preparation	  of	  reagents	  
Penicillin-­‐streptomycin	  was	  stored	  in	  11	  mL	  aliquots	  at	  -­‐20°C.	  Gentamicin	  solution	  was	  divided	  into	  
two	  50	  mL	  aliquots	  and	  stored	  at	  room	  temperature.	  Amphotericin	  B	  was	  reconstituted	  in	  sterile	  
double	  distilled	  water	  according	  to	  the	  manufacturer’s	  instructions	  to	  a	  final	  concentration	  of	  250	  
µg	  mL-­‐1	  amphotericin	  B	  and	  250	  µg	  mL-­‐1	  sodium	  desoxycholate,	  then	  passed	  through	  a	  sterile	  filter	  
and	  stored	   in	  1.5	  mL	  aliquots	  at	   -­‐20°C	   in	   the	  dark.	  PBS	   tablets	  were	  dissolved	   in	  100	  mL	  Milli-­‐Q	  
water	  per	  tablet,	  autoclaved,	  and	  stored	  at	  room	  temperature.	  10x	  0.5%	  trypsin-­‐EDTA	  was	  diluted	  
to	  0.05%	  with	  PBS,	  sterile	  filtered	  and	  stored	  in	  50	  mL	  aliquots	  at	  -­‐20°C.	  
2.1.4	   Cell	  culture	  reagents	  
Cell	  culture	  medium	  with	  antibiotics	  and	  FBS	  was	  composed	  of	  L-­‐15	  with	  2%	  (v/v)	  gentamicin,	  2%	  
(v/v)	   penicillin-­‐streptomycin	   and	   5%	   (v/v)	   FBS.	   Cell	   culture	   medium	   without	   antibiotics	   was	  
composed	   of	   L-­‐15	   with	   5%	   (v/v)	   FBS.	   Artificial	   freshwater	   is	   defined	   as	   water	   prepared	   to	   the	  
standard	   used	   for	   maintaining	   fish	   such	   as	   the	   Organisation	   for	   Economic	   Co-­‐operation	   and	  
Development	  (OECD)	  (OECD305,	  2012).	  OECD	  freshwater	  (FW)	  was	  composed	  of	  2.0	  mM	  CaCl2,	  0.5	  
mM	  MgSO4,	   0.8	  mM	   NaHCO3,	   77.1	   μM	   KCl	   at	   pH	   7.7	   and	   aerated	   until	   oxygen	   saturation	   was	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achieved,	  then	  stored	  for	  2	  days	  at	  4°C	  with	  further	  aeration	  before	  use.	  L-­‐15	  exposure	  medium	  
was	  composed	  of	  L-­‐15	  cell	  culture	  medium	  without	  any	  supplementation.	  
2.1.5	   Animal	  husbandry	  
Gill	   cells	   for	   the	   use	   in	   primary	   cultures	   were	   obtained	   from	   juvenile	   diploid	   rainbow	   trout	  
weighing	  50-­‐120	  g	  purchased	  from	  a	  trout	  farm	  (in	  Hampshire,	  UK).	  Fish	  were	  acclimatised	  for	  at	  
least	  2	  weeks	   in	  three	  1000	  L	   fiberglass	  aquaria	  at	  King’s	  College	  London,	  and	  maintained	  at	  13-­‐
14°C	  in	  recirculating	  aerated	  city	  of	  London	  tap	  water	  ([Na+]	  =	  0.53	  mM,	  [Ca2+]	  =	  0.92	  mM,	  [Mg2+]	  =	  
0.14	  mM,	  [K+]	  =	  0.066	  mM	  and	  [NH4+]	  =	  0.027	  mM)	  that	  was	  passed	  through	  carbon,	  mechanical	  
and	  biological	  filters.	  Photoperiod	  was	  maintained	  at	  a	  constant	  14	  hour	  light	  10	  hour	  dark	  cycle	  
and	  fish	  were	  fed	  a	  daily	  1%	  (w/w)	  ration	  of	  fish	  chow.	  
2.2	  Methods	  
Methods	  follow	  those	  described	  in	  Schnell,	  Stott,	  et	  al.	  (2016)	  and	  in	  the	  DVD	  included	  at	  the	  back	  
of	  this	  thesis.	  
2.2.1	   Sterile	  techniques	  
Sterile	   techniques	  were	  used	   throughout	  all	   cell	   culture	  procedures,	  which	  were	  performed	   in	  a	  
laminar	  flow	  hood.	  Equipment,	  containers	  and	  solutions	  were	  either	  autoclaved	  at	  120°C	  at	  15	  psi	  
for	  20	  minutes,	  or	  sterile	  filtered.	  Dissecting	  equipment	  was	  disinfected	  with	  ethanol	  (70%).	  Plastic	  
ware	  was	  purchased	  sterile	  and	  used	  once.	  
2.2.2	   Quality	  assurance	  
Good	   laboratory	   practice	   (GLP)	   was	   followed	   throughout	   the	   laboratory	   procedures	   and	   data	  
analysis.	  Where	  appropriate,	   instruments	  were	  routinely	  checked	  or	  calibrated	  and	  reagents	  and	  
materials	  were	  certified	  for	  cell	  culture	  procedures.	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2.2.3	   Cell	  isolation	  
The	  gill	  cell	  isolation	  and	  culture	  procedure	  was	  based	  on	  methods	  previously	  described	  by	  Pärt	  et	  
al.	   (1993);	  Wood	  &	   Pärt	   (1997);	   Kelly	   et	   al.	   (2000)	   and	   Fletcher	   et	   al.	   (2000)	   and	   developed	   by	  
Wood	  et	  al.	  (2002),	  Walker	  et	  al.	  (2008)	  and	  Schnell,	  Stott	  et	  al.	  (2016).	  The	  technique	  used	  in	  our	  
laboratory	  is	  described	  below	  and	  summarised	  (along	  with	  the	  developed	  double	  seeded	  inverted	  
–	  DSII	   –	   technique,	   see	   Chapter	   3)	   in	   Figure	   2.1.	   Firstly,	   the	   permeable	  membrane	   inserts	  were	  
placed	  in	  a	  companion	  well	  plate	  and	  conditioned	  with	  200	  μL	  cell	  culture	  medium	  with	  FBS	  and	  
antibiotics	  in	  the	  apical	  compartment	  and	  stored	  at	  18°C.	  Next,	  one	  or	  two	  fish	  (depending	  on	  cell	  
numbers	  required)	  were	  randomly	  isolated	  from	  the	  aquarium	  and	  sacrificed	  using	  the	  Schedule	  1	  
technique	   (Home	  Office,	  1986).	  Displacing	   the	  operculum	  on	  one	  side	   revealed	   the	   first	  of	  4	  gill	  
arches	   (Fig	   2.2A).	   These	   were	   removed	   by	   cutting	   the	   gill	   arch	   dorsally	   and	   ventrally,	   blotted	  
carefully	  to	  remove	  gill	  mucus	  and	  placed	  into	  20	  mL	  PBS	  in	  a	  Petri	  dish	  (Fig	  2.2B).	  Filaments	  were	  
cut	  from	  the	  arches	  (leaving	  the	  branchial	  artery	  intact	  on	  the	  gill	  arch)	  and	  placed	  into	  10	  mL	  of	  
filament	  washing	  solution	  (solution	  1,	  Fig	  2.1),	  comprised	  of	  4%	  (v/v)	  penicillin-­‐streptomycin,	  4%	  
(v/v)	  gentamicin	  and	  3%	  (v/v)	  amphotericin	  B	  solution	  in	  PBS,	  in	  another	  Petri	  dish.	  The	  filaments	  
were	   teased	  and	  cut	  apart	  using	  a	   scalpel	  and	   transferred	   to	  a	   fresh	  10	  mL	  of	   filament	  washing	  
solution	  in	  a	  50	  mL	  conical	  tube	  and	  incubated	  for	  10	  minutes	  on	  ice.	  The	  gill	  filaments	  were	  then	  
centrifuged	  (250	  g,	  4°C,	  5	  minutes)	  and	  the	  filament	  washing	  solution	  was	  aspirated	  and	  replaced	  
with	  a	  further	  10	  mL	  of	  fresh	  filament	  washing	  solution	  before	   incubating	  for	  10	  minutes	  on	   ice.	  
Centrifugation	   was	   repeated	   (same	   centrifuge	   settings)	   and	   following	   aspiration	   the	   tryptic	  
digestion	   followed	  whereby	   the	   filaments	  were	   first	  pretreated	  with	  500	  μL	  0.05%	   trypsin-­‐EDTA	  
(solution	   2,	   Fig	   2.1),	   which	   was	   immediately	   removed	   by	   centrifuging	   at	   the	   same	   settings,	  
followed	  by	   two	  rounds	  of	  digestion	  with	  5	  mL	   trypsin	  on	  an	  orbital	   shaker	   for	  12	  minutes	   (325	  
rpm).	  After	  each	  trypsinisation,	  the	  filaments	  were	  passed	  through	  a	  100	  μm	  cell	  strainer	  into	  20	  
mL	  PBS	  containing	  an	  excess	  of	  FBS	  (10%	  v/v)	   (solution	  3,	  Fig	  2.1)	   to	  deactivate	  the	  trypsin.	  This	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was	  centrifuged	  (250	  g,	  4°C,	  10	  minutes)	  and	  the	  pellet	  was	  resuspended	  in	  2.5%	  FBS	  (v/v)	  in	  PBS	  
(solution	  4,	  Fig	  2.1).	  After	  a	  further	  centrifugation	  (same	  10	  minute	  centrifuge	  settings)	  the	  pellet	  
was	  fiercely	  dislodged	  by	  flicking	  the	  conical	  tube	  to	  ensure	  proper	  mixing	  of	  cells	  upon	  addition	  of	  
20	  mL	  cell	  culture	  medium	  with	  antibiotics	  and	  FBS	  (solution	  5,	  Fig	  2.1).	  A	  total	  viable	  gill	  cell	  count	  
was	   obtained	   using	   Trypan	   blue	   and	   a	   haemocytometer	   and	   cells	   were	   deemed	   of	   acceptable	  
viability	  at	  >80%.	  The	  cells	  were	  then	  seeded	  as	  below;	  in	  flasks	  or	  immediately	  onto	  cell	  culture	  
inserts.	  
	  
Fig	  2.2	  Four	  gill	  arches	  are	  located	  underneath	  each	  operculum	  (A)	  on	  the	  lateral	  sides	  of	  the	  rainbow	  trout	  head.	  Bar	  =	  1	  
cm.	  Gill	  arches	  are	  dissected	  by	  cutting	  the	  cartilage	  of	  the	  arch	  and	  placed	  into	  PBS	  (B).	  Bar	  =	  1	  cm.	  	  
2.2.4	   Seeding	  in	  cell	  culture	  flasks	  
For	   experiments	   requiring	   primary	   gill	   cells	   first	   grown	   in	   cell	   culture	   flasks	   (‘SSI’),	   cells	   were	  
seeded	  at	  a	  density	  of	  20-­‐25	  x	  106	  in	  3	  mL	  per	  25	  cm2	  cell	  culture	  flask	  or	  40-­‐60	  x	  106	  in	  10	  mL	  per	  
75	  cm2	  flask.	  These	  flasks	  were	  washed	  24	  hours	  later	  with	  PBS	  to	  remove	  unattached	  cell	  debris,	  
A	  
B	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and	   the	   media	   was	   replaced	   with	   3	   or	   10	   mL	   (respectively)	   cell	   culture	   medium	   with	   FBS	   and	  
without	  antibiotics	  and	  maintained	  at	  18°C	  in	  the	  dark,	  with	  media	  changes	  every	  2-­‐3	  days	  (Wood	  
&	  Pärt,	   1997).	  After	  6-­‐9	  days,	  when	  cells	   appeared	  confluent,	   they	  were	   trypsinised	  by	  applying	  
200-­‐500	  μL	  0.05%	  trypsin-­‐EDTA	  for	  3-­‐5	  minutes	  at	  room	  temperature,	  with	  gentle	  agitation.	  The	  
cells	   were	   then	   collected	   in	   cell	   culture	  medium	  with	   FBS	   and	   without	   antibiotics,	   counted	   (as	  
above)	  and	  seeded	  on	  inserts	  at	  a	  cell	  density	  of	  0.7	  x	  106	  per	  1.5	  mL	  per	   insert.	  The	  basolateral	  
compartment	  contained	  2.0	  mL	  of	  cell	  culture	  medium	  with	  FBS.	  The	  gill	  cell	  cultures	  were	  then	  
maintained	  as	  below.	  In	  later	  chapters,	  ‘SSI’	  will	  refer	  to	  this	  culture	  technique.	  
2.2.5	   Double	  seeded	  inserts	  
For	  primary	  gill	  cells	  seeded	  straight	  onto	  the	  permeable	  membrane	  inserts,	  cells	  were	  seeded	  at	  a	  
density	  of	  1.2	  x	  106	  cells	  in	  a	  volume	  of	  600	  μL	  cell	  culture	  medium	  with	  FBS	  and	  antibiotics	  per	  cell	  
culture	  insert	  (so	  that	  with	  the	  pre-­‐conditioning	  step,	  the	  final	  volume	  in	  the	  apical	  compartment	  
was	  800	  μL).	  The	  basolateral	  compartment	  was	  filled	  with	  1000	  μL	  of	  cell	  culture	  medium	  with	  FBS	  
and	  antibiotics.	  The	  low	  evaporation	  lid	  was	  replaced	  and	  the	  cells	  were	  maintained	  at	  18°C	  in	  the	  
dark.	  This	  was	  termed	  ‘day	  0’	  (Fig	  2.1).	  
After	  the	  first	  day	  of	  cell	  seeding,	  the	  above	  cell	  isolation	  procedures	  were	  repeated,	  resulting	  in	  a	  
solution	  of	  cells	  in	  cell	  culture	  medium	  with	  FBS	  and	  antibiotics.	  Cells	  were	  counted	  and	  diluted	  to	  
1.2	   x	  106	   cells	  per	  800	  μL	  of	   cell	   culture	  medium	  with	   FBS	  and	  antibiotics,	   and	  kept	  on	   ice.	   The	  
medium	   from	   the	   previously	   seeded	   inserts	   was	   carefully	   aspirated	   (basolateral	   compartment	  
first,	  then	  apical	  compartment	  to	  maintain	  hydrostatic	  pressure	  on	  the	  apically	  seeded	  cells).	  The	  
cells	  were	  then	  carefully	  washed	  twice	  with	  200	  μL	  PBS.	  800	  μL	  of	   the	  new	  gill	  cell	   solution	  was	  
applied	  carefully	   to	   the	  apical	  compartment,	   so	  as	  not	   to	  disturb	   the	  cells	  already	  attached.	  The	  
basolateral	  compartment	  was	  refilled	  with	  1000	  μL	  cell	  culture	  medium	  with	  FBS	  and	  antibiotics.	  
The	  gill	  cell	  cultures	  were	  then	  maintained	  at	  18°C	  in	  the	  dark	  for	  24	  hours.	  This	  was	  termed	  ‘day	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1’.	   Twenty-­‐four	   hours	   later,	   the	   cell	   culture	   medium	   was	   aspirated	   and	   the	   DSI	   epithelia	   were	  
washed	   twice	  with	  200	  μL	  PBS	   to	   remove	   the	  cell	  debris	   from	  seeding.	  The	  cell	   culture	  medium	  
with	  FBS	  and	  antibiotics	  was	  then	  replaced	  with	  full	  volumes	  –	  1.5	  mL	  in	  the	  apical	  compartment	  
(applied	   first	   to	   maintain	   hydrostatic	   pressure	   on	   the	   cells)	   and	   2.0	   mL	   in	   the	   basolateral	  
compartment.	  This	  was	  termed	  ‘day	  2’.	  
	  
Fig	  2.3	  Membrane	  development	  was	  monitored	  by	  daily	  transepithelial	  electrical	  resistance	  (TER)	  measurements	  using	  a	  
custom-­‐modified	  epithelial	  tissue	  voltohmmeter	  fitted	  with	  chopstick	  electrodes.	  The	  electrode	  arms	  are	  inserted	  above	  
and	  below	  the	  gill	  cell	  epithelium	  of	  each	  insert,	  such	  that	  one	  arm	  of	  the	  electrode	  is	  in	  the	  apical,	  and	  the	  other	  in	  the	  
basolateral	  compartment.	  
2.3	   Maintenance	  
On	  day	  4,	  the	  media	  was	  changed	  to	  cell	  culture	  medium	  with	  FBS	  (1.5	  mL	  in	  the	  apical	  and	  2.0	  mL	  
in	   the	  basolateral),	   as	   the	   cells	   no	   longer	   required	   antibiotic	   supplementation.	   The	  media	   could	  
then	  be	  changed	  every	  2	  or	  3	  days	  whilst	  the	  DSI	  gill	  cell	  epithelia	  develop.	  This	  development	  was	  
monitored	   by	   daily	   transepithelial	   electrical	   resistance	   (TER)	   measurements	   using	   a	   custom-­‐
modified	  epithelial	   tissue	  voltohmmeter	   fitted	  with	  chopstick	  electrodes	  with	  the	  mode	  selected	  
to	   ‘R’	   (the	   resistance	   setting).	   Briefly,	   the	  electrode	  was	   inserted	  over	   the	   gill	   cell	   epithelium	  of	  
each	   insert,	   such	  that	  one	  arm	  of	   the	  electrode	   is	   in	   the	  apical,	  and	  the	  other	   in	   the	  basolateral	  
compartment	  (Fig	  2.3).	  Once	  a	  current	  is	  generated,	  the	  voltohmmeter	  can	  make	  a	  measurement	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of	  transepithelial	  electrical	  resistance	  that	  corresponds	  to	  the	  tightness	  of	  the	  gill	  epithelium,	  and	  
hence	   its	   development,	   without	   disturbing	   the	   epithelia.	   A	   ‘blank’	   cell	   free	   insert	   (for	   12	   well	  
culture	   plates)	   gave	   a	   value	   of	   180	   Ω	   cm2,	   which	   was	   subtracted	   from	   each	  measurement.	   An	  
encouraging	   development	   would	   show	   TER	   values	   in	   the	   region	   of	   5000	   Ω	   cm2	   by	   day	   7	   (see	  
Chapter	  3).	  
2.4	   RTgill-­‐W1	  
The	   rainbow	   trout	   gill	   cell	   line,	   RTgill-­‐W1,	   was	   kindly	   donated	   by	   Prof	   Kristin	   Schirmer	   and	  
maintained	  in	  our	  laboratory	  by	  Dr	  Sabine	  Schnell	  according	  to	  Bols	  et	  al.	  (1994).	  Briefly,	  the	  cells	  
were	  routinely	  cultured	  at	  18°C	   in	  75	  cm2	  cell	  culture	   flasks	   in	  L-­‐15	  with	  10%	  (v/v)	  FBS,	  2%	  (v/v)	  
gentamicin	   and	   2%	   (v/v)	   penicillin-­‐streptomycin.	   The	   cells	   were	   maintained	   and	   split	   once	   per	  
week.	  When	  required,	  RTgill-­‐W1	  cells	  were	  trypsinised	  by	  applying	  200-­‐500	  μL	  0.05%	  trypsin-­‐EDTA	  
for	  3-­‐5	  minutes	  at	  room	  temperature,	  with	  gentle	  agitation.	  The	  cells	  were	  then	  collected	   in	  cell	  
culture	  medium	  with	  10%	   (v/v)	   FBS	  and	  without	  antibiotics,	   counted	  and	  seeded	  on	   inserts	  at	  a	  
cell	  density	  of	  0.2	  x	  106	  cells	  per	  insert,	  in	  the	  same	  cell	  culture	  volumes	  –	  1.5	  mL	  in	  the	  apical	  and	  
2.0	  mL	  in	  the	  basolateral.	  TER	  measurements	  were	  conducted	  as	  outlined	  above.	  
2.5	   Cell	  culture	  exposures	  
Once	   gill	   cell	   cultures	   were	   ready	   for	   experimentation,	   the	   cell	   culture	   medium	   with	   FBS	   was	  
removed,	  and	  the	  epithelia	  were	  washed	  twice	  with	  200	  μL	  PBS	  and	  placed	  in	  a	  new	  companion	  
well	   plate	   to	   insure	   no	   traces	   of	   FBS	   remained.	   The	   apical	   surface	   of	   the	   cells	   could	   then	   be	  
exposed	   to	   sterile	   1.5	   mL	   apical	   FW,	   whilst	   the	   basolateral	   remained	   in	   L-­‐15	   medium	   without	  
supplementation.	   Substances	   (pharmaceuticals,	   paracellular	   markers,	   etc.)	   could	   be	   added	   to	  
either	  FW	  or	  L-­‐15	  accordingly.	  
	  
2.	  General	  Materials	  and	  Methods	  
Lucy	  C.	  Stott	  |	  61	  
2.6	   N	  and	  biological	  replicates	  
Throughout,	   the	   numbers	   of	   individual	   inserts	   per	   condition	   are	   denoted	   as	   n,	   derived	   from	  
biological	   replicates	   (referring	   to	   one	   set	   of	   epithelia	   derived	   from	  2	   fish	   for	  DSI)	   indicating	   the	  
numbers	  of	   fish	   from	  which	  they	  were	   isolated.	  For	  cells	  grown	   in	   flasks	   (SSI),	   these	  cells	  will	  be	  
from	  at	  least	  2	  fish,	  pooled	  together	  and	  seeded.	  For	  the	  cell	  line	  RTgill-­‐W1,	  the	  passage	  number	  
(P)	  is	  quoted.	  
3.	  Characterisation	  
Lucy	  C.	  Stott	  |	  62	  
	  
Chapter	  3	  
The	  characterisation	  of	  the	  primary	  rainbow	  trout	  gill	  cell	  system,	  




Several	  gill	  surrogates	  exist	  that	  can	  be	  used	  to	  investigate	  the	  transport	  of	  substances	  over	  the	  gill	  
and	  into	  fish.	  The	  most	  advanced	  primary	  gill	  cell	  culture	  model	  involves	  the	  seeding	  of	  cells	  over	  
two	   days	   using	   the	   double	   seeded	   insert	   (DSI)	   technique.	   This	   was	   developed	   from	   the	   single	  
seeded	  insert	  (SSI)	  method.	  The	  immortalised	  gill	  cell	   line,	  RTgill-­‐W1,	  also	  exists	  and	  was	  isolated	  
in	   1995.	   This	   chapter	   characterised	   the	   features	   of	   these	   three	   systems,	   SSI,	   DSI	   and	  RTgill-­‐W1.	  
Micrographs	  showed	  the	  different	  cell	  morphologies	  of	  the	  primary	  cells	  compared	  to	  the	  gill	  cell	  
line.	   After	   days	   of	   development,	   DSI	   epithelia	   exhibited	   the	   highest	   transepithelial	   resistance	  
(TER),	   to	   values	   similar	   to	   in	   vivo.	   All	   gill	   cell	   preparations	   showed	   increases	   in	   TER,	   and	   hence	  
membrane	  tightness,	  after	  apical	  freshwater	  application.	  In	  DSI,	  transepithelial	  potential	  (TEP)	  was	  
positive	  with	  respect	  to	  TER	  and	  became	  negative	  upon	  apical	   freshwater	  application,	  as	  seen	   in	  
vivo.	   The	   permeability	   of	   DSI	   rapidly	   decreased	   as	   TER	   increased,	   indicating	   the	   formation	   of	   a	  
tight	  epithelium	  that	  is	  paracellulary	  impermeable.	  DSI	  had	  the	  lowest	  epithelial	  permeability	  of	  all	  
cell	  preparations,	  and	  RTgill-­‐W1	  had	  the	  highest.	  Mitochondria-­‐rich	  cells	  (MRCs)	  can	  be	  observed	  
in	   DSI,	   as	   well	   as	   the	   tight	   junction	   protein,	   zonula	   occludin	   (ZO-­‐1).	   ZO-­‐1	  was	   also	   observed	   in	  
double	   seeded	   inverted	   (DSII)	   preparations	   that	   were	   later	   used	   in	   the	   culture	   of	   primary	   gill	  
epithelial	   cells	  and	  3D	  hepatocyte	   spheroids.	  The	   initial	   characterisation	  of	   this	   showed	   that	   the	  
co-­‐culture	  of	  these	  two	  different	  cell	  types	  resulted	  in	  tighter	  gill	  epithelium	  development.	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3.2	  Introduction	  
The	   gills	   of	   freshwater	   teleost	   fish	   are	   a	   multifunctional	   organ;	   comprising	   multiple	   cell	   types	  
performing	  specific	  physiological	  activities.	  Owing	  to	  the	  differences	  in	  osmotic	  potential	  between	  
the	  freshwater	  environment	  and	  that	  of	  internal	  body	  fluids,	  the	  gill	  maintains	  a	  protective	  barrier	  
to	  the	  aquatic	  environment,	  as	  well	  as	  controlling	  the	  uptake	  of	  oxygen	  and	  excretion	  of	  carbon	  
dioxide	  and	  nitrogenous	  waste.	  
Fletcher	  et	  al.	  (2000)	  developed	  a	  double	  seeding	  technique	  (DSI)	  that	  enables	  primary	  gill	  cells	  to	  
be	   cultured	   on	   permeable	   membrane	   inserts	   in	   a	   two-­‐compartment	   model.	   This	   method	   was	  
further	  developed	  (Walker	  et	  al.,	  2008)	  and	  then	  optimised	  in	  our	  laboratory	  (Schnell,	  Stott	  et	  al.,	  
2016).	  This	  procedure	  produces	  a	  gill	  epithelium	  with	  features	  akin	  to	  the	  in	  vivo	  gill	  tissue	  (Kelly	  et	  
al.,	  2000).	  These	  characteristics	   include	  a	  gill	  epithelium	  composed	  of	  different	  cell	  types	  such	  as	  
pavement	   cells	   (PVC),	   mitochondria-­‐rich	   cells	   (MRC)	   and	   mucous	   cells,	   high	   transepithelial	  
resistance	  (TER),	  a	  transepithelial	  potential	  (TEP),	  low	  paracellular	  permeability	  and	  tight	  junction	  
proteins	   including	   zonula	   occludin	   (ZO-­‐1),	   occludins	   and	   claudins	   (Chasiotis	   et	   al.,	   2012).	  
Importantly,	   this	   system	   is	   able	   to	   tolerate	   freshwater	   at	   the	   apical	   surface	   of	   the	   cells	   and	  
produces	   a	   negative	   transepithelial	   potential	   (TEP)	   (Stott	   et	   al.,	   2015),	   further	   simulating	   the	   in	  
vivo	  scenario.	  The	  tolerance	  of	  the	  in	  vitro	  gill	  to	  freshwater	  is	  important	  if	  we	  are	  to	  recreate	  the	  
gill	  epithelium	  for	  bioconcentration	  and	  ecotoxicological	  study.	  
This	  chapter	  will	  present	  the	  full	  characterisation	  of	  the	  primary	  gill	  cell	  culture	  system;	  necessary	  
for	   its	  proof	  of	   functionality	  as	  an	   in	  vitro	  gill	  epithelium	  with	  which	  further	  experiments	   in	   later	  
chapters	  were	  based	  upon.	  This	  chapter	  will	   focus	  on	  the	  single	  seed	  of	  primary	  cells	   (SSI,	  using	  
cells	  that	  were	  initially	  cultured	  in	  cell	  culture	  flasks),	  double	  seeds	  of	  primary	  cells	  (DSI)	  and	  the	  
immortalised	  rainbow	  trout	  gill	  cell	  line	  RTgill-­‐W1	  (see	  Chapter	  2)	  in	  terms	  of	  cell	  morphology,	  TER,	  
TEP,	  permeability,	  tight	  junctions	  and	  cell	  type.	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The	  DSI	  technique	  (Fig	  3.1A)	  was	  further	  altered	  in	  our	  laboratory	  to	  the	  double	  seeded	  inverted	  
insert	  (DSII),	  whereby	  the	  cells	  are	  grown	  on	  the	  underside	  of	  the	  insert	  (Fig	  3.1B;	  Schnell,	  Stott,	  et	  
al.,	   2016).	   Culturing	   in	   this	   way	   allows	   the	   system	   to	   be	   used	   as	   a	   solvent-­‐free	   dosing	   system	  
similar	  to	  that	  described	  by	  Kramer	  et	  al.	  (2010)	  and	  also	  allows	  a	  reduction	  in	  the	  volume	  of	  the	  
receiving	   compartment	   thus	   increasing	   the	   chemical	   analytical	   power	   necessary	   for	   assessing	  
xenobiotic	  biotransformation.	   This	   chapter	   therefore	  also	  presents	   the	   initial	   characterisation	  of	  
the	  DSII	  gill	  epithelial	  system	  and	   its	  co-­‐culture	  for	  the	  first	  time	  with	  another	  cell	   type,	  rainbow	  




Fig	  3.1	  Summary	  of	  the	  DSI	  and	  DSII	  cell	  culture	  procedures	  of	  primary	  rainbow	  trout	  gill	  cells.	  Reconstructed	  as	  (A)	  DSI	  
or	  (B)	  DSII	  preparations.	  The	  epithelium	  attaches	  to	  the	  permeable	  membrane	  supports	  and	  polarises	  so	  as	  to	  have	  an	  
apical	  and	  basolateral	  cell	  surface	  (right).	  Epithelia	  are	  bathed	  on	  both	  sides	  with	  cell	  culture	  medium	  supplemented	  
with	  FBS	  and	  antibiotics	  during	  development	  (left).	  For	  experimental	  purposes,	  freshwater	  can	  replace	  cell	  culture	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3.3	  Materials	  and	  methods	  
3.3.1	   Reagents	  and	  suppliers	  
Reagents	  purchased	  were	   the	  same	  as	   those	  outlined	   in	  Chapter	  2	  with	   the	   following	  additions.	  
Rhodamine-­‐123,	   Hoechst,	   bovine	   serum	   albumin	   (BSA),	   poly(2-­‐hydroxyethylmethacrylate)	  
(pHEMA),	   Trypan	   blue,	   ethylenediaminetetraacetic	   acid	   (EDTA),	   sodium	   bicarbonate	   (NaHCO3),	  
Triton™	  X-­‐100	  and	  crystalline	  paraformaldehyde	  were	  obtained	  from	  Sigma	  Aldrich;	  the	  latter	  was	  
made	  up	  according	  to	  manufacturer’s	  instructions.	  Hank’s	  balanced	  salt	  solutions	  (HBSS)	  with	  and	  
without	   calcium	   and	   magnesium	   and	   Alexa	   Fluor	   AF488	   were	   purchased	   from	   Invitrogen	   Life	  
Technologies.	   Primary	   zonula	   occludin	   (ZO-­‐1)	   rabbit	   antibody	   was	   purchased	   from	   Abcam.	  
Collagenase	  D	  was	   obtained	   from	  Roche	   Scientific.	   Vectashield	  was	   purchased	   from	  Vectorlabs.	  
Finally,	  14C-­‐mannitol	  (specific	  activity	  20	  Ci	  mmol−1)	  was	  purchased	  from	  Amersham	  Biosciences.	  
3.3.2	   Equipment	  and	  suppliers	  
Equipment	  used	  was	  the	  same	  as	  those	  outlined	  in	  Chapter	  2	  with	  the	  following	  additions.	  Six	  well	  
culture	   plates	   were	   purchased	   from	   BD	   Falcon;	   23G	   hypodermic	   needles	   and	   polythene	   tubing	  
(0.76	  mm	  internal	  diameter;	  1.22	  mm	  external	  diameter)	  were	  purchased	  from	  Smiths	  Medical,	  UK	  
and	   the	   peristaltic	   pump	   was	   produced	   by	   Watson	   Marlow,	   UK.	   The	   gyratory	   shaker	   was	  
manufactured	  by	   Innova	  (model	  number	  2000	  with	  a	  1.9	  cm	  orbit).	  The	   light	  microscope	  was	  an	  
Eclipse	   TE200	   by	   Nikon	  with	   a	   digital	   camera	   (DXM1200,	   Nikon)	   and	   the	   imaging	   software	  was	  
Lucia	  G	  by	  Nikon.	  The	  confocal	  microscope	  was	  produced	  by	  Leica	  and	  the	  imaging	  software	  was	  
Leica	  Confocal	  Software	  by	  Leica.	  The	  liquid	  scintillation	  fluid	  was	  purchased	  from	  Ecolume	  and	  the	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3.3.3	   Preparation	  of	  reagents	  
Reagents	  were	  prepared	  as	  outlined	  in	  Chapter	  2.	  Hank’s	  Balanced	  Salt	  Solution	  (HBSS)	  without	  
calcium	  or	  magnesium	  was	  supplemented	  with	  4.2	  mM	  NaHCO3	  and	  2.3	  mM	  EDTA.	  pHEMA	  was	  
reconstituted	  in	  90%	  ethanol	  to	  2.5%.	  Collagenase	  D	  was	  reconstituted	  in	  HBSS	  with	  calcium	  and	  
magnesium	  to	  0.1%	  with	  4.2	  mM	  NaHCO3.	  
3.3.4	   Cell	  culture	  reagents	  
The	   primary	   gill	   cell	   culture	   and	   RTgill-­‐W1	   culture	   media	   was	   the	   same	   as	   that	   described	   in	  
Chapter	  2.	   3D	   spheroidal	  hepatocyte	   cell	   culture	  medium	  was	   composed	  of	   L-­‐15	  with	  10%	   (v/v)	  
FBS.	  
3.3.5	   Gill	  cell	  culture	  methods	  
The	  general	  material	  and	  methods	  for	  the	  SSI,	  DSI	  gill	  cell	  culture	  and	  RTgill-­‐W1	  procedures	  can	  be	  
found	  in	  Chapter	  2.	  SSI	  will	  always	  refer	  to	  primary	  gill	  cells	  first	  cultured	  in	  flasks,	  then	  trypsinised	  
and	  seeded	  onto	  cell	  culture	  inserts	  as	  detailed	  in	  Chapter	  2.	  Seeding	  densities	  on	  inserts	  are	  0.7	  x	  
106	  for	  SSI,	  (2	  x)	  1.2	  x	  106	  for	  DSI	  and	  0.2	  x	  106	  for	  RTgill-­‐W1.	  
3.3.6	   Double	  seeded	  inverted	  inserts	  
The	   following	   method	   describes	   the	   same	   double	   seeded	   insert	   (DSI)	   technique,	   with	   the	  
amendment	   of	   culturing	   on	   the	   underside	   of	   the	   insert,	   and	   so	   is	   termed	   the	   double	   seeded	  
inverted	   insert	   (DSII)	   technique	   (Fig	   2.1;	   Fig	   3.1B;	   Schnell,	   Stott	   et	   al.,	   2016).	   Firstly,	   permeable	  
membrane	   inserts	  were	  placed	  upside	  down	  on	  glass	  slides	   (i.e.	  a	   flat	  surface)	   in	  a	  sterile	  Gilson	  
‘tip	  box’	  with	  damp	  cotton	  wool	  inside	  to	  provide	  a	  moist	  environment	  and	  reduce	  evaporation	  of	  
culture	   medium.	   These	   were	   preconditioned	   with	   200	   μL	   cell	   culture	   medium	   with	   FBS	   and	  
antibiotics	  on	  the	   insert	  membrane	   (Fig	  2.1,	  DSII).	  The	  previous	  gill	   cell	   isolation	  procedure	  then	  
followed	  (Chapter	  2),	  after	  which	  cells	  were	  seeded	  at	  a	  density	  of	  1.2	  x	  106	  in	  200	  μL	  cell	  culture	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medium	  with	   FBS	   and	   antibiotics.	   The	   tip	   box	  was	   carefully	   shut	   and	   the	   gill	   cell	   cultures	  were	  
maintained	   on	   the	   upside	   down	   inserts	   at	   18°C	   in	   the	   dark	   (‘day	   0’).	   After	   the	   first	   day	   of	   cell	  
seeding,	   24	   hours	   later,	   the	   cell	   isolation	   procedures	   were	   repeated	   resulting	   in	   a	   new	   gill	   cell	  
culture	   suspension.	   Cells	  were	   counted	   and	   diluted	   to	   1.2	   x	   106	   cells	   per	   200	   μL	   of	   cell	   culture	  
medium	  with	  FBS	  and	  antibiotics,	  and	  kept	  on	  ice.	  The	  medium	  from	  the	  previously	  seeded	  inserts	  
was	  removed	  and	  the	  cells	  were	  carefully	  washed	  twice	  with	  200	  μL	  PBS.	  200	  μL	  of	  the	  new	  gill	  cell	  
solution	   was	   then	   applied	   carefully	   to	   the	   membrane	   of	   the	   upside	   down	   insert,	   so	   as	   not	   to	  
disturb	  the	  cells	  already	  attached,	  the	  Gilson	  tip	  box	  lid	  was	  replaced	  and	  cells	  were	  maintained	  at	  
18°C	   in	   the	   dark	   for	   a	   further	   24	   hours	   (‘day	   1’).	   On	   day	   2,	   the	   inverted	   inserts	   could	   then	   be	  
washed	  as	  previously	  and	  turned	  right-­‐way-­‐up	  and	  placed	   in	  a	  companion	  well	  plate.	  Finally,	  1.5	  
mL	  of	  cell	  culture	  medium	  with	  FBS	  and	  antibiotics	  was	  applied	  to	  the	  apical	  compartment,	  with	  
2.0	  mL	  in	  the	  basolateral	  (where	  the	  cells	  were	  growing	  on	  the	  underside	  of	  the	  insert).	  The	  DSII	  
epithelia	  were	  maintained	  and	  prepared	  for	  experimental	  procedures	  in	  the	  same	  way	  as	  DSI,	  but	  
by	  adding	   freshwater	   into	   the	  basolateral	   compartment	   (the	  apical	   cell	   surface)	   and	   cell	   culture	  
medium	  in	  the	  apical	  compartment	  (the	  basolateral	  cell	  surface)	  (Fig	  3.1B).	  
3.3.7	   3D	  hepatocyte	  cell	  culture	  
For	   the	   development	   and	   optimisation	   of	   the	   3D	   spheroidal	   hepatocytes	   culture	   protocol,	   the	  
following	  methods	  were	  employed	  based	  on	  those	  described	  by	  Baron	  et	  al.	  (2012).	  
3.3.8	   Rainbow	  trout	  dissection	  
One	   rainbow	   trout	   was	   randomly	   isolated	   from	   the	   aquarium	   and	   sacrificed	   using	   Schedule	   1	  
techniques	   (Home	   Office,	   1986).	   Its	   external	   surface	   was	   sterilised	   with	   70%	   ethanol	   and	   the	  
whole	   body	   was	   placed	   right-­‐flank	   down	   on	   a	   dissecting	  mat	   in	   a	   laminar	   flow	   hood.	   The	   first	  
incision	  was	  a	  cut	  at	   the	  anus	  using	  a	  scalpel,	  upwards	  towards	  the	   lateral	   line	   (approximately	  2	  
cm,	  Fig	  3.2A).	  Two	  horizontal	  cuts	  followed,	  one	  along	  the	  ventral	  edge	  towards	  the	  pectoral	  fins,	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followed	  by	  a	  further	  cut	  along	  the	  lateral	  line	  to	  the	  operculum.	  The	  resulting	  fillet	  was	  removed	  
to	  expose	   the	  body	   cavity	   (Fig	  3.2B).	  Carefully	  pulling	  back	   the	  pyloric	   caecae	   revealed	   the	   liver	  
and	  hepatic	  portal	  vein,	  and	  cutting	  the	  pericardial	  cavity	  tissue	  exposed	  the	  heart	  (Fig	  3.3A).	  
	  
Fig	  3.2	  Image	  of	  a	  rainbow	  trout	  showing	  (A)	  the	  initial	  cut	  from	  the	  anus	  to	  the	  lateral	  line.	  Bar	  =	  3	  cm.	  The	  left	  lateral	  
fillet	  is	  removed	  to	  expose	  the	  body	  cavity	  (B).	  The	  liver	  (ii)	  is	  located	  next	  to	  the	  heart	  (i)	  and	  underneath	  the	  pyloric	  
cacae	  (iii).	  Bar	  =	  1.5	  cm).	  
3.3.9	   In	  situ	  liver	  perfusion	  
A	  23G	  hypodermic	  needle	  inserted	  into	  polythene	  tubing	  was	  connected	  to	  a	  calibrated	  peristaltic	  
pump	  and	  flushed	  through	  with	  100%	  ethanol.	  After	  running	  through	  with	  HBSS	  without	  metals,	  
the	  needle	  was	  inserted	  into	  the	  hepatic	  portal	  vein	  (Fig	  3.3B)	  and	  perfusion	  initiated	  at	  a	  rate	  of	  1	  
mL	  min-­‐1.	  After	  the	  initial	  yellowing	  of	  the	  liver	  as	  the	  blood	  was	  displaced	  (after	  approximately	  1	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continued	  for	  a	  further	  9	  minutes.	  The	  liver	  was	  kept	  damp	  throughout	  by	  applying	  a	  few	  mL	  of	  L-­‐
15.	  The	  perfusion	  then	  proceeded	  with	  0.1%	  Collagenase	  D	  for	  a	   further	  15	  minutes.	  During	  this	  




Fig	  3.3	  Stages	  of	  the	  in	  situ	  liver	  perfusion.	  A	  needle	  is	  inserted	  into	  the	  hepatic	  portal	  vein	  (B)	  and	  the	  cells	  are	  
disaggregated	  with	  Collagenase	  D.	  The	  liver	  can	  be	  observed	  to	  yellow	  and	  mottle	  as	  the	  internal	  cellular	  matrices	  are	  
digested	  and	  the	  hepatic	  cells	  disaggregate.	  Finally,	  the	  liver	  is	  dissected	  intact	  by	  severing	  the	  hepatic	  portal	  vein,	  veins	  
and	  arteries,	  connective	  tissue	  and	  gall	  bladder	  (I).	  Bar	  =	  1	  cm.	  
matrices	   and	   the	   hepatic	   cells	   disaggregate	   (Fig	   3.3C-­‐H).	   At	   this	   point,	   the	   Collagenase	   D	   was	  
flushed	  through	  with	  L-­‐15	  for	  approximately	  2	  minutes.	  The	   liver	  was	  then	  dissected	  by	  severing	  
the	  hepatic	  portal	  vein,	  veins	  and	  arteries	  and	  connective	  tissue.	  The	  gall	  bladder	  was	  removed	  by	  
severing	  at	   the	  duct	   to	  retain	   the	  bile	  within	  and	  the	   liver	  was	  placed	  on	  a	  sterile	  Petri	  dish	   (Fig	  
3.3I).	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3.3.10	   Hepatocyte	  isolation	  and	  seeding	  
Approximately	  15	  mL	  of	  L-­‐15	  medium	  was	  applied	  to	  a	  Petri	  dish	  and	  the	  liver	  membrane	  was	  cut	  
to	  expose	  the	  disaggregated	  cells	  in	  solution.	  Any	  parts	  having	  bypassed	  the	  perfusion	  (appearing	  
red	  from	  blood)	  were	  removed	  along	  with	  the	  membrane.	  The	  resulting	  cell	   solution	  was	  drawn	  
into	  a	  20	  mL	  syringe	  and	  passed	  through	  a	  100	  μL	  and	  then	  40	  μL	  cell	  strainer	  into	  a	  sterile	  50	  mL	  
conical	   tube,	   and	   the	   volume	   was	   adjusted	   to	   20	   mL	   with	   L-­‐15.	   The	   cell	   suspension	   was	   then	  
centrifuged	  (50	  g,	  18°C,	  3	  minutes),	  aspirated	  (to	  remove	  non-­‐hepatic	  cells)	  and	  resuspended	  in	  a	  
further	   20	  mL	   of	   L-­‐15.	   This	  was	   repeated	   twice	  more	   until	   the	   final	   resuspension	   in	   20	  mL	   cell	  
culture	   medium	   with	   FBS.	   A	   total	   viable	   gill	   cell	   count	   was	   obtained	   using	   Trypan	   blue	   and	   a	  
haemocytometer	  and	  cells	  were	  deemed	  of	  acceptable	  viability	  at	  >80%.	  
Hepatic	   cells	  were	   seeded	   at	   3.0	   x	   106	   cells	  mL-­‐1	   in	   3	  mL	   L-­‐15	  with	   5%	   FBS	   per	  well	   in	   a	   6	  well	  
culture	  plate	  pre-­‐coated	  and	  dried	  with	  500	  μL	  pHEMA	  (to	  discourage	  cell	  attachment).	  Wells	  were	  
transferred	  immediately	  to	  a	  gyratory	  shaker	  at	  70	  RPM	  at	  room	  temperature.	  
3.3.11	   Maintenance	  
After	  24	  hours,	  2	  mL	  of	  cell	  culture	  medium	  and	  unattached	  cell	  debris	  was	  removed	  from	  each	  
well	  and	  new	  medium	  replaced.	  From	  that	  point	  onwards	  2	  mL	  cell	   culture	  media	  was	   removed	  
and	   replaced	  with	  new	  every	  48	  hours	  until	   day	  7.	   The	   spheroids	  were	  monitored	  daily	  by	   light	  
microscope	  observation.	  
3.3.12	   Light	  microscopy	  
Different	  preparations	  of	  cells	  were	  visualised	  using	  a	  light	  microscope,	  digital	  camera	  and	  imaging	  
software	  as	  outlined	  in	  Chapter	  2.	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3.3.13	   Transepithelial	  electrical	  resistance	  
TER	   development	   in	   SSI,	   DSI	   and	   RTgill-­‐W1	  was	  monitored	   for	   1-­‐7	   or	   8	   days	   after	   seeding	   onto	  
permeable	   membrane	   inserts.	   TER	   measurements	   were	   conducted	   as	   described	   in	   Chapter	   2,	  
using	  a	  custom-­‐modified	  epithelial	  tissue	  voltohmmeter	  fitted	  with	  chopstick	  electrodes	  in	  mode	  
‘R’.	  The	  TER	  was	  measured	  in	  3	  sets	  of	  SSI	  epithelia	  (n	  =	  30	  from	  6	  fish),	  3	  sets	  of	  DSI	  epithelia	  (n	  =	  
36	  from	  1	  biological	  replicate)	  and	  RTgill-­‐W1	  (n	  =	  6,	  passage	  90)	  grown	  in	  cell	  culture	  medium	  with	  
FBS	  and	  antibiotics	  in	  both	  the	  apical	  and	  basolateral	  compartments.	  
To	  monitor	  the	  effect	  of	  apical	  FW	  exposure	  in	  epithelia,	  TER	  was	  measured	  before	  (from	  day	  1	  to	  
day	  7,	  4	  or	  9)	  and	   in	   the	   following	  days	  after	  1.5	  mL	  FW	  was	  added	  to	   the	  apical	  compartment,	  
whilst	  the	  basolateral	  contained	  2.0	  mL	  L-­‐15	  in	  SSI	  (n	  =	  6	  from	  6	  fish),	  DSI	  epithelia	  (n	  =	  6	  from	  2	  
biological	  replicates)	  and	  RTgill-­‐W1	  preparations	  (n	  =	  4,	  passage	  90).	  
3.3.14	   Transepithelial	  electrical	  potential	  
TEP	  between	  the	  two	  sides	  of	  DSI	  epithelia	  was	  measured	  using	  the	  same	  voltohmmeter	  with	  the	  
mode	   selected	   to	   ‘V’.	   To	   determine	   if	   a	   relationship	   between	   TER	   and	   TEP	   existed,	   TEP	   was	  
measured	  in	  symmetrical	  conditions	  (n	  =	  19)	  in	  epithelia	  at	  varying	  degrees	  of	  development,	  with	  
TER	  values	  from	  1-­‐15	  kΩ	  cm2.	  To	  monitor	  the	  effect	  of	  FW	  application	  on	  TEP,	  TEP	  was	  monitored	  
before	  and	  6	  hours	  after	  FW	  application	  (n	  =	  8).	  All	  TEP	  measurements	  are	  expressed	  as	  basal	  side	  
relative	  to	  the	  apical	  at	  0	  mV.	  
3.3.15	   Paracellular	  permeability	  
Paracellular	  epithelial	  permeability	  was	  determined	  using	  14C-­‐mannitol	  with	  a	  molecular	  weight	  of	  
182	   Daltons.	   Using	   this	  marker	   as	   opposed	   to	   conventional	   polyethylene	   glycol	   (PEG)	   polymers	  
(typically	  400-­‐40,000	  Daltons)	  quantifies	  paracellular	  transport	  of	  molecules	  with	  similar	  molecular	  
weights	  to	  mannitol,	  which	  is	  more	  applicable	  to	  the	  paracellular	  transport	  of	  pharmaceuticals	  in	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later	   chapters	   (Hubatsch	  et	  al.,	  2007).	  To	  monitor	  paracellular	   transport	  at	  various	  points	  of	  DSI	  
epithelial	  development,	  DSI	  epithelia	  with	  TER	  values	  ranging	  from	  0-­‐15	  kΩ	  cm2	  were	  exposed	  to	  
0.013	  μCi	  (2.2	  ×	  105	  dpm)	  14C-­‐mannitol	  (n	  =	  37	  from	  4	  biological	  replicates)	  in	  1.5	  mL	  sterile	  FW	  in	  
the	   apical	   compartment,	   whilst	   the	   basolateral	   contained	   2.0	   mL	   L-­‐15	   (Wood	   et	   al.,	   1998,	  
Hubatsch	  et	  al.,	  2007).	  After	  gentle	  mixing,	  aliquots	  of	  100	  μL	  were	  taken	  from	  the	  apical	  and	  basal	  
compartments	  at	  time	  0	  and	  24	  h,	  and	  placed	  in	  2	  mL	  liquid	  scintillation	  fluid	  and	  the	  radioactivity	  
was	   measured	   by	   beta	   counting	   on	   a	   scintillation	   counter.	   Paracellular	   flux	   after	   24	   h	   was	  
calculated	  using	  the	  equation	  
𝑃𝑒𝑟𝑚𝑒𝑎𝑏𝑖𝑙𝑖𝑡𝑦   𝑐𝑚  𝑠!! =    [∆𝑀]!"   ×  𝑣𝑜𝑙𝑢𝑚𝑒𝑀!"  ×  𝑡𝑖𝑚𝑒  ×  3600  ×  𝑎𝑟𝑒𝑎	  
where	  [ΔM]BL	  is	  the	  change	  in	  radioactivity	  in	  the	  basal	  compartment,	  MAP	  is	  the	  radioactivity	  at	  
the	  start,	  time	  is	  24	  hours	  and	  area	  is	  0.9	  cm2	  (Fletcher	  et	  al.,	  2000).	  
To	   investigate	   the	   paracellular	   permeability	   of	   different	   cell	   preparations	   in	   symmetrical	   and	  
asymmetrical	  conditions,	  the	  TER	  of	  RTgill-­‐W1	  (n	  =	  4	  and	  3),	  SSI	  (n	  =	  3	  and	  4	  from	  6	  fish),	  and	  DSI	  (n	  
=	  12	  and	  10	  from	  4	  biological	  replicates)	  was	  measured	  and	  then	  preparations	  were	  exposed.	  14C-­‐
mannitol	   (0.013	   μCi;	   2.2	   ×	   105	   dpm)	   was	   applied	   apically	   to	   either	   1.5	   mL	   L-­‐15	   or	   FW	   (for	  
symmetrical	  or	  asymmetrical	  conditions),	  whilst	  the	  basolateral	  compartment	  always	  contained	  L-­‐
15.	  Aliquots	  of	  100	  μL	  were	  taken	  and	  counted	  as	  above.	  Cell	  free	  inserts	  were	  used	  to	  calculate	  
permeability	   through	   the	   PET	   membrane	   on	   which	   the	   cells	   grew	   in	   both	   symmetrical	   and	  
asymmetrical	  conditions	  (n	  =	  4).	  
3.3.16	   Mitochondria-­‐rich	  cell	  staining	  
Approximately	  1	  x	  106	  freshly	  isolated	  cells	  were	  resuspended	  in	  1	  mL	  of	  5	  μM	  Rhodamine-­‐123	  in	  
PBS	  and	  incubated	  for	  15	  minutes	  in	  the	  dark	  at	  room	  temperature.	  To	  view	  MRC	  present	  in	  DSI	  
epithelia,	  cell	  cultures	  that	  had	  surpassed	  a	  TER	  of	  5000	  Ω	  cm2	  (n	  =	  2)	  were	  washed	  twice	  with	  200	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μL	   PBS	   and	   detached	   by	   applying	   400	   μL	   0.05%	   trypsin-­‐EDTA	   in	   the	   apical	   compartment	   for	   2	  
minutes	  at	  room	  temperature.	  400	  μL	  of	  cell	  culture	  medium	  with	  FBS	  was	  applied	  to	  stop	  tryptic	  
digestion	  and	  the	  cells	  were	  carefully	  scraped	  from	  the	  cell	  culture	  membrane	  using	  a	  pipette	  and	  
collected.	  The	  cells	  were	  centrifuged	  (250	  g,	  4°C,	  5	  minutes)	  and	  resuspended	  in	  500	  μL	  of	  5	  μM	  
Rhodamine-­‐123	  in	  PBS	  for	  15	  minutes	  in	  the	  dark	  at	  room	  temperature.	  From	  both	  preparations	  of	  
freshly	   isolated	   and	   DSI	   cells,	   several	   100	   μL	   aliquots	   were	   transferred	   to	   microscope	   slides	  
underneath	   a	   cover	   slip,	   and	   the	   cells	   were	   visualised	   using	   a	   fluorescent	   microscope,	   digital	  
camera,	  and	  imaging	  software.	  
3.3.17	   ZO-­‐1	  protein	  localisation	  
Two	  DSI	  epithelia	  cultured	   for	  14	  days	  and	  with	  TERs	  of	  7730	  and	  9890	  Ω	  cm2,	  were	  exposed	   in	  
either	  symmetrical	  (L-­‐15	  medium	  both	  sides	  of	  the	  epithelium),	  or	  asymmetrical	  (apical	  FW	  and	  L-­‐
15	  in	  the	  basolateral	  compartment)	  for	  24	  hours.	  The	  epithelia	  were	  then	  washed	  twice	  with	  200	  
μL	  PBS	  and	  fixed	  for	  15	  minutes	  using	  400	  μL	  of	  3.7%	  (v/v)	  paraformaldehyde	  in	  PBS	  in	  the	  apical	  
compartment,	  and	  600	  μL	   in	   the	  basolateral.	  Three	  200	  μL	  PBS	  washes	   followed,	  where	  the	  PBS	  
was	  left	  on	  the	  apical	  surface	  of	  the	  epithelia	  for	  5	  minutes	  each	  time	  and	  shaken	  at	  30	  RPM.	  400	  
μL	   of	   0.1%	   (v/v)	   Triton™	   in	   PBS	   was	   applied	   in	   the	   apical	   compartment,	   and	   600	   μL	   in	   the	  
basolateral,	  for	  10	  minutes	  at	  room	  temperature	  to	  permeabilise	  the	  epithelia.	  Afterwards,	  400	  μL	  
of	  3%	  (w/v)	  bovine	  serum	  albumin	  (BSA)	  in	  PBS	  was	  applied	  for	  30	  minutes	  at	  room	  temperature	  
to	   block	   non-­‐specific	   protein	   interactions.	   0.5%	   (v/v)	   primary	   zonula	   occludin	   (ZO-­‐1)	   rabbit	  
antibody	  was	  prepared	  in	  3%	  (v/v)	  BSA	  in	  PBS,	  and	  400	  μL	  was	  added	  to	  each	  apical	  compartment	  
and	  incubated	  at	  4°C	  in	  a	  damp	  box	  (containing	  damp	  tissue	  to	  reduce	  evaporation)	  overnight.	  The	  
following	  day,	  the	  epithelia	  were	  washed	  twice	  with	  200	  μL	  PBS	  and	  labeled	  using	  400	  μL	  of	  0.1%	  
(v/v)	  Alexa	  Fluor	  green	  (AF488)	  in	  PBS,	  applied	  to	  the	  apical	  surface	  of	  each	  epithelium	  for	  1	  hour	  
at	  room	  temperature	  in	  the	  dark.	  Afterwards,	  epithelia	  were	  again	  washed	  twice	  with	  200	  μL	  PBS,	  
and	  400	  μL	  of	  5	  μM	  Hoechst	  in	  PBS	  was	  applied	  (to	  label	  cell	  nuclei)	  and	  incubated	  for	  15	  minutes	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at	  room	  temperature	  in	  the	  dark.	  Afterwards,	  the	  epithelia	  were	  washed	  3	  x	  200	  μL	  PBS,	  and	  the	  
cell	  culture	  inserts	  were	  cut	  from	  their	  plastic	  holders	  using	  a	  scalpel	  and	  placed	  cell-­‐side-­‐up	  on	  a	  
microscope	   slide.	  One	  drop	  of	  mounting	  media	  was	   applied	  under	   a	   cover	   slip,	  which	  was	   then	  
varnished	  onto	  the	  slide.	  The	  slides	  were	  left	  to	  dry	  overnight	  in	  the	  dark	  (wrapped	  in	  foil)	  at	  4°C	  
before	  visualisation.	  
3.3.18	   Double	  seeded	  inverted	  inserts	  
TER,	   TEP	   and	   paracellular	   permeability	  were	  measured	   in	   the	   same	  way	   as	  DSI,	   previously.	  DSII	  
epithelia	   were	   also	   stained	   for	   ZO-­‐1	   as	   before,	   but	   with	   the	   amendment	   that	   all	   washes	   and	  
staining	  solutions	  were	  added	  to	  the	  basolateral	  compartment	  (the	  apical	  cell	  surface).	  
3.3.19	   DSII	  and	  3D	  hepatocyte	  co-­‐culture	  
DSII	   epithelia	   at	   9	   days	   and	   with	   a	   TER	   >	   5000	   Ω	   cm2	   (n	   =	   7)	   were	   prepared	   for	   experimental	  
procedures	   as	   outlined	   previously.	   Liver	   hepatocytes	   at	   9	   days	   and	   observed	   to	   have	   reached	  
morphological	  maturity	  were	  counted	  and	  collected	   from	  two	  6-­‐well	  culture	  plates	   into	  a	  14	  mL	  
conical	  tube	  and	  allowed	  to	  settle.	  The	  culture	  medium	  was	  aspirated	  and	  replaced	  with	  10	  mL	  L-­‐
15	   to	   wash,	   and	   again	   the	   livers	   were	   allowed	   to	   settle	   before	   aspirating.	   These	   were	   finally	  
resuspended	  in	  4.5	  mL	  cell	  culture	  medium	  with	  FBS	  and	  antibiotics.	  1.5	  mL	  liver	  hepatocytes	  were	  
added	  to	  three	  of	  the	  DSII	  epithelia	  in	  the	  apical	  compartment,	  whilst	  the	  remaining	  four	  DSII	  had	  
1.5	  mL	  cell	  culture	  medium	  with	  FBS	  and	  antibiotics	  added.	  2.0	  mL	  cell	  culture	  medium	  with	  FBS	  
and	   antibiotics	  was	   added	   to	   the	   basolateral	   compartment	   of	   all	   DSII.	   Gill	   epithelial	  membrane	  
integrity	  of	  DSII	  and	  DSII	  co-­‐cultures	  were	  then	  monitored	  by	  daily	  measurements	  of	  TER.	  
3.3.20	   Analysis	  of	  data	  and	  statistics	  
The	  relationship	  between	  TER	  and	  TEP	  was	  analysed	  by	  ordinary	   least	  squares	   linear	   regression.	  
An	   independent	  samples	  t-­‐test	  with	  equal	  variances	  assumed	  was	  used	  to	  test	   for	  differences	   in	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TEP	  before	  and	  after	  FW	  exposure	  and	  statistical	  significance	  was	  accepted	  when	  P	  <	  0.05	  (SPSS	  
software,	   SPSS	   Inc.).	   Differences	   of	   permeability	   in	   symmetrical	   or	   asymmetrical	   conditions	  
between	   cell	   free	   inserts	   and	   RTgill-­‐W1,	   SSI	   or	   DSI	   were	   tested	   for	   by	   a	   one-­‐way	   analysis	   of	  
variance	   (ANOVA)	   and	   post	   hoc	   testing	   using	   Tukey’s	   honest	   significance	   test	   (HSD).	   Statistical	  
significance	  was	  accepted	  when	  P	  <	  0.05	  (SPSS	  software,	  SPSS	  Inc.).	  The	  paracellular	  permeability	  
of	  DSII	  epithelia	   in	   symmetrical	  and	  asymmetrical	   conditions	  were	  compared	   to	   that	  of	   cell	   free	  
inserts	   and	   DSI	   epithelia	   using	   an	   independent	   samples	   t-­‐test	   with	   equal	   variances	   assumed.	  
Differences	   in	   the	   TER	   of	   DSII	   and	   DSII	   co-­‐cultured	   with	   hepatocytes	   were	   tested	   for	   using	   an	  
independent	  samples	  t-­‐test	  with	  equal	  variances	  assumed	  and	  statistical	  significance	  was	  accepted	  
when	   P	   <	   0.05	   (SPSS	   software,	   SPSS	   Inc.).	   All	   graphical	   illustrations	  were	   produced	   using	   either	  
Excel	  (Microsoft	  Office)	  or	  Sigmaplot	  (Systat	  Software	  Inc.).	  
	  
3.4	  Results	  
3.4.1	   Light	  microscopy	  
Primary	   gill	   cells	   cultured	   in	   cell	   culture	   flasks	   (Fig	   3.4A)	   were	   visualised	   adhered	   to	   the	   flask	  
surface,	   or	   in	   globular	   form	   preparing	   for	   or	   having	   undergone	   mitotic	   division.	   Less	   easily	  
visualised	   are	   DSI	   primary	   gill	   cells	   on	  membrane	   inserts,	   as	   the	  microscope	   views	   from	   below	  
through	  the	  insert	  membrane.	  Nevertheless,	  cells	  were	  observed	  adhering	  to	  the	  insert	  membrane	  
(Fig	   3.4B).	   RTgill-­‐W1	   cells	   exhibit	   different	   cell	   morphology	   (Bols	   et	   al.,	   1994),	   and	   successfully	  
attach	  to	  the	  insert	  membranes,	  with	  fewer	  unattached	  cells	  and	  debris	  (Lee	  et	  al.,	  2009).	  
3.4.2	   Transepithelial	  electrical	  resistance	  
Epithelial	  development	  was	  monitored	  by	  daily	  measurements	  of	  TER	   in	  symmetrical	  conditions.	  
TER	  in	  SSI	  reached	  585.2	  ±	  31.2,	  498.0	  ±	  24.2	  and	  608.8	  ±	  62.0	  Ω	  cm2	  after	  7	  days	  (n	  =	  12,	  12	  and	  6;	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Fig	  3.4	  Phase	  contrast	  micrographs	  of	  gill	  epithelial	  cells.	  After	  isolation,	  primary	  gill	  cells	  can	  attach	  and	  grow	  in	  cell	  
culture	  flasks	  with	  cell	  culture	  medium	  with	  FBS	  and	  with	  or	  without	  antibiotics.	  These	  cells	  can	  then	  be	  seeded	  onto	  
inserts	  (SSI)	  (A).	  Primary	  cells	  can	  also	  be	  seeded	  directly	  onto	  culture	  inserts	  (B)	  using	  DSI	  culture	  techniques.	  The	  
immortalised	  rainbow	  trout	  gill	  cell	  line,	  RTgill-­‐W1,	  also	  successfully	  attaches	  and	  grows	  in	  the	  same	  cell	  system	  set	  up	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Fig	  3.5A)	  and	  typically	  showed	  a	  70%	  increase	  in	  TER	  and	  there	  were	  no	  differences	  in	  TER	  values	  
between	  different	  sets	  of	  epithelia.	  After	  8	  days,	  the	  TER	  of	  DSI	  epithelia	  increased	  by	  around	  97%	  
and	  reached	  25.5	  ±	  1.0,	  23.0	  ±	  1.5	  and	  22.9	  ±	  2.1	  kΩ	  cm2	   (n	  =	  12,	  12	  and	  12;	  Fig	  3.5B),	  with	  no	  
difference	  between	  sets	  of	  epithelia.	  After	  8	  days,	  the	  TER	  in	  RTgill-­‐W1	  cells	  increased	  by	  34%	  and	  
reached	  28.5	  ±	  3.4	  Ω	  cm2	  (n	  =	  4;	  Fig	  3.5C).	  
In	  asymmetrical	   conditions	  when	  water	   is	  placed	  on	   the	  apical	   surface	  on	  day	  7,	   SSI	   showed	  an	  
increase	  in	  TER	  from	  0.5	  ±	  0.0	  to	  3.8	  ±	  0.3	  kΩ	  cm2.	  TER	  remained	  above	  3.0	  kΩ	  cm2	  for	  24	  hours	  
before	  declining	  to	  0.4	  ±	  0.0	  kΩ	  cm2	  by	  day	  10	  and	  lower	  values	  thereafter	  (n	  =	  30;	  Fig	  3.6A).	  The	  
TER	   of	  DSI	   epithelia	   increased	   from	  27.4	   ±	   0.4	   kΩ	   cm2	   to	   33.2	   ±	   0.1	   kΩ	   cm2	   after	   24	   hours	   FW	  
exposure,	  then	  decreased	  to	  30.8	  ±	  0.7	  kΩ	  cm2	  after	  48	  hours,	  before	  decreasing	  to	  values	  below	  
16.8	  ±	  2.39	  kΩ	  cm2	  thereafter	  (n	  =	  36;	  Fig	  3.6B).	  RTgill-­‐W1	  TER	  rose	  from	  24.5	  ±	  2.9	  Ω	  cm2	  to	  45.0	  ±	  
9.1	  Ω	  cm2	  after	  24	  hours	  and	  remained	  at	  higher	  values	  for	  the	  resulting	  3	  days	  (n	  =	  4;	  Fig	  3.6C).	  
3.4.3	   Transepithelial	  electrical	  potential	  	  
The	  mean	  TEP	   in	  symmetrical	  conditions	  with	  L-­‐15	  both	  sides	  of	   the	  epithelia	  was	  -­‐0.5	  ±	  0.1	  mV	  
and	  no	  relationship	  between	  TER	  and	  TEP	  existed	  during	  symmetrical	  conditions	   (r2	  =	  0.046,	  n	  =	  
19;	   Fig	   3.7A).	   After	   apical	   freshwater	   application	   TEP	   in	   the	   basolateral	   compartment	   became	  
significantly	  more	  negative	  (with	  respect	  to	  the	  apical	  compartment)	  from	  -­‐0.9	  ±	  0.1	  mV	  to	  -­‐12.9	  ±	  
2.9	  mV	  after	  6	  hours	  apical	  FW	  exposure	  (P	  <	  0.05;	  n	  =	  8;	  Fig	  3.7B).	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Fig	  3.5	  The	  development	  of	  TER	  from	  1	  or	  3	  to	  8	  days	  in	  (A)	  3	  sets	  of	  SSI	  preparations	  (n	  =	  12,	  12	  and	  6	  from	  6	  fish),	  (B)	  3	  
sets	  of	  DSI	  (n	  =	  12,	  12	  and	  12	  from	  1	  biological	  replicate)	  (note	  the	  axis	  in	  kΩ	  cm2)	  and	  (C)	  RTgill-­‐W1	  cells	  (n	  =	  4,	  P90)	  in	  
symmetrical	  conditions	  with	  cell	  culture	  medium	  with	  FBS	  and	  antibiotics	  both	  sides	  of	  the	  epithelia.	  Symbols	  (circles,	  
diamonds	  or	  triangles)	  represent	  groups	  of	  epithelia	  from	  different	  cell	  preparations.	  The	  values	  represent	  mean	  ±	  SEM.	  
Error	  bars	  are	  behind	  data	  points	  where	  none	  can	  be	  seen.	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Fig	  3.6	  TER	  in	  symmetrical	  conditions	  with	  cell	  culture	  medium	  with	  FBS	  and	  antibiotics	  both	  sides	  of	  the	  epithelia	  
(orange	  circles),	  until	  apical	  freshwater	  application	  with	  L-­‐15	  in	  the	  basal	  compartment	  (blue	  circles)	  in	  (A)	  SSI	  
preparations	  (n	  =	  24),	  (B)	  DSI	  (n	  =	  6)	  and	  (C)	  RTgill-­‐W1	  cells	  (n	  =	  4).	  Note	  the	  axes	  in	  (A)	  and	  (B)	  are	  in	  kΩ	  cm2.	  The	  values	  
represent	  mean	  ±	  SEM.	  Error	  bars	  are	  behind	  data	  points	  where	  none	  can	  be	  seen.	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Fig	  3.7	  (A)	  The	  relationship	  between	  TEP	  and	  TER	  in	  DSI	  epithelia	  in	  symmetrical	  conditions	  with	  cell	  culture	  medium	  
with	  FBS	  and	  antibiotics	  both	  sides	  of	  the	  epithelia	  (n	  =	  19,	  r2	  =	  0.046).	  (B)	  TEP	  in	  symmetrical	  conditions	  before	  FW	  
application	  with	  L-­‐15	  both	  sides	  of	  the	  epithelia	  (orange	  bar)	  and	  after	  FW	  application	  to	  the	  apical	  compartment,	  whilst	  
the	  basolateral	  contained	  L-­‐15	  after	  6	  hours	  (blue	  bar)	  (n	  =	  8).	  Significant	  differences	  are	  indicated	  by	  the	  asterisk	  
(independent	  samples	  t-­‐test;	  *P	  <	  0.05).	  Values	  are	  mean	  ±	  SEM.	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3.4.4	   Paracellular	  permeability	  
In	  DSI	  preparations,	  small	  increases	  in	  TER	  resulted	  in	  large	  decreases	  in	  paracellular	  14C-­‐mannitol	  
influx	  (Fig	  3.8A).	  A	  TER	  of	  between	  200-­‐1000	  Ω	  cm2	  exhibited	  the	  highest	  mannitol	  permeability	  of	  
1.5	   ±	   0.2	   x	   10-­‐6	   cm	   s-­‐1	   (n	   =	   9).	   Those	   with	   a	   TER	   of	   1-­‐2	   kΩ	   cm2	   showed	   a	   decreased	  mannitol	  
permeability	  of	  0.9	  ±	  0.1	  x	  10-­‐6	  cm	  s-­‐1	  (n	  =	  11),	  whilst	  those	  >	  2	  kΩ	  cm2	  showed	  the	  lowest	  mannitol	  
permeability	  (0.1	  ±	  0.0	  x	  10-­‐6	  cm	  s-­‐1;	  n	  =	  13),	  with	  little	  variation	  between	  epithelia	  (Fig	  3.8A).	  
No	   differences	   in	   paracellular	   permeability	   between	   symmetrical	   and	   asymmetrical	   conditions	  
existed	  within	  different	  preparations	  of	  gill	  cell	  epithelia	  (P	  >	  0.05;	  Table	  3.1;	  Fig	  3.8B).	  
Table	  3.1	  
Summary	  of	  the	  14C-­‐mannitol	  permeabilities	  and	  TER	  of	  gill	  cell	  preparations.	  
	   Symmetrical	  (L-­‐15:L-­‐15)	   Asymmetrical	  (FW:L-­‐15)	  
	   TER	  ±	  SEM	   Permeability	  	   TER	  ±	  SEM	   Permeability	  
	   (Ω	  cm2)	   (x	  10-­‐6	  cm	  s-­‐1)	   (Ω	  cm2)	   (x	  10-­‐6	  cm	  s-­‐1)	  
Cell	  free	   0	  ±	  0	   4.68	  ±	  0.5	   0	  ±	  0	   3.63	  ±	  0.1	  
RTgill-­‐W1	   34	  ±	  3	   2.85	  ±	  0.1	   36	  ±	  2	   3.01	  ±	  0.1	  
SSI	   1240	  ±	  30	   0.22	  ±	  0.0	   1252	  ±	  11	   0.17	  ±	  0.0	  
DSI	   22970	  ±	  2000	   0.01	  ±	  0.0	   16423	  ±	  1690	   0.07	  ±	  0.0	  
Values	  represent	  average	  +/-­‐	  SEM	  
There	  was	  a	  significant	  difference	  in	  paracellular	  permeability	  between	  all	  cell	  preparations	  in	  both	  
symmetrical	   and	   asymmetrical	   conditions	   (F(7,36)	   =	   233.22;	   P	   =	   0.000).	   All	   gill	   cell	   preparations	  
exhibited	  significantly	  lower	  paracellular	  permeability	  than	  cell	  free	  conditions	  in	  symmetrical	  (P	  =	  
0.000)	  and	  asymmetrical	  conditions	  (P	  =	  0.000)	  apart	  from	  RTgill-­‐W1.	  Despite	  large	  differences	  in	  
TER	  between	  SSI	  and	  DSI,	  both	  these	  preparations	  of	  primary	  cells	  showed	  a	  significant	  decrease	  in	  
permeability	   compared	   to	   the	   cell	   free	   control	   (P	  =	   0.000;	   Table	   3.1;	   Fig	   3.8B)	   and	   the	   cell	   line	  
RTgill-­‐W1	  (P	  =	  0.000;	  Table	  3.1;	  Fig	  3.8B).	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Fig	  3.8	  14C-­‐mannitol	  permeability	  in	  gill	  cell	  epithelial	  preparations.	  14C-­‐mannitol	  was	  applied	  to	  the	  apical	  compartment	  
and	  its	  appearance	  monitored	  in	  the	  basolateral.	  (A)	  shows	  the	  relationship	  between	  14C-­‐mannitol	  permeability	  (after	  24	  
hours	  in	  asymmetrical	  conditions)	  and	  TER	  in	  DSI	  epithelia.	  Each	  data	  point	  represents	  one	  DSI	  epithelium	  (n	  =	  37)	  from	  
4	  biological	  replicates.	  (B)	  shows	  the	  reduction	  in	  mannitol	  permeability	  from	  the	  cell	  free	  condition	  in	  RTgill-­‐W1	  cell	  
preparations	  (n	  =	  4),	  SSI	  (n	  =	  4	  from	  2	  biological	  replicates)	  and	  DSI	  epithelia	  (n	  =	  10	  from	  3	  biological	  replicates).	  Orange	  
bars	  are	  symmetrical	  (L-­‐15:L-­‐15)	  and	  blue	  are	  asymmetrical	  (FW:L-­‐15)	  conditions.	  Those	  epithelia	  that	  are	  significantly	  
different	  from	  others	  are	  indicated	  by	  a	  different	  capital	  letter	  (one-­‐way	  ANOVA;	  P	  <	  0.05).	  Values	  are	  mean	  ±	  SEM.	  
Error	  bars	  are	  behind	  bars	  where	  none	  can	  be	  seen.	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Fig	  3.9	  Phase	  contrast	  microscope	  images	  of	  cells	  freshly	  isolated	  from	  the	  rainbow	  trout	  gill	  and	  stained	  with	  
Rhodamine-­‐123	  in	  (A)	  white	  light	  and	  (B)	  fluorescent	  light.	  An	  overlay	  of	  the	  two	  pictures	  identifies	  those	  mitochondria-­‐
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3.4.5	   Mitochondria-­‐rich	  cell	  staining	  
The	  presence	  of	  MRCs	  was	  observed	  in	  preparations	  of	  freshly	  isolated	  primary	  rainbow	  trout	  gill	  
cells	  stained	  with	  5	  μM	  Rhodamine-­‐123,	  confirming	  their	  presence	  after	  the	  initial	  isolation.	  These	  
can	  be	  viewed	  (e.g.	  at	  the	  arrow)	  in	  white	  light	  conditions	  (Fig	  3.9A),	  in	  fluorescent	  light	  (Fig	  3.9B),	  
and	   indeed	  when	  the	  two	  images	  are	  superimposed	  upon	  one	  another	  (Fig	  3.9C).	  Likewise,	  MRC	  
cells	  were	  observed	  in	  DSI	  epithelia	  that	  had	  surpassed	  5000	  Ω	  cm2	  and	  had	  been	  trypsinised	  and	  
stained	  with	  Rhodamine-­‐123	  (Fig	  3.10).	  
	  
Fig	  3.10	  Phase	  contrast	  microscope	  images	  of	  a	  cell	  isolated	  from	  a	  DSI	  epithelial	  preparation	  and	  stained	  with	  5	  μM	  
Rhodamine-­‐123	  (red).	  Light	  micrograph	  (A)	  and	  fluorescent	  image	  (B)	  of	  the	  cell.	  Overlaying	  the	  two	  images	  (C)	  confirms	  
the	  red	  fluorescent	  signal	  from	  the	  DSI	  cell,	  identifying	  it	  as	  a	  mitochondria-­‐rich	  cell	  (MRC).	  Bar	  =	  25	  μm.	  
3.4.6	   ZO-­‐1	  protein	  localisation	  
Staining	   using	   5	   μM	  Hoechst	   allowed	   visualisation	   of	   DSI	   cell	   nuclei	   (blue)	   in	   both	   preparations	  
from	   symmetrical	   and	   asymmetrical	   exposures	   (Fig	   3.11A;	   Fig	   3.11B).	  Overlaying	  of	   some	  nuclei	  
can	  be	  seen	  where	  cells	  were	  growing	   in	   layers.	  ZO-­‐1	  was	  successfully	  visualised	   (green)	  around	  
the	   periphery	   of	   cells.	   In	   this	   way,	   the	   cell	   surface	   morphology	   can	   be	   observed	   as	   a	   typical	  
polygonal	  ‘carpet’	  of	  PVCs.	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Fig	  3.11	  Confocal	  microscope	  images	  of	  DSI	  epithelia	  in	  (A)	  symmetrical	  conditions	  with	  L-­‐15	  media	  on	  both	  sides	  of	  the	  
epithelium	  and	  (B)	  in	  asymmetrical	  conditions	  with	  FW	  in	  the	  apical	  compartment	  and	  L-­‐15	  media	  in	  the	  basolateral	  for	  
24	  hours	  before	  cell	  fixing.	  Cell	  nuclei	  were	  stained	  with	  5	  μM	  Hoechst	  (blue)	  and	  tight	  junctions	  with	  zonula	  occludin	  
antibody	  (green).	  Bar	  =	  50	  μm.	  
3.4.7	   Double	  seeded	  inverted	  inserts	  
Similar	   to	  DSI	  epithelia,	   the	  TER	  of	  DSII	  epithelia	  rose	  during	  epithelial	  development	   from	  54.7	  ±	  
7.7	   Ω	   cm2	   on	   day	   4	   to	   15.5	   ±	   3.0	   kΩ	   cm2	   on	   day	   9	   (n	   =	   3),	   showing	   an	   increase	   of	   99%.	   After	  
freshwater	  exposure	   to	   the	  apical	   surface	  of	  DSII	  epithelia,	  TEP	  became	  positive	  with	   respect	   to	  
the	   apical	   (the	   basolateral	   surface),	   indicating	   a	   negative	   transepithelial	   potential	   across	   the	  
epithelium,	  like	  that	  seen	  in	  DSI.	  
DSII	  gill	  epithelia	  with	  a	  TER	  of	  3170	  ±	  360	  Ω	  cm2	  exhibited	  a	  mannitol	  permeability	  of	  0.1	  ±	  0.0	  x	  
10-­‐6	   cm	   s-­‐1	   in	   symmetrical	   conditions	   (n	   =	   3).	   This	   was	   significantly	   different	   from	   the	   cell	   free	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showed	  a	  mannitol	  permeability	  of	  0.1	  ±	  0.0	  x	  10-­‐6	  cm	  s-­‐1	  (n	  =	  8)	  which	  was	  significantly	  different	  
from	  the	  cell	  free	  control	  and	  not	  significantly	  different	  from	  the	  permeability	  of	  DSI	  epithelia	  (P	  =	  
0.000	  and	  P	  =	  0.06).	  
Staining	  using	  5	  μM	  Hoechst	   showed	   cell	   nuclei	   (blue)	   in	  DSII	   epithelia	   in	  both	   symmetrical	   and	  
asymmetrical	  conditions	  (Fig	  3.12A;	  Fig	  3.12B).	  Like	  in	  DSI,	  ZO-­‐1	  was	  visualised	  (green)	  around	  the	  
periphery	  of	  all	  cells	  and	  the	  DSII	  epithelia	  exhibited	  the	  typical	  polygonal	  ‘carpet’	  of	  cells	  on	  the	  
apical	  surface.	  
	  
Fig	  3.12	  Confocal	  microscope	  images	  of	  DSII	  epithelia	  in	  (A)	  symmetrical	  conditions	  with	  L-­‐15	  media	  on	  both	  sides	  of	  the	  
epithelium	  and	  (B)	  in	  asymmetrical	  conditions	  with	  FW	  in	  the	  apical	  compartment	  and	  L-­‐15	  media	  in	  the	  basolateral	  for	  
24	  hours	  before	  cell	  fixing.	  Cell	  nuclei	  were	  stained	  with	  5	  μM	  Hoechst	  (blue)	  and	  tight	  junctions	  with	  zonula-­‐occludin	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3.4.8	   DSII	  and	  3D	  hepatocyte	  co-­‐culture	  
Liver	   hepatocytes	  were	   observed	   to	   reach	  morphological	  maturity	   over	   9	   days	   in	   rotational	   cell	  
culture	  (Fig	  3.13A-­‐F).	  
	  
Fig	  3.13	  Phase	  contrast	  micrographs	  of	  3D	  liver	  hepatocytes	  developing	  through	  days	  2-­‐4	  (A-­‐C)	  and	  7-­‐9	  (D-­‐F).	  Bar	  =	  100	  
μm.	  Spheroids	  can	  be	  observed	  as	  small	  clusters	  on	  the	  second	  and	  third	  day	  after	  seeding	  into	  6	  well	  culture	  plates	  
coated	  in	  pHEMA	  (A	  and	  B).	  By	  day	  4,	  irregularly	  shaped	  immature	  spheroids	  have	  formed	  (C).	  The	  hepatocytes	  become	  
larger,	  with	  defined	  edges	  by	  days	  7	  and	  8	  (D	  and	  E)	  before	  reaching	  similarly	  shaped	  spheroids	  by	  day	  9	  (F).	  
	  
After	   the	   addition	   of	   mature	   hepatocytes	   to	   the	   basolateral	   surface	   of	   DSII	   epithelia	   (into	   the	  
apical	  chamber)	  on	  day	  9,	  the	  TER	  is	  shown	  to	  increase	  to	  values	  significantly	  higher	  than	  that	  of	  
cultures	  of	  only	  DSII	   on	  days	  9,	   10	   and	  11	   (P	  <	  0.05;	  n	   =	   7;	   Fig	   3.14),	   and	   the	   spheroids	   remain	  
morphologically	  stable	  during	  this	  time.	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Fig	  3.14	  The	  TER	  from	  2	  to	  22	  days	  of	  DSII	  epithelia	  (☐)	  and	  DSII	  epithelia	  in	  co-­‐culture	  with	  hepatocytes	  ()	  from	  day	  9	  
(dashed	  line)	  in	  symmetrical	  conditions	  with	  cell	  culture	  medium	  with	  FBS	  and	  antibiotics	  both	  sides	  of	  the	  epithelia.	  
Significant	  differences	  are	  indicated	  by	  the	  asterisk	  (independent	  samples	  t-­‐test;	  *P	  <	  0.05).	  The	  values	  represent	  mean	  
±	  SEM.	  Error	  bars	  are	  behind	  data	  points	  where	  none	  can	  be	  seen.	  
	  
3.5	  Discussion	  
The	  gill	  epithelial	  cells	  freshly	  isolated	  from	  juvenile	  rainbow	  trout	  can	  be	  cultured	  successfully	  in	  
cell	  culture	  flasks	  and	  on	  permeable	  membrane	  inserts	  using	  the	  SSI	  and	  DSI	  techniques.	  Likewise,	  
the	   immortalised	  rainbow	  trout	  gill	  cell	   line	  RTgill-­‐W1	  attaches	  and	  proliferates	  on	  the	  same	  cell	  
culture	   inserts.	  Gill	   epithelia	   grown	   from	  SSI	   cells	   are	   populations	   of	   solely	   PVCs	   (Wood	  &	  Pärt,	  
1997).	  
During	  gill	  cell	  epithelial	  development,	  SSI	  cells	  exhibited	  increases	  in	  TER	  of	  70%	  over	  7	  days.	  DSI	  
epithelial	  cells	  exhibited	  greater	  TER	  development,	  with	  values	  increasing	  approximately	  100-­‐fold	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Ω	   cm2	   after	   7-­‐14	   days,	   as	   has	   been	   previously	   documented	   (Fletcher	   et	   al.,	   2000;	  Wood	   et	   al.,	  
2002).	  An	   increase	   in	  TER	   is	   indicative	  of	   the	  organisation	  of	  an	  epithelial	   cell	   layer.	   Increases	   in	  
TER	  are	  not	  due	  to	   increases	   in	  cell	  number	  or	  growth,	  but	  rather	  the	   increases	   in	  tight	   junction	  
proteins	   expression	   and	   interaction	   (Wood	   et	   al.,	   2002),	   especially	   between	   PVCs	   and	   MRCs	  
(Fletcher	  et	  al.,	  2000),	  of	  which	  the	  latter	  are	  not	  present	  in	  SSI	  preparations	  (Wood	  et	  al.,	  1998),	  
and	   thus	  may	  explain	   their	  more	   limited	  epithelial	  development	   in	   terms	  of	  TER.	  Tight	   junctions	  
can	  also	  be	  observed	  in	  transmission	  electron	  micrographs	  of	  primary	  gill	  cells	  cultured	  using	  the	  
DSI	  technique	  (Wood	  &	  Pärt,	  1997;	  Fletcher	  et	  al.,	  2000).	  Mammalian	  epithelial	  cells	  cultured	  on	  
permeable	  cell	  culture	   inserts	  form	  epithelia	  with	  TERs	  of	  325	  Ω	  cm-­‐2	   for	  Caco-­‐2	  (Dickman	  et	  al.,	  
2000),	  <1000	  Ω	  cm-­‐2	  in	  blood-­‐brain	  barrier	  (BBB)	  models	  (Wilhelm	  et	  al.,	  2011)	  and	  173	  Ω	  cm-­‐2	  in	  
MDCK	  cells	   (Irvine	  et	  al.,	  1999).	   In	  contrast,	   the	  gills	  present	  a	   formidable	  barrier	   to	  paracellular	  
transport	   and	   the	   TER	   values	   observed	   in	   SSI	   and	   DSI	   confirm	   these	   preparations	   as	   ‘tight’	  
epithelia.	   The	   TER	   of	   RTgill-­‐W1	   cell	   preparations	   plateaued	   at	   lower	   values,	   equivalent	   to	  
approximately	  0.1%	  of	  the	  TER	  seen	  in	  DSI	  cell	  cultures.	  Addition	  of	  tetrabromocinnamic	  acid	  and	  
cortisol,	   both	   stimulators	   of	   the	   development	   of	   TER,	   to	   RTgill-­‐W1	   preparations	   does	   cause	  
improvement	  in	  RTgill-­‐W1	  TER	  development	  (Trubitt	  et	  al.,	  2015),	  but	  not	  to	  the	  values	  observed	  
in	  DSI	  preparations.	  
For	   all	   cell	   preparations,	   application	   of	   apical	   freshwater	   resulted	   in	   the	   increase	   of	   TER,	  which	  
dropped	  after	  48	  hours	  for	  DSI	  and	  SSI	  but	  was	  maintained	  in	  RTgill-­‐W1.	  The	  DSI	  exposed	  to	  apical	  
freshwater	   in	   this	   instance	   had	   already	   high	   TER	   values	   around	   27	   kΩ	   cm2,	   so	   after	   24	   hours	  
showed	   a	   smaller	   increase	   in	   TER.	   Typically,	   the	   increase	   in	   TER	   observed	   after	   freshwater	  
application	  depended	  on	  the	  TER	  before	  FW	  exposure	  –	  DSI	  epithelia	  at	  lower	  TER	  values	  around	  
5-­‐10	  kΩ	  cm2	  show	  much	  greater	  increases	  to	  similar	  30	  kΩ	  cm2	  values	  before	  declining	  as	  before,	  
whilst	  those	  at	  already	  high	  values	  show	  smaller	  increases,	  as	  they	  have	  already	  appeared	  to	  reach	  
their	   upper	   limit	   of	   TER	   values.	   Rapid	   increases	   in	   TER	  upon	   freshwater	   application	   are	  brought	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about	  by	   fast	   changes	   in	   transcellular	   or	   paracellular	   conductance	   in	   the	  epithelium	   (Wood	  and	  
Pärt,	  1997).	  The	  SSI	  and	  DSI	  epithelia	  show	  the	  highest	  observed	  TER	  after	  7	  days	  of	  development	  
and	  after	  freshwater	  application	  (Fig	  3.6;	  Wood	  et	  al.,	  2002),	  higher	  compared	  to	  other	  freshwater	  
gill	   surrogates	   such	  as	   the	  killifish	  opercular	  epithelium,	  which	   increases	   from	  294	   to	  660	  Ω	  cm2	  
after	   freshwater	   application	   (Wood	   &	  Marshall,	   1994),	   or	   the	   Nile	   tilapia	   opercular	   epithelium,	  
which	  increases	  from	  169	  to	  1052	  Ω	  cm2	  (Burgess	  et	  al.,	  1998).	  
In	  symmetrical	  conditions,	  no	  relationship	  between	  TER	  and	  TEP	  was	  observed,	  as	  the	  conditions	  
either	   side	   of	   the	   gill	   epithelium	   are	   the	   same.	   In	   these	   conditions,	   TEP	   is	   slightly	   negative	   and	  
becomes	   more	   negative	   after	   apical	   freshwater	   application	   (-­‐12.9	   ±	   2.9	   mV;	   -­‐10.3	   ±	   0.2	   mV,	  
Fletcher	   et	   al.,	   2000)	   to	   values	   similar	   to	   that	   observed	   in	   vivo	   (Potts,	   1984).	   The	   change	   in	  
membrane	   potential	   to	   basolateral	   negative	   generates	   an	   electrical	   gradient	   that	   aids	   cation	  
partitioning	   across	   the	   gill	   epithelium,	   specifically	   the	   differential	   permeability	   of	   the	   tight	  
junctions	  to	  Na+	  compared	  with	  Cl−	  (Fletcher	  et	  al.,	  2000).	  
Once	   a	   tight	   epithelium	   (>	   2000	   Ω	   cm2)	   has	   formed,	   the	   DSI	   in	   vitro	   gill	   presents	   a	   barrier	   to	  
paracellular	   transport	   that	   is	   relatively	   impermeable	  to	  the	  paracellular	  permeability	  marker	  14C-­‐
mannitol	  (Stott	  et	  al.,	  2015;	  Fig	  3.8A).	  The	  paracellular	  marker	  PEG4000	  also	  showed	  the	  relative	  
impermeability	   of	   DSI	   epithelia	   (Fletcher	   et	   al.,	   2000).	   Like	   increases	   in	   TER,	   this	   is	   not	   due	   to	  
increases	  in	  cell	  numbers	  or	  growth,	  but	  to	  the	  increases	  in	  tight	  junction	  proteins	  that	  form	  over	  
time	  as	   the	  epithelium	  develops	   (Wood	  et	  al.,	  2002).	  No	  differences	   in	  paracellular	  permeability	  
were	   observed	   between	   symmetrical	   and	   asymmetrical	   conditions	   in	   all	   gill	   cell	   preparations,	  
indicating	  that	  the	  application	  of	  freshwater	  does	  not	  disrupt	  the	  tight	  junctions	  formed	  between	  
gill	  cells,	  even	  after	  24	  hours.	  
In	  symmetrical	  conditions,	  the	  mannitol	  permeability	  of	  RTgill-­‐W1	  was	  significantly	  lower	  than	  that	  
of	   cell	   free	   inserts	   indicating	   that	   this	   epithelial	   cell	   line	   forms	   an	   impermeable	   layer.	  However,	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when	   freshwater	   is	   applied	   in	   asymmetrical	   conditions,	   no	   differences	   exist	   between	   the	  
permeability	  of	  cell	  free	  inserts	  and	  RTgill-­‐W1	  preparations,	  indicating	  that	  epithelia	  formed	  of	  this	  
cell	   line	   are	   permeable	   after	   24	   hours	   of	   freshwater	   exposure.	   For	   primary	   gill	   cells,	   the	  
paracellular	  permeability	  in	  SSI	  and	  DSI	  were	  significantly	  lower	  than	  both	  the	  cell	  free	  inserts	  and	  
the	   RTgill-­‐W1	   preparations	   in	   symmetrical	   conditions,	   and	   also	   after	   24	   hours	   of	   freshwater	  
exposure.	  These	  primary	  cells	  can	  tolerate	  freshwater	  at	  their	  apical	  surface	  due	  to	  their	  features	  
that	  are	  similar	  to	  the	  intact	  gill	  (Wood	  et	  al.,	  2002).	  MRCs	  contain	  an	  abundance	  of	  mitochondria	  
employed	   to	   synthesise	   the	   ATP	   required	   for	   active	   ionic	   transport	   (Perry,	   1997).	   The	  
mitochondrial	   fluorescent	  dye	  Rhodamine-­‐123	  identified	  those	  cells	  with	  abundant	  mitochondria	  
as	  MRCs	   in	   freshly	   isolated	  primary	   gill	   cells	   (Fig	   3.9)	   and	   cells	   grown	   in	  DSI	   (Fig	   3.10).	   Previous	  
work	  has	  estimated	  that	  DSI	  retain	  approximately	  10-­‐15%	  MRC,	  similar	  to	  those	  observed	   in	  vivo	  
(Walker	  et	  al.,	  2007).	  The	  SSI	  technique	  yields	  an	  epithelium	  composed	  of	  uniform	  PVCs	  and	  so	  no	  
MRCs	   can	   be	   observed	   (Wood	   et	   al.,	   2002).	  MRCs	   have	   also	   been	   observed	   in	   preparations	   of	  
RTgill-­‐W1	  grown	  on	  inserts	  and	  stained	  with	  Rhodamine-­‐123	  (Lee	  et	  al.,	  2009).	  
DSI	  epithelia	  exhibited	  a	  characteristic	  polygonal	  carpet	  of	  PVCs	  with	  the	  tight	  junction	  protein	  ZO-­‐
1	   adjoining	   cells	   (Fig	   3.11;	   Walker	   et	   al.,	   2007).	   ZO-­‐1	   and	   other	   transmembrane	   and	   cytosolic	  
proteins	  stitch	  cells	  together	  to	  form	  tight	  junctions	  (Chasiotis	  et	  al.,	  2012)	  (Fig	  1.4).	  In	  the	  teleost	  
gill,	   tight	   junction	   proteins	   form	   connections	   between	   cells	   to	   produce	   a	   barrier	   between	   the	  
environment	   and	   internal	  milieu	   of	   the	   organism	   (González-­‐Mariscal	   et	   al.,	   2003).	   The	   proteins	  
occludin	   and	   claudin	   are	   integral	   to	   the	   TJ	   backbone,	   as	   well	   as	   cadherins,	   ZOs	   and	   junction	  
adhesion	  molecules	   (JAMs)	   (Bauer	   et	   al.,	   2010;	   González-­‐Mariscal	   et	   al.,	   2003).	   Communication	  
between	  exposed	  transmembrane	  proteins	  between	  cells	  and	  ZO-­‐1	  allows	  information	  about	  the	  
external	   environment	   to	   be	   relayed	   to	   the	   cell	   nucleus,	   affecting	   transcriptional	   pathways	  
regulating	  membrane	  permeability	  (Chasiotis	  et	  al.,	  2012).	  The	  ZO-­‐1	  proteins	  visualised	  in	  DSI	  link	  
the	   external	   tight	   junction	   proteins	   such	   as	   claudin	   and	   occludins	   to	   the	   internal	   actin	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cytoskeleton,	  whilst	  also	  acting	  to	  transduce	  signals	  to	  the	  nucleus	  about	  tight	  junction	  formation	  
and	  cell	  proliferation	  (Bauer	  et	  al.,	  2010).	  The	  DSI	  tight	  junction	  complex	  is	  also	  evident	  by	  the	  high	  
TER	  measurements	  documented	  above.	  ZO-­‐1	   is	  also	  present	   in	  cultures	  of	  SSI	  and	   is	  confined	  to	  
the	   apical	   surface	   of	   the	   epithelium	  as	   in	  DSI,	   and	   addition	   of	   cortisol	   caused	   the	   deepening	   of	  
these	  tight	  junctions	  and	  increased	  the	  barrier	  properties	  of	  epithelia	  (Sandbichler	  et	  al.,	  2011b).	  
ZO-­‐1	  mRNA	  has	  been	  detected	  in	  RTgill-­‐W1	  epithelia	  grown	  on	  inserts,	  but	  its	   level	   is	  unaffected	  
by	   treatments	  with	   cortisol,	   and	   other	   hormone	   treatments	   such	   as	   carp	   growth	   hormone	   and	  
ovine	  prolactin	  (Trubitt	  et	  al.,	  2015).	  
A	   new	   double	   seeded	   inverted	   insert	   (DSII)	   technique	   is	   described.	   The	   development	   of	   this	  
protocol	   from	   the	  DSI	   technique	  was	   required	   to	   reduce	   the	  distance	  between	  cells	  of	  different	  
organ	  origins	  during	  co-­‐culture	  (as	  used	  in	  the	  in	  vitro	  blood	  brain	  barrier,	  BBB;	  Santaguida	  et	  al.,	  
2006),	  and	  to	  reduce	  the	  volumes	  of	  receiver	  medium	  to	   increase	  the	  chemical	  analytical	  power	  
necessary	  for	  assessing	  xenobiotic	  biotransformation	  (Kramer	  et	  al.,	  2010).	  Here	  for	  the	  first	  time,	  
the	   DSII	   epithelia	   are	   characterised	   and	   found	   to	   exhibit	   the	   same	   epithelial	   properties	   as	   DSI	  
preparations	  (Schnell,	  Stott,	  et	  al.,	  2016).	  The	  DSII	  develop	  in	  a	  similar	  way	  to	  DSI	  and	  reach	  TER	  
values	   as	   high	   as	   those	   previously	   observed.	   The	   permeability	   of	   DSII	   was	   found	   to	   not	   be	  
significantly	  different	  from	  DSI,	  and	  so	  these	  DSII	  preparations	  form	  a	  tight	  epithelial	  barrier	  with	  
low	  paracellular	  permeability.	  Furthermore,	   the	  ZO-­‐1	  protein	  was	   identified	   in	  DSII	  preparations,	  
and	  the	  epithelia	  exhibited	  the	  same	  polygonal	  morphology	  (Fig	  3.12)	  as	  that	  seen	  in	  DSI	  (Fig	  3.11).	  
The	  3D	  spheroidal	  hepatocyte	  primary	  cell	  culture	  described	  here	  was	  developed	  by	  Baron	  et	  al.	  
(2012)	  and	  successfully	  optimised	  for	  use	  in	  our	  laboratory	  such	  that	  the	  spheroids	  produced	  (Fig	  
3.13)	   morphologically	   resembled	   those	   previously	   described	   (Baron	   et	   al.,	   2012).	   The	   use	   of	  
spheroidal	   hepatocytes	   is	   an	   important	   advancement	   in	   the	   use	   of	   alternative	   in	   vitro	  methods	  
(3Rs)	  to	  study	  aquatic	  ecotoxicology,	  as	  the	  spheroids	  represent	  a	  more	  organotypic	  system,	  and	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exhibit	  properties	  more	  akin	  to	  the	  in	  vivo	  organ	  such	  as	  glucose	  and	  albumin	  production	  (more	  so	  
than	  2D	  monolayers)	  and	  reduced	  lactate	  dehydrogenase	  (LDH)	  leakage.	  
The	  co-­‐culture	  of	  primary	  DSII	  gill	  cell	  cultures	  and	  3D	  spheroidal	  hepatocytes	  is	  documented	  here	  
for	   the	   first	   time.	   The	   co-­‐culture	  of	   different	   cell	   types	   simulates	   the	   in	   vivo	   environment	  more	  
accurately	  than	  monoculture	  and	  allows	  important	  cell-­‐to-­‐cell	  communication	  (Miki	  et	  al.,	  2012).	  It	  
is	  widely	  used	  in	  BBB	  study,	  as	  the	  co-­‐culture	  of	  different	  cell	  types	  promote	  the	  development	  of	  
epithelia	  with	  higher	  TER,	  deeper	  tight	  junctions	  and	  cells	  that	  display	  more	  pronounced	  structural	  
changes	  with	  better	  functionality	  than	  when	  grown	  as	  monocultures	  (Dehouk	  et	  al.,	  1990;	  Hurst	  &	  
Fritz,	  1996;	  Abbott	  et	  al.,	  2006).	  Here,	  both	  the	  DSII	  and	  spheroids	  remain	  viable	  during	  co-­‐culture,	  
and	   the	   TER	   of	   DSII	   in	   co-­‐culture	   is	   shown	   to	   be	   significantly	   greater	   than	   that	   of	   DSII	   in	  
monoculture	  on	  the	  first	  3	  days	  after	  co-­‐culture.	  This	  primary	  rainbow	  trout	  in	  vitro	  cell	  system	  can	  
be	  used	  to	  study	  the	  uptake	  of	  xenobiotics	  across	  the	  gill	  and	  the	  metabolism	  of	  xenobiotics	  in	  the	  
liver,	  which	  may	  more	  accurately	  represent	  the	  process	  in	  vivo.	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Chapter	  4	  
The	  paracellular	  permeability	  of	  gill	  cell	  epithelia	  
	  
4.1	  Abstract	  
There	  is	  high	  demand	  for	  developing	  alternative	  methods	  to	  in	  vivo	  experimentation.	  A	  number	  of	  
ecotoxicity	   tests	   use	   live	   fish	   that	  have	   to	  be	   carried	  out	  due	   to	  REACH	   legislation.	   Two	  models	  
currently	  being	  investigated	  to	  supplement	  or	  replace	  live	  fish	  in	  ecotoxicity	  testing	  are	  primary	  gill	  
cells	  and	  the	  gill	  cell	  line	  RTgill-­‐W1.	  The	  advantage	  of	  the	  former	  is	  that	  it	  allows	  the	  exposure	  of	  
gill	   cells	   to	  waterborne	  chemicals,	  mimicking	  one	  of	   the	  most	  critical	   sites	  of	   toxicity	  of	   fish,	   the	  
gill.	   This	   ability	   to	   form	   a	   polarised	   epithelium	   capable	   of	   tolerating	  water	   at	   the	   apical	   surface	  
would	  be	  desirable	  in	  the	  gill	  cell	   line	  RTgill-­‐W1	  if	   it	  were	  to	  be	  used	  as	  a	  replacement	  for	  whole	  
fish	  uptake	  assays.	   To	  assess	   the	  ability	  of	  RTgill-­‐W1	  cells	   to	   form	  a	   tight	  epithelium	  on	   the	   cell	  
culture	  inserts	  as	  used	  in	  primary	  gill	  cell	  models,	  a	  number	  of	  culture	  scenarios	  were	  performed.	  
RTgill-­‐W1	  was	  previously	  cultured	  in	  flasks	  for	  more	  than	  12	  months	  in	  cell	  culture	  medium	  (L-­‐15),	  
or	  medium	  supplemented	  with	  either	  cortisol	  (100	  ng	  mL-­‐1)	  or	  epithelial	  growth	  factor	  (100	  ng	  mL-­‐
1)	  before	  being	  seeded	  at	  different	  densities	  on	  culture	   inserts.	   In	  some,	  primary	  gill	  cells	   (either	  
freshly	   isolated	  or	  cultured	  previously	   in	   flasks)	  were	   then	  seeded	  on	  top.	  For	  each	  scenario	   the	  
transepithelial	  resistance	  (TER)	  was	  monitored	  for	  7-­‐10	  days	  before	  water	  was	  added	  to	  the	  apical	  
surface	  for	  48	  hours.	  The	  epithelial	  permeability	  of	  the	  different	  preparations	  was	  also	  measured	  
using	   14C-­‐mannitol.	   TER	   increased	   in	   RTgill-­‐W1	   cells	   cultured	   on	   permeable	   supports	   and	  
supplemented	   with	   cortisol.	   This	   was	   observed	   most	   in	   RTgill-­‐W1	   cells	   seeded	   at	   the	   lowest	  
seeding	  density	   (0.1	   x	   106)	   and	  with	   0.7	   x	   106	   primary	   gill	   cells,	   previously	   grown	   in	   cell	   culture	  
flasks,	   seeded	   on	   top.	   The	   paracellular	   permeability	   of	   these	   was	   also	   lowest	   in	   symmetrical	  
conditions	   and	   in	   asymmetrical	   conditions	   after	   24	   hours	   of	   freshwater	   exposure	   to	   the	   apical	  
surface	  of	  the	  cells.	  However,	  the	  symmetrical	  paracellular	  permeability,	  with	  cell	  culture	  medium	  
both	  sides	  of	  the	  epithelium,	  is	  still	  higher	  than	  that	  of	  just	  single	  seeded	  (SSI)	  primary	  gill	  cells.	  In	  
asymmetrical	   conditions	   however,	   paracellular	   permeability	   decreased	   to	   values	   similar	   to	   SSI	  
cells.	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4.2	  Introduction	  
Advances	   in	   primary	   gill	   cell	   culture	   techniques	   have	   provided	   an	   in	   vitro	  model	   to	   study	   the	  
freshwater	  gill	   (Bury	  et	  al.,	  2014).	  This	   system	  cultures	  primary	  gill	   cells	  on	  a	   flat	  permeable	  cell	  
culture	   membrane	   in	   a	   two-­‐compartment	   model	   that	   promotes	   the	   development	   of	   a	   gill	  
epithelium	   with	   an	   apical	   and	   basolateral	   cell	   surface.	   In	   this	   way,	   cells	   maintain	   many	   of	   the	  
physiological	   characteristics	   of	   the	   tissue	   from	   which	   they	   were	   isolated	   (Schnell,	   Stott	   et	   al.,	  
2016).	  However,	   there	  are	  disadvantages	   in	  dealing	  with	  primary	  cells	   in	  culture;	   it	  being	   labour	  
intensive	   and	   producing	   cell	   cultures	   with	   shorter	   life	   spans	   (Bols	   et	   al.,	   2005).	   Furthermore,	  
individual	  differences	  between	  animals	  from	  which	  cells	  are	  obtained	  mean	  there	  is	  more	  likely	  to	  
be	   variation	   between	   biological	   replicates,	   which	  may	   lead	   to	   difficulties	   in	   obtaining	   data	   in	   a	  
reproducible	  manner.	  
An	  alternative	  to	  primary	  rainbow	  trout	  cell	  culture	  uses	  immortalised	  cell	  lines,	  the	  availability	  of	  
which	   has	   increased	   in	   recent	   years	   and	   removes	   the	   requirement	   for	   live	   fish	   in	   line	  with	   the	  
reduction,	   refinement	   and	   replacement	   (3Rs)	   of	   animals	   in	   scientific	   procedures.	   Cell	   lines	   are	  
used	   to	   assay	   common	   cellular	   responses	   such	   as	   cytotoxicity,	   cell	   growth,	   genotoxicity	   and	  
xenobiotic	   metabolism	   (Bols	   et	   al.,	   2005).	   Rainbow	   trout	   cell	   lines	   include	   populations	   derived	  
from	  seven	  different	   tissues,	   including	  RTL-­‐W1	   (Lee	  et	   al.,	   1993)	  derived	   from	   liver;	  RTG-­‐2	   from	  
gonad	  (Wolf	  &	  Quimby,	  1962);	  RTgutGC	  from	  intestine	  (Kawano	  et	  al.,	  2011);	  RTbrain	  from	  brain	  
(Ganassin	  &	  Bols,	  1997);	  RTS11	  from	  spleen	  (Ganassin	  &	  Bols,	  1998);	  RTP-­‐2,	  RTP-­‐91E	  and	  RTP-­‐91F	  
from	  the	  female	  and	  male	  pituitary	  (Bols	  et	  al.,	  1995;	  Tom	  et	  al.,	  2001)	  and	  RTgill-­‐W1	  from	  the	  gill	  
(Bols	   et	   al.,	   1994).	  Compared	   to	  primary	  gill	   cells,	   the	  gill	   cell	   line	  RTgill-­‐W1	   is	   relatively	  easy	   to	  
maintain	  and	  handle	  and	  can	  be	  routinely	  cultured	  in	  the	  laboratory	  for	  many	  passages	  (Bols	  et	  al.,	  
1994).	  The	   repeated	  culture	  of	  cell	   lines	  may	   result	   in	   the	   loss	  of	  morphological	  or	  physiological	  
characteristics	  of	   the	  original	   cells	  or	   tissue,	   including	   the	   loss	  of	   three	  dimensional	   structure	  or	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differences	   in	   mRNA	   expression	   during	   the	   stabilisation	   of	   cell	   lines	   (Fischer	   et	   al.,	   2011).	  
Pavement	  cells,	  mitochondria-­‐rich	  cells	  and	  goblet	   cells	  have	  been	   reported	   in	  RTgill-­‐W1	   (Lee	  et	  
al.,	  2009),	  although	  the	  microridges	  of	  PVCs	  are	  absent,	  the	  numbers	  of	  mitochondria	  in	  MRCs	  are	  
fewer	   and	   the	   Golgi	   complex	   and	   cytoplasmic	   droplets	   of	   mucous	   cells	   are	   absent	   (Bols	   et	   al.,	  
1994).	   Furthermore,	   a	   fundamental	   physiological	   feature	   of	   gill	   epithelial	  membrane	   integrity	   is	  
high	  transepithelial	   resistance	   (corresponding	  to	   low	  paracellular	  permeability),	  which	  the	  RTgill-­‐
W1	   cell	   line,	   appears	   to	   lack	   (Trubitt	   et	   al.,	   2015).	   Once	   cultured	   on	   permeable	   supports,	  
transepithelial	  resistance	  values	  in	  RTgill-­‐W1	  typically	  reach	  30	  Ω	  cm2,	  whilst	  primary	  gill	  cells	  can	  
surpass	  values	  one	  thousand	  times	  that	  to	  around	  30,000	  Ω	  cm2	  (see	  Chapter	  3).	  The	  RTgill-­‐W1	  cell	  
line	   also	   appears	   to	   be	   deficient	   in	   certain	   metabolic	   enzymes	   such	   as	   CYP1A	   (Schirmer	   et	   al.,	  
1998).	  Nonetheless,	  the	  removal	  of	  the	  requirement	  of	  live	  fish	  offers	  an	  appealing	  advantage	  of	  
using	   fish	   cell	   lines,	   and	   their	   incorporation	   into	   regulatory	   testing	   legislation	   has	   been	  
recommended	  (Dayeh	  et	  al.,	  2013).	  
Low	   paracellular	   permeability	   is	   principle	   in	   the	   functioning	   of	   the	   freshwater	   gill,	   due	   to	   the	  
osmotic	   gradient	   between	   blood	   and	   external	   freshwater	   that	   has	   to	   be	  maintained	   (González-­‐
Mariscal	  et	  al.,	  2003).	  In	  vivo,	  this	  is	  achieved	  through	  the	  development	  of	  tight	  junctions	  between	  
cells	  provided	  by	  proteins	  such	  as	  claudin,	  occludin,	  cadherin,	  zonula	  occludin	  (ZO-­‐1)	  and	  junction	  
adhesion	  molecules	  (JAMs)	  (Chasiotis	  et	  al.,	  2012).	  Some	  of	  these	  have	  been	  characterised	  in	  both	  
primary	  gill	  cells	  (Sandbichler	  et	  al.,	  2011a)	  and	  RTgill-­‐W1	  (Trubitt	  et	  al.,	  2015).	  
Culturing	   primary	   gill	   cells	   with	   cortisol	   has	   been	   shown	   to	   improve	   epithelial	   development	   as	  
illustrated	   by	   increases	   in	   transepithelial	   resistance	   and	   decreases	   in	   paracellular	   permeability	  
(Chasiotis	   et	   al.,	   2010).	   Furthermore,	   occludin	   protein	   abundance	   increased	   dose-­‐dependently	  
with	   cortisol	   treatment	   (Chasiotis	   et	   al.,	   2010).	   Epidermal	   growth	   factor	   (EGF)	   binds	   to	   the	   EGF	  
receptor	  resulting	  in	  cell	  growth	  proliferation	  and	  differentiation.	  In	  epidermal	  cells,	  this	  is	  known	  
to	  encourage	  the	  formation	  of	  tighter	  junctions	  between	  cells	  by	  concentrating	  the	  tight	  junction	  
4.	  Paracellular	  permeability	  of	  gill	  cell	  epithelia	  
Lucy	  C.	  Stott	  |	  97	  
protein	  ZO-­‐1	  at	  these	  junctions	  (González-­‐Mariscal	  et	  al.,	  2003).	  However	  application	  of	  10	  ng	  mL-­‐1	  
to	   primary	   gill	   cell	   medium	   did	   not	   significantly	   improve	   either	   attachment	   efficiency	   or	   cell	  
growth	  as	  measured	  by	  3H-­‐thymidine	  incorporation	  (Pärt	  et	  al.,	  1993).	  
In	  blood	  brain	  barrier	  (BBB)	  in	  vitro	  models,	  cells	  of	  different	  types	  may	  be	  co-­‐cultured	  together	  in	  
order	   to	   induce	   certain	   epithelial	   characteristics	   such	   as	   higher	   transepithelial	   resistance,	   low	  
paracellular	  permeability	  and	  transporter	  expression	  (Wilhelm	  et	  al.,	  2011).	  Astrocytes	  are	  known	  
to	  stimulate	  BBB	  properties	  in	  other	  endothelial	  cells	  and	  so	  can	  be	  co-­‐cultured	  with	  cell	   lines	  to	  
produce	  a	  more	  accurate	  BBB	  model	  (Gaillard	  et	  al.,	  2001).	  
In	  this	  study,	  the	  rainbow	  trout	  gill	  cell	  line	  RTgill-­‐W1	  was	  treated	  with	  EGF	  or	  cortisol	  to	  improve	  
epithelial	   development	   and	   membrane	   integrity	   in	   terms	   of	   transepithelial	   resistance	   and	  
paracellular	   permeability.	   Some	   populations	   were	   also	   co-­‐cultured	   with	   primary	   cells	   (either	  
freshly	   isolated	  or	  previously	  seeded	  in	  cell	  culture	  flasks)	   in	  order	  to	  further	  stimulate	  epithelial	  
membrane	   development.	   Transepithelial	   resistance	   (TER)	   was	   monitored	   for	   7-­‐10	   days,	   after	  
which	  a	  mannitol	  permeability	  assay	  was	  conducted	  to	  quantify	  paracellular	  permeability.	  
	  
4.3	  Materials	  and	  Methods	  
4.3.1	   Reagents	  and	  suppliers	  
Reagents	  purchased	  were	   the	  same	  as	   those	  outlined	   in	  Chapter	  2	  with	   the	   following	  additions.	  
Epidermal	  growth	  factor	  (EGF)	  and	  cortisol	  were	  purchased	  from	  Sigma	  Aldrich.	  14C-­‐mannitol	  was	  
obtained	  from	  Amersham	  as	  before.	  
4.3.2	   Equipment	  and	  suppliers	  
Equipment	  used	  was	  the	  same	  as	  those	  outlined	  in	  Chapter	  2.	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4.3.3	   Preparation	  of	  reagents	  
Reagents	  were	  prepared	  as	  outlined	  in	  Chapter	  2.	  
4.3.4	   Cell	  culture	  reagents	  
Cell	   culture	   reagents	   were	   prepared	   as	   outlined	   in	   Chapter	   2.	   During	   culture	   and	  maintenance	  
before	   experimental	   procedures,	   EGF	   or	   cortisol	   were	   added	   to	   RTgill-­‐W1	   culture	  medium	   at	   a	  
concentration	  of	  100	  ng	  mL-­‐1.	  
4.3.5	   Methods	  
The	  general	  material	  and	  methods	  for	  the	  maintenance	  of	  RTgill-­‐W1	  and	  the	  primary	  cell	  culture	  
of	   both	   SSI	   (single	   seeded	   inserts	   from	  primary	   cells	   initially	   cultured	   in	   flasks)	   and	  DSI	   (double	  
seeded	  inserts)	  are	  outlined	  in	  Chapter	  2.	  
4.3.6	   RTgill-­‐W1	  cell	  culture	  
The	   rainbow	   trout	   gill	   cell	   line,	   RTgill-­‐W1,	   was	   maintained	   according	   to	   Bols	   et	   al.	   (1994).	   At	  
passage	  P70,	   the	   cells	  were	   split	   into	   3	   cell	   culture	   flasks	   and	  maintained	   in	   normal	   cell	   culture	  
media	  supplemented	  with	  antibiotics	  (L-­‐15)	  or	  with	  additional	  EGF	  or	  cortisol	  at	  a	  concentration	  of	  
100	  ng	  mL-­‐1	   (Pärt	   et	   al.,	   1993;	  Wood	  et	   al.,	   2002).	  Dr	   Sabine	  Schnell	  maintained	   the	   cells	  under	  
these	  conditions	  for	  more	  than	  12	  months	  according	  to	  the	  normal	  maintenance	  protocol.	  
4.3.7	   Experimental	  set	  up	  
RTgill-­‐W1	  cells	  at	  passage	  P90-­‐114	  (Fig	  4.1)	  cultured	   in	  L-­‐15,	  EGF	  or	  cortisol,	  were	  trypsinised	  by	  
removing	   the	   culture	   medium	   before	   applying	   500	   μL	   0.05%	   trypsin-­‐EDTA	   for	   approximately	   3	  
minutes	  at	   room	  temperature.	  Applying	  10	  mL	  of	  cell	   culture	  solution	  stopped	  the	  action	  of	   the	  
trypsin	  and	  cells	  were	  collected	  in	  a	  50	  mL	  conical	  tube.	  RTgill-­‐W1	  cells	  were	  stained	  for	  viability	  
using	  Trypan	  blue	  and	  diluted	   in	   cell	   culture	  medium	   to	   the	  appropriate	   cell	   concentration.	   The	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cells	  were	  then	  seeded	  onto	  permeable	  membrane	  inserts	  at	  densities	  of	  0.1,	  0.2	  or	  0.5	  x	  106	  (n	  =	  
24	  per	  seeding	  density	  [3],	  per	  condition	  [3],	  total	  n	  =	  216,	  Fig	  4.1)	  in	  1.5	  mL	  and	  2.0	  mL	  cell	  culture	  
medium	   (with	   or	   without	   supplementation	   with	   EGF	   or	   cortisol)	   in	   the	   apical	   and	   basal	  
compartments	  respectively	  and	  maintained	  at	  18°C	   in	  the	  dark.	  The	  first	  of	  these	  sets	  (n	  =	  8	  per	  
seeding	  density)	  was	  maintained	  for	  7-­‐10	  days	  with	  a	  media	  change	  every	  2-­‐3	  days	  (Fig	  4.1A).	  The	  
second	  set	  (n	  =	  8)	  was	  seeded	  the	  next	  day	  with	  0.7	  x	  106	  primary	  gill	  cells	  that	  had	  been	  grown	  in	  
flasks	  for	  6-­‐8	  days	  previously	  (Wood	  &	  Pärt,	  1997)	  (Fig	  4.1B),	  and	  the	  third	  set	  (n	  =	  8)	  with	  1.2	  x	  106	  
freshly	  isolated	  primary	  rainbow	  trout	  gill	  cells	  (Chapter	  2)	  (Fig	  4.1C).	  These	  preparations	  were	  also	  
maintained	  at	  18°C	  in	  the	  dark	  for	  7-­‐10	  days	  with	  a	  media	  change	  every	  2-­‐3	  days.	  
4.3.8	   Epithelial	  development	  and	  L-­‐15	  or	  freshwater	  exposure	  
The	   development	   of	   cells	   to	   form	   electrically	   tight	   epithelia	   was	   monitored	   by	   transepithelial	  
resistance	   (TER)	   for	   7-­‐10	   days	   following	   cell	   seeding	   using	   a	   custom-­‐modified	   epithelial	   tissue	  
voltohmmeter	  fitted	  with	  chopstick	  electrodes.	  As	  previously,	  a	  ‘blank’	  cell	  free	  insert	  (for	  12	  well	  
culture	  plates)	  gave	  a	  value	  of	  180	  Ω	  cm2,	  which	  was	  subtracted	  from	  each	  measurement.	  At	  days	  
7-­‐10,	   all	   inserts	   were	   prepared	   by	   washing	   with	   2	   x	   200	   μL	   PBS	   and	   1.5	   mL	   of	   L-­‐15	   without	  
antibiotics	  or	  FBS	  was	  applied	  to	  the	  apical	  chamber	  of	  half	  of	  the	  epithelia	  (symmetrical;	  n	  =	  108),	  
whilst	   the	   other	   half	   were	   changed	   to	   FW	   (asymmetrical;	   n	   =	   108;	   Fig	   4.1).	   The	   basolateral	  
compartment	  always	  contained	  2.0	  mL	  L-­‐15.	  TER	  was	  then	  again	  monitored.	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Fig	  4.1	  Diagram	  of	  the	  experimental	  set	  up	  and	  passage	  numbers	  of	  RTgill-­‐W1	  cells	  routinely	  cultured	  in	  flasks	  (>	  6	  
months)	  in	  cell	  culture	  medium	  with	  antibiotics	  (L15;	  orange	  plates),	  or	  with	  supplementation	  with	  100	  ng	  mL-­‐1	  
epidermal	  growth	  factor	  (EGF;	  green	  plates)	  or	  100	  ng	  mL-­‐1	  cortisol	  (red	  plates)	  and	  seeded	  at	  0.1,	  0.2	  and	  0.5	  x106	  cells	  
per	  insert	  (A).	  Inserts	  in	  (B)	  were	  double	  seeded	  on	  top	  the	  next	  day	  with	  0.7	  x	  106	  primary	  rainbow	  trout	  gill	  cells	  grown	  
in	  flasks	  for	  the	  previous	  6-­‐9	  days,	  whilst	  those	  in	  (C)	  were	  seeded	  on	  top	  with	  1.2	  x	  106	  freshly	  isolated	  rainbow	  trout	  gill	  
cells.	  The	  first	  set	  (1)	  were	  exposed	  to	  L-­‐15	  in	  symmetrical	  conditions	  for	  24	  hours	  whilst	  those	  in	  (2)	  were	  exposed	  to	  
apical	  freshwater	  for	  24	  hours	  in	  asymmetrical	  conditions.	  
A 
Single seed (SSI) RTgill-W1 
1 Symmetrical 2 Asymmetrical 
B 
SSI RTgill-W1, DSI 1° Flask (0.7 x 106) 
C 
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4.3.9	   Paracellular	  permeability	  
To	  provide	  the	  quantitative	  assessment	  of	  paracellular	  permeability,	   the	  transport	  of	  the	  marker	  
molecule	  14C-­‐mannitol	  across	  gill	  epithelia	  was	  measured	  (Petri	  et	  al.,	  2004).	  This	  marker	  has	  low	  
protein	   binding	   affinity	   and	   a	   lower	   molecular	   weight	   than	   the	   PEG-­‐4000	   commonly	   used	   in	  
permeability	   assays,	   making	   it	   more	   sensitive	   so	   that	   small	   changes	   in	   permeability	   between	  
conditions	  may	  be	  detected	  (Shah	  et	  al.,	  2007).	  
Twenty-­‐four	   hours	   after	   FW	  or	   L-­‐15	   exposure,	   0.013	   μCi	   (2.2	   x	   105	   dpm	  mL-­‐1)	   14C-­‐mannitol	  was	  
applied	  to	  the	  apical	  compartment	  (in	  either	  FW	  or	  L-­‐15	  medium	  accordingly)	  and	  its	  appearance	  
was	  monitored	  in	  the	  L-­‐15	  medium	  in	  the	  basolateral	  compartment	  after	  24	  hours.	  From	  this,	  the	  
mannitol	  flux	  was	  calculated	  using	  the	  following	  equation	  
𝑃𝑒𝑟𝑚𝑒𝑎𝑏𝑖𝑙𝑖𝑡𝑦   𝑐𝑚  𝑠!! =    [∆𝑀]!"   𝑥  𝑣𝑜𝑙𝑢𝑚𝑒𝑀!"  𝑥  𝑡𝑖𝑚𝑒  𝑥  3600  𝑥  𝑎𝑟𝑒𝑎	  
where	   [ΔM]BL	   is	   the	  change	   in	  radioactivity	   in	   the	  basal	  compartment,	  MAP	   is	   the	  radioactivity	  at	  
the	  start,	  time	  is	  24	  hours,	  3600	  converts	  hours	  to	  seconds	  and	  area	  is	  0.9	  cm2	  (Wood	  et	  al.,	  1998).	  
The	  rate	  of	  flux	  was	  then	  expressed	  as	  a	  percentage	  of	  the	  mannitol	  flux	  in	  the	  cell	  free	  negative	  
control.	  Data	  are	  expressed	  as	  means	  ±	  SEM,	  n	  =	  3-­‐4	  in	  each	  condition	  (Fig	  4.1).	  
4.3.10	   Analysis	  of	  data	  and	  statistics	  
Differences	   in	   the	  paracellular	   permeability	   of	   gill	   cell	   cultures	  were	   tested	   for	  within	   a	   seeding	  
condition	  for	  either	  symmetrical	  or	  asymmetrical	  scenarios	  –	  that	   is	  within	  the	  RTgill-­‐W1	  seeded	  
group	  (Fig	  4.2A;	  Fig	  4.3A),	  the	  RTgill-­‐W1	  with	  primary	  flask	  cells	  seeded	  on	  top	  (Fig	  4.2B;	  Fig	  4.3B)	  
and	  RTgill-­‐W1	  with	  freshly	  isolated	  primary	  cells	  (Fig	  4.2C;	  Fig	  4.3C).	  The	  data	  were	  expressed	  as	  a	  
percentage	  of	  mannitol	   flux	   in	  a	  cell	   free	  control	   insert	  and	  then	   log	  transformed,	  before	  testing	  
for	   differences	   by	   a	   two-­‐way	  ANOVA.	   Statistical	   significance	  was	   accepted	  when	  P	   <	   0.05	   (SPSS	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software	  v21,	  SPSS	  Inc.).	  All	  graphical	  illustrations	  were	  produced	  using	  either	  Excel	  or	  PowerPoint	  
(Microsoft	  Office)	  or	  Sigmaplot	  (Systat	  Software	  Inc.).	  
	  
4.4	  Results	  
4.4.1	   Epithelial	  development	  
Dr	  Sabine	  Schnell	  completed	  the	  TER	  measurements	  to	  monitor	  epithelial	  development	  and	  so	  the	  
data	  for	  this	  is	  not	  shown	  but	  instead	  a	  general	  summary	  of	  results	  is	  included.	  
RTgill-­‐W1	  (Fig	  4.1A)	  cultured	  in	  L-­‐15	  or	  L-­‐15	  supplemented	  with	  EGF	  showed	  no	  increases	   in	  TER	  
after	  7	  days	  of	  culture.	  Those	  cells	  cultured	  with	  cortisol	   increased	  from	  approximately	  20	  Ω	  cm2	  
to	  65	  Ω	  cm2.	  
RTgill-­‐W1	   double	   seeded	   with	   primary	   cells	   previously	   grown	   in	   flasks	   (Fig	   4.1B)	   showed	   no	  
increases	   in	  TER	  when	  cultured	   in	  L-­‐15	  alone.	  Those	  co-­‐cultured	   in	  L-­‐15	  supplemented	  with	  EGF	  
increased	   to	   from	   around	   20	   to	   144,	   116	   and	   64	   Ω	   cm2	   for	   the	   0.1,	   0.2	   and	   0.5	   x	   106	   seeding	  
conditions	  respectively.	  Those	  cultured	  with	  100	  ng	  mL-­‐1	  cortisol	  showed	  the	   largest	   increases	  of	  
all	  conditions	  from	  around	  20	  to	  354	  Ω	  cm2	  for	  the	  0.1	  x	  106	  seeding	  condition,	  and	  values	  to	  130	  
and	  55	  Ω	  cm2	  for	  the	  0.2	  and	  0.5	  x	  106	  RTgill-­‐W1	  seeding	  densities.	  
RTgill-­‐W1	  double	  seeded	  with	  freshly	   isolated	  primary	  cells	   (Fig	  4.1C)	  showed	  no	  changes	   in	  TER	  
when	  cultured	  in	  L-­‐15	  alone	  in	  all	  seeding	  densities.	  Those	  cultured	  in	  L-­‐15	  supplemented	  with	  EGF	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4.4.2	   Paracellular	  Permeability	  
RTgill-­‐W1	   cells	   seeded	   alone,	   in	   symmetrical	   conditions	   (with	   L-­‐15	   both	   side	   of	   the	   epithelium)	  
showed	   the	   lowest	   permeability	   when	   not	   supplemented	   with	   EGF	   or	   cortisol,	   in	   all	   seeding	  
densities.	   RTgill-­‐W1	   cells	   seeded	   at	   0.2	   x	   106	   had	   the	   lowest	   mannitol	   permeability	   of	   60.99	   ±	  
2.18%	  of	  the	  cell	  free	  control	  (Table	  4.1;	  Fig	  4.2A).	  RTgill-­‐W1	  cells	  seeded	  at	  the	  lowest	  density	  of	  
0.1	   x	   106	   and	   supplemented	   with	   100	   ng	   mL-­‐1	   EGF	   had	   the	   highest	   at	   93.92	   ±	   3.80%	   cell	   free	  
control.	  Here,	  seeding	  density	  and	  culture	  condition	  had	  a	  significant	  effect	  on	  permeability	   (P	  <	  
0.001),	  but	  not	  when	  combined	  (P	  =	  0.069;	  Table	  4.1;	  Fig	  4.2A).	  
Table	  4.1	  
Summary	  of	  the	  14C-­‐mannitol	  permeabilities	  of	  RTgill-­‐W1	  treatments,	  expressed	  as	  %	  of	  the	  cell	  free	  control.	  
	   	   Permeability	  (x	  10-­‐6	  cm	  s-­‐1)	  















0.1	   L-­‐15	   70.55	  ±	  3.33	   43.11	  ±	  1.59	   61.42	  ±	  1.26	   100.22	  ±	  3.77	   66.83	  ±	  2.42	   75.02	  ±	  1.05	  
	   EGF	   93.92	  ±	  3.80	   48.82	  ±	  2.46	   70.25	  ±	  5.89	   84.49	  ±	  2.17	   44.76	  ±	  5.83	   80.52	  ±	  0.74	  
	   Cortisol	   82.10	  ±	  1.97	   28.05	  ±	  0.84	   59.10	  ±	  1.66	   88.16	  ±	  0.34	   7.09	  ±	  0.69	   86.63	  ±	  2.85	  
0.2	   L-­‐15	   60.99	  ±	  2.18	   54.75	  ±	  5.53	   62.99	  ±	  3.46	   101.11	  ±	  2.50	   70.70	  ±	  1.21	   70.26	  ±	  1.19	  
	   EGF	   76.55	  ±	  1.91	   64.31	  ±	  2.81	   77.55	  ±	  2.41	   79.35	  ±	  1.40	   58.51	  ±	  5.83	   75.36	  ±	  2.34	  
	   Cortisol	   77.43	  ±	  2.60	   38.42	  ±	  1.55	   65.65	  ±	  6.65	   70.25	  ±	  0.98	   25.08	  ±	  1.91	   74.55	  ±	  5.21	  
0.5	   L-­‐15	   63.91	  ±	  2.84	   52.93	  ±	  2.59	   63.29	  ±	  2.63	   86.01	  ±	  1.37	   54.00	  ±	  0.97	   58.96	  ±	  1.11	  
	   EGF	   76.37	  ±	  1.82	   66.43	  ±	  1.26	   71.79	  ±	  6.42	   71.25	  ±	  0.30	   54.55	  ±	  0.70	   59.96	  ±	  1.38	  
	   Cortisol	   70.65	  ±	  1.50	   44.61	  ±	  2.60	   60.99	  ±	  1.23	   64.82	  ±	  0.68	   40.15	  ±	  4.96	   70.40	  ±	  2.24	  
Values	  represent	  average	  +/-­‐	  SEM	  
All	   RTgill-­‐W1	   cells	   seeded	   with	   primary	   gill	   cells	   previously	   grown	   in	   flasks	   showed	   the	   lowest	  
paracellular	   permeability,	   and	   the	   seeding	   density	   of	   RTgill-­‐W1	   and	   culture	   condition	   had	   a	  
significant	  effect	  on	  permeability	  (P	  <	  0.001),	  but	  again,	  not	  when	  combined	  (Table	  4.1;	  Fig	  4.2B).	  
RTgill-­‐W1	  cells	  seeded	  at	  0.1	  x	  106	  and	  cultured	   in	  L-­‐15	  with	  cortisol,	  with	  a	  seeding	  of	  0.7	  x	  106	  
primary	  cells	  grown	  in	  flasks,	  exhibited	  the	   lowest	  mannitol	  permeability	  of	  all,	  at	  28.05	  ±	  0.84%	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that	  of	  the	  cell	  free	  control.	  The	  actual	  flux	  value	  obtained	  was	  1.06	  ±	  0.03	  x	  10-­‐6	  cm	  s-­‐1,	  which	  is	  
still	   higher	   than	   that	  obtained	   for	   a	  preparation	  of	   primary	   cells	   grown	  previously	   in	   flasks	   (SSI)	  
alone	  (0.22	  ±	  0.00	  x	  10-­‐6	  cm	  s-­‐1).	  
RTgill-­‐W1	   cells	   cultured	   with	   a	   second	   seed	   of	   freshly	   isolated	   primary	   gill	   cells	   exhibited	   no	  
differences	  between	  all	   flux	   values	   in	   terms	  of	   seeding	  density	   (Table	  4.1;	   Fig	  4.2C).	  Differences	  
were	   significant	  depending	  on	  culture	  medium	  condition	   (P	  =	  0.05)	  and	   the	   lowest	  permeability	  
observed	  was	  seen	   in	  RTgill-­‐W1	  cells	   seeded	  at	  0.5	  x	  106	  and	  with	   freshly	   isolated	  primary	  cells,	  
and	  cultured	  with	  100	  ng	  mL-­‐1	  cortisol	  at	  59.10	  ±	  1.66%	  of	  the	  cell	  free	  control.	  
After	  24	  hours	  of	  freshwater	  exposure	   in	  asymmetrical	  conditions,	  RTgill-­‐W1	  cells	  cultured	  alone	  
on	   inserts	  without	   supplementation	  of	  EGF	  or	   cortisol	   in	   the	  cell	   culture	  medium	  exhibited	  high	  
epithelial	  paracellular	  permeability	  –	  those	  seeded	  at	  0.1	  and	  0.2	  x	  106	  showed	  values	  the	  same	  or	  
higher	   than	   that	   of	   the	   cell	   free	   control	   (>100%;	   Fig	   4.3A).	   Neither	   seeding	   density	   nor	   culture	  
medium	  condition	  significantly	  affected	  the	  permeability.	  
RTgill-­‐W1	   cells	   cultured	   with	   primary	   cells	   grown	   previously	   in	   flasks	   showed	   the	   lowest	  
permeability	   after	   24	   hours	   of	   freshwater	   exposure.	   Here,	   both	   seeding	   density	   and	   culture	  
condition	   combined	   significantly	   affected	   mannitol	   flux	   (P	   <	   0.001;	   Fig	   4.3B).	   The	   lowest	  
permeability	  obtained	  was	  7.09	  ±	  0.69%	  that	  of	  the	  cell	  free	  control,	  and	  was	  from	  RTgill-­‐W1	  cells	  
seeded	  at	  0.1	  x	  106,	  with	  0.7	  x	  106	  flask	  primary	  cells	  on	  top	  and	  supplemented	  with	  100	  ng	  mL-­‐1	  
cortisol.	  The	  actual	  flux	  value	  obtained	  for	  this	  was	  0.24	  ±	  0.02	  x	  10-­‐6	  cm	  s-­‐1,	  and	  is	  similar	  to	  the	  
value	  obtained	  from	  flask	  primary	  cells	  seeded	  alone	  (SSI)	  after	  24	  hours	  of	  freshwater	  exposure	  
(0.17	  ±	  0.03	  x	  10-­‐6	  cm	  s-­‐1).	  
Finally,	  the	  permeability	  of	  RTgill-­‐W1	  cells	  seeded	  with	  1.2	  x	  106	  freshly	  isolated	  primary	  gill	  cells	  
was	  significantly	  affected	  by	  seeding	  density	  (P	  <	  0.001)	  and	  culture	  medium	  condition	  (P	  <	  0.001),	  
although	  not	  combined	  (P	  =	  0.155;	  Fig	  4.3C).	  The	  lowest	  permeability	  obtained	  here	  was	  58.96	  ±	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1.11%	  that	  of	  the	  cell	  free	  control,	  and	  was	  obtained	  by	  seeding	  RTgill-­‐W1	  cells	  cultured	  without	  
supplemented	  medium	  and	  seeded	  at	  0.5	  x	  106	  with	  1.2	  x	  106	  freshly	  isolated	  primary	  cells	  on	  top.	  
	  
	   	  
4.	  Paracellular	  permeability	  of	  gill	  cell	  epithelia	  
Lucy	  C.	  Stott	  |	  106	  
	  
Fig	  4.2	  The	  24	  hour	  14C-­‐mannitol	  permeability	  in	  symmetrical	  conditions	  (L-­‐15	  either	  side	  of	  the	  epithelia)	  of	  RTgill-­‐W1	  
routinely	  cultured	  in	  flasks	  (>	  12	  months)	  in	  cell	  culture	  medium	  with	  antibiotics	  (L-­‐15;	  orange	  bars),	  or	  with	  
supplementation	  with	  100	  ng	  mL-­‐1	  epidermal	  growth	  factor	  (EGF;	  green	  bars)	  or	  100	  ng	  mL-­‐1	  cortisol	  (red	  bars)	  and	  
seeded	  at	  0.1,	  0.2	  and	  0.5	  x106	  cells	  per	  insert	  (A).	  Inserts	  in	  (B)	  were	  double	  seeded	  on	  top	  the	  next	  day	  with	  0.7	  x	  106	  
primary	  rainbow	  trout	  gill	  cells	  grown	  in	  flasks	  for	  the	  previous	  6-­‐9	  days,	  whilst	  those	  in	  (C)	  were	  seeded	  on	  top	  with	  1.2	  
x	  106	  freshly	  isolated	  rainbow	  trout	  gill	  cells.	  The	  flux	  took	  place	  after	  7-­‐10	  days	  culture	  and	  exposure	  to	  L-­‐15	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Fig	  4.3	  The	  24	  hour	  14C-­‐mannitol	  permeability	  in	  asymmetrical	  conditions	  (freshwater	  in	  the	  apical	  compartment)	  of	  
RTgill-­‐W1	  routinely	  cultured	  in	  flasks	  (>	  12	  months)	  in	  cell	  culture	  medium	  with	  antibiotics	  (L-­‐15;	  orange	  bars),	  or	  with	  
supplementation	  with	  100	  ng	  mL-­‐1	  epidermal	  growth	  factor	  (EGF;	  green	  bars)	  or	  100	  ng	  mL-­‐1	  cortisol	  (red	  bars)	  and	  
seeded	  at	  0.1,	  0.2	  and	  0.5	  x106	  cells	  per	  insert	  (A).	  Inserts	  in	  (B)	  were	  double	  seeded	  on	  top	  the	  next	  day	  with	  0.7	  x	  106	  
primary	  rainbow	  trout	  gill	  cells	  grown	  in	  flasks	  for	  the	  previous	  6-­‐9	  days,	  whilst	  those	  in	  (C)	  were	  seeded	  on	  top	  with	  1.2	  
x	  106	  freshly	  isolated	  rainbow	  trout	  gill	  cells.	  The	  flux	  took	  place	  after	  7-­‐10	  days	  culture	  and	  exposure	  to	  apical	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4.5	  Discussion	  
The	  gill	  is	  the	  principle	  organ	  used	  to	  study	  the	  transport	  of	  waterborne	  toxicants	  into	  fish.	  In	  situ,	  
the	  gills	  are	  difficult	   to	  study,	   requiring	   the	  mouth,	  gills	  and	  body	  of	   the	  animal	   to	  be	  separated	  
into	  compartments,	  which	  can	  cause	  distress	  to	  the	  animal	  in	  in	  vivo	  studies	  (e.g.	  Fitzsimmons	  et	  
al.,	  2001).	  The	   in	  vitro	  gill	  provides	  a	  worthy	  system	  to	  study	   the	   transport	  properties	  of	   the	  gill	  
(Bury	  et	  al.,	  2014),	  and	  both	  primary	  cells	  and	   immortalised	  cell	   lines	  provide	  useful	  tools	   in	  this	  
research.	  Most	  notably,	  using	   these	   in	  vitro	   cells	   reduces	   the	  numbers	  of	  whole	  animals	  used	   in	  
scientific	  studies	  (Scholz	  et	  al.,	  2013),	  a	  notion	  that	  is	  supported	  in	  the	  EU	  (REACH,	  2009).	  Large	  n	  
numbers	   of	   groups	   of	   cells	   can	   be	   obtained	   from	   a	   single	   animal,	   or	   indeed	   from	   stocks	   of	  
immortalised	  cell	  lines	  (although	  fish	  cell	  lines	  do	  not	  currently	  form	  any	  part	  of	  any	  regulation	  yet;	  
Schirmer,	   2006,	   but	   recommendations	   have	   been	   made	   for	   their	   incorporation;	   Dayeh	   et	   al.,	  
2013).	  
Primary	  gill	  cells	  require	  more	  careful	  handing	  to	  isolate	  and	  successfully	  culture	  (Schnell,	  Stott	  et	  
al.,	  2016)	  and	  often	  produce	  results	  with	  greater	  variability	  due	  to	  individual	  differences	  between	  
animals	   from	  which	   cells	   are	   obtained.	   Furthermore,	   live	   fish	   are	   necessary	   in	   order	   to	   isolate	  
primary	  cells	  from	  the	  gill,	  which	  the	  cell	  line	  RTgill-­‐W1	  does	  not	  require.	  Using	  RTgill-­‐W1	  offers	  a	  
useful	   system	   in	  which	   to	   study	   the	   rainbow	   trout	   gill	   (Fischer	  et	   al.,	   2010;	  2011;	  Kramer	  et	   al.,	  
2010;	   Lee	   et	   al.,	   2006;	   Lee	   et	   al.,	   2009)	   and	   is	   a	   valuable	   complement	   to	  whole	   animal	   studies	  
(Stadnicka-­‐Michalak	  et	  al.,	  2014).	  However,	  certain	  physiological	  characteristics	  of	  the	  freshwater	  
gill	   are	   lacking	   in	   cell	   cultures	   of	   RTgill-­‐W1,	   including	   the	  microridge	   architecture	   of	   PVCs,	   high	  
numbers	   of	  mitochondria	   in	  MRCs,	   the	  Golgi	   complex	   and	   cytoplasmic	   droplets	   of	  mucous	   cells	  
(Bols	   et	   al.,	   1994),	   metabolic	   enzymes	   such	   as	   CYP1A	   (Schirmer	   et	   al.,	   1998)	   and	   high	  
transepithelial	  resistance	  values	  (Trubitt	  et	  al.,	  2015).	  In	  fish,	  transepithelial	  resistance	  indicates	  a	  
measure	   of	   epithelial	   integrity	   and	   tightness	   in	   terms	   of	   both	   transcellular	   and	   paracellular	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pathways	   (Chasiotis	   et	   al.,	   2012).	   This	   study	   aimed	   to	   improve	   the	   epithelial	   characteristics	   of	  
RTgill-­‐W1	  by	  supplementing	  culture	  medium	  with	  known	  promoters	  of	  epithelial	  development,	  or	  
induce	  these	  characteristics	  by	  co-­‐culturing	  with	  primary	  gill	  cells.	  
Transepithelial	   resistance	   increased	   in	   RTgill-­‐W1	   cells	   cultured	   on	   permeable	   supports	   and	  
supplemented	  with	  cortisol	  in	  cell	  culture	  medium.	  This	  increase	  was	  observed	  most	  in	  RTgill-­‐W1	  
cells	   seeded	   at	   the	   lowest	   seeding	   density	   (0.1	   x	   106)	   and	   with	   0.7	   x	   106	   primary	   gill	   cells,	  
previously	  grown	  in	  cell	  culture	  flasks,	  seeded	  on	  top.	  The	  paracellular	  permeability	  of	  these	  was	  
also	  lowest	  in	  symmetrical	  conditions	  and	  in	  asymmetrical	  conditions	  after	  24	  hours	  of	  freshwater	  
exposure	   to	   the	   apical	   surface	   of	   the	   cells.	  However,	   the	   symmetrical	   paracellular	   permeability,	  
with	   cell	   culture	  medium	   both	   sides	   of	   the	   epithelium,	   is	   still	   higher	   than	   that	   of	   just	   SSI	   cells,	  
indicating	  that	  this	  epithelial	  preparation	  is	  ‘leakier’	  than	  just	  SSI	  alone.	  In	  asymmetrical	  conditions	  
however,	  paracellular	  permeability	  decreased	  to	  values	  similar	  to	  SSI	  epithelia.	  
In	   RTgill-­‐W1,	   supplementation	   of	   culture	  medium	  with	   cortisol	   elevates	   TER	   in	   a	   concentration-­‐
dependent	  manner	   to	   values	   over	   80	   Ω	   cm2	   (Trubitt	   et	   al.,	   2015),	   a	   little	  more	   than	  what	  was	  
achieved	   here.	   Likewise,	   culturing	   primary	   gill	   cells	   with	   cortisol	   has	   been	   shown	   to	   improve	  
epithelial	   development	   by	   increasing	   transepithelial	   resistance	   and	   decreasing	   paracellular	  
permeability	   (Chasiotis	   et	   al.,	   2010),	   which	   is	   also	   reflected	   in	   lower	   unidirectional	   Na+	   and	   Cl–	  
fluxes	   (Kelly	  &	  Wood,	  2001).	  Cortisol	   is	   thought	   to	  act	   through	  an	   inhibition	  of	   cell	  proliferation	  
and	  mitosis	  and	  an	  increase	  of	  the	  maintenance	  of	  total	  gill	  cells;	  suggesting	  that	  cortisol	  reduces	  
cell	  degeneration	  (Leguen	  et	  al.,	  2007).	  Taken	  together,	  the	  improvement	  in	  TER	  and	  paracellular	  
permeability	  brought	  about	  in	  this	  study	  suggests	  that	  cortisol	  is	  acting	  on	  both	  RTgill-­‐W1	  cells	  and	  
primary	  gill	  cells,	  of	  which	  the	  latter	  cultured	  using	  SSI	  –	  that	  is,	  primary	  gill	  cells	  previously	  grown	  
in	  cell	  culture	  flasks	  –	  appears	  to	  be	  more	  positively	  affected	  than	  primary	  gill	  cells	  freshly	  isolated	  
and	  seeded.	  However,	  this	  improvement	  does	  not	  match	  that	  seen	  in	  primary	  cells	  cultured	  alone	  
with	  cortisol	  (Chasiotis	  et	  al.,	  2010),	  so	  although	  it	  can	  be	  concluded	  that	  there	  is	  a	  positive	  effect	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of	  co-­‐culturing	  RTgill-­‐W1	  with	  primary	  gill	  cells,	   these	  advantages	  do	  not	  equal	   those	  from	  using	  
primary	  gill	  cell	  cultures	  such	  as	  SSI	  and	  DSI	  alone.	  The	  practical	  significance	  of	  this	   is	  that	  RTgill-­‐
W1	   cell	   cultures	   should	   not	   be	   used	   for	   xenobiotic	   uptake	   studies,	   as	   their	   epithelia	   are	   not	  
physiologically	  tight	  enough	  to	  present	  a	  realistic	  biological	  barrier	  that	  the	  freshwater	  gill	  is.	  Still,	  
there	   is	   scope	   for	   the	   improvement	   of	   RTgill-­‐W1	   gill	   preparations	   through	   the	   use	   of	   other	  
supplementations	  such	  as	  stem	  cell	  growth	  media.	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Chapter	  5	  




The	   gill	   is	   the	   principle	   site	   of	   xenobiotic	   transfer	   to	   and	   from	   the	   aqueous	   environment.	   To	  
replace,	  refine	  or	  reduce	  (3Rs)	  the	  large	  numbers	  of	  fish	  used	  in	  in	  vivo	  uptake	  studies	  an	  effective	  
in	   vitro	  model	   is	   required	   that	  mimics	   the	   function	  of	   the	   teleost	  gill.	   This	   study	  uses	  a	   rainbow	  
trout	  primary	  gill	  cell	  culture	  system	  to	  assess	  the	  uptake	  and	  efflux	  of	  pharmaceuticals	  across	  the	  
gill.	   Bidirectional	   transport	   studies	   in	   symmetrical	   conditions	   (with	   L-­‐15	   both	   sides	   of	   the	  
epithelium)	   of	   seven	   pharmaceuticals	   showed	   they	   were	   transported	   transcellularly	   across	   the	  
epithelium.	  However,	   studies	  conducted	   in	  asymmetrical	  conditions	  with	  water	  at	   the	  apical	  cell	  
surface	   showed	   the	   enhanced	  uptake	  of	   propranolol,	   ranitidine	   and	   imipramine.	   Concentration-­‐
equilibrated	   conditions	   without	   a	   concentration	   gradient	   suggested	   that	   a	   proportion	   of	   the	  
uptake	   of	   propranolol	   and	   imipramine	   is	   via	   a	   carrier-­‐mediated	   process.	   Further	   study	   using	  
propranolol	  showed	  that	  its	  transport	  is	  pH-­‐dependent	  and	  at	  very	  low,	  environmentally	  relevant	  
concentrations	  (ng	  L−1),	  transport	  deviated	  from	  linearity.	  At	  higher	  concentrations,	  passive	  uptake	  
dominated.	  Known	  inhibitors	  of	  drug	  transport	  proteins	  inhibited	  propranolol	  uptake,	  whilst	  some	  
were	  without	   effect.	   Together	   this	   suggests	   the	   involvement	   of	   some	  members	   of	   SLC	   and	  ABC	  
drug	  transporter	  families	  in	  pharmaceutical	  transport.	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5.2	  Introduction	  
In	   vivo	   ecotoxicology	   testing	   produces	   bioconcentration	   factor	   (BCF)	   values	   that	   indicate	   the	  
potential	  of	  a	  compound	  to	  bioconcentrate	  within	  an	  organism	  (OECD305,	  2012).	  Highly	   lipophilic	  
compounds	  are	  exposed	  to	  fish	  via	  the	  diet,	  whilst	  others	  via	  the	  water;	  the	  principle	  being	  to	  use	  
the	  uptake	  and	  depuration	  rates	  to	  calculate	  a	  compounds	  propensity	  to	  bioconcentrate.	  Typically,	  
each	  test	  can	  use	  up	  to	  108	  fish	  per	  compound	  and	  many	  thousands	  of	  fish	  are	  used	  for	  this	  test	  
every	   year	   (Scholz	   et	   al.,	   2013).	   Alternative	   methods	   can	   be	   developed	   to	   replace	   these	  
standardised	   whole	   fish	   studies	   to	   recognise	   and	   classify	   environmental	   hazards	   (Creton	   et	   al.,	  
2013;	   Wolf	   et	   al.,	   2007).	   This	   requires	   the	   identification	   and	   validation	   of	   appropriate	   in	   vitro	  
systems	   that	   could	   replace	   such	   studies	   (Baron	  et	  al.,	   2012).	  To	   find	  alternatives	   to	   the	  OECD305	  
water	  exposure	   it	   is	   necessary	   to	   identify	   a	   suitable	   fish	   gill	  model	   that	  mimics	   the	   intact	  organ	  
because	  the	  gill,	  being	  constantly	  and	  continuously	  exposed	  to	  substances	  in	  water,	  is	  the	  principle	  
site	  of	  xenobiotic	  uptake	  (Bury	  et	  al.,	  2014).	  Consequently,	  the	  use	  of	  the	  primary	  gill	  cell	  culture	  
model	  (described	  in	  Chapters	  2	  and	  3)	  in	  pharmaceutical	  uptake	  and	  efflux	  studies	  was	  assessed	  as	  
a	  compliment	  to	  whole	  fish	  studies.	  
The	  following	  study	  investigates	  the	  uptake	  and	  efflux	  of	  7	  pharmaceuticals	  across	  the	  in	  vitro	  gill.	  
It	  was	  hypothesised	  that	  both	  passive	  transcellular	  and	  carrier-­‐mediated	  transport	  of	  xenobiotics	  
(see	  Chapter	  1	  for	  further	  details)	  across	  the	  gill	  are	  likely	  principle	  drivers	  in	  determining	  the	  rate	  
of	   uptake	   of	   waterborne	   compounds	   (McKim	   &	   Erickson,	   1991).	   Briefly,	   passive	   transcellular	  
transport	   depends	   on	   the	   pH	   of	   the	   solution	   (changes	   in	   pH	   can	   change	   the	   speciation	   of	  
pharmaceuticals	  to	  ionised	  forms,	  which	  reduce	  their	  passive	  uptake	  over	  biological	  membranes),	  
acid	  base	  constants	  (pKa)	  and	  the	  lipophilicity	  of	  the	  compound,	  whereas	  facilitated	  transport	  may	  
be	   via	   members	   of	   the	   solute	   carrier	   (SLC)	   and	   ATP-­‐binding	   casette	   (ABC)	   transporter	   families	  
(Dobson	   &	   Kell,	   2008).	   Therefore,	   to	   investigate	   carrier	   mediated	   transport	   for	   some	   of	   these	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pharmaceuticals,	   concentration	   equilibrated,	   pH-­‐dependent,	   and	   concentration-­‐dependent	  
assays,	  as	  well	  as	  membrane	  channel	  inhibitor	  studies	  were	  conducted.	  In	  addition,	  the	  uptake	  of	  
propranolol	  across	  the	   in	  vitro	  gill	  model	  was	  compared	  to	   in	  silico	  and	   in	  vivo	  data	  (Owen	  et	  al.,	  
2009),	  to	  demonstrate	  the	  use	  of	  this	  model	  as	  a	  predictive	  tool	  for	  pharmaceutical	  uptake	  in	  live	  
fish.	  
	  
5.3	  Materials	  and	  methods	  
5.3.1	   Reagents	  and	  suppliers	  
All	   drugs	   used	   in	   transport	   assays	   were	   at	   concentration	   of	   1	   μg	   L-­‐1	   to	   represent	   those	   levels	  
detected	   in	   the	   environment	   whilst	   remaining	   within	   detectable	   limits	   (Table	   5.1).	   These	   were	  
radiolabeled	  and	  re-­‐suspended	  in	  ethanol	  or	  methanol	  with	  a	  final	  solvent	  concentration	  in	  assay	  
conditions	  of	  <0.0003%,	  and	  chosen	  to	  demonstrate	  a	  range	  of	  different	  classes	  (β1-­‐,	  β2-­‐	  and	  non-­‐
specific	  β-­‐	  receptor	  agonists,	  a	  H2-­‐	  receptor	  agonist	  and	  a	  tricyclic	  anti-­‐depressant)	  with	  mid-­‐range	  
Log	  Kow	  values	   (see	  Table	  5.1).	   3H-­‐propranolol	  hydrochloride	   (29.0	  Ci	  mmol-­‐1)	  was	  obtained	   from	  
Amersham	   Biosciences.	   3H-­‐metoprolol	   (29.7	   Ci	   mmol-­‐1),	   3H-­‐formoterol	   (18.5	   Ci	   mmol-­‐1)	   and	   3H-­‐
terbutaline	   (29.0	   Ci	   mmol-­‐1)	   were	   obtained	   from	   Vitrax.	   3H-­‐atenolol	   (7.3	   Ci	   mmol-­‐1)	   and	   3H-­‐
ranitidine	   (2.5	   Ci	   mmol-­‐1)	   were	   obtained	   from	   Moravek	   Biochemicals,	   and	   3H-­‐imipramine	  
hydrochloride	   (48.5	  Ci	  mmol-­‐1)	   from	  Perkin-­‐Elmer.	  Propranolol	  hydrochloride	  was	  obtained	   from	  
Sigma	  Aldrich.	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Table	  5.1	  
Properties	  of	  selected	  pharmaceuticals	  and	  the	  levels	  at	  which	  they	  are	  found	  in	  the	  environment.	  
Pharmaceutical	   Use	   MW	   pKa	   Log	  Kow
1	   Log	  Kow
2	   Environmental	  
levels	  (ng	  L-­‐1)	  
Propranolol	   non-­‐selective	  β	  antagonist	   259.340	   9.4	   2.54	   1.12	  *	   33	  3	  
Metoprolol	   β1	  receptor	  antagonist	   267.364	   9.6	   1.76	   -­‐0.90	  #	   410	  3	  
Atenolol	   β1	  receptor	  antagonist	   266.336	   9.6	   0.67	   0.0015	  *	   940	  3	  
Formoterol	   long-­‐acting	  β2	  agonist	   344.405	   7.9	  a	  /9.2	  b	   1.93	   0.41	  *	   n/a	  











	   120	  3	  
0.14	  5	  
1	  Parameter	  Client	  (Tetko	  et	  al.,	  2005)	  
2	  Environmental	  Risk	  Assessment	  data,	  experimentally	  measured	  values	  (AstraZeneca,	  2012)	  
3	  Kostich	  et	  al.	  (2014)	  
4	  Breitholtz	  et	  al.	  (2012)	  
5	  Giebułtowicz	  &	  Nałęcz-­‐Jawecki	  (2014)	  
a	  Acidic;	  b	  basic	  
*pH	  7.4;	  #pH	  7	  
	  
5.3.2	   Equipment	  and	  suppliers	  
Equipment	  used	  was	  the	  same	  as	  those	  outlined	  in	  Chapter	  2.	  The	  pH	  meter	  was	  by	  Corning.	  
5.3.3	   Preparation	  of	  reagents	  
Reagents	  were	  prepared	  as	  detailed	  in	  Chapter	  2.	  
5.3.4	   Cell	  culture	  reagents	  
Cell	  culture	  reagents	  were	  prepared	  as	  outlined	  in	  Chapter	  2.	  
5.3.5	   Methods	  
The	   same	   standardised	  procedure	   for	   the	   culture	   of	  DSI	   primary	   gill	   cells	   on	   permeable	   inserts,	  
and	   their	   preparation	   for	   exposure,	  was	   used	   as	   detailed	   in	   Chapter	   2.	   All	   assays	   took	   place	   at	  
18°C.	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5.3.6	   Bidirectional	  transport	  assays	  and	  apparent	  permeability	  coefficients	  
Bidirectional	  transport	  assays	  (BTA)	  assess	  both	  passive	  and	  facilitated	  transport	  in	  a	  bidirectional	  
manner,	   from	   apical	   to	   basal	   (uptake)	   or	   vice	   versa	   (efflux).	   In	   these,	   concentration	   gradient	  
conditions	   exist,	   whereby	   total	   transport	   is	   a	   sum	   of	   both	   passive	   transcellular	   and	   carrier-­‐
mediated	   processes.	   DSI	   epithelia	   were	   exposed	   to	   test	   compounds	   in	   either	   symmetrical	   or	  
asymmetrical	  conditions.	  Symmetrical	  contained	  1.5	  and	  2.0	  mL	  L-­‐15	   (without	  FBS)	   in	  apical	  and	  
basal	   compartments	   respectively,	  whilst	   asymmetrical	   required	   the	   application	   of	   1.5	  mL	   FW	   in	  
the	  apical	  compartment	  and	  2.0	  mL	  L-­‐15	  in	  the	  basal.	  The	  test	  compound	  was	  added	  to	  either	  the	  
apical	   side	   (uptake;	  A:B)	  or	  basal	   compartment	   (efflux;	  B:A)	   at	   a	   concentration	  of	   1	  μg	   L-­‐1.	   Each	  
experimental	   condition	  used	  3-­‐5	  epithelia	   from	  1-­‐2	  biological	   replicates.	   For	  all	   experiments	   the	  
FW	  or	  L-­‐15	  from	  the	  apical	  or	  basal	  compartment	  was	  mixed	  before	  taking	  100	  μL	  samples	  at	  0,	  6,	  
24,	   30	   and	   48	   hours.	   Each	   100	   μL	   aliquot	   sample	   was	   placed	   into	   a	   scintillation	   vial	   with	  
scintillation	   fluid	  and	  beta	  counted,	  and	  the	  drug	  concentration	  was	  calculated	  from	  the	  specific	  
radioactivities.	  For	  uptake	  and	  efflux	  BTA,	  apparent	  permeability	  coefficients	  (Papp)	  at	  6	  hours	  were	  
calculated	  using	  the	  following	  equation.	  
𝑃!""  (𝑐𝑚  𝑠!!  ) =    𝑑𝑄𝑑𝑡   ×    1𝐴  ×𝐶!3600 	  
where	  dQ/dt	  is	  the	  flux	  rate	  of	  the	  drug	  (pmol	  L-­‐1	  h-­‐1),	  A	  is	  the	  surface	  area	  of	  the	  monolayer	  (0.9	  
cm2)	   and	  C0	   is	   the	   initial	   concentration	  of	   the	  drug	   in	   the	  donor	   compartment	   (fM)	   (Petri	   et	   al.,	  
2004).	   Transport	   ratios	   (TR)	   for	   both	   uptake	   and	   efflux	   were	   calculated	   using	   the	   following	  
equations	  (Schwab	  et	  al.,	  2003).	  
𝑈𝑝𝑡𝑎𝑘𝑒  𝑇𝑅 =   𝑃!""  !:!𝑃!""  !:!	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𝐸𝑓𝑓𝑙𝑢𝑥  𝑇𝑅 =   𝑃!""  !:!𝑃!""  !:!	  
An	  uptake	  or	  efflux	  TR	  ≥	  1.5	   is	   considered	  an	   indicator	  of	   active	   transport	   (Schwab	  et	  al.,	   2003;	  
Luna-­‐Tortós	   et	   al.,	   2008).	   For	   time-­‐dependent	   BTA,	   the	   results	   were	   also	   expressed	   as	   the	  
percentage	  of	  the	  initial	  drug	  concentration	  of	  the	  donor	  compartment	  for	  uptake	  (A:B)	  and	  efflux	  
(B:A)	  over	  48	  hours.	  
5.3.7	   Concentration	  equilibrated	  transport	  assays	  
Concentration	   equilibrated	   transport	   assays	   (CETA)	   examine	   transport	   by	   adding	   equivalent	  
concentrations	  on	   either	   side	  of	   the	   gill	   epithelium	  and	   assessing	   the	  movement	  of	   compounds	  
over	  time	  to	  evaluate	  carrier-­‐mediated	  uptake	  or	  efflux	  regardless	  of	  passive	  transport	  processes,	  
as	  used	  in	  blood-­‐brain	  barrier	  transport	  assays	  (Luna-­‐Tortós	  et	  al.,	  2008).	  The	  same	  experimental	  
procedures	  for	  BTA	  were	  used	  (in	  symmetrical	  and	  asymmetrical	  conditions),	  but	  with	  both	  apical	  
and	  basal	  compartments	  containing	  test	  drugs	  at	  the	  same	  concentration	  of	  1	  μg	  L-­‐1.	  The	  results	  
are	  expressed	  as	  a	  percentage	  of	   the	   initial	  concentration	   in	  each	  compartment	   (apical	  or	  basal)	  
over	  time.	  
5.3.8	   The	  pH-­‐dependent	  transport	  of	  propranolol	  
DSI	  epithelia	  were	  exposed	  in	  apical	  FW	  adjusted	  to	  pH	  6	  (by	  addition	  of	  HCl),	  pH	  8	  or	  pH	  9.5	  (by	  
addition	  of	  NaOH).	  The	  basolateral	  contained	  2.0	  mL	  L-­‐15.	  Radiolabeled	  propranolol	  was	  added	  at	  
a	  concentration	  of	  1	  μg	  L-­‐1	  to	  either	  the	  apical	  or	  basal	  compartments	  (BTA)	  to	  investigate	  uptake	  
and	  efflux.	  At	  6	  hours	  a	  100	  μL	  sample	  was	  collected	  from	  the	  apical	  and	  basal	  compartments	  and	  
the	  radioactivity	  analysed	  as	  above.	  The	  apparent	  permeability	  coefficients	  (Papp)	  were	  calculated	  
using	  the	  equation	  shown	  previously.	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5.3.9	   The	  concentration-­‐dependent	  uptake	  of	  propranolol	  
DSI	  epithelia	  (n	  =	  54)	  were	  exposed	  to	  17	  concentrations	  of	  propranolol	  ranging	  from	  0.014-­‐10000	  
μg	   L-­‐1.	   Concentrations	   above	   0.1	   μg	   L-­‐1	   were	   made	   using	   propranolol	   hydrochloride	   and	  
radiolabeled	   propranolol	   as	   a	   marker.	   Experiments	   were	   conducted	   in	   asymmetrical	   conditions	  
with	  propranolol	  added	  to	  the	  FW	  in	  the	  apical	  compartment,	  thus	  mimicking	  the	  in	  vivo	  scenario	  
(Owen	  et	  al.,	  2009).	  Radioactivity	  was	  analysed	  as	  previously	  described.	  
5.3.10	   The	  inhibition	  of	  the	  uptake	  of	  propranolol	  
Epithelia	  were	  pre-­‐incubated	  with	  an	  inhibitor	  at	  a	  concentration	  100	  times	  higher	  (400	  nM)	  than	  
that	   of	   propranolol.	   Amantadine,	   cimetidine,	   cyclosporine	   A,	   MK571,	   quinidine	   or	   verapamil	  
hydrochloride	  were	  dissolved	  in	  DMSO	  (0.1%	  in	  final	  solution)	  and	  added	  to	  the	  apical	  (in	  0.75	  mL	  
FW)	   or	   basal	   (in	   1.0	  mL	   L-­‐15	  medium).	   Controls	   and	   compartments	  without	   inhibitor	   contained	  
0.1%	   DMSO.	   After	   1	   hour,	   volumes	   were	   replaced	   with	   1.5	   mL	   FW	   containing	   1	   μg	   L-­‐1	   (4	   nM)	  
propranolol	  in	  the	  apical	  compartment,	  and	  the	  basal	  contained	  2.0	  mL	  plain	  L-­‐15,	  whilst	  keeping	  
the	   final	   concentration	  of	   inhibitor	   at	   400	  nM	   throughout.	   The	   same	   sampling	  procedure	   as	   for	  
BTA	  at	  time	  0,	  6	   (not	   for	  cyclosporine	  A),	  24,	  36	  and	  48	  hours	  proceeded	  and	  the	  uptake	  Papp	  of	  
propranolol	  was	  calculated	  as	  previously.	  The	  Papp	  in	  all	  inhibitor	  free	  controls	  was	  expressed	  as	  a	  
percentage	   of	   the	   mean	   (100%)	   and	   the	   change	   in	   uptake	   Papp	   (inhibition)	   in	   the	   presence	   of	  
inhibitors	  was	  expressed	  as	  a	  percentage	  of	  this	  mean	  control.	  
5.3.11	   Analysis	  of	  data	  and	  statistics	  
For	  bidirectional	  Papp	  comparisons	  between	  the	  uptake	  and	  efflux,	  an	  independent	  samples	  t-­‐test	  
with	  equal	   variances	  assumed	  was	  used	  and	   statistical	   significance	  was	  accepted	  when	  P	   <	  0.05	  
(SPSS	  software,	  SPSS	  Inc.).	  The	  same	  statistical	  analysis	  was	  used	  to	  test	  for	  differences	  between	  
asymmetrical	  and	  symmetrical	  uptake	  or	  efflux	  Papp	  for	  each	  drug	  to	  assess	  the	  effect	  of	  apical	  FW	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application.	   For	   the	   time	   dependent	   BTA,	   significant	   differences	   between	   the	   uptake	   and	   efflux	  
percentage	  of	  the	  donor	  compartment	  were	  tested	  for	  by	  one-­‐way	  analysis	  of	  variance	  (ANOVA)	  
on	   log-­‐transformed	   data	   (SPSS	   software,	   SPSS	   Inc.).	   For	   the	   time-­‐dependent	   CETA,	   statistical	  
significance	  of	   differences	   between	   each	  percentage	   increase	   or	   decrease	   in	   the	   apical	   or	   basal	  
compartments	   were	   also	   tested	   for	   by	   one-­‐way	   ANOVA	   (after	   log	   transformation).	   Differences	  
between	   the	  uptake	  of	  propranolol	  at	  different	  pHs,	  and	   similarly	   the	  efflux,	  were	   tested	   for	  by	  
one-­‐way	  ANOVA	  and	  statistical	  significance	  was	  accepted	  when	  P	  <	  0.05	  (SPSS	  software,	  SPSS	  Inc.).	  
The	  rate	  of	  propranolol	  flux	  for	  each	  concentration	  in	  the	  dose	  response	  was	  calculated	  at	  6	  hours	  
and	   analysed	   by	   ordinary	   least	   squares	   linear	   regression	   to	   describe	   the	   best	   fit,	   and	   further	  
analysis	  of	  low	  dose	  concentrations	  were	  analysed	  by	  cubic	  polynomial	  regression	  to	  best	  describe	  
the	  relationship	  (SPSS	  software,	  SPSS	  Inc.).	  Statistical	  differences	  between	  inhibitor	  (applied	  either	  
apically	   or	   basally)	   and	   the	   inhibitor	   free	   control	  were	   tested	   for	   by	   one-­‐way	   ANOVA	   (after	   log	  
transformation)	  and	  statistical	  significance	  was	  accepted	  at	  P	  <	  0.05.	  
5.3.12	   Comparison	  to	  predicted	  and	  actual	  plasma	  concentrations	  
In	   vitro	   propranolol	   ‘internal’	   concentrations	   after	   uptake	   (A:B)	   from	   the	   dose	   response	   study	  
were	  compared	  to	  predicted	  in	  silico	  and	  actual	  in	  vivo	  plasma	  concentrations	  of	  propranolol	  in	  O.	  
mykiss.	   The	   predicted	   partition	   of	   propranolol	   between	  blood	   and	  water	   can	   be	   determined	   by	  
[plasma]	   =	   0.87	   [water]	   as	   described	   by	   Owen	   et	   al.	   (2009).	   This	   was	   calculated	   using	   the	  
mammalian	  fish	  leverage	  model,	  whereby	  the	  predicted	  plasma	  concentration	  can	  be	  described	  by	  
multiplying	   the	   environmental	   concentration	   by	   the	   blood	   to	   water	   partitioning	   coefficient	  
(Huggett	   et	   al.,	   2004)	   using	   the	   Fitzsimmons	  model	   for	   the	   partitioning	   of	   compounds	   between	  
blood	   and	   water	   (Fitzsimmons	   et	   al.,	   2001).	   Actual	   plasma	   concentrations	   of	   propranolol	   in	  O.	  
mykiss	  were	  obtained	  from	  Owen	  et	  al.	  (2009).	  In	  vitro	  propranolol	  concentrations	  at	  6	  hours	  (n	  =	  
3-­‐6	   from	   3	   biological	   replicates)	   were	   tested	   for	   correlation	   to	   in	   silico	   and	   in	   vivo	   plasma	  
concentrations	  by	  ordinary	  least	  squares	  linear	  regression	  (SPSS	  software,	  SPSS	  Inc.).	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5.4	  Results	  
5.4.1	   Apparent	  permeability	  coefficients	  and	  transport	  ratios	  
In	  symmetrical	  conditions	  with	  L-­‐15	  medium	  on	  both	  sides	  of	  the	  gill	  cell	  epithelium,	  no	  significant	  
differences	  between	  Papp	  A:B	  and	  Papp	  B:A	  for	  all	  7	  pharmaceuticals	  were	  observed	  (Fig	  5.1A),	  yet	  all	  
permeabilities	  were	  higher	  than	  that	  of	  the	  paracellular	  marker	  mannitol	  (except	  for	  atenolol;	  Papp	  
A:B:	  0.1	  ±	  0.03	  x	  10-­‐6	  cm	  s-­‐1	  and	  Papp	  B:A:	  0.1	  ±	  0.02	  x	  10-­‐6	  cm	  s-­‐1	  compared	  to	  mannitol;	  Papp	  A:B:	  0.1	  ±	  
0.01	  x	  10-­‐6	  cm	  s-­‐1,	  see	  Chapter	  3).	  In	  asymmetrical	  conditions	  with	  FW	  at	  the	  apical	  surface	  of	  the	  
gill	   epithelium,	   Papp	   A:B	   was	   significantly	   higher	   than	   Papp	   B:A	   (P	   <	   0.001)	   for	   propranolol	   and	  
imipramine,	   whilst	   no	   significant	   differences	   existed	   between	   uptake	   and	   efflux	   Papp	   of	   the	  
remaining	   5	   drugs	   metoprolol,	   atenolol,	   formoterol,	   terbutaline	   and	   ranitidine	   (Fig	   5.1B).	   For	  
propranolol,	  the	  Papp	  A:B	  increased	  significantly	  from	  1.7	  ±	  0.2	  x	  10-­‐6	  cm	  s-­‐1	  in	  symmetrical	  to	  2.7	  ±	  
0.2	  x	  10-­‐6	  cm	  s-­‐1	  in	  asymmetrical	  conditions	  (P	  <	  0.05)	  and	  Papp	  B:A	  decreased	  significantly	  from	  1.1	  ±	  
0.02	  to	  0.8	  ±	  0.1	  x	  10-­‐6	  cm	  s-­‐1	  (P	  <	  0.05)	  (Fig	  5.1A;	  Fig	  5.1B).	  Similarly	  for	  imipramine	  a	  significant	  
increase	  in	  Papp	  A:B	  from	  symmetrical	  (1.9	  ±	  0.2	  x	  10-­‐6	  cm	  s-­‐1)	  to	  asymmetrical	  (3.0	  ±	  0.1	  x	  10-­‐6	  cm	  s-­‐1;	  
P	  <	  0.05)	  and	  a	  significant	  decrease	  in	  Papp	  B:A	  (2.2	  ±	  0.04	  to	  1.6	  ±	  0.1	  x	  10-­‐6	  cm	  s-­‐1;	  P	  <	  0.05)	  (Fig	  5.1A	  
and	  B)	  was	  observed.	  
Propranolol	   showed	   uptake	   TR	   values	   greater	   than	   1.5	   in	   both	   symmetrical	   and	   asymmetrical	  
conditions,	   whilst	   for	   imipramine;	   this	   was	   only	   observed	   in	   asymmetrical	   conditions.	   Both	  
metoprolol	   and	  atenolol	   had	  efflux	   TR	   values	   greater	   than	  1.5	   in	   symmetrical	   and	  asymmetrical	  
respectively	  (Table	  5.2).	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Fig	  5.1	  The	  apparent	  permeability	  coefficients	  (Papp)	  for	  uptake	  (Papp	  A:B,	  peach	  or	  blue	  bars)	  and	  efflux	  (Papp	  B:A,	  orange	  
bars)	  of	  seven	  pharmaceuticals	  (1	  μg	  L-­‐1)	  across	  the	  DSI	  gill	  cell	  epithelium	  at	  6	  hours	  in	  symmetrical	  conditions	  (A)	  and	  
asymmetrical	  conditions	  (B).	  Significant	  differences	  between	  the	  Papp	  A:B	  and	  Papp	  B:A	  for	  a	  drug	  within	  a	  condition	  
(symmetrical	  or	  asymmetrical)	  are	  indicated	  by	  asterisk	  (independent	  samples	  t-­‐test;	  ***	  P	  <	  0.001).	  Significant	  
differences	  between	  symmetrical	  and	  asymmetrical	  Papp	  A:B	  or	  Papp	  B:A	  for	  each	  drug	  are	  indicated	  by	  hash	  tag	  in	  (B)	  
(independent	  samples	  t-­‐test;	  #P	  <	  0.05).	  All	  experiments	  were	  performed	  in	  triplicate	  or	  more	  (n	  =	  3-­‐5)	  from	  at	  least	  1	  
biological	  replicate	  and	  values	  are	  shown	  as	  means	  ±	  SEM.	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Table	  5.2	  
The	  uptake	  and	  efflux	  transport	  ratios	  (TR)	  of	  7	  drugs	  in	  symmetrical	  and	  asymmetrical	  conditions.	  
	   Uptake	  TR	   	   Efflux	  TR	  
	   Symmetrical	   Asymmetrical	   	   Symmetrical	   Asymmetrical	  
Propranolol	   1.52*	  	   3.21*	  	   	   0.66	  	   0.31	  	  
Metoprolol	   0.56	  	   1.32	  	   	   1.78*	  	   0.76	  	  
Atenolol	   0.74	  	   0.60	  	   	   1.34	  	   1.67*	  	  
Formoterol	   1.08	  	   0.97	  	   	   0.93	  	   1.03	  	  
Terbutaline	   0.92	  	   0.89	  	   	   1.09	  	   1.13	  	  
Ranitidine	   1.21	  	   0.88	  	   	   0.83	  	   1.14	  	  
Imipramine	   0.84	  	   1.83*	  	   	   1.19	   0.55	  
*	  indicates	  values	  greater	  than	  1.5	  
5.4.2	   Bidirectional	  transport	  assays	  
In	   symmetrical	   conditions	   with	   L-­‐15	   medium	   on	   both	   sides	   of	   the	   epithelium,	   ranitidine	   and	  
imipramine	   exhibited	   greater	   efflux	   transport	   from	   the	   basal	   to	   the	   apical	   compartments	   at	   24	  
hours	   (P	   <	   0.05)	   and	   at	   30	   and	   48	   hours	   (P	   <	   0.05)	   respectively	   (Fig	   5.2A).	   In	   asymmetrical	  
conditions	  involving	  the	  application	  of	  FW	  at	  the	  apical	  surface,	  more	  propranolol,	  ranitidine	  and	  
imipramine	  were	  taken	  up	  across	  the	  gill	  cell	  surface	  than	  were	  effluxed	  after	  48	  hours.	  This	  was	  
significantly	  more	  so	  at	  6	  (P	  <	  0.001)	  and	  24,	  30	  and	  48	  (P	  <	  0.01)	  hours	  for	  propranolol,	  30	  hours	  
(P	   <	   0.01)	   for	   ranitidine	   and	  at	   all	   sampling	  points	   (6,	   24,	   30	   and	  48	  hours)	   for	   imipramine	   (P	   <	  
0.001)	   (Fig	   5.2A).	   Metoprolol,	   formoterol	   and	   terbutaline	   showed	   slightly	   greater	   uptake	   than	  
efflux	  after	  48	  hours,	  and	  this	  was	  significantly	  more	  so	  for	  formoterol	  at	  48	  hours	  (P	  <	  0.05).	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Fig	  5.2	  The	  transport	  assays	  of	  six	  pharmaceuticals:	  propranolol,	  metoprolol,	  formoterol,	  terbutaline,	  ranitidine	  and	  
imipramine,	  in	  the	  DSI	  rainbow	  trout	  primary	  gill	  cell	  system	  over	  48	  hours	  under	  (A)	  bidirectional	  transport	  assays	  (BTA)	  
and	  (B)	  concentration	  equilibrated	  transport	  assays	  (CETA)	  conditions.	  For	  BTA	  (A)	  the	  drug	  is	  applied	  at	  a	  concentration	  
of	  1	  μg	  L
-­‐1
	  to	  either	  the	  apical	  (
	  	  	  	  	  	  	  	  	  	  
)	  for	  apical	  to	  basal	  transport;	  uptake,	  A:B	  or	  basal	  compartment	  (
	  	  	  	  	  	  	  	  	  	  	  	  	  
)	  for	  basal	  to	  
apical	  transport;	  efflux,	  B:A	  in	  either	  symmetrical	  (L-­‐15	  medium	  in	  both	  compartments)	  or	  asymmetrical	  (freshwater	  in	  
the	  apical	  compartment	  and	  L-­‐15	  medium	  in	  the	  basal)	  conditions.	  For	  this	  assay,	  data	  are	  shown	  as	  a	  percentage	  of	  the	  
initial	  drug	  concentration	  in	  the	  donor	  chamber	  versus	  time.	  For	  CETA	  (B),	  the	  drug	  is	  added	  to	  both	  the	  apical	  and	  basal	  
compartments	  at	  the	  same	  concentration	  (1	  μg	  L
-­‐1
)	  in	  both	  symmetrical	  and	  asymmetrical	  conditions.	  Data	  are	  shown	  as	  
a	  percentage	  of	  the	  initial	  concentration	  in	  either	  the	  apical	  or	  basal	  versus	  time.	  For	  both	  assays,	  significant	  differences	  
between	  the	  two	  compartments	  are	  indicated	  by	  asterisk	  (One-­‐way	  ANOVA;	  *P	  <	  0.05;	  **P	  <	  0.01;	  ***P	  <	  0.001).	  All	  
experiments	  were	  performed	  in	  triplicate	  or	  more	  (n	  =	  3-­‐6)	  from	  at	  least	  1	  biological	  replicate	  and	  values	  are	  shown	  as	  
means	  ±	  SEM. 
5.4.3	   Concentration	  equilibrated	  transport	  assays	  
In	  symmetrical	  conditions	  with	  L-­‐15	  and	  test	  drug	  on	  both	  sides	  of	  the	  epithelium,	  no	  significant	  
differences	   between	   percentage	   of	   the	   initial	   drug	   concentrations	   in	   the	   apical	   and	   basal	  
compartments	   were	   observed	   for	   metoprolol,	   terbutaline	   and	   ranitidine	   at	   all	   time	   points	   (Fig	  
5.2B).	  The	  percentage	  of	  the	  initial	  concentration	  of	  formoterol	  was	  more	  in	  the	  apical	  than	  basal	  
but	   only	   significantly	   so	   at	   24	   hours	   (P	   <	   0.05).	   The	   percentage	   of	   the	   initial	   concentration	   of	  
propranolol	  in	  the	  apical	  compartment	  was	  significantly	  more	  than	  the	  basal	  at	  all	  sampling	  points	  
after	   0	   hours	   (6	   and	   24	   hours	   P	   <	   0.01	   and	   30	   and	   48	   hours	  P	   <	   0.05).	   This	   was	   also	   seen	   for	  
imipramine,	  which	  showed	  the	  same	  increased	  basal	  to	  apical	  transport	  (P	  <	  0.001	  at	  6,	  24	  and	  30	  
hours	  and	  P	  <	  0.01	  at	  48	  hours).	  However,	  in	  asymmetrical	  conditions	  the	  situation	  was	  reversed	  
whereby	   increased	   apical	   to	   basal	   transport,	   indicative	   of	   facilitated	   uptake,	   resulted	   in	  
significantly	  more	  propranolol	   and	   imipramine	   in	   the	  basal	   compartments	   (P	   <	  0.01	  at	  24	  hours	  
and	  P	  <	  0.001	  to	  30	  and	  48	  hours	  for	  propranolol	  and	  P	  <	  0.01	  at	  6,	  24	  and	  30	  hours	  and	  P	  <	  0.001	  
at	  48	  hours	  for	  imipramine).	  The	  same	  was	  true	  for	  ranitidine	  in	  asymmetrical	  conditions	  but	  to	  a	  
lesser	  degree	  (P	  <	  0.05	  at	  24,	  30	  and	  48	  hours).	  Metoprolol,	  formoterol	  and	  terbutaline	  showed	  no	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signs	  of	  facilitated	  transport	  across	  the	  epithelium	  as	  no	  significant	  differences	  were	  observed	  (Fig	  
5.2B).	  
5.4.4	   The	  pH-­‐dependent	  transport	  of	  propranolol	  
A	  decrease	  in	  pH	  from	  8	  to	  6	  resulted	  in	  the	  significant	  reduction	  in	  the	  uptake	  permeability	  (Papp	  
A:B)	   of	   propranolol	   from	   2.7	   ±	   0.2	   x	   10-­‐6	   to	   0.4	   ±	   0.03	   x	   10-­‐6	   cm	   s-­‐1	   (P	   <	   0.001)	   in	   asymmetrical	  
conditions.	  The	  effect	  was	  opposite	  for	  efflux	  permeability	  (Papp	  B:A)	  with	  an	  increase	  from	  0.8	  ±	  0.1	  
to	  2.8	  ±	  0.1	  x	  10-­‐6	  cm	  s-­‐1	  (P	  <	  0.001;	  Fig	  5.3).	  An	  increase	  in	  pH	  from	  8	  to	  9.5	  was	  without	  significant	  
effect	  (Fig	  5.3).	  
	  
Fig	  5.3	  The	  pH	  dependent	  uptake	  of	  propranolol.	  Shown	  are	  the	  apparent	  permeability	  coefficients	  (Papp)	  for	  uptake	  (Papp	  
A:B,	  blue	  bars)	  and	  efflux	  (Papp	  B:A,	  orange	  bars)	  of	  propranolol	  (1	  μg	  L
-­‐1)	  across	  the	  DSI	  gill	  cell	  epithelium	  at	  6	  hours	  in	  
asymmetrical	  conditions	  at	  three	  different	  pHs.	  Significant	  differences	  between	  uptake	  Papp	  or	  efflux	  Papp	  are	  indicated	  
by	  asterisk	  (One-­‐way	  ANOVA;	  ***	  P	  <	  0.001).	  All	  experiments	  were	  performed	  in	  triplicate	  or	  more	  (n	  =	  3-­‐5)	  from	  2	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5.4.5	   The	  concentration-­‐dependent	  uptake	  of	  propranolol	  
A	   positive	   linear	   correlation	   between	   concentration	   (0.014-­‐10000	   μg	   L-­‐1)	   and	   rate	   of	   flux	   of	  
propranolol	   was	   observed	   with	   regression	   line	   representing	   the	   best	   fit	   of	   [rate]	   =	   0.052	  
[concentration]	  (n	  =	  54,	  r2	  =	  0.974,	  Fig	  5.4A).	  However	  at	  lower	  propranolol	  concentrations	  (0.014-­‐
0.14	   μg	   L-­‐1)	   a	   2nd	   order	   polynomial	   regression	   best	   described	   the	   concentration	   response	  
relationship	   (n	   =	   24,	   r2	   =	   0.927,	   Fig	   5.4B)	   rather	   than	   linear	   (n	   =	   24,	   r2	   =	   0.908)	   with	   line	  
representing	  the	  best	  fit	  of	  [rate]	  =	  0.057	  [concentration].	  
	  
Fig	  5.4	  The	  concentration	  dependent	  uptake	  of	  propranolol	  (uptake;	  A:B)	  at	  6	  hours	  after	  exposure	  to	  (A)	  17	  propranolol	  
concentrations	  ranging	  from	  0.014	  to	  10000	  μg	  L-­‐1	  with	  the	  line	  representing	  the	  fit	  of	  [rate]	  =	  0.052	  [concentration]	  (n	  =	  
54,	  r2	  =	  0.974)	  (note	  at	  lower	  concentrations	  that	  multiple	  data	  points	  are	  stacked)	  and	  (B)	  low	  propranolol	  
concentrations	  (0.014-­‐0.14	  μg	  L-­‐1)	  with	  the	  line	  representing	  the	  fit	  of	  [rate]	  =	  0.057	  [concentration]	  (n	  =	  24,	  r2	  =	  0.927).	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5.4.6	   The	  inhibition	  of	  the	  uptake	  of	  propranolol	  
	  
Fig	  5.5	  The	  inhibition	  of	  the	  uptake	  of	  1	  μg	  L-­‐1	  (4	  nM)	  propranolol	  from	  apical	  (freshwater)	  to	  basal	  (L-­‐15	  medium)	  using	  
400	  nM	  of	  the	  six	  inhibitors	  amantadine	  (A);	  cimetidine	  (B);	  cyclosporine	  A	  (C);	  MK571	  (D);	  quinidine	  (E)	  and	  verapamil	  
(F),	  applied	  either	  apically,	  AP	  (	  	  	  	  	  	  	  	  )	  or	  basally,	  BL	  (	  	  	  	  	  	  	  	  	  ).	  Data	  are	  shown	  as	  percentage	  of	  the	  mean	  control,	  CTL	  (	  	  	  	  	  	  	  )	  over	  
time.	  Significant	  differences	  between	  the	  apically	  applied	  inhibitor	  and	  the	  control	  are	  indicated	  by	  asterisk	  (One-­‐way	  
ANOVA;	  *P	  <	  0.05;	  **P	  <	  0.01;	  ***P	  <	  0.001).	  Significant	  differences	  between	  the	  basally	  applied	  inhibitor	  and	  the	  
control	  are	  indicated	  by	  hash	  tag	  (#P	  <	  0.05;	  ##P	  <	  0.01;	  ###P	  <	  0.001).	  All	  experiments	  were	  performed	  in	  triplicate	  or	  
more	  (n	  =	  3-­‐6	  from	  at	  least	  1	  biological	  replicate	  for	  inhibitor	  studies;	  n	  =	  18	  from	  6	  biological	  replicates	  for	  the	  inhibitor	  
free	  controls)	  and	  values	  are	  shown	  as	  means	  ±	  SEM.	  
Amantadine	   and	   verapamil	   did	   not	   inhibit	  Papp	   A:B	   of	   propranolol	   (Fig	   5.5A;	   Fig	   5.5F).	   Apical	   and	  
basal	  cimetidine	  application	  significantly	   inhibited	   the	   transport	  of	  propranolol	  at	  all	   time	  points	  
(apart	   from	  basal	  at	   time	  6	  hours)	  by	  approximately	  40%	  to	  61.4%	  ±	  3.4	   (apical	  application)	  and	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a	  significant	  inhibition	  of	  propranolol	  transport	  after	  48	  hours	  to	  69.9%	  (±	  3.7)	  that	  of	  the	  control	  
(P	  <	  0.01)	  for	  apical	  application	  and	  to	  66.3%	  (±	  6.1)	  (P	  <	  0.001)	  for	  basal	  (Fig	  5.5C).	  Application	  of	  
the	   inhibitors	   MK571	   and	   quinidine	   again	   showed	   a	   significant	   decrease	   in	   propranolol	  
permeability	  over	  time	  by	  approximately	  40%	  that	  of	  the	  control	  at	  48	  hours	  for	  both	  apical	  and	  
basal	  applications	  (P	  <	  0.001)	  (Fig	  5.5D;	  Fig	  5.5E).	  
5.4.7	   Comparison	  to	  predicted	  and	  actual	  propranolol	  plasma	  concentrations	  
Table	  5.3	  
Propranolol	   concentrations	   in	   silico	   (predicted),	   in	   vivo	   and	   in	   vitro	   (measured	   at	   various	   external	  
propranolol	  concentrations).	  
Nominal	   propranolol	   concentration	  
in	  water	  (μg	  L
-­‐1
)	  	  
In	  silico	  (ng	  mL
-­‐1
)	  
(Hugget	  et	  al.,	  2004)	  
In	  vivo	  (ng	  mL
-­‐1
)	  
(Owen	  et	  al.,	  2009)	  
In	  vitro	  (ng	  mL
-­‐1
)	  	  
0.1	  	   0.087	   n/a	   0.04	  (±	  0.002)	  
1.0	  	   0.87	   0.94*	  (n/a)	   0.10	  (±	  0.001)	  
10	  	   8.7	   3.3	  (±	  0.4)	   0.72	  (±	  0.02)	  
100	  	   87	   16	  (±	  7)	   7.5	  (±	  0.3)	  
1000	  	   870	   280	  (±	  116)	   79.5	  (±	  7.3)	  
10000	  	   8700	   5200	  (±	  1333)	   812	  (±	  158)	  
100000	  	   87000	   n/a	   5545	  (±	  313)	  
*pooled	  plasma	  sample	  	  
Propranolol	  is	  not	  toxic	  to	  primary	  gill	  cells	  at	  concentrations	  <10000	  μg	  L-­‐1	  (based	  on	  MTT	  assays,	  
data	  not	  shown).	  Predicted	  plasma	  concentrations	  were	  calculated	  using	  [plasma]	  =	  0.87	  [water]	  
and	   actual	   plasma	   concentrations	   from	   Owen	   et	   al.	   (2009)	   (Table	   5.3).	   A	   linear	   correlation	  
between	   predicted	   plasma	   concentration	   and	   in	   vitro	   basal	   concentrations	   was	   obtained	   and	  
described	  by	  [in	  vitro]	  =	  0.063	  [predicted]	  (n	  =	  21,	  r2	  =	  0.995,	  Fig	  5.6A).	  Furthermore,	  a	  correlation	  
between	  actual	  plasma	  concentrations	   (Owen	  et	  al.,	  2009)	  and	   in	  vitro	  basal	  concentrations	  was	  
obtained	  and	  described	  by	  [in	  vitro]	  =	  0.155	  [actual]	  (n	  =	  21,	  r2	  =	  0.966,	  Fig	  5.6B).	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Fig	  5.6	  Propranolol	  concentrations	  in	  the	  basal	  compartment	  of	  the	  primary	  gill	  cell	  model	  after	  6	  hours	  apical	  exposure	  
to	  propranolol	  in	  asymmetrical	  conditions	  plotted	  against	  (A)	  predicted	  (see	  text)	  O.	  mykiss	  propranolol	  plasma	  
concentrations	  (0.1-­‐100000	  μg	  L-­‐1)	  with	  regression	  line	  representing	  the	  fit	  of	  [in	  vitro]	  =	  0.063	  [predicted]	  (n	  =	  21,	  r2	  =	  
0.995)	  or	  (B)	  actual	  in	  vivo	  plasma	  concentrations	  (1-­‐10000	  μg	  L-­‐1)	  after	  40	  days	  exposure	  (Owen	  et	  al.,	  2009)	  with	  the	  
regression	  line	  representing	  the	  fit	  of	  [in	  vitro]	  =	  0.155	  [actual]	  (n	  =	  21,	  r2	  =	  0.966)	  (table	  3).	  Basal	  in	  vitro	  concentrations	  
were	  performed	  in	  triplicate	  or	  more	  (n	  =	  3-­‐5)	  and	  represent	  mean	  ±	  SEM	  from	  3	  biological	  replicates.	  
	  
5.5	  Discussion	  
The	   development	   of	   suitable	   in	   vitro	   cellular	   models	   to	   replace,	   refine	   and	   reduce	   (3Rs)	   the	  
numbers	  of	  fish	  used	  in	  ecotoxicological	  studies	  is	  an	  important	  requirement	  in	  current	  regulatory	  
testing	   (Scholz	   et	   al.,	   2013).	   Pharmaceuticals	   in	   the	   environment	   are	   contaminants	   of	   emerging	  
concern	  and	  their	  behavior	  in	  water	  affects	  uptake	  into	  biological	  systems	  (Boxall	  et	  al.,	  2012).	  Log	  
Kow	  is	  often	  used	  to	  determine	  the	  bioconcentration	  potential	  of	  a	  compound,	  which	  may	  not	  be	  
relevant	   to	   ionisable	   compounds	   such	   as	   pharmaceuticals	   (Hermens	   et	   al.,	   2013).	   The	   pH-­‐
corrected	   Log	  Dow	   is	   used	   to	   account	   for	   the	   fraction	  of	   ionisable	   and	  nonionisable	   species	   of	   a	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include	  partitioning	  across	  a	  biological	  membrane.	  The	  present	   study	   is	   the	   first	   to	  demonstrate	  
how	  a	  primary	  rainbow	  trout	  gill	  cell	  culture	  system	  can	  be	  used	  to	  assess	  pharmaceutical	  uptake	  
from	  water	  across	  a	  biological	  membrane.	  Therefore,	  this	  offers	  a	  potential	  alternative	  to	  replace	  
whole	  organism	  pharmaceuticals	  uptake	   studies	  at	  differing	  water	   chemistries,	   such	  as	  different	  
pHs,	  the	  presence	  of	  dissolved	  organic	  matter	  or	  real	  water	  samples	  from	  the	  field.	  
Once	  a	   tight	  epithelium	  (>5000	  Ω	  cm2,	  see	  Chapter	  3)	  has	   formed,	   the	  gills	  present	  a	  barrier	   for	  
paracellular	   transport	   that	   is	   relatively	   impermeable	  to	  the	  paracellular	  permeability	  marker	  14C-­‐
mannitol	  (Fig	  3.7A).	  All	  pharmaceuticals	  (except	  atenolol)	  were	  transported	  across	  the	  epithelium	  
in	  both	  directions	  at	  a	  rate	  greater	  than	  that	  of	  14C-­‐mannitol,	  indicating	  that	  their	  transport	  is	  via	  a	  
transcellular	  or	  carrier-­‐mediated	  process,	  as	  all	  exhibit	  molecular	  weights	  greater	  than	  that	  of	  the	  
marker	  (Hubatsch	  et	  al.,	  2007;	  Schwab	  et	  al.,	  2003).	  
The	   application	   of	   apical	   freshwater	   resulted	   in	   significantly	   different	   drug	   permeations	   for	  
propranolol	  and	  imipramine	  where	  more	  is	  taken	  up	  across	  the	  epithelium	  from	  the	  water	  than	  is	  
effluxed	  from	  the	  basolateral	  compartment	  (Table	  5.2;	  Fig	  5.1B;	  Fig	  5.2A).	  The	  uptake	  of	  ionisable	  
chemicals	  such	  as	  pharmaceuticals	  depends	  on	  pH	  and	  the	  acid	  base	  constant	   (pKa)	   (Lahti	  et	  al.,	  
2011).	   Both	   propranolol	   and	   imipramine	   are	  weak	   bases	  with	   pKa	   values	   around	   9.5.	   Using	   the	  
Henderson-­‐Hasselbalch	   equation,	   99%	   of	   propranolol	   and	   imipramine	   exist	   in	   their	   protonated	  
ionised	  form	  at	  pH	  7.4	   in	  symmetrical	  conditions,	  which	  then	  falls	   to	  98%	  in	   freshwater	  at	  pH	  8.	  
Here,	   at	   pH	   8,	   more	   of	   the	   natural	   unionised	   forms	   are	   lipid-­‐soluble,	   and	   thus	   may	   cross	   the	  
membrane	   via	   passive	   transcellular	   routes	   explaining	   the	   enhanced	   uptake.	   However,	   the	   1%	  
change	  in	  speciation	  is	  unlikely	  to	  fully	  account	  for	  the	  difference	  in	  uptake	  observed	  (Fig	  5.1)	  and	  
other	  factors	  are	  likely	  to	  play	  a	  role.	  For	  example,	  in	  symmetrical	  conditions	  TEP	  is	  positive	  (1.9	  ±	  
0.2	  mV)	  and	  becomes	  negative	  after	  apical	  freshwater	  application	  (−10.3	  ±	  0.2	  mV,	  Fletcher	  et	  al.,	  
2000;	  −12.9	  ±	  2.9	  mV,	  data	  not	  shown),	   to	  a	  value	  similar	  to	  that	  observed	   in	  vivo	   (Potts,	  1984).	  
The	   change	   in	  membrane	  potential	   to	  basolateral	   negative	   generates	   an	  electrical	   gradient	   that	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aids	   cation	   partitioning	   across	   the	   membrane	   (Fletcher	   et	   al.,	   2000).	   Alternatively,	   TR	   values	  
greater	   than	   1.5	   in	   asymmetrical	   conditions	   for	   propranolol	   and	   imipramine	   in	   BTA	   conditions	  
(Table	  5.2)	  indicate	  that	  a	  proportion	  of	  the	  transport	  is	  via	  a	  carrier-­‐mediated	  process	  (Schwab	  et	  
al.,	   2003).	   This	  observation	  was	   substantiated	  by	   the	   concentration	  equilibrated	   transport	   assay	  
(CETA)	   that	   eliminates	   concentration	   dependent	   passive	   transport	   across	   the	   gill	   epithelium	  
allowing	   the	   observation	   of	   carrier-­‐mediated	   processes	   that	   drive	   xenobiotic	   transport.	   In	   CETA	  
the	   difference	   in	   partitioning	   of	   radioactivity	   between	   the	   two	   compartments	   is	   not	   due	   to	  
disproportional	   loss	   of	   compound	   adhering	   to	   the	   plastic	   ware	   of	   the	   apical	   and	   basolateral	  
compartments,	   since	   in	   cell	   free	   blank	   insert	   experiments	   equal	   absorption	   is	   seen	   in	   each	  
compartment	   (an	   acid	   wash	   recovered	   less	   than	   1%	   of	   the	   initial	   radioactivity	   added	   in	   each).	  
Thus,	  it	  is	  possible	  to	  conclude	  that	  for	  propranolol	  and	  imipramine,	  facilitated	  transport	  makes	  up	  
approximately	  10%	  of	  the	  total	  transport,	  and	  around	  5%	  for	  ranitidine	  efflux	  (Fig	  5.2B).	  
Uptake	  rates	  are	  important	  for	  predicting	  potential	  internal	  concentrations	  and	  are	  used	  to	  predict	  
effects	   based	   on	   the	   "read	   across"	   hypothesis	   and	  Mode	   of	   Action	   (Rand-­‐Weaver	   et	   al.,	   2013).	  
Much	   of	   the	   in	   vivo	   uptake	   work	   used	   for	   these	   predictions	   expose	   fish	   to	   very	   high	   water	  
concentrations	  and	  extrapolates	  back	  to	  these	  lower	  environmentally	  relevant	  values.	  Propranolol	  
uptake	   is	   dose	   dependent	   over	   the	  whole	   range	   of	   concentrations	   but	   in	   the	   low,	   ng	   L-­‐1	   range,	  
uptake	  deviates	  from	  linearity	  (0.014	  –	  0.14	  μg	  L-­‐1,	  Fig	  5.4).	  A	  similar	  result	  was	  obtained	  for	  the	  
uptake	   at	   very	   low	   concentrations	   of	   iron	   across	   zebrafish	   gills	   and	   was	   attributable	   to	   proton	  
dependent	  metal	  transporters	  (Bury	  &	  Grosell,	  2003).	  The	  facilitated	  transport	  of	  propranolol	  that	  
occurs	   at	   these	   environmentally	   relevant	   concentrations	   (Kostich	   et	   al.,	   2014)	   is	   of	   interest	  
because	  it	  suggests	  that	  the	  predictive	  models	  for	  uptake	  using	  data	  derived	  for	  higher	  doses	  may	  
underestimate	  uptake.	  
The	  uptake	  of	  propranolol	  is	  pH	  dependent	  up	  to	  pH	  8,	  after	  which	  further	  increases	  do	  not	  cause	  
significant	   effects	   (Fig	   5.3).	   This	   again	   could	   be	   attributed	   to	   the	   difference	   in	   composition	   of	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ionised	  and	  unionised	  species	  at	  different	  pHs,	  with	  a	  caveat	  that	  a	  proportion	  of	  transport	  is	  likely	  
via	  a	  facilitated	  process.	  However,	  it	  should	  be	  noted	  that	  the	  pH	  of	  the	  apical	  bulk	  compartment,	  
and	  the	  microclimate	  at	  the	  boundary	  layer,	  were	  not	  measured	  after	  the	  6	  hour	  duration	  of	  the	  
experiment,	  and	  variations	  in	  such	  may	  account	  for	  changes	  in	  drug	  uptake.	  pH	  dependent	  uptake	  
of	   propranolol	   has	   been	  observed	   in	   other	   epithelia	   including	   retina	   (Kubo	   et	   al.,	   2013),	   Caco-­‐2	  
cells	   (Wang	   et	   al.,	   2010)	   and	   kidney	   MDCK	   cells	   (Dudley	   et	   al.,	   2000).	   In	   contrast,	   efflux	   of	  
propranolol	  is	  far	  greater	  at	  pH	  6	  than	  uptake	  (Fig	  5.3).	  This	  may	  suggest	  the	  export	  of	  propranolol	  
or	  its	  metabolite	  is	  pH	  dependent.	  Candidates	  for	  drug	  export	  are	  the	  ABC	  transporters;	  however	  
these	  are	  not	  directly	  regulated	  by	  pH	  changes	  (Altenberg	  et	  al.,	  1993;	  Neuhoff	  et	  al.,	  2003).	  The	  
internal	  pH	  of	  the	  cells	  is	  constant	  against	  external	  pH	  changes	  and	  thus	  intracellular	  speciation	  of	  
the	  drug	  is	  unlikely	  to	  explain	  potential	  increase	  in	  efflux.	  It	  is	  therefore	  likely	  that	  there	  are	  other	  
propranolol	  parent	  and/or	  metabolite	  exporters	  present	  on	  the	  gill.	  
Propranolol	  uptake	  from	  water	  was	  inhibited	  by	  cimetidine,	  cyclosporine	  A,	  MK571	  and	  quinidine.	  
These	   are	   inhibitors	   of	   a	   number	   solute	   carrier	   and	   ABC	   transporters.	   Many	   human	   SLCs	  
implicated	  in	  drug	  transport	  (SLC15s,	  SLCOs,	  SLC22s	  and	  SLC47s	  [Dobson	  &	  Kell,	  2008;	  Giacomini	  et	  
al.,	  2010])	  are	  homologous	  to	  SLCs	  found	  in	  teleost	  fish	  (Verri	  et	  al.,	  2012).	  Similarly,	  ATP-­‐binding	  
cassette	   (ABC)	   transporters	   involved	   in	   the	  cellular	  efflux	  of	   toxicants	  such	  as	  ABCBs,	  ABCCs	  and	  
ABCG2	  (Deeley	  et	  al.,	  2006)	  are	  considered	  highly	  conserved	  amongst	  vertebrates	  (Dean	  &	  Annilo,	  
2005)	  and	  have	  been	  documented	   in	   rainbow	  trout	  cells	  both	   in	  vivo	  and	   in	  vitro	   (Fischer	  et	  al.,	  
2011;	  Lončar	  et	  al.,	  2010)	  but	  not	  fully	  characterised.	  Recent	  microarray	  studies	  using	  the	  primary	  
gill	  cell	  culture	  system	  have	  identified	  the	  presence	  of	  these	  transcripts	  for	  a	  number	  of	  SLCs,	  ABCs	  
as	  well	   as	   biotransformation	   enzymes	   (Schnell,	   Bury,	   Kille	  &	  Hogstrand,	   unpublished	   data).	   But,	  
the	  identification	  of	  active	  proteins	  requires	  further	  work.	  
The	  application	  of	   cimetidine	  and	  quinidine,	  which	  both	   interact	  with	  organic	  cation	   transporter	  
OCT2	   (SLC22A2)	   (Giacomini	  et	  al.,	  2010;	  Koepsell,	  2013)	   significantly	   reduce	  propranolol	  uptake.	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Propranolol	   transport	   via	   OCT2	  was	   observed	   in	   renal	   LLC-­‐PK1	   cells	   transiently	   transfected	  with	  
hOCT2-­‐V5,	  more	  specifically	   in	  the	  active	  uptake	  of	   its	  cationic	  form	  across	  the	  apical	  membrane	  
(Dudley	   et	   al.,	   2000).	   Cimetidine	   is	   also	   used	   as	   a	   blocker	   of	   cisplatin	   transport	   by	   OCT2	   in	  
zebrafish	  lateral	   line	  hair	  cells	  (Thomas	  et	  al.,	  2013)	  and	  the	  presence	  of	  OCT2-­‐like	  proteins	  have	  
been	  suggested	  in	  other	  teleost	  fish	  gill	  epithelia	  (Verri	  et	  al.,	  2012).	  MK571	  is	  an	  inhibitor	  of	  the	  
multidrug	   resistance	  protein	   (MRP)	  efflux	  pumps	   (Deeley	  et	   al.,	   2006)	  and	   significantly	   inhibited	  
propranolol	  uptake.	  The	  main	  MRP	  expressed	  in	  the	  gill	  is	  MRP3	  (ABCC3)	  (Lončar	  et	  al.,	  2010).	  P-­‐
glycoprotein	   (Pgp;	  ABCB1)	   is	   implicated	   in	  propranolol	   transport	   in	   rabbit	   conjunctivial	  epithelial	  
cells	  (Yang	  et	  al.,	  2000)	  and	  Caco-­‐2	  cells	  (Wang	  et	  al.,	  2010)	  and	  is	  present	  in	  rainbow	  trout	  tissues	  
but	  at	  low	  levels	  in	  the	  gill	  (Lončar	  et	  al.,	  2010).	  Whether	  Pgp	  is	  involved	  in	  propranolol	  transport	  
in	  the	  gill	  cell	  culture	  system	  is	  unclear.	   In	  addition	  to	  inhibiting	  OCT2,	  quinidine	  also	  acts	  as	  Pgp	  
inhibitor	   (Giacomini	   et	   al.,	   2010)	   and	   cyclosporine	   A,	   another	   Pgp	   inhibitor,	   also	   blocked	  
propranolol	  transport	  but	  this	  may	  be	  via	  MRP	  inhibition	  instead.	  Application	  of	  the	  Pgp	  inhibitor	  
verapamil	   however	   did	   not	   affect	   propranolol	   transport	   (Fig	   5.5F).	   Taken	   together	   these	  
observations	   would	   suggest	   that	   OCT2	   and	  MRP3	  may	   be	   candidates	   for	   propranolol	   transport	  
across	   the	   teleost	   gill	   epithelium,	   but	   the	   location	   (apical	   or	   basolateral	   membrane)	   of	   these	  
transporters,	  and	  others,	  needs	  further	  assessment.	  
Owen	  et	  al.	  (2009)	  showed	  that	  predicted	  plasma	  concentrations	  (Fitzsimmons	  et	  al.,	  2001)	  were	  
good	   indicators	   of	   propranolol	   uptake	   over	   a	   range	   of	   high	   concentrations.	   Our	   data	   also	  
correlates	  well	  with	  predicted	  (Fig	  5.6A)	  and	  measured	  plasma	  concentrations	  (Fig	  5.6B).	  However,	  
in	   vitro	   propranolol	   concentrations	   in	   the	   basolateral	   compartment	  were	   an	   average	   6%	   of	   the	  
predicted	  and	  16%	  of	  actual	  plasma	  concentrations,	  whilst	  actual	  plasma	  concentrations	  were	  only	  
59%	  of	  predicted	  (Owen	  et	  al.,	  2009).	  In	  vivo	  bioconcentration	  studies	  can	  involve	  an	  uptake	  phase	  
of	   60	   days	   until	   a	   steady	   state	   is	   reached	   (OECD305;	   2012).	   Owen	   et	   al.	   (2009)	   used	   a	   40-­‐day	  
exposure	  period,	  and	  both	  procedures	  used	  a	  flow	  through	  system	  with	  a	  steady-­‐state	  endpoint.	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This	   in	   vitro	   assay	   took	   place	   over	   6	   hours	   in	   a	   static	   system,	  which	   could	   account	   for	   reduced	  
propranolol	  uptake.	  Furthermore,	  actual	  plasma	  concentrations	  may	  be	  lower	  than	  predicted	  as	  a	  
proportion	  of	  the	  drug	  may	  bind	  to	  proteins	  or	  be	  metabolised	  by	  the	  gill,	  which	  prediction	  models	  
fail	  to	  take	  into	  account.	  Nevertheless,	  the	  relationships	  between	  this	  in	  vitro	  system	  to	  predicted	  
and	  actual	  propranolol	  plasma	  concentrations	  suggest	  its	  applicability	  as	  a	  suitable	  in	  vitro	  model	  
to	   investigate	   the	   uptake	   of	   xenobiotics	   and	   when	   combined	   with	   elimination	   rates,	   may	  
supplement	   in	   vivo	   bioconcentration	   fish	   studies.	   This	   model	   provides	   a	   rapid	   and	   ethically	  
acceptable	  tool	  with	  which	  to	  perform	  a	  preliminary	  assessment	  of	  compounds	  of	  low	  Log	  Kow,	  and	  
as	   such	   is	   ideal	   for	   large	   numbers	   of	   pharmaceuticals	   that	   typically	   have	   a	   lower	   propensity	   to	  
bioaccumulate.	  
This	  study	  shows	  that	  as	  well	  as	  the	  passive	  uptake	  and	  efflux	  of	  neutral	  forms	  of	  pharmaceuticals,	  
water	  enhances	  drug	  uptake	  of	  ionisable	  pharmaceuticals	  via	  both	  passive	  transcellular	  and	  carrier	  
mediated	  processes.	  Hence,	  the	  ability	  of	  this	  system	  to	  tolerate	  freshwater	  is	  fundamental	  if	  we	  
are	  to	  simulate	  in	  vivo	  drug	  uptake	  across	  the	  gill.	  In	  addition,	  the	  facilitated	  uptake	  of	  propranolol	  
was	  more	  evident	  at	  low	  concentrations	  that	  are	  more	  environmentally	  relevant;	  suggesting	  that	  
in	  certain	  situations	  uptake	  may	  be	  under	  predicted.	  Indeed	  there	  is	  significant	  variation	  (five-­‐fold)	  
recorded	  in	  plasma	  concentrations	  of	  individual	  fish	  exposed	  to	  pharmaceuticals	  in	  vivo	  (Owen	  et	  
al.,	   2009),	   and	   it	   could	   be	   that	   individual	   differences	   in	   transporter	   expression	   may	   be	   a	  
mechanistic	   explanation	   for	   this	   variance.	   The	   use	   of	   this	   system	   provides	   an	   opportunity	   to	  
reduce	   the	   numbers	   of	   fish	   used	   in	   regulatory	   ecotoxicological	   testing	   as	   the	   primary	   gill	   cells	  
cultured	  from	  two	  fish	  may	  provide	  many	  individual	  gill	  cell	  cultures,	  and	  this	  method	  bypasses	  in	  
vivo	   drug	   exposures	   and	   uses	   much	   less	   test	   compound,	   thus	   offering	   refinement	   through	  
improved	  animal	  welfare	  methods.	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Chapter	  6	  
The	  metabolism	  of	  pharmaceuticals	  by	  gill	  cell	  epithelia	  
	  
6.1	  Abstract	  
The	  metabolism	  of	  chemicals	  after	  they	  pass	  into	  fish	  has	  been	  attributed	  to	  a	  reason	  why	  models	  
used	  to	  predict	  BCF	  values	  might	  be	  unreliable,	  as	  they	  fail	  to	  take	  this	  into	  account.	  The	  gill	  is	  the	  
primary	  route	  of	  uptake	  of	  pharmaceuticals,	  but	  whether	  it	  metabolises	  pharmaceuticals	  has	  not	  
been	  fully	  ascertained.	  This	  study	  utilised	  an	  in	  vitro	  primary	  rainbow	  trout	  gill	  cell	  model	  and	  the	  
gill	  cell	  line	  RTgill-­‐W1,	  grown	  on	  permeable	  membrane	  inserts	  in	  a	  two-­‐compartment	  model.	  The	  
primary	   gill	   cell	   culture	   technique	   produces	   epithelia	   that	   mimic	   the	   intact	   organ	   and	   can	  
withstand	  apical	  freshwater	  application.	  Thus,	  environmentally	  relevant	  types	  and	  concentrations	  
of	  pharmaceuticals	  can	  be	  added	  to	  the	  apical	  surface	  of	  the	  gill	  in	  the	  freshwater,	  like	  the	  in	  vivo	  
scenario.	  This	  study	  aimed	  to	  show	  that	  the	  gill	   is	  metabolically	  active	  through	  cytochrome	  P450	  
activity	  and	  is	  a	  ‘first-­‐pass’	  organ	  of	  waterborne	  xenobiotic	  metabolism	  in	  fish.	  Cytochrome	  P450	  
assays	  indicated	  the	  presence	  of	  CYP1A,	  which	  may	  play	  a	  role	  in	  the	  metabolism	  of	  xenobiotics	  at	  
the	  gill	  organ	  level.	  An	  appropriate	  solid	  phase	  extraction	  (SPE)	  method	  was	  optimised	  to	  analyse	  
freshwater	   (the	   apical	   compartment)	   and	   cell	   culture	   medium	   samples	   (the	   basolateral	  
compartment)	   after	   propranolol	   exposure	   at	   a	   range	   of	   concentrations	   over	   24	   hours.	   High-­‐
performance	   liquid	   chromatography	   (HPLC)	   analysis	   using	   a	   validated	   method	   confirmed	   the	  
xenobiotic	  metabolic	  capacity	  of	  this	  primary	  gill	  cell	  culture,	  as	  the	  metabolite	  of	  propranolol,	  4-­‐
hydroxypropranolol,	  was	  confirmed	  in	  both	  basal	  cell	  medium	  and	  apical	  water	  samples,	  indicating	  
the	  presence	  of	  metabolite	  uptake	  and	  efflux,	  respectively.	  
	   	  
6.	  Metabolism	  of	  pharmaceuticals	  
Lucy	  C.	  Stott	  |	  135	  
6.2	  Introduction	  
Pharmaceuticals	  enter	   the	  aquatic	  environment	   through	  the	   improper	  or	   insufficient	   removal	  by	  
wastewater	  treatment	  plants	  (Kostich	  et	  al.,	  2014).	  Awareness	  of	  their	  effect	  on	  aquatic	  species	  is	  
increasing	   (Lajeunesse	  et	   al.,	   2011)	   and	   legislation	   requires	   the	  bioconcentration	   factor	   (BCF)	   of	  
chemicals	  to	  be	  determined	  to	  evaluate	  the	  bioconcentrative	  properties	  of	  the	  parent	  compound	  
(OECD305,	  2012).	  Many	  physiological	  transport	  and	  metabolic	  systems	  are	  conserved	  between	  taxa	  
(Lukenbach	   et	   al.,	   2014;	   Schreiber	   et	   al.,	   2011),	   leading	   to	   the	   suggestion	   that	   these	   parent	  
compounds	   may	   also	   be	   metabolised	   by	   non-­‐target	   aquatic	   species	   (Gunnarsson	   et	   al.,	   2008).	  
Biotransformation	   of	   compounds	   can	   strongly	   influence	   the	   extent	   to	   which	   metabolites	  
bioconcentrate	   in	   fish	  and	  so	  actual	  BCF	  values	  may	  be	  under-­‐	  or	  over-­‐estimated	   (Gomez	  et	  al.,	  
2010).	  
Pharmaceuticals	  are	  metabolised	  by	  cytochrome	  P450	  (CYP)	  enzymes	  that	   typically	  add	  hydroxyl	  
groups	   to	   aid	   solubility.	   There	   are	   over	   1000	   known	   CYP	   enzymes	   identified	   throughout	   the	  
vertebrate	   lineage,	   approximately	   60	   have	   been	   identified	   in	   humans	   (Anzenbacher	   &	  
Anzenbacherová,	  2001),	  and	  of	  these	  ,	  CYP1A2,	  2C9,	  2C8,	  2C19,	  2D6,	  and	  3A4	  gene	  expression	  is	  
induced	   by	   xenobiotics	   (Levien	   &	   Baker,	   2003).	   Gene	   expression	   is	   not	   a	   measure	   of	   activity,	  
however,	  and	  catalytic	  alkoxyresorufin-­‐O-­‐dealkylase	  assays	  are	  used	  to	  detect	  specific	  CYP	  enzyme	  
induction	   and	   inhibition	   in	   response	   to	   xenobiotic	   exposure	   by	   measuring	   the	   amount	   of	  
fluorescent	   resorufin	   produced.	   For	   example,	   the	   activities	   of	   ethoxy-­‐,	   methoxy-­‐resorufin-­‐O-­‐
dealkylases	  (EROD	  and	  MROD)	  can	  quantify	  CYP1A	  and	  CYP1A2	  activity,	  respectively.	  
To	  date,	  CYP	  enzymes	  identified	  in	  rainbow	  trout	  total	  10,	  and	  some	  information	  is	  known	  on	  their	  
induction	   and	   inhibition	   (Table	   6.1).	   The	   trout	   CYP1A	   family	   is	   analogous	   to	  mammalian	  CYP1A,	  
with	   similar	   substrate	   specificity	   that	   is	   inducible	   by	   beta-­‐naphthoflavone	   (BnF)	   (Carlsson	   et	   al.,	  
1999;	   Carlsson	  &	   Pärt,	   2001;	   Jönsson	   et	   al.,	   2002)	   and	   inhibited	   by	   alpha-­‐naphthoflavone	   (AnF)	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(Thibaut	  et	   al.,	   2006).	   The	   rainbow	   trout	   liver	   is	   the	  principle	   site	  of	   xenobiotic	  metabolism	  and	  
primary	  liver	  cells	  have	  been	  shown	  to	  be	  metabolically	  active	  in	  S9	  fractions	  (Conners	  et	  al.,	  2013;	  
Gomez	  et	  al.,	  2011),	  and	  in	  2D	  monoculture	  and	  3D	  spheroid	  culture	  (Baron	  et	  al.,	  2012;	  Uchea	  et	  
al.,	  2013).	  
Table	  6.1	  
Rainbow	  trout	  CYP	  isoforms	  and	  their	  proposed	  inducers,	  inhibitors	  and	  assays.	  
Family	   Symbol	   Inducer	   Inhibitor	   Assay	  
CYP1	   1A	   BNFa	   ANFa	  
Clotrimazolec	  
EROD	  
CYP2	   2K	   	   Ketoconazoleb	   (ω-­‐1)-­‐	   and	   (ω-­‐2)-­‐Laurate	   hydroxylase	  
(CYP2K-­‐like)	  
	   2M	   	   Ketoconazoleb	   ω-­‐Laurate	  hydroxylase	  (CYP2M-­‐like)	  





	   3A45	   Phenobarbital*,	  rifampicin*	   Ethynylestradiolb	   	  
CYP4	   4T1	   	   	   	  
CYP11	   11A	   	   	   	  
	   11B	   	   	   	  
CYP17	   17	   	   	   	  
CYP19	   19	   Phenobarbital*,	  rifampicin*	   	   	  
*Mammalian	  data	  
a	  Rainbow	  trout	  primary	  in	  vitro	  gill	  cells	  (Carlsson	  et	  al.,	  1999)	  
b	  Carp	  liver	  subcellular	  fractions	  (Thibaut	  et	  al.,	  2006)	  
c	  Rainbow	  trout	  hepatic	  microsomes	  (Burkina	  et	  al.,	  2013)	  
	  
In	  order	  to	  reach	  the	   liver	   for	  detoxification,	  xenobiotics	  must	  first	  enter	  the	  fish	  via	  the	  diet,	  or	  
over	   the	   dermis	   or	   gill.	   The	   gill	   is	   the	   primary	   site	   of	   oxygen	   uptake	   and	   nitrogenous	   waste	  
excretion,	   ion	  transport	  (Evans	  et	  al.,	  2005)	  and	  xenobiotic	  uptake	  (Bury	  et	  al.,	  2014;	  Stott	  et	  al.,	  
2015).	  In	  vitro,	  primary	  gill	  cell	  suspensions	  and	  S9	  fractions	  are	  metabolically	  active;	  they	  contain	  
CYP	  enzymes	  that	  are	  inducible	  resulting	  in	  the	  depletion	  of	  parent	  compound	  and	  the	  formation	  
of	   hydroxy-­‐metabolites	   (Bartram	   et	   al.,	   2011;	   Gomez	   et	   al.,	   2010;	   Gomez	   et	   al.,	   2011).	   We	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hypothesise	   that	   the	   rainbow	   trout	   gill	   is	   a	  metabolic	   organ,	   offering	   ‘first-­‐pass’	  metabolism	   of	  
xenobiotics	  to	  be	  excreted	  or	  further	  metabolised.	  
The	  non-­‐selective	  beta-­‐antagonist	  propranolol	  has	  been	  detected	  in	  surface	  waters	  in	  the	  UK	  and	  
is	   present	   on	   the	   Environmental	   Agency’s	   (EA)	   targeted	   monitoring	   programme	   for	  
pharmaceuticals	   in	   the	  aquatic	  environment	   (Hilton	  et	  al.,	  2003).	  Propranolol	  has	  a	  BCF	  value	  of	  
160	  in	  mussels	  (AstraZeneca,	  2012)	  and	  is	  known	  to	  cross	  the	  rainbow	  trout	  gill	  epithelium	  in	  vitro	  
(Stott	   et	   al.,	   2015).	   In	   humans,	   propranolol	   is	  metabolised	   via	   three	   pathways	   to	  more	   than	   12	  
metabolites	  by	  three	  known	  CYPs,	  but	  chiefly	  by	  CYP1A2	  and	  CYP2D6	  (Fig	  6.1;	  Walle	  et	  al.,	  1983;	  
Walle	   et	   al.,	   1985;	   Mehvar	   &	   Brocks,	   2001).	   In	   rainbow	   trout	   propranolol	   is	   metabolised	   by	  
primary	  in	  vitro	  gill	  cells	  in	  suspension	  or	  S9	  fractions	  (Bartram	  et	  al.,	  2011;	  Gomez	  et	  al.,	  2010).	  
The	  following	  study	  aimed	  to	  quantify	  the	  metabolism	  of	  propranolol	  at	  the	  gill	  using	  primary	  and	  
immortalised	   in	   vitro	   gill	   cells	   cultured	  on	  permeable	   supports.	  Primary	  gill	   cells	   cultured	   first	   in	  
cell	   culture	   flasks	   (SSI)	   are	   known	   to	   contain	   a	   population	   solely	   of	   pavement	   cells,	   the	   main	  
respiratory	  cell	  of	  the	  freshwater	  gill	  epithelium	  (Wood	  et	  al.,	  1998).	  Primary	  DSI	  epithelia	  are	  the	  
most	   accurate	   representation	   of	   the	   rainbow	   trout	   gill	   and	   contain	  multiple	   cell	   types	   including	  
PVCs	  and	  mitochondria-­‐rich	  cells	  (MRCs),	  the	  cells	  responsible	  for	  active	  and	  ionic	  transport	  at	  the	  
gill	  (Wood,	  2001).	  The	  immortalised	  rainbow	  trout	  gill	  cell	  line,	  RTgill-­‐W1,	  also	  contains	  PVCs	  and	  
MRCs	  (Lee	  et	  al.,	  2009)	  but	   lacks	  some	  metabolic	  enzymes	  such	  as	  CYP1A	  (Schirmer	  et	  al.,	  1998)	  
and	   other	   epithelial	   physiological	   characteristics	   such	   as	   high	   transepithelial	   resistance.	   These	  
differences	   in	   epithelial	   characteristics	   could	   explain	   any	   observed	   differences	   in	   transport	   and	  
metabolism.	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Fig	  6.1	  The	  main	  pathways	  of	  propranolol	  metabolism	  in	  humans.	  Adapted	  from	  Mehvar	  &	  Brocks	  (2001).	  
	  
6.3	  Materials	  and	  methods	  
6.3.1	   Reagents	  and	  suppliers	  
Propranolol	   hydrochloride,	   (±)-­‐4-­‐hydroxypropranolol	   hydrochloride	   (of	   analytical	   standard),	  
ammonium	   acetate	   and	   ethoxy-­‐resorufin-­‐O-­‐dealkylase	   (EROD)	   were	   purchased	   from	   Sigma	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was	  obtained	   from	  Santa	  Cruz	  Biotechnology.	  Bradford	  dye	  reagent	  was	  purchased	   from	  Biorad.	  
Analytical	  grade	  methanol,	  acetonitrile	  and	  ultrapure	  HPLC	  water	  were	  purchased	  from	  VWR.	  
6.3.2	   Equipment	  and	  suppliers	  
Equipment	  used	  was	  the	  same	  as	  those	  outlined	  in	  Chapter	  2	  with	  the	  following	  additions.	  Oasis	  
HLB	   cartridges	   (6	  mL,	   200	  mg)	  were	  purchased	   from	  Waters	   Ltd.	   The	  24-­‐port	   SPE	  manifold	  was	  
purchased	   from	   Thermo	   Scientific.	   The	   evaporation	   system	   was	   a	   TurboVap	   LV	   produced	   by	  
Biotage.	   The	   Agilent	   1200	   series	   HPLC	   system	  was	   equipped	  with	   degasser,	   quaternary	   pumps,	  
autosampler,	  column	  oven	  and	  UV	  detector	  produced	  by	  Agilent	  Technologies.	  This	  was	  controlled	  
by	  GINA	  Star	  software	  version	  5.8	  produced	  by	  Raytest.	  The	  HPLC	  system	  used	  a	  Waters	  SunFire	  
C18	  column	  (3.5	  μm,	  2.1	  mm	  ×	  150	  mm)	  (Waters)	  fitted	  with	  a	  SecurityGuard™	  guard	  column	  (2.0	  
mm	  ID;	  Phenomenex).	  HPLC	  amber-­‐glass	  vials	  were	  purchased	  from	  Fisher	  Scientific.	  For	  protein	  
quantification	  96	  well	  plates	  were	  purchased	  from	  Nunc.	  The	  multiwall	  plate	  reader	  was	  produced	  
by	  Synergy	  HT	  and	  operated	  using	  the	  KC4	  program.	  
6.3.3	   Preparation	  of	  reagents	  
Reagents	   were	   prepared	   as	   detailed	   in	   Chapter	   2.	   Standard	   solutions	   of	   propranolol	   and	  
hydroxypropranolol	  were	  diluted	   from	  stocks	  made	   in	  ultrapure	  water	   into	   freshwater,	  L-­‐15	  and	  
phase	  A	  for	  standard	  HPLC	  calibrations.	  EROD	  was	  reconstituted	   into	  10	  mM	  stock	   in	  DMSO	  and	  
resorufin	  to	  a	  2	  mM	  stock	  in	  DMSO	  and	  stored	  at	  -­‐20oC	  in	  the	  dark.	  
6.3.4	   Cell	  culture	  reagents	  
Cell	  culture	  reagents	  were	  prepared	  as	  outlined	  in	  Chapter	  2.	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6.3.5	   Methods	  
The	  general	  material	  and	  methods	   for	   the	  cell	  culture	  and	  maintenance	  of	  SSI	   (from	  primary	  gill	  
cells	  first	  cultured	  in	  cell	  culture	  flasks),	  DSI	  and	  RTgill-­‐W1	  can	  be	  found	  in	  Chapter	  2.	  SSI	  cells	  were	  
cultured	  for	  at	  least	  1	  week	  before	  exposure	  after	  having	  reached	  a	  plateau	  in	  TER	  (Fig	  3.2A).	  DSI	  
epithelia	  were	  used	  once	  they	  had	  passed	  a	  TER	  of	  5000	  Ω	  cm2.	  RTgill-­‐W1	  was	  cultured	  for	  at	  least	  
1	  week	  on	  permeable	  inserts.	  Before	  xenobiotic	  exposure,	  cell	  culture	  medium	  was	  removed	  and	  
inserts	  were	  washed	   as	   detailed	   in	   Chapter	   2	   to	   remove	   traces	   of	   FBS.	   All	   assays	   took	   place	   at	  
18°C.	  
6.3.6	   EROD	  induction	  and	  inhibition	  
BnF	   and	   AnF	   are	   hydrophobic	   and	   in	   water	   have	   the	   tendency	   to	   adhere	   to	   plastic	   ware,	   thus	  
lowering	   exposure	   concentrations.	   To	   reduce	   this	   the	   exposure	  was	   performed	   in	   L-­‐15	  medium	  
(Leguen	   et	   al.,	   2000).	   BnF	   and	   AnF	   were	   diluted	   from	   a	   10	   mM	   stock	   in	   DMSO	   to	   a	   final	  
concentration	  of	  10	  μM	  (Carlsson	  et	  al.,	  1999)	  in	  L-­‐15	  (0.01%	  DMSO).	  The	  control	  L-­‐15	  contained	  
the	  same	  concentration	  of	  DMSO.	  For	  induction	  assays,	  1.5	  mL	  of	  the	  BnF	  solution	  was	  applied	  to	  
the	  apical	  cell	  surface	  (the	  apical	  compartment)	  of	  SSI	  epithelia	  (n	  =	  4	  from	  3	  fish),	  DSI	  epithelia	  (n	  
=	  3	  from	  2	  fish,	  1	  biological	  replicate)	  and	  RTgill-­‐W1	  epithelia	  (n	  =	  3,	  Passage	  number	  108)	  with	  2.0	  
mL	  L-­‐15	  in	  the	  basolateral	  compartment	  for	  24	  hours	  at	  18°C.	  Similarly	  for	  inhibition	  assays,	  1.5	  mL	  
AnF	  solution	  was	  applied	  to	  the	  apical	  compartment	  in	  the	  same	  way.	  
After	  24	  hours,	  the	  exposure	  medium	  was	  removed	  (basolateral	  first,	  then	  the	  apical)	  and	  gill	  cell	  
epithelia	  were	  washed	  twice	  with	  200	  μL	  PBS.	  2	  μM	  EROD	  was	  made	  in	  PBS	  from	  a	  2	  mM	  stock	  in	  
DMSO,	  and	  200	  μL	  was	  applied	  to	  the	  apical	  cell	  surface.	  This	  was	  incubated	  at	  room	  temperature	  
in	  the	  dark	  for	  20	  minutes.	  The	  whole	  200	  μL	  was	  then	  transferred	  to	  a	  black	  96	  well	  plate	  and	  the	  
florescence	  of	  the	  formed	  resorufin	  was	  read	  at	  544	  nm	  (emission)	  and	  590	  nm	  (excitation)	  using	  a	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multiwall	   plate	   reader.	   Quantification	  was	  made	   by	   calibration	  with	   a	   resorufin	   standard	   curve	  
(0.02-­‐2	  μM	  in	  PBS	  from	  a	  2	  mM	  stock	  in	  DMSO)	  constructed	  on	  each	  plate.	  
6.3.7	   Propranolol	  exposure	  
SSI	   epithelia	   (n	   =	   3	   from	   3	   fish),	   DSI	   epithelia	   (n	   =	   3	   from	   1	   biological	   replicate)	   and	   RTgill-­‐W1	  
epithelia	   (n	   =	   3,	   P108)	   were	   prepared	   for	   experimental	   procedures	   as	   previously	   described	  
(Chapter	  2).	  1000	  μg	  L-­‐1	  of	  propranolol	  in	  FW	  was	  applied	  to	  the	  apical	  compartments,	  whilst	  the	  
basolateral	   remained	   in	   L-­‐15	   for	   24	   hours	   at	   18°C.	   After	   24	   hours,	   the	   exposure	   medium	   was	  
removed	  and	  the	  EROD	  assay	  was	  carried	  out	  exactly	  as	  above.	  
6.3.8	   Protein	  quantification	  assays	  
To	   determine	   cellular	   protein	   content	   following	   the	   EROD	   assay,	   gill	   cell	   epithelia	   were	   again	  
washed	  twice	  with	  200	  μL	  PBS,	  exposed	  to	  200	  μL	  Milli-­‐Q	  water	  and	  left	  at	  room	  temperature	  for	  
20	  minutes,	  before	  the	  whole	  plate	  was	  transferred	  to	  -­‐80°C	  for	  at	   least	  24	  hours.	  Samples	  were	  
thawed	  and	  three	  5	  μL	  samples	  from	  each	  insert	  was	  transferred	  to	  a	  clear	  96	  well	  plate	  with	  250	  
μL	   of	   Bradford	   dye	   and	   left	   to	   incubate	   at	   room	   temperature	   in	   the	   dark	   for	   5	   minutes.	   The	  
absorbance	   was	   read	   at	   595	   nm	   using	   a	   multiwall	   plate	   reader	   and	   quantification	   made	   by	  
calibration	  with	  a	  protein	  standard	  curve	  (0.13-­‐2	  mg	  mL-­‐1	  BSA	  in	  Milli-­‐Q	  water)	  constructed	  on	  the	  
same	  plate.	  Protein	  was	  quantified	  to	  express	  EROD	  activity	  per	  mg	  of	  protein.	  
6.3.9	   Propranolol	  exposure	  for	  HPLC	  analysis	  
SSI,	   DSI	   and	   RTgill-­‐W1	  were	   cultured,	  maintained	   and	   prepared	   for	   experimental	   procedures	   as	  
outlined	  above.	  Propranolol	  was	  applied	  to	  either	  the	  apical	  compartment	  in	  1.5	  mL	  FW	  with	  L-­‐15	  
in	  the	  basolateral	  (‘uptake’)	  (n	  =	  12),	  or	  in	  2.0	  mL	  L-­‐15	  with	  1.5	  mL	  FW	  in	  the	  apical	  (‘efflux’)	  (n	  =	  
12)	  at	  a	  concentration	  of	  10,	  100	  and	  1000	  μg	  L-­‐1.	  Excess	  exposure	  L-­‐15	  and	  FW	  with	  and	  without	  
propranolol	  (time	  0)	  were	  stored	  at	  -­‐80°C,	  the	  same	  as	  samples	  as	  outlined	  below.	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6.3.10	   Sample	  collection	  and	  storage	  
At	  each	  time	  point,	  1,	  3,	  6	  and	  24	  hours	  after	  exposure,	  the	  2.0	  mL	  of	  L-­‐15	  medium	  was	  removed	  
from	   the	  basolateral	  well	   and	   stored	   in	  a	  14	  mL	   conical	   tube,	   and	   the	  1.5	  mL	  FW	  was	   removed	  
from	   the	   apical	   compartment	   and	   stored	   in	   a	   2.0	   mL	   eppendorf.	   These	   were	   immediately	  
transferred	  to	  -­‐80°C	  until	  samples	  underwent	  SPE,	  when	  they	  were	  thawed,	  pooled	  (n	  =	  3,	  giving	  a	  
total	  volume	  of	  6	  mL	  for	  L-­‐15	  samples	  and	  4.5	  mL	  for	  FW	  samples)	  and	  used	  immediately.	  
6.3.11	   Solid	  phase	  extraction	  of	  samples	  and	  standard	  solutions	  
The	   same	   SPE	   protocol	   was	   used	   for	   both	   sample	   and	   standard	   solution	   (below)	   preparation.	  
Firstly,	   Oasis	   HLB	   cartridges	   were	   conditioned	  with	   6	  mL	   of	  methanol	   and	   rinsed	  with	   6	  mL	   of	  
ultrapure	  water	  under	  a	  vacuum	  (20	  psi)	  on	  a	  24-­‐port	  SPE	  manifold.	  The	  samples	  or	  standards	  (of	  
known	  propranolol	  and	  hydroxypropranolol	  concentrations),	   in	  either	  6	  mL	  of	  L-­‐15	  or	  4.5	  mL	  FW	  
respectively)	   were	   then	   loaded	   onto	   the	   preconditioned	   cartridges	   at	   a	   rate	   of	   2	   mL	   min-­‐1.	  
Cartridges	   were	   then	   washed	   with	   half	   the	   volume	   previously	   applied	   of	   ultra-­‐pure	   water	   (i.e.	  
either	  3	  mL	  for	  L-­‐15	  or	  2.25	  mL	  for	  FW	  samples)	  and	  dried	  for	  30	  minutes	  under	  a	  vacuum.	  Sample	  
extracts	   were	   then	   eluted	   with	   either	   6	   mL	   or	   4.5	   mL	   methanol	   (for	   L-­‐15	   or	   FW	   samples,	  
respectively)	  and	  dried	  under	  pure	  nitrogen	  (1.0	  bar)	  whilst	  heated	  to	  40°C	  using	  an	  evaporation	  
system.	  Extract	  residues	  were	  reconstituted	  in	  either	  600	  μL	  (for	  L-­‐15	  samples	  or	  standards)	  or	  450	  
μL	  (for	  FW	  samples	  or	  standards)	  of	  phase	  A	  solvent	  (see	  below),	  achieving	  a	  concentration	  of	  x10	  
the	  original.	  This	  was	  transferred	  to	  a	  2	  mL	  HPLC	  amber-­‐glass	  vial,	  crimped	  shut	  and	  immediately	  
injected	  onto	  the	  HPLC	  system.	  
6.3.12	   Standard	  solutions	  for	  HPLC	  
Individual	   stock	   standard	   solutions	   (2	   mg	   mL-­‐1)	   of	   propranolol	   and	   hydroxypropranolol	   were	  
prepared	   in	  HPLC	   grade	  ultra-­‐pure	  water	   and	   stored	   at	   -­‐80°C.	  Working	   standard	   solutions	  were	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prepared	  firstly	  by	  diluting	  the	  two	  stocks	  together	  50:50	  to	  create	  a	  working	  stock	  of	  1	  mg	  mL-­‐1	  
propranolol	   and	  hydroxypropranolol	   in	  HPLC	   grade	  ultrapure	  water.	  Working	   standard	   solutions	  
were	  prepared	  through	  appropriate	  dilutions	   in	  either	  6	  mL	  L-­‐15	  culture	  media	  or	  4.5	  mL	  FW	  to	  
obtain	  concentrations	  between	  100-­‐100000	  μg	  L-­‐1,	  to	  be	  used	  immediately.	  
6.3.13	   Apparatus	  and	  chromatographic	  conditions	  
This	  HPLC	  method	  was	  developed	  and	  optimised	  on	  an	  Agilent	  1200	  series	  HPLC	  system.	  Analytes	  
ran	  at	  a	  flow	  rate	  of	  0.2	  mL	  min−1	  using	  automatic	   injection	  at	  a	  volume	  of	  20	  μL.	  Mobile	  phases	  
were	  90:10	  (v/v)	  10	  mM	  ammonium	  acetate	  in	  water:acetonitrile	  (phase	  A)	  and	  20:80	  (v/v)	  10	  mM	  
ammonium	  acetate	  in	  water:acetonitrile	  (phase	  B).	  The	  profile	  used	  an	  isocratic	  mobile	  phase	  B	  at	  
30%	   for	   10	   minutes	   with	   a	   column	   oven	   temperature	   of	   45°C.	   Detection	   of	   the	   analytes	   was	  
carried	  out	  at	  254	  nm	  and	  quantification	  was	  carried	  out	  by	  calculating	  the	  peak	  area	  using	  GINA	  
Star	  software.	  Confirmation	  of	  the	  analytes	  was	  achieved	  using	  the	  retention	  time	  of	  the	  analytical	  
standard	  (Fig	  6.4).	  
6.3.14	   Method	  validation	  using	  standard	  solutions	  
Instrumental	   linearity	   was	   determined	   by	   measuring	   the	   peak	   area	   of	   propranolol	   and	  
hydroxypropranolol	  at	  6	  concentrations	  (from	  500-­‐100000	  μg	  L-­‐1)	   in	  ultra-­‐pure	  HPLC	  grade	  water	  
(n	   =	   3).	   Method	   linearity	   was	   determined	   by	   measuring	   the	   peak	   area	   of	   propranolol	   and	  
hydroxypropranolol	   at	   6	   concentrations	   (from	  500-­‐10000	  μg	   L-­‐1)	  made	   in	   either	   L-­‐15	  or	   FW	  and	  
after	  having	  undergone	   SPE	  and	   reconstituted	   in	  mobile	  phase	  A.	   Limits	  of	   detection	   (LOD)	   and	  
quantification	  (LOQ)	  were	  determined	  for	  both	  propranolol	  and	  hydroxypropranolol	  in	  either	  L-­‐15	  
or	  FW	  after	  SPE	  from	  the	  linear	  calibration	  of	  the	  method,	  calculated	  using	  the	  equations	  
𝐿𝑂𝐷 = 3𝑆𝐷!𝑏 	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𝐿𝑂𝑄 =   10𝑆𝐷!𝑏 	  
where	   SDa	   is	   the	   standard	   deviation	   of	   the	   lowest	  measured	   analyte	   and	   b	   is	   the	   slope	   of	   the	  
regression	   line	   (Shrivastava	   &	   Gupta,	   2011).	   The	   percentage	   recoveries	   were	   calculated	   by	  
comparing	  peak	  area	  of	  analytes	  spiked	  with	  3	  concentrations	  (1,	  5,	  10	  mg	  L-­‐1)	  of	  propranolol	  and	  
hydroxypropranolol	  in	  either	  L-­‐15	  or	  FW	  before	  and	  after	  (with	  the	  expected	  concentrations)	  SPE	  
(n	  =	  3).	  Instrumental	  retention	  times	  for	  propranolol	  and	  hydroxypropranolol	  in	  either	  FW	  or	  L-­‐15	  
were	   determined	   in	   all	   standards	   (n	   =	   15)	   to	   calculate	   the	   mean	   value	   (±SD)	   for	   analyte	  
identification	  from	  samples.	  Intraday	  reliability	  was	  determined	  for	  3	  concentrations	  (1,	  5,	  10	  mg	  L-­‐
1)	   of	   propranolol	   and	  hydroxypropranolol	   in	   both	   L-­‐15	   and	   FW	  after	   SPE	   (n	  =	   3).	   The	   same	  was	  
repeated	  for	  2	  further	  days	  to	  calculate	  interday	  reliability.	  Method	  precision	  was	  determined	  for	  
propranolol	  and	  hydroxypropranolol	   in	  both	  L-­‐15	  and	  FW	  after	  SPE	  at	  3	  concentrations	   (1,	  5,	  10	  
mg	   L-­‐1)	   (n	   =	   6).	   Control	   samples	   containing	   no	   propranolol	   or	   hydroxypropranolol	   were	   also	  
analysed	   for	   background	   correction	   purposes.	   Finally,	   mobile	   phase	   A	   was	   injected	   between	  
batches	  of	   samples	   (FW	  or	   L-­‐15)	   to	  minimise	   the	  possibility	   of	   carry	   over.	  None	  of	   the	   analytes	  
were	  detected	  in	  any	  of	  the	  mobile	  phases	  or	  ultra-­‐pure	  water	  used	  in	  this	  study.	  
6.3.15	   Analysis	  of	  data	  and	  statistics	  
EROD	  activity	  was	  expressed	  as	  the	  mass	  of	  resorufin	  produced	  per	  min	  per	  mg	  of	  protein.	  Results	  
of	   the	   EROD	   assays	   are	   expressed	   as	   means	   ±	   SEM	   for	   each	   condition.	   To	   test	   for	   significant	  
increases	   or	   decreases	   in	   EROD	   activity	   levels	   compared	   to	   the	   control	   baseline	   values,	   an	  
independent	  samples	  t-­‐test	  with	  equal	  variances	  assumed	  was	  used	  and	  statistical	  significance	  was	  
accepted	  when	  P	   <	  0.05	   (SPSS	   software,	  SPSS	   Inc.).	   Likewise,	   for	   significant	  differences	  between	  
normal	  EROD	  activity	  and	  those	  values	  from	  exposure	  to	  1000	  μg	  L-­‐1	  propranolol,	  an	  independent	  
samples	   t-­‐test	   with	   equal	   variances	   assumed	   was	   again	   used	   and	   statistical	   significance	   was	  
accepted	  when	  P	  <	  0.05	  (SPSS	  software,	  SPSS	  Inc.).	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Samples	  (n	  =	  3)	  for	  HPLC	  analysis	  were	  pooled	  to	  increase	  to	  concentrations	  that	  were	  identifiable.	  
Quantification	  of	   the	   analytes	   in	   apical	   FW	  and	  basolateral	   L-­‐15	  was	  made	  based	  on	   their	   peak	  
areas	   relative	   to	   the	   calibration	   curve	  made	   from	   the	   standard	   solutions.	   The	   values	  were	   then	  
expressed	  as	  a	  percentage	  of	  the	  initial	  concentration	  of	  propranolol	  at	  time	  0	  for	  all	  time	  points.	  
Because	  samples	  were	  pooled,	  these	  samples	  were	  not	  statistically	  compared	  to	  one	  another.	  All	  




6.4.1	   EROD	  induction	  and	  inhibition	  
EROD	   activity	   in	   SSI	   epithelia	   was	   16.04	   ±	   2.97	   pmol	   resorufin	   min-­‐1	   mg	   protein-­‐1	   and	   was	   not	  
induced	  by	  10	  μM	  BnF	  or	  inhibited	  by	  10	  μM	  AnF	  (Fig	  6.2A).	  Baseline	  EROD	  activity	  in	  DSI	  epithelia	  
was	   at	   a	   similar	   rate	   of	   17.78	   ±	   0.47	   pmol	   resorufin	   min-­‐1	   mg	   protein-­‐1.	   This	   was	   significantly	  
induced	   by	   10	   μM	   BnF	   to	   33.77	   ±	   0.93	   pmol	   resorufin	   min-­‐1	   mg	   protein-­‐1	   (P	   <	   0.001)	   and	  
significantly	  inhibited	  by	  10	  μM	  AnF	  to	  10.84	  ±	  3.17	  pmol	  resorufin	  min-­‐1	  mg	  protein-­‐1	  (P	  <	  0.001;	  
Fig	  6.2B).	  RTgill-­‐W1	  epithelia	  had	  the	  lowest	  EROD	  activity	  of	  0.08	  ±	  0.00	  pmol	  resorufin	  min-­‐1	  mg	  
protein-­‐1	  that	  was	  not	  significantly	  induced	  nor	  inhibited	  (Fig	  6.2C).	  
6.4.2	   EROD	  activity	  from	  propranolol	  exposure	  
After	  24	  hours	  exposure	  to	  1000	  μg	  L-­‐1	  propranolol,	  SSI	  epithelia	  showed	  no	  significant	   increases	  
or	   decreases	   in	   EROD	   activity	   (Fig	   6.3A).	   DSI	   epithelia	   showed	   a	   significant	   inhibition	   of	   EROD	  
activity,	  from	  7.09	  ±	  0.86	  in	  control	  cells	  to	  3.68	  ±	  0.78	  pmol	  resorufin	  min-­‐1	  mg	  protein-­‐1	  (P	  <	  0.05;	  
Fig	  6.3B).	  RTgill-­‐W1	  cells	  also	  showed	  no	  significant	  differences	  in	  EROD	  activity	  (Fig	  6.3C).	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Fig	  6.2.	  Baseline	  control	  7-­‐ethoxyresorufin	  О-­‐deethylase	  (EROD)	  activity	  levels	  (orange	  bars),	  induced	  activity	  (dark	  grey	  
bars)	  from	  24	  hours	  exposure	  to	  10	  μM	  β-­‐naphthoflavone	  and	  inhibited	  activity	  (light	  grey	  bars)	  from	  24	  hour	  exposure	  
to	  10	  μM	  α-­‐naphthoflavone	  in	  (A)	  SSI	  (n	  =	  4	  from	  3	  fish)	  (B)	  DSI	  (n	  =	  3	  from	  2	  fish,	  1	  biological	  replicate)	  and	  (C)	  RTgill-­‐W1	  
(n	  =	  3,	  P108).	  Significant	  differences	  from	  the	  control	  are	  indicated	  by	  the	  asterisk	  (independent	  samples	  t-­‐test;	  ***P	  <	  
0.001)	  and	  values	  are	  means	  ±	  SEM.	  
*** 
*** 
6.	  Metabolism	  of	  pharmaceuticals	  
Lucy	  C.	  Stott	  |	  147	  
	  
Fig	  6.3.	  Baseline	  control	  7-­‐ethoxyresorufin	  О-­‐deethylase	  (EROD)	  activity	  levels	  (orange	  bars)	  and	  EROD	  activity	  after	  24	  
hours	  exposure	  to	  1000	  μg	  L-­‐1	  propranolol	  in	  freshwater	  (PR;	  green	  bars)	  in	  (A)	  SSI	  (n	  =	  3	  from	  3	  fish)	  (B)	  DSI	  (n	  =	  3	  from	  1	  
biological	  replicate)	  and	  (C)	  RTgill-­‐W1	  (n	  =	  3,	  P108).	  Significant	  differences	  from	  the	  control	  are	  indicated	  by	  the	  asterisk	  
(independent	  samples	  t-­‐test;	  *P	  <	  0.05)	  and	  values	  are	  means	  ±	  SEM.	   	  
* 
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6.4.3	   Optimisation	  of	  HPLC	  conditions	  
The	  mobile	  phase	  used,	  a	  mixture	  of	  10	  mM	  ammonium	  acetate	  with	  water	  and	  acetonitrile,	  was	  
found	  to	  be	  suitable	  for	  the	  separation	  of	  the	  two	  analytes,	  propranolol	  and	  hydroxypropranolol.	  A	  
column	   oven	   temperature	   of	   45°C	   further	   aided	   separation.	   The	   UV	   region	   that	   gave	   a	   shared	  
absorption	   for	   both	   compounds	   was	   scanned	   and	   254	   nm	   was	   found	   to	   be	   the	   optimum	   for	  
simultaneous	  determination	  during	  the	  10	  minute	  run.	  Figure	  6.4	  shows	  the	  separation	  of	  analytes	  
in	   freshwater	   (Fig	   6.4A)	   and	   L-­‐15	  medium	   (Fig	   6.4B)	   (with	   satisfactorily	   separated	   peak	   of	   L-­‐15	  
solutes;	  Fig	  6.4B*)	  obtained	  using	  this	  method.	  
6.4.4	   Method	  performance	  characteristics	  
The	  development	  of	  appropriate	  SPE	  and	  an	  HPLC	  method	  for	   the	  extraction	  of	  propranolol	  and	  
hydroxypropranolol	   from	   both	   freshwater	   and	   L-­‐15	  medium	   produced	   analyte	   peaks	   that	   were	  
detectable	  and	  quantifiable	  (Fig	  6.4)	  and	  a	  method	  that	  was	  validated	  as	  summarised	  in	  Table	  6.2.	  
Instrumental	  linearity	  produced	  good	  fits	  for	  both	  propranolol	  and	  hydroxypropranolol,	  achieving	  
R2	  values	  of	  1	  and	  0.9997	  respectively	  over	  the	  concentration	  range	  500-­‐10000	  μg	  L-­‐1	  (n	  =	  3).	  Limits	  
of	  detection	  for	  propranolol	  extracted	  from	  FW	  and	  L-­‐15	  were	  49.72	  and	  6.46	  μg	  L-­‐1,	  whilst	  those	  
for	   hydroxypropranolol	   were	   higher	   at	   105.26	   and	   72.20	   μg	   L-­‐1.	   Limits	   of	   quantification	   were	  
165.74	   and	   21.54	   μg	   L-­‐1	   for	   propranolol	   in	   FW	   and	   L-­‐15,	   and	   350.88	   and	   240.66	   μg	   L-­‐1	   for	  
hydroxypropranolol.	  Correlation	  coefficients	  of	  R2	  >	  0.99	  were	  achieved	  for	  the	  method	  linearities	  
for	  all	  compounds.	  Mean	  absolute	  recoveries	  for	  propranolol	  ranged	  from	  80-­‐91%	  and	  23-­‐74%	  for	  
hydroxypropranolol.	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Fig	  6.4.	  Typical	  chromatograms	  of	  the	  standard	  retention	  times	  and	  intensities	  of	  hydroxypropranolol	  (1)	  and	  
propranolol	  (2)	  obtained	  from	  a	  freshwater	  (FW)	  standard	  (A)	  and	  an	  L-­‐15	  cell	  culture	  medium	  standard	  (B),	  both	  pre-­‐
spiked	  and	  having	  undergone	  SPE.	  The	  peak	  of	  inorganic	  salts	  and	  amino	  acids	  present	  in	  L-­‐15	  is	  separated	  from	  the	  
analytes	  (*).	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Table	  6.2	  
HPLC	  method	  performance	  characteristics.	   	  















(min)	   	   (μg	  L-­‐1)	   (%)	   (%)	   (%)	  
n	  =	  15	   n	  =	  5	   	   	   	   n	  =	  3	  
FW	   Propranolol	   8.38	  ±	  0.18	   0.9982	   1000	   100	  ±	  1.5	   100	  ±	  5.3	   92	  ±	  1.3	  
	   	   	   5000	   101	  ±	  11.8	   101	  ±	  9.4	   80	  ±	  9.0	  
	   	   	   	   10000	   100	  ±	  6.8	   100	  ±	  5.4	   82	  ±	  5.3	  
	   Hydroxy	  
-­‐propranolol	  
3.67	  ±	  0.07	   0.9972	   1000	   100	  ±	  4.9	   101	  ±	  7.5	   23	  ±	  3.2	  
	   	   	   5000	   102	  ±	  18.3	   101	  ±	  11.8	   56	  ±	  10.8	  
	   	   	   	   10000	   100	  ±	  5.3	   100	  ±	  3.2	   60	  ±	  3.3	  
L-­‐15	   Propranolol	   8.44	  ±	  0.11	   0.9988	   1000	   102	  ±	  15.2	   101	  ±	  7.8	   85	  ±	  15.4	  
	   	   	   5000	   100	  ±	  5.0	   100	  ±	  6.2	   82	  ±	  4.1	  
	   	   	   	   10000	   100	  ±	  2.1	   100	  ±	  4.7	   83	  ±	  1.8	  
	   Hydroxy	  
-­‐propranolol	  
3.66	  ±	  0.07	   0.9980	   1000	   100	  ±	  4.4	   100	  ±	  5.6	   46	  ±	  4.7	  
	   	   	   5000	   100	  ±	  5.4	   100	  ±	  6.3	   63	  ±	  4.0	  
	   	   	   	   10000	   100	  ±	  1.2	   100	  ±	  4.3	   74	  ±	  0.9	  
a	  retention	  time	  
b	  standard	  deviation	  
6.4.5	   HPLC	  analysis	  
The	  epithelia	  exposed	  to	  10	  and	  100	  μg	  L-­‐1	  propranolol	  resulted	  in	  peaks	  of	  analytes	  that	  were	  far	  
lower	   than	  the	  detectable	   limits	  and	  so	  quantification	  using	   this	  HPLC	  method	  and	  could	  not	  be	  
used.	  
SSI	  epithelia	  exposed	  to	  1000	  μg	  L-­‐1	  propranolol	  in	  FW	  (the	  apical	  compartment;	  uptake)	  or	  in	  L-­‐15	  
(the	  basolateral	  compartment;	  efflux)	  contained	  100%	  propranolol	   in	  these	  donor	  compartments	  
at	   time	   0	   hours	   (Fig	   6.5A;	   Fig	   6.5B).	   In	   uptake	   assays,	   the	   concentration	   of	   propranolol	   in	   FW	  
remained	  at	  100%	  of	  the	  initial	  until	  24	  hours	  when	  it	  dropped	  to	  89.71%	  due	  to	  its	  appearance	  in	  
the	   basolateral	   compartment	   (Fig	   6.5A).	   In	   efflux	   assays,	   the	   appearance	   of	   propranolol	   in	   the	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basolateral	  receiving	  compartment	  occurred	  sooner,	  after	  1	  hour,	  reaching	  4.10%	  that	  of	  the	  initial	  
concentration	  of	  the	  donor	  (Fig	  6.5B).	  Hydroxypropranolol	  was	  not	  detected	  in	  any	  of	  the	  samples.	  
In	  uptake	  assays	  using	  DSI	  epithelia,	  the	  amount	  of	  propranolol	  declined	  from	  100%	  of	  the	  initial	  at	  
time	   1,	   3	   and	   6	   hours	   to	   89.22%	   after	   24	   hours	   (Fig	   6.5C).	   In	   the	   basolateral	   compartment,	  
propranolol	  was	  detected	  at	  24	  hours	  only	  (Fig	  6.5C),	  at	  8.78%	  of	  the	  initial	  concentration	  of	  the	  
donor	  compartment.	  Hydroxypropranolol	  was	  detected	   in	   the	  apical	  donor	  compartment	  after	  1	  
hour,	  and	  remained	  at	  approximately	  40	  μg	  L-­‐1	  for	  the	  remaining	  time	  up	  to	  24	  hours	  (Fig	  6.5C).	  No	  
hydroxypropranolol	  was	  measured	  in	  the	  basolateral	  L-­‐15	  receiver	  compartment.	  In	  efflux	  assays,	  
the	  amount	  of	  propranolol	  declined	  more	  quickly	  from	  100%	  to	  89%	  after	  6	  hours	  (Fig	  6.5D).	  This	  
was	  observed	  to	  appear	  in	  the	  receiving	  apical	  compartment	  after	  just	  1	  hour,	  resulting	  in	  8.72%	  
of	   the	   initial	   concentration	   after	   24	  hours	   (Fig	   6.5D).	  Hydroxypropranolol	  was	   again	  detected	   in	  
the	  apical	  compartment	  after	  1	  hour,	  and	  remained	  at	  28-­‐37	  μg	  L-­‐1	  for	  the	  remaining	  time	  up	  to	  24	  
hours	  (Fig	  6.5D).	  Again,	  no	  hydroxypropranolol	  was	  detected	  in	  the	  basolateral	  L-­‐15	  compartment.	  
Assays	   using	   the	   rainbow	   trout	   gill	   cell	   line	   RTgill-­‐W1	   showed	   results	   similar	   to	   those	   obtained	  
from	  SSI	  gill	  cell	  cultures.	  The	  concentration	  of	  propranolol	  in	  the	  apical	  compartment	  remained	  at	  
100%	  until	   24	  hours	  when	   it	   had	  declined	   to	   91.31%	  of	   the	   initial	   concentration	   (Fig	   6.5E).	   This	  
resulted	  in	  the	  appearance	  of	  propranolol	  in	  the	  receiving	  basolateral	  compartment	  of	  8.68%	  at	  24	  
hours	  (Fig	  6.5E).	  In	  efflux	  assays,	  the	  concentration	  of	  propranolol	  decreased	  sooner,	  after	  3	  hours,	  
and	   appeared	   in	   the	   receiving	   apical	   compartment	   at	   1%	   the	   initial	   concentration,	   reaching	   a	  
maximum	  of	  6.38%	  of	  the	  initial	  concentration	  after	  24	  hours	  (Fig	  6.5F).	  Hydroxypropranolol	  was	  
not	  detected	  in	  any	  of	  the	  samples.	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Fig	  6.5.	  The	  transport	  of	  propranolol	  across	  the	  SSI	  (A	  &	  B)	  or	  DSI	  (C	  &	  D)	  primary	  rainbow	  trout	  primary	  gill	  cell	  
epithelium,	  or	  RTgill-­‐W1	  epithelia	  (E	  &	  F)	  over	  24	  hours.	  Propranolol	  is	  applied	  at	  a	  concentration	  of	  1000	  μg	  L-­‐1	  to	  either	  
the	  apical	  (A,	  C,	  E)	  for	  apical	  to	  basal	  transport;	  uptake,	  or	  basal	  compartment	  (B,	  D,	  F)	  for	  basal	  to	  apical	  transport;	  
efflux,	  in	  asymmetrical	  (freshwater	  in	  the	  apical	  compartment	  and	  L-­‐15	  medium	  in	  the	  basal)	  conditions.	  Orange	  lines	  
represent	  L-­‐15	  and	  blue	  lines	  water	  samples.	  The	  green	  circles	  represent	  propranolol	  and	  the	  red	  diamonds	  represent	  
hydroxypropranolol.	  Data	  are	  shown	  as	  a	  percentage	  of	  the	  initial	  propranolol	  concentration	  versus	  time.	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6.5	  Discussion	  
These	  SPE	  and	  HPLC	  methods	  are	   the	   first	  documentation	  of	   the	  extraction	  of	  a	  pharmaceutical	  
and	   its	   metabolite	   from	   aqueous	   samples	   obtained	   from	   the	   exposure	   of	   primary	   and	  
immortalised	  gill	  cell	  cultures	  cultured	  on	  permeable	  membrane	  inserts.	  Analysis	  using	  HPLC	  first	  
required	   the	   development	   of	   a	   SPE	   method	   that	   produced	   a	   sample	   with	   high	   enough	  
concentrations	   of	   parent	   compounds	   and	   metabolites	   for	   analysis.	   This	   was	   achieved	   in	   three	  
ways.	  Firstly,	   the	   loading	  volumes	  onto	  SPE	  cartridges	  were	  from	  pooled	  samples	   to	  either	  6	  mL	  
for	   L-­‐15	   or	   4.5	   mL	   for	   FW.	   This	   provided	   a	   high	   enough	   concentration	   of	   propranolol	   and	  
hydroxypropranolol	   to	   be	   retained	   on	   the	   SPE	   cartridge,	   but	   unfortunately	   meant	   that	   three	  
samples	  were	  pooled,	  thus	  reducing	  the	  n	  number	  of	  samples	  to	  1	  and	  eliminating	  the	  option	  of	  
statistical	   analysis.	   Loading	   of	   smaller	   volumes	   resulted	   in	   the	   elution	   of	   compounds	   at	  
concentrations	   below	   detectable	   limits.	   Secondly,	   analytes	   stored	   on	   SPE	   cartridges	   after	   being	  
dried	   down	   were	   reconstituted	   in	   volumes	   ten	   times	   less	   the	   original	   volume	   loaded	   onto	   the	  
cartridge	  (600	  μL	  for	  L-­‐15	  samples	  or	  standards	  and	  450	  μL	  for	  FW	  samples	  or	  standards	  in	  phase	  A	  
solvent).	  This	  brought	  these	  concentrations	  up	  to	  detectable	  and	  quantifiable	  limits.	  Thirdly,	  it	  was	  
found	  that	  samples	  of	  L-­‐15	  contained	  a	  number	  of	  solutes	  that	  needed	  to	  be	  removed.	  Leibovitz's	  
L-­‐15	  cell	  culture	  medium	  without	  phenol	  red	  contained	  17	  amino	  acids	  with	  molecular	  weights	  less	  
than	  204	  and	  at	  concentrations	  less	  than	  500	  mg	  L-­‐1,	  8	  vitamins	  with	  molecular	  weights	  less	  than	  
478	  and	  at	  concentrations	  less	  than	  2	  mg	  L-­‐1,	  7	  inorganic	  salts	  with	  molecular	  weights	  less	  than	  142	  
and	   at	   concentrations	   less	   than	   400	  mg	   L-­‐1	   (except	   sodium	   chloride	   at	   8	   g	   L-­‐1),	   as	  well	   as	  D-­‐(+)-­‐
galactose	  and	  sodium	  pyruvate.	  During	  method	  development,	  L-­‐15	  samples	  produced	  a	  large	  peak	  
of	  these	  salts	  and	  vitamins	  that	  distorted	  the	  view	  of	  any	  analyte	  peaks.	  Therefore,	  a	  method	  was	  
developed	   that	  washed	   the	   SPE	   cartridges	  of	   these	   solutes,	  whilst	   allowing	   the	  propranolol	   and	  
hydroxypropranolol	   to	   remain	  adhered	   to	   the	  cartridge.	   Similarly,	   the	  mobile	  phase	  and	  column	  
temperature	   further	   aided	   this	   separation	   (Fig	   6.4B*).	   In	   this	   way,	   we	   obtained	   good	   absolute	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recoveries	  for	  propranolol	  ranging	  from	  80-­‐91%	  and	  fair	  recoveries	  for	  hydroxypropranolol	  of	  23-­‐
74%	  (only	  two	  of	  these	  were	  below	  50%;	  23	  and	  43%).	  This	  again	  resulted	   in	  analytes	  that	  were	  
able	  to	  be	  detected	  for	  HPLC	  analysis,	  but	  only	  for	  experiments	  run	  at	  1000	  μg	  L-­‐1,	  those	  at	  10	  and	  
100	  μg	  L-­‐1	  were	  disregarded	  for	  analysis	  using	  HPLC.	  
CYP1A-­‐catalysed	  O-­‐deethylation	  of	  ethoxyresorufin	  (EROD)	  is	  widely	  used	  as	  a	  biomarker	  for	  aryl	  
hydrocarbon	  receptor	   (AhR)	  agonist	  exposure	   in	  wild	  populations	  of	   fish	   (Whyte	  et	  al.,	  2001).	   In	  
rainbow	  trout,	  EROD	  can	  be	  induced	  in	  gill	  filaments	  (Jönsson	  et	  al.,	  2002),	  branchial	  microsomes	  
(Lindström-­‐Seppä	  &	  Oikari,	   1990),	   gill	   S9	   fractions	   (Bartram	   et	   al.,	   2011)	   and	   in	   primary	   gill	   cell	  
cultures	  (Carlsson	  et	  al.,	  1999;	  Carlsson	  &	  Pärt,	  2001).	  Through	  an	  optimised	  EROD	  assay	  method,	  
this	   study	   showed	   CYP1A	   activity	   as	   measured	   in	   an	   EROD	   induction	   and	   inhibition	   in	   primary	  
rainbow	  trout	  gill	  cells	  in	  SSI	  and	  DSI	  (Fig	  6.2A;	  Fig	  6.2B).	  Exposure	  to	  BnF	  at	  10	  μM	  failed	  to	  induce	  
EROD	  activity	   in	  SSI	  to	  values	  higher	  than	  that	  of	  the	  control.	  Previously,	   it	  was	  found	  that	  EROD	  
could	  be	  induced	  in	  SSI	  by	  BnF	  in	  a	  concentration	  dependent	  manner,	  which	  peaked	  at	  0.1	  μM	  BnF	  
to	   approximately	   36	   pmol	   resorufin	  min-­‐1	  mg	   protein-­‐1,	   and	   declined	   to	   control	   levels	   at	   higher	  
concentrations,	   for	   which	   the	   highest	   tested	   was	   1	   μM	   BnF	   (producing	   approximately	   14	   pmol	  
resorufin	  min-­‐1	  mg	  protein-­‐1)	  (Carlsson	  &	  Pärt,	  2001).	  This	  is	  similar	  to	  the	  SSI	  EROD	  vales	  obtained	  
here	  (16.04	  ±	  2.97	  pmol	  resorufin	  min-­‐1	  mg	  protein-­‐1)	   for	  a	  10	  μM	  BnF	  exposure.	  This	   is	   the	  first	  
time	   rainbow	   trout	   DSI	   epithelia	   have	   been	   shown	   to	   contain	   inducible	   and	   inhibitable	   EROD	  
activities.	  DSI	  epithelia	  cultured	  from	  the	  gills	  of	  tilapia	  have	  previously	  been	  shown	  to	  significantly	  
induce	  EROD	  activity	  in	  response	  to	  benzo(a)pyrene	  (BaP)	  (Zhou	  et	  al.,	  2006),	  but	  to	  activities	  that	  
are	  five	  times	  lower	  than	  those	  obtained	  here.	  Similarly,	  baseline	  values	  were	  reported	  as	  <1	  pmol	  
resorufin	  min-­‐1	  mg	   protein-­‐1	   (Zhou	   et	   al.,	   2006),	   whereas	   those	  measured	   in	   our	   rainbow	   trout	  
control	  DSI	  epithelia	  was	  17.78	  ±	  0.47	  pmol	  resorufin	  min-­‐1	  mg	  protein-­‐1.	  These	  differences	  could	  
be	  due	  to	  differences	  between	  EROD	  activity	  in	  the	  gills	  of	  tilapia	  and	  rainbow	  trout	  or	  differences	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between	  EROD	  assay	  protocols.	  EROD	  has	  not	  been	   induced	   in	  RTgill-­‐W1	   (Schirmer	  et	  al.,	  1998)	  
and	  CYP1A	  activity	  remained	  undetected	  in	  this	  cell	  line	  in	  this	  study.	  
The	   extensive	   metabolism	   of	   propranolol	   is	   well	   documented	   in	   both	   humans	   and	   mammals	  
(Masubuchi	  et	  al.,	  1994;	  Walle	  et	  al.,	  1983;	  Walle	  et	  al.,	  1985).	  This	  metabolism	  is	  brought	  about	  
by	   oxidative	   reactions	   initially	   performed	   by	   cytochrome	   P450	   involving	   side-­‐chain	  
glucuronidation,	  ring	  hydroxylation	  and	  side-­‐chain	  N-­‐desisopropylation	  (Fig	  6.1;	  Masubuchi	  et	  al.,	  
1994).	   In	   human	   liver	   microsomes,	   propranolol	   4-­‐	   and	   5-­‐hydroxylation	   is	   catalysed	   mainly	   by	  
CYP2D6,	  whilst	  CYP1A2	  catalyses	  the	  side	  chain	  N-­‐desisopropylation	  of	  propranolol	  (Masubuchi	  et	  
al.,	   1994).	   “Reading	   across”	   to	   fish,	   one	  might	   expect	   some	   aspect	   of	   the	   latter	   pathway	   to	   be	  
present	   in	   fish	   due	   to	   the	   CYP1A-­‐like	   activities	   of	   piscine	   CYP1A	   (Uno	   et	   al.,	   2012).	   Indeed,	  
propranolol	  has	  been	  shown	  to	  induce	  CYP1A	  as	  shown	  by	  increased	  EROD	  activity	  in	  vivo	  in	  both	  
rainbow	   trout	   liver	   hepatocytes	   (Laville	   et	   al.,	   2004),	   gill	   samples	   from	   whole	   fish	   exposure	  
(producing	  5.7	  pmol	  resorufin	  min-­‐1	  mg	  protein-­‐1	  from	  a	  400	  μg	  L-­‐1	  exposure,	  Bartram	  et	  al.,	  2011)	  
and	   in	   vitro	   in	   primary	   gill	   cell	   suspensions	   which	   produced	   2.1-­‐6.1	   pmol	   resorufin	   min-­‐1	   mg	  
protein-­‐1	   from	   a	   200	   μg	   L-­‐1	   exposure	   (Bartram	   et	   al.,	   2011).	   In	   the	   current	   study	   however,	  
propranolol	   significantly	   inhibited	   EROD	   activity	   in	   DSI	   after	   a	   24	   hour	   exposure	   to	   1000	   μg	   L-­‐1.	  
Another	   study	   investigated	   the	   inhibitory	   effects	   of	   polycyclic	   aromatic	   hydrocarbons,	   flavones	  
and	   coumarins	   on	   CYP1A1	   and	   A2,	   and	   likewise	   found	   xenobiotics	   such	   as	   propranolol	   to	   be	  
potent	   inhibitors	   of	   CYP1A1	   and	   A2	   in	   cDNA-­‐expressed	   enzymes	   and	   human	   liver	   microsomes	  
(Tassaneeyakul	  et	  al.,	  1993).	  Propranolol	  did	  not	  appear	  to	   induce	  or	   inhibit	  EROD	  activity	   in	  SSI,	  
nor	  RTgill-­‐W1,	  and	  EROD	  activity	   remained	  near	  baseline	  values	  after	  exposure	   to	  1000	  μg	  L-­‐1	   in	  
freshwater.	  
Propranolol	   is	   metabolised	   in	   both	   liver	   and	   gill	   S9	   fractions	   prepared	   from	   rainbow	   trout,	   as	  
shown	  by	  a	  70%	  and	  25%	  (respectively)	  loss	  of	  parent	  compound	  over	  90	  minutes	  (Gomez	  et	  al.,	  
2010).	  The	  gills	  show	  intrinsic	  clearance	  rates	  of	  propranolol	  that	  are	  significantly	  lower	  than	  that	  
6.	  Metabolism	  of	  pharmaceuticals	  
Lucy	  C.	  Stott	  |	  156	  
of	  the	  liver	  (Gomez	  et	  al.,	  2010)	  probably	  because	  the	  metabolic	  activity	  in	  rainbow	  trout	  gill	  cells	  
is	   7-­‐60	   times	   less	   than	   isolated	   hepatocytes	   (and	   substrate	   dependent)	   (Leguen	   et	   al.,	   2000).	  
Substrate	  depletion	  assays	  show	  the	  significant	  metabolism	  of	  propranolol	   in	  rainbow	  trout	   liver	  
S9	  fractions	  and	  CYP1A	  is	  the	  likely	  enzyme	  catalysing	  its	  metabolism	  in	  fish	  (Conners	  et	  al.,	  2013).	  
Up	   to	   10	   phase	   I	   metabolites	   of	   propranolol	   have	   also	   been	   documented	   (some	   remain	  
unidentified)	  in	  2D	  primary	  trout	  hepatocyte	  cell	  cultures	  and	  7	  of	  these	  are	  also	  found	  in	  human	  
2D	   hepatic	   cultures	   (Dr	   Stewart	   Owen,	   personal	   communication).	   Propranolol	   is	   passively	   and	  
actively	  taken	  up	  over	  the	  trout	  gill	  epithelium	  in	  vitro	  (Stott	  et	  al.,	  2015)	  and	  we	  again	  show	  here	  
its	  transport	  from	  donor	  to	  receiver	  compartments	  in	  SSI,	  DSI	  and	  RTgill-­‐W1	  and	  uptake	  and	  efflux	  
rates	   appear	   to	   be	   comparable,	   with	   similar	   amounts	   of	   propranolol	   appearing	   in	   receiver	  
compartments.	  We	  know	  that	   for	  DSI,	  a	  proportion	  of	   this	  uptake	   is	  active;	  whilst	  concentration	  
equilibrated	  transport	  assays	  (CETA)	  using	  SSI	  show	  this	   is	  not	  the	  case	  (Stott	  et	  al.,	  unpublished	  
data).	  This	  is	  perhaps	  owing	  to	  the	  absence	  of	  mitochondria-­‐rich	  cells	  (MRCs)	  in	  SSI	  (Wood	  et	  al.,	  
1998),	  the	  main	  sites	  of	  active	  and	  ionic	  transport	  in	  the	  rainbow	  trout	  gill	  (Wood,	  2001).	  
In	  DSI	  epithelia,	  hydroxypropranolol	  was	  identified	  and	  measured	  in	  apical	  water	  samples	  in	  both	  
apical	  and	  basolateral	  propranolol	  exposures.	  Hydroxypropranolol	  was	  not	  detected	  in	  basolateral	  
L-­‐15	  samples,	  which	  could	  be	  due	  to	  its	  absence	  entirely	  at	  the	  basolateral	  surface	  of	  gill	  epithelia,	  
or	  a	  distortion	  of	   its	  peak	   from	  the	   large	   salt	  and	  vitamin	  peak	  obtained	   from	  L-­‐15	   samples	   (Fig	  
6.4B*),	   and	   a	   more	   sensitive	   method	   of	   identification	   (and	   quantification),	   such	   as	   ultra-­‐high	  
performance	  liquid	  chromatography-­‐tandem	  mass	  spectrometry	  (UPLC/MS),	  could	  be	  used.	  SSI	  or	  
RTgill-­‐W1	   did	   not	   produce	   hydroxypropranolol	   and	   it	   was	   undetected	   in	   all	   samples.	  We	   could	  
assume	  that	  its	  formation	  is	  due	  to	  the	  presence	  of	  MRCs	  in	  DSI,	  as	  this	  cell	  type	  is	  absent	  in	  SSI,	  
but	  MRCs	  appear	   to	  be	  present	   in	  RTgill-­‐W1	   (Lee	  et	  al.,	  2009)	  although	  at	  much	   fewer	  numbers	  
(Bols	  et	  al.,	  1994)	  and	  metabolic	  enzymes	  such	  as	  CYP1A	  are	   lacking	   (Schirmer	  et	  al.,	  1998).	  The	  
only	   study	   to	   date	   investigating	   the	   metabolism	   of	   propranolol	   in	   whole	   fish	   (crucian	   carp,	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Carassius	  carassius)	  reports	  the	  formation	  of	  five	  metabolites	  by	  the	  liver	  (Ding	  et	  al.,	  2015).	  These	  
are	  N-­‐desisopropylated	  propranolol,	  propranolol	  glucuronic	  acid,	  monohydroxylated	  propranolol,	  
hydroxypropranolol	  glucuronide	  and	  dihydroxypropranolol	  glucuronide,	  formed	  by	  the	  same	  three	  
processes	  present	  in	  mammals	  –	  side	  chain	  glucuronidation,	  aromatic	  ring	  hydroxylation	  and	  side	  
chain	  N-­‐desisopropylation	  (Masubuchi	  et	  al.,	  1994).	  This	  suggests	  that	  hepatic	  metabolism	  may	  be	  
the	  primary	  elimination	  mechanism	  once	  propranolol	   is	  absorbed	   in	  to	  fish	  (via	  the	  diet	  or	  gills),	  
and	  hence	  there	  is	  no	  need	  to	  absorb	  hydroxypropranolol,	  initially	  produced	  here	  at	  the	  gill,	  and	  it	  
is	  rapidly	  effluxed	  as	  a	  primary	  efflux	  mechanism	  (Fig	  6.5C	  &	  D).	  
This	   study	  presents	   the	   first	   evidence	   for	   the	  metabolism	  of	  propranolol	   at	   the	   in	   vitro	   rainbow	  
trout	  gill	  epithelium.	  This	  is	  important	  as	  it	  suggests	  that	  less	  propranolol	  may	  be	  taken	  up	  into	  the	  
organism	  over	  the	  gill,	  as	  a	  small	  proportion	  of	  it	  appears	  to	  be	  rapidly	  metabolised	  and	  effluxed	  
out	  of	  the	  gill.	  The	  DSI	  primary	  gill	  cell	  epithelium	  represents	  the	  most	  accurate	  in	  vitro	  model	  to	  
study	  these	  processes	   (Bury	  et	  al.,	  2014).	  Using	  such	   in	  vitro	  models	  can	  provide	   information	  on	  
metabolites	   to	  be	   incorporated	   in	  environmental	   risk	  assessments	  of	  human	  pharmaceuticals	  as	  
suggested	   in	  guidelines	   issued	  by	   the	  European	  Agency	   for	   the	  Evaluation	  of	  Medicinal	  Products	  
(EMEA)	  (EMEA,	  2006).	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When	  new	  products	  containing	  chemicals	  are	  bought	  to	  the	  market,	  their	  safety	  and	  that	  of	  their	  
active	   components	   are	  determined	   so	   that	   the	  potential	   environmental	   risk	   can	  be	   assessed.	   In	  
Europe,	   the	   safety	   of	   chemicals	   is	   assessed	   by	   directives	   such	   as	   REACH	   (The	   Registration,	  
Evaluation,	  Authorisation	  &	  Restriction	  of	  Chemicals,	  REACH,	  2009)	  for	  the	  evaluation	  of	  industrial	  
chemicals,	   the	   EMEA	   (European	  Agency	   for	   the	   Evaluation	  of	  Medicinal	   Products)	   for	  medicines	  
and	   specific	   European	   Union	   (EU)	   directives	   for	   plant	   protection	   products	   (PPP)	   and	   biocidal	  
products	  (BioP)	  (e.g.	  EU,	  2013	  and	  EU,	  2012,	  respectively).	  In	  the	  US	  similar	  directives	  such	  as	  The	  
Federal	   Insecticide,	  Fungicide,	  and	  Rodenticide	  Act	   (FIFRA)	  and	  The	  Toxic	  Substances	  Control	  Act	  
(TSCA)	   exist.	   Most	   of	   these	   bodies	   accept	   the	   use	   of	   testing	   guidelines	   provided	   by	   the	  
Organisation	   of	   Economic	   Co-­‐operation	   and	   Development	   (OECD)	   to	   assess	   a	   chemicals	   safety,	  
which	   reduces	   the	   variation	   of	   testing	  methods	   between	   laboratories	   and	   harmonises	   the	   data	  
produced.	  
To	   evaluate	   a	   compound’s	   environmental	   risk,	   a	   specific	   OECD	   test	   guideline	   will	   be	   used	  
depending	  on	  the	  route	  of	  exposure	  and	  the	  environmental	  compartment	  to	  which	  it	  is	  added.	  For	  
example,	  owing	  to	  their	  application	  to	  plants,	  all	  PPP	  and	  some	  BioP	  require	  testing	  in	  birds	  using	  
the	  Avian	  Acute	  Toxicity	  Test	  (OECD223,	  2010).	  The	  test	  guideline	  Bioaccumulation	  in	  Fish:	  Aqueous	  
and	  Dietary	  Exposure	  (OECD305,	  2012)	  is	  required	  in	  many	  instances	  for	  chemicals	  that	  may	  enter	  
water	  systems.	  These	  include	  industrial	  chemicals	  produced	  or	  imported	  in	  over	  100	  tons	  per	  year	  
and	  with	  a	  Log	  Kow	  >	  3,	  all	  plant	  protection	  products	  with	  Log	  Kow	  >	  3,	  all	  anti-­‐fouling	  agents	  and	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detergents	  used	  as	  biocidal	  products,	  some	  human	  and	  veterinary	  medicinal	  products	  and	  certain	  
food	  and	  cosmetic	  drugs	  (OECD,	  2012).	  Each	  test	  on	  one	  compound	  uses	  at	  least	  108	  fish	  (Scholz	  
et	  al.,	  2013),	  and	  so	  it	  is	  estimated	  that	  millions	  of	  fish	  are	  used	  in	  this	  test	  worldwide	  each	  year.	  
Within	  the	  OECD	  there	  is	  scope	  for	  the	  implementation	  of	  alternative	  methods	  where	  appropriate,	  
in	   line	  with	  the	  OECD’s	  commitment	  to	  the	  3Rs	  –	   the	  replacement,	   reduction	  and	  refinement	  of	  
the	   use	   of	   animals	   in	   scientific	   research	   (OECD,	   2012).	   Furthermore,	   the	   Fish	   Toxicity	   Testing	  
Framework	   put	   together	   by	   the	  OECD	   in	   2012	   (OECD,	   2012),	   provided	   a	   review	   of	   existing	   fish	  
toxicity	  test	  guidelines	  and	  suggested	  where	  reductions	  in	  the	  numbers	  of	  animals	  used	  could	  be	  
made.	  Test	  OECD305	  was	  advised	  to	  be	  improved	  to	  minimise	  animal	  use	  by	  reducing	  the	  number	  
of	  test	  concentrations	  per	  compound,	  by	  refining	  the	  number	  of	  sampling	  points	  during	  a	  test	  and	  
refining	  the	  numbers	  of	  animals	  sampled	  at	  each	  point	  (OECD,	  2012).	  
Furthermore,	  legislative	  directives	  such	  as	  REACH	  and	  the	  EMEA,	  as	  well	  as	  in	  many	  similar	  Asian	  
and	  North	  American	  regulatory	  bodies,	  have	  also	  committed	  to	  the	  adoption	  of	  the	  3Rs	  principle.	  
There	   have	   been	   many	   advances	   in	   mammalian	   animal	   alternatives,	   especially	   in	   the	   cosmetic	  
industry	   (e.g.	   skin	   corrosion	   tests)	   (Leist	   et	   al.,	   2012),	   but	  much	   less	   so	   in	   aquatic	   toxicology	   –	  
perhaps	  owing	  to	  the	  ease	  at	  which	  aquatic	  species	  can	  be	  dosed	  via	  the	  water.	  One	  of	  the	  main	  
reasons	  for	  the	  so	  few	  alternative	  methods	  is	  not	  due	  to	  their	  lacking	  in	  numbers,	  but	  the	  lack	  of	  
acceptance	  of	  the	  method	  to	  provide	  applicable	  results	  (Lillicrap	  et	  al.,	  2016).	  In	  order	  to	  replace	  
animal	  tests	  with	  in	  vitro	  alternatives,	  the	  most	  physiologically	  realistic	  cellular	  models	  need	  to	  be	  
validated	   and	   proven	   to	   show	   results	   similar	   to	   in	   vivo	   in	   terms	   of	   toxicity	   (Tanneberger	   et	   al.,	  
2013)	  or	  growth	  (Stadnicka-­‐Michalak	  et	  al.,	  2015).	  
Many	  now	  argue	  for	  the	  stronger	  push	  to	  incorporate	   in	  vitro	  alternatives	  into	  aquatic	  regulatory	  
testing	   (Lillicrap	   et	   al.,	   2016),	   such	   as	   the	   use	   of	   fish-­‐derived	   cell	   lines	   in	   the	   assessment	   of	  
environmental	  contaminants	  (Bols	  et	  al.,	  2005;	  Dayeh	  et	  al.,	  2013;	  Lee	  et	  al.,	  2009).	  Using	  cell	  lines	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as	  an	   in	  vitro	  alternative	  system	  to	  whole	  animal	  studies	  has	   its	  advantages,	  one	  such	  being	  that	  
they	  produce	  results	  with	  better	  reproducibility	  as	   individual	  differences	  are	  removed.	  There	  are	  
also	  reductions	  in	  time,	  costs	  and	  space	  when	  using	  cell	  models	  as	  opposed	  to	  housing	  populations	  
of	  fish	  in	  laboratories.	  As	  in	  Chapter	  3,	  the	  rainbow	  trout	  gill	  cell	   line	  RTgill-­‐W1	  is	  easy	  to	  obtain,	  
maintain	  and	  handle	  and	  can	  be	  routinely	  cultured	  in	  the	  laboratory	  for	  many	  passages	  (Bols	  et	  al.,	  
1994),	  although	  it	  also	  exhibits	  the	  loss	  of	  certain	  physiological	  features	  of	  the	  original	  tissue	  (see	  
Chapter	   4).	   Furthermore,	   fish	   cell	   lines	   typically	   underestimate	   in	   vivo	   toxicity	   by	   3	   orders	   of	  
magnitude	  (Tanneberger	  et	  al.,	  2013).	  It	  was	  proposed	  that	  this	  difference	  can	  be	  reduced	  in	  three	  
ways:	   1)	  by	  using	   cells	   derived	   from	   the	   specific	   tissue	  where	   the	  mode	  of	   action	  of	   a	   chemical	  
occurs,	  2)	  modifying	   the	  culture	  environment	   to	   like	   that	  of	   the	   in	  vivo	   and	  3)	  by	   increasing	   the	  
amount	  of	  chemical	  exposed	  by	  fraction	  to	  cells	  (Schirmer,	  2006).	  This	  study	  using	  the	  primary	  gill	  
cell	  system	  has	  accomplished	  these.	  Firstly,	  by	  directly	  isolating	  the	  cells	  of	  the	  gill,	  the	  cells	  of	  the	  
primary	   site	   of	   xenobiotic	   uptake	   are	   used.	   Furthermore,	   this	   process	   also	   allows	   the	   culture	  
environment	  to	  be	  as	  close	  to	  that	  of	  the	   in	  vivo	  scenario,	  as	  test	  concentrations	  of	  drugs	  can	  be	  
added	  to	  the	  apical	  surface	  of	  gill	  cells	   in	   freshwater	   (see	  Chapters	  5	  &	  6)	  as	  opposed	  to	  culture	  
medium	  as	  is	  often	  required	  by	  fish	  cell	  lines,	  that	  may	  contain	  solutes	  that	  alter	  processes	  such	  as	  
transporter	   expression	   (Fischer	   et	   al.,	   2011).	   Lastly,	   rather	   than	   scaling	   up	   the	   dosing	  
concentrations	   to	   initiate	   a	   cellular	   response,	   this	   system	   has	   exposed	   cells	   to	   much	   more	  
environmentally	  relevant	  and	  therefore	  realistic	  concentrations.	  
Here,	  the	  present	  study	  is	  the	  first	  to	  demonstrate	  how	  a	  primary	  gill	  cell	  system	  can	  be	  cultured	  
(Schnell,	   Stott,	   et	   al.,	   2016)	   and	   used	   to	   assess	   the	   uptake	   and	   efflux	   (Stott	   et	   al.,	   2015)	   and	  
metabolism	  (Stott	  et	  al.,	  in	  preparation)	  of	  pharmaceuticals	  across	  and	  within	  an	  in	  vitro	  biological	  
membrane,	   which	   can	   provide	   data	   that	   can	   complement	   BCF	   tests.	   Here,	   the	   more	   relevant	  
morphological,	   physiological,	   transport	   and	   metabolic	   characteristics	   of	   primary	   gill	   cells	   when	  
cultured	  using	  the	  DSI	  technique	  is	  shown	  (Schnell,	  Stott	  et	  al.,	  2016).	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Fig	  7.1	  Proposed	  tiered	  assessment	  strategy	  for	  evaluating	  bioaccumulation	  data	  adapted	  from	  Lillicrap	  et	  al.,	  2016.	  (B:	  
Bioaccumulative;	  vB:	  very	  Bioaccumulative.	  *A	  refined	  BCF	  could	  be	  considered	  if	  any	  data,	  such	  as	  is	  detailed	  in	  Tier	  2,	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Primary	   gill	   DSI	   have	   the	   potential	   for	  many	   varied	   applications.	   Toxicity	   testing	   using	   different	  
endpoints	   such	   as	   cell	   viability	   and	   transcriptomics	  will	   provide	   information	   on	   in	   vivo	   rainbow	  
trout	   toxicity.	   Indeed,	   DSI	   expressed	   metallothionein,	   a	   protein	   that	   binds	   heavy	   metals,	   as	   a	  
predictor	  of	  zinc	  and	  silver	  toxicity	  with	  similar	  sensitivity	  to	  that	  of	   in	  vivo	   (Walker	  et	  al.,	  2008).	  
The	  primary	  DSI	   also	  have	  potential	   to	  be	  used	  as	  a	  biomonitoring	   tool,	   as	   freshwater	   collected	  
from	  the	  environment	  can	  be	  directly	  added	  onto	  cells	  (Minghetti	  et	  al.,	  2014;	  Schnell	  et	  al.,	  2015)	  
and	   the	   resulting	   cell	   viability	   and	   changes	   in	   transcription	   levels	   of	   responsive	   genes	   can	   be	  
measured.	  
The	  use	  of	  this	  system	  is	  not	  limited	  to	  investigate	  pharmaceutical	  uptake,	  efflux	  and	  metabolism	  
in	  freshwater	  fish.	  A	  range	  of	  contaminants	  with	  different	  modes	  of	  entry	  can	  be	  applied	  and	  could	  
include	  dioxins,	  metals	  and	  polychlorinated	  biphenyls.	   Indeed,	  preliminary	  work	  has	  begun	  using	  
this	   system	   to	   investigate	   the	   uptake	   and	   metabolism	   of	   a	   range	   of	   other	   classes	   of	  
pharmaceuticals	  including	  warfarin,	  ibuprofen	  and	  gemfibrozil	  (Chang	  et	  al.,	  in	  preparation).	  
What	  currently	  remains	  is	  the	  challenge	  of	  incorporating	  alternative	  assessment	  strategies	  like	  this	  
into	  regulatory	  testing	  for	  evaluating	  bioaccumulation	  data.	  Lillicrap	  et	  al.	  (2016)	  propose	  a	  tiered	  
assessment	   strategy	   that	   incorporates	   information	   for	   evaluating	   fish	   bioaccumulation	   data	   (Fig	  
7.1).	   In	   this	   way,	   they	   present	   guidance	   on	   how	   to	   build	   up	   a	   ‘Weight	   of	   Evidence’	   in	   Tier	   2,	  
including	   using	   ‘Read	  Across’,	   and	   already	   existing	   BCF	   information	   and	   data	   generated	   from	   in	  
vitro	  models,	  with	   the	   intention	   to	   bypass	   the	  need	   for	   so	  many	   tests	   using	   live	   fish.	   This	  work	  
offers	   the	  preliminary	  validation	  of	  an	  alternative	   in	   vitro	  method	   that	   can	  be	   incorporated	   into	  
Tier	  2	  to	  assess	  the	  bioconcentrative	  potential	  of	  compounds.	  Furthermore,	  this	  system	  shows	  the	  
potential	  of	  compounds	  to	  be	  metabolised,	  and	  perhaps	  can	  so	  further	  when	  this	  system	  is	  used	  in	  
combination	  with	  hepatic	  spheroids	  (Fig	  7.2),	  and	  so	  it	  has	  the	  potential	  to	  offer	  a	  powerful	  tool	  to	  
consider	  the	  major	  metabolic	  routes	  in	  a	  fish	  (Lillicrap	  et	  al.,	  2016).	  
7.	  General	  Discussion	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Future	  directions	  
Tissue	   specific	   in	   vitro	   models	   provide	   a	   portion	   of	   information	   on	   the	   total	   metabolism	   of	  
xenobiotics	  by	  an	  organism.	  Combining	  cells	  of	  different	  tissues	  from	  an	  organism	  and	  exposing	  to	  
xenobiotics	  will	  provide	  a	  more	  accurate	  and	  detailed	  representation	  of	  the	   in	  vivo	  response	  and	  
allow	  the	  ‘crosstalk’	  of	  different	  cell	  types.	  The	  DSII	  system	  with	  the	  co-­‐culture	  of	   liver	  spheroids	  
(Fig	  7.2A),	  as	  outlined	  in	  Chapter	  3,	  has	  the	  potential	  to	  provide	  this	  information.	  In	  this	  way,	  there	  
is	  scope	  for	  the	  co-­‐culture	  of	  other	  epithelial	  tissues,	  such	  as	  the	  gut,	  using	  the	  same	  cell	  culture	  
inverted	   technique,	   with	   liver	   spheroids	   (Fig	   7.2B).	   This	   information	   gathered	   together	   can	   be	  
collated	   together	   to	   produce	   a	   ‘virtual	   fish’	   to	   predict	   the	   outcomes	   of	   ecotoxicological	   uptake,	  
efflux	  and	  metabolism	  studies	  in	  live	  fish.	  
	  
Fig	  7.2	  Development	  of	  the	  ‘virtual	  fish’	  cellular	  models	  that	  combine	  cultures	  of	  different	  organs	  such	  as	  (A)	  gill	  DSII	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a  b  s  t  r  a  c  t
The  gill is the  principle  site  of xenobiotic  transfer  to  and  from  the  aqueous  environment.  To replace,
reﬁne  or  reduce  (3Rs)  the  large numbers  of ﬁsh  used  in  in  vivo  uptake  studies  an  effective  in  vitro  screen
is  required  that  mimics  the  function  of  the  teleost  gill.  This  study  uses  a rainbow  trout (Oncorhynchus
mykiss)  primary  gill cell  culture  system  grown  on permeable  inserts,  which  tolerates  apical  freshwa-
ter  thus  mimicking  the intact  organ,  to assess  the  uptake  and  efﬂux  of pharmaceuticals  across  the  gill.
Bidirectional  transport  studies  in  media  of seven  pharmaceuticals  (propranolol,  metoprolol,  atenolol,
formoterol,  terbutaline,  ranitidine  and  imipramine)  showed  they  were  transported  transcellularly  across
the epithelium.  However,  studies  conducted  in water  showed  enhanced  uptake  of propranolol,  ranitidine
and  imipramine.  Concentration-equilibrated  conditions  without  a  concentration  gradient  suggested  that
a proportion  of  the  uptake  of propranolol  and  imipramine  is  via  a carrier-mediated  process.  Further  study
using propranolol  showed  that its transport  is pH-dependent  and  at very  low  environmentally  relevant
concentrations  (ng  L−1),  transport  deviated  from  linearity.  At  higher  concentrations,  passive  uptake  dom-
inated.  Known  inhibitors  of drug  transport  proteins;  cimetidine,  MK571,  cyclosporine  A  and  quinidine
inhibited  propranolol  uptake,  whilst  amantadine  and  verapamil  were  without  effect.  Together  this  sug-
gests  the involvement  of  speciﬁc  members  of  SLC  and  ABC  drug  transporter  families  in  pharmaceutical
transport.
© 2014  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
There are currently over 140,000 compounds that are being
reassessed for their bioconcentrative properties as a part of the
EU Registration, Evaluation, Authorization & Restriction of Chem-
icals (REACH) initiative (REACH, 2009). Conventionally, the main
determinant used for assessing bioconcentration of a compound
is the octanol–water partitioning coefﬁcient (Kow), a measure of
Abbreviations: 3Rs, reduce, reﬁne, replace; A, apical; ABC, ATP-binding cas-
sette; B, basal; BCF, bioconcentration factor; BTA, bi-directional transport assay;
CETA, concentration equilibrated transport assay; Ci, Curie; Dpm, disintegrations
per minute; Kow, octanol–water partitioning coefﬁcient; MRP, multidrug resis-
tance protein; OCT, organic cation transporter; OECD, Organisation for Economic
Co-operation and Development; Papp, apparent permeability coefﬁcient; pKa, dis-
sociation constant; QSARs, quantitative structure–activity relationships; REACH,
Registration, Evaluation, Authorization & Restriction of Chemicals; SLC, solute car-
rier; TER, transepithelial resistance; TEP, transepithelial potential; TR, transport
ratio.
∗ Corresponding author. Tel.: +44 2078484091; fax: +44 2078484500.
E-mail address: Nic.Bury@kcl.ac.uk (N.R. Bury).
hydrophobicity that drives sorption and accumulation, and a main
input parameter in quantitative structure–activity relationships
(QSARs) (Hansch, 1969). However, this may  not be fully applica-
ble to pharmaceuticals, many of which are polar and ionizable
(Hermens et al., 2013). In this case, the pH-corrected octanol–water
partitioning coefﬁcient, Dow, may  be used, but this fails to take into
account other major interactions such as hydrogen bonding and van
der Waals forces, as well as uptake via carrier-mediated processes
(Dobson and Kell, 2008; Sugano et al., 2010).
In vivo ecotoxicology testing produces bioconcentration factor
(BCF) values that indicate the potential of a compound to biocon-
centrate within an organism (OECD305, 2012). Fish are exposed to
highly lipophilic compounds via the diet, whilst to others via the
water; the principle being to use the uptake and depuration rates
to calculate the propensity of a compound to bioconcentrate. Typ-
ically, each test can use up to 108 ﬁsh per compound and many
thousands of ﬁsh are used for this test every year (Scholz et al.,
2013). There is currently a desire to develop alternative methods to
replace these standardized whole ﬁsh studies to recognize and clas-
sify environmental hazards (Creton et al., 2013; Wolf et al., 2007).
This requires the identiﬁcation and validation of appropriate in vitro
http://dx.doi.org/10.1016/j.aquatox.2014.12.007
0166-445X/© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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systems that could replace such studies (Baron et al., 2012; Uchea
et al., 2013). To ﬁnd alternatives to the OECD305 water exposure it
is necessary to identify a suitable ﬁsh gill model that mimics the
intact organ because the gill, being constantly and continuously
exposed to substances in water, is the principle site of xenobiotic
uptake (Bury et al., 2014).
Fletcher et al. (2000) developed a double-seeding technique that
enables primary gill cells to be cultured on permeable membrane
inserts in a two-compartment model. This cultured epithelium
comprises the different cell types (mitochondrial rich cells, respi-
ratory cells and mucus cells) found in the gill and produces
high transepithelial resistance (reviewed by Bury et al., 2014).
Importantly, the system is able to tolerate apical freshwater and
produces a negative transepithelial potential, further simulating
the in vivo scenario. This is crucial when investigating the transport
of ionizable compounds such as pharmaceuticals that may  behave
differently in culture medium and water. Furthermore, the gill cells
from two ﬁsh can be used to create up to 72 individual gill epithe-
lial inserts for assaying, thus potentially reducing numbers of ﬁsh
in in vivo testing.
The present study thus aims to use the in vitro gill to investi-
gate the uptake and efﬂux of seven pharmaceuticals representing
a range of classes. We  hypothesize that both passive transcellu-
lar and carrier-mediated transport of xenobiotics across the gill
are likely principle drivers in determining the rate of uptake of
waterborne compounds (Mckim and Erickson, 1991). Passive tran-
scellular transport depends on the pH of the solution, acid–base
constants (pKa) and the lipophilicity of the compound, whereas
facilitated transport may  be via members of the solute carrier (SLC)
and ATP-binding casette (ABC) transporter families (Dobson and
Kell, 2008). Therefore, to investigate carrier-mediated transport
for some of these pharmaceuticals, concentration-equilibrated,
pH-dependent, and concentration-dependent assays, as well as
membrane channel inhibitor studies were conducted. In the con-
text of this work, paracellular transport refers to the movement
of compounds over membranes between cells and passive trans-
port refers to concentration-dependent transcellular processes,
whereas facilitated transport indicates concentration-independent
carrier-mediated transport via membrane channel proteins. In
addition, the uptake of propranolol across the in vitro gill model was
compared to in silico and in vivo data (Owen et al., 2009), to demon-
strate the use of this model as a predictive tool for pharmaceutical
uptake.
2. Materials and methods
2.1. Animal husbandry
Gill cells for the use in primary cultures were obtained from
juvenile diploid rainbow trout weighing 50–120 g purchased
from a trout farm (Hampshire, UK). Fish were acclimatized in
three 1000 L ﬁberglass aquaria at King’s College, London, and
maintained at 13–14 ◦C in recirculating aerated city of London
tap water ([Na+] = 0.53 mM,  [Ca2+] = 0.92 mM,  [Mg2+] = 0.14 mM,
[K+] = 0.066 mM and [NH4+] = 0.027 mM),  which was passed
through carbon, mechanical and biological ﬁlters. Photoperiod was
maintained at a constant 14 h light/10 h dark cycle and ﬁsh were
fed a daily 1% (w/w) ration of ﬁsh chow.
2.2. Gill cell culture
Sterile techniques were used throughout all cell culture pro-
cedures. Equipment, containers and solutions were autoclaved or
sterile ﬁltered (0.2 m,  Corning). The gill cell isolation procedure
was based on methods previously documented (Fletcher et al.,
2000) and the cell culture double-seeded insert (DSI) technique as
described by Walker et al. (2008) and Wood et al. (2002). Brieﬂy,
primary gill cells are isolated, washed and resuspended in L-15
medium (Invitrogen) supplemented with FBS (5% (v/v)) (Sigma)
and seeded onto a permeable polyethylene terephthalate (PET)
membrane inserts with 0.4 m pores with an area of 0.9 cm2 and
maintained at 18 ◦C. This Transwell system (Corning) has an apical
compartment above and a basal compartment below.
The development of an intact and electrically tight gill epithe-
lium was monitored daily through ‘blank’-corrected measurements
of transepithelial resistance (TER) using a custom-modiﬁed epithe-
lial tissue voltohmeter (EVOMX; World Precision Instruments)
ﬁtted with chopstick electrodes (STX-2). The same device was used
to measure transepithelial potential (TEP) before and after freshwa-
ter application. DSI epithelia that reached a TER of ≥5 k cm2 were
considered developed and electrically ‘tight’ for experimental pro-
cedures. In this instance, DSI preparations were washed twice with
PBS (to remove any media supplemented with FBS) and exposed
to radiolabeled pharmaceuticals apically in either L-15 medium
(without FBS) or freshwater (2.0 mM CaCl2, 0.5 mM MgSO4, 0.8 mM
NaHCO3, 77.1 M KCl at pH 7.7), or basally, always in L-15
medium. L-15 medium has an osmolarity of 300–320 mOsm kg−1
(Invitrogen) and that of freshwater is around 15 mOsm kg−1. All
experiments and exposures are based on individual inserts (n)
derived from at least one biological replicate. Due to the seeding
procedure over two  days, one biological replicate is derived from
two ﬁsh.
2.3. Membrane permeability
Paracellular permeability was measured using the paracellu-
lar marker 14C-mannitol (20 Ci mmol−1, Amersham Biosciences,
CAS no. 88404-24-4). Thirty-seven DSI epithelia with TER val-
ues ranging from 0 to 14 k cm2 were exposed to 0.013 Ci
(2.2 × 105 dpm) 14C-mannitol in 1.5 mL  sterile freshwater in the
apical compartment, with 2.0 mL  L-15 medium in the basal
(Hubatsch et al., 2007). From this, a TER value at which paracellular
transport is at its most minimal can be deduced as a threshold for
when epithelia are ready for transport assays (≥5 k cm2). Aliquots
of 100 L were taken from the apical and basal compartments at
time 0 and 24 h, and placed in 2 mL liquid scintillation ﬂuid (Ecol-
ume) and radioactivity measured by beta counting (Tri Carb 460CD
liquid scintillation system; Packard). Mannitol ﬂux after 24 h was
calculated using Eq. (1):
Permeability (cm s−1) = [M]BL × volume
MAP × time × 3600 × area
(1)
where [M]BL is the change in radioactivity in the basal compart-
ment, MAP is the radioactivity at the start, time is 24 h and area is
0.9 cm2 (Fletcher et al., 2000).
2.4. Radiolabeled pharmaceuticals
All drugs used in transport assays were at a concentration
of 1 g L−1 to represent the levels detected in the environment
whilst remaining within detectable limits (Table 1). These were
purchased radiolabeled and re-suspended in ethanol or methanol
with a ﬁnal solvent concentration in assay conditions of <0.0003%,
and chosen to demonstrate a range of different classes (1-,
2- and non-speciﬁc -receptor agonists, a H2-receptor agonist
and a tricyclic anti-depressant) with mid-range log Kow values
(see Table 1). This method of using labeled compounds allows
for the recovery of label during cell-free conditions to calculate
the amount that sticks to plastic ware. Furthermore, the label
may  be detected as either the parent compound or biotrans-
formed products. 3H-propranolol hydrochloride (29.0 Ci mmol−1,
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Table  1
Properties of selected pharmaceuticals and the levels at which they are found in the environment.
Pharmaceutical Use MW pKa log Kow1 log Kow2 Environmental levels (ng L−1)
Propranolol Non-selective  antagonist 259.340 9.4 2.54 1.12* 333
Metoprolol 1 receptor antagonist 267.364 9.6 1.76 –0.90# 4103
Atenolol 1 receptor antagonist 266.336 9.6 0.67 0.0015* 9403
Formoterol Long-acting 2 agonist 344.405 7.9a/9.2b 1.93 0.41* n/a
Terbutaline 2-Adrenergic receptor agonist 225.284 8.86a/9.76b 1.25 1.29 74
Ranitidine H2-receptor antagonist 314.4 8.08 1.47 1203
Imipramine Tricyclic antidepressant 280.407 9.4 4.39 0.145
1 Parameter Client (Tetko et al., 2005).
2 Environmental Risk Assessment data, experimentally measured values (AstraZeneca, 2014).
3 Kostich et al. (2014).
4 Breitholtz et al. (2012).





CAS no. 152588-63-93) was obtained from Amersham Biosciences.
3H-metoprolol (29.7 Ci mmol−1), 3H-formoterol (18.5 Ci mmol−1)
and 3H-terbutaline (29.0 Ci mmol−1) were obtained from Vit-
rax. 3H-Atenolol (7.3 Ci mmol−1) and 3H-ranitidine (2.5 Ci mmol−1)
were obtained from Moravek Biochemicals, and 3H-imipramine
hydrochloride (48.5 Ci mmol−1, CAS no. 113-52-0) from Perkin-
Elmer.
2.5. Bidirectional transport assays and apparent permeability
coefﬁcients
Bidirectional transport assays (BTA) assess both passive and
facilitated transport in a bidirectional manner, from apical to basal
(uptake) or vice versa (efﬂux). In these, concentration gradient con-
ditions exist, whereby total transport is a sum of both passive
transcellular and carrier-mediated processes. DSI epithelia with a
TER > 5 k cm2 with low paracellular transport rates were exposed
to test compounds in either symmetrical or asymmetrical condi-
tions. Symmetrical contained 1.5 and 2.0 mL  L-15 (without FBS) in
apical and basal compartments respectively, whilst asymmetrical
required the application of 1.5 mL  freshwater in the apical compart-
ment and 2.0 mL  L-15 in the basal. The test compound was  added to
either the apical side (uptake; A:B) or basal compartment (efﬂux;
B:A) at a concentration of 1 g L−1. Each experimental condition
used 3–5 epithelial inserts from 1 to 2 biological replicates. For all
experiments the water or media from the apical or basal compart-
ment was mixed before taking 100 L samples at 0, 6, 24, 30 and
48 h. Each 100 L aliquot sample was placed into scintillation vials
with scintillation ﬂuid and beta-counted, and the drug concentra-
tion was calculated from the speciﬁc radioactivities. For uptake and
efﬂux BTA, apparent permeability coefﬁcients (Papp) at 6 h were
calculated using Eq. (2):
Papp(cm s−1) = (dQ/dt  × 1/(A × C0))3600 (2)
where dQ/dt is the ﬂux rate of the drug (pmol L−1 h−1), A is the
surface area of the monolayer (0.9 cm2) and C0 is the initial con-
centration of the drug in the donor compartment (fM) (Petri et al.,
2004). Transport ratios (TR) for both uptake and efﬂux were calcu-
lated using Eqs. (3) and (4) (Schwab et al., 2003).
Uptake TR = Papp A:B
Papp B:A
(3)
Efﬂux TR = Papp B:A
PappA:B
(4)
An uptake or efﬂux TR ≥ 1.5 is considered an indicator of active
transport (Schwab et al., 2003; Luna-Tortós et al., 2008). For
time-dependent BTA, the results were also expressed as the per-
centage of the initial drug concentration of the donor compartment
for uptake (A:B) and efﬂux (B:A) over 48 h.
2.6. Concentration equilibrium transport assays
Concentration equilibrium transport assays (CETA) examine
transport by adding equivalent concentrations on either side
of the gill epithelium and assessing the movement of com-
pounds over time to evaluate carrier-mediated uptake or efﬂux
regardless of passive transport processes, as used in blood–brain
barrier transport assays (Luna-Tortós et al., 2008). The same
experimental procedures for BTA were used (in symmetrical and
asymmetrical conditions), but with both apical and basal com-
partments containing test drugs at the same concentration of
1 g L−1. The results are expressed as a percentage of the ini-
tial concentration in each compartment (apical or basal) over
time.
2.7. The pH-dependent transport of propranolol
DSI epithelia were exposed in apical freshwater adjusted to pH
6 (by addition of HCl), pH 8 or pH 9.5 (by addition of NaOH; Corning
pH meter 140). Radiolabeled propranolol was  added at a concentra-
tion of 1 g L−1 to either the apical or basal compartments (BTA) to
investigate uptake and efﬂux. At 6 h a 100 L sample was collected
from the apical and basal compartments and radioactivity analyzed
as above, and apparent permeability coefﬁcients (Papp) calculated
using Eq. (2).
2.8. The concentration-dependent uptake of propranolol
DSI epithelia (n = 54) were exposed to 17 concentrations of
propranolol ranging from 0.014 to 10,000 g L−1. Concentrations
above 0.1 g L−1 were made using propranolol hydrochloride
(Sigma, CAS no. 318-98-9) and radiolabeled propranolol as a
marker. Experiments were conducted in asymmetrical conditions
with propranolol added to the water in the apical compart-
ment, thus mimicking the in vivo scenario (Owen et al., 2009).
Radioactivity was  analyzed as previously described in Section
2.3.
2.9. The inhibition of the uptake of propranolol
Cells were pre-incubated with inhibitor at a concentration
100 times higher (400 nM)  than that of propranolol to competi-
tively inhibit the membrane channel. Amantadine (Sigma, CAS no.
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768-94-5), cimetidine (ICN, CAS no. 51481-61-9), cyclosporine A
(Fluka, CAS no. 59865-13-3), MK571 (Tocris Biosciences, CAS no.
115104-28-4), quinidine (Sigma, CAS no. 56-54-2) or verapamil
hydrochloride (Fluka, CAS no. 152-11-4) were dissolved in DMSO
(0.1% in ﬁnal solution) and added to the apical (in 0.75 mL  freshwa-
ter) or basal (in 1.0 mL  L-15 medium). Controls and compartments
without inhibitor contained 0.1% DMSO. After 1 h, volumes were
replaced with 1.5 mL  freshwater containing 1 g L−1 (4 nM)  pro-
pranolol apically and 2.0 mL  L-15 basally, whilst keeping the ﬁnal
concentration of inhibitor at 400 nM throughout. The same samp-
ling procedure as for BTA at time 0, 6 (not for cyclosporine A), 24,
36 and 48 h proceeded and the uptake Papp of propranolol was  cal-
culated using Eq. (2). The Papp in all inhibitor-free controls were
expressed as a percentage of the mean (100%) and the change in
uptake Papp (inhibition) in the presence of inhibitors was  expressed
as a percentage of this mean control.
2.10. Analysis of data and statistics
For bidirectional Papp comparisons between the uptake and
efﬂux, an independent samples t-test with equal variances assumed
was used and statistical signiﬁcance was accepted when P < 0.05
(SPSS software, SPSS Inc.). The same statistical analysis was used
to test for differences between asymmetrical and symmetrical
uptake or efﬂux Papp for each drug to assess the effect of apical
freshwater application. For the time-dependent BTA signiﬁcant dif-
ferences between the uptake and efﬂux percentage of the donor
compartment were tested for by one-way analysis of variance
(ANOVA) on log-transformed data (SPSS software, SPSS Inc.). For
the time-dependent CETA the statistical signiﬁcance of differences
between each percentage increase or decrease in the apical or
basal compartments were also tested for by one-way ANOVA (after
log transformation). Differences between the uptake of propra-
nolol at different pHs, and similarly the efﬂux, were tested for
by ANOVA and statistical signiﬁcance was accepted when P < 0.05
(SPSS software, SPSS Inc.). The propranolol ﬂux for each concen-
tration in the concentration–response evaluation was  calculated
at 6 h and analyzed by ordinary least squares linear regression
to describe the best ﬁt, and further analysis of low concentra-
tions was done by cubic polynomial regression to best describe
the relationship (SPSS software, SPSS Inc.). Statistical differences
between inhibitor (applied either apically or basally) and the
inhibitor-free control were tested for by one-way ANOVA (after
log transformation) and the statistical signiﬁcance was set to
P < 0.05.
2.11. Comparison to predicted and actual plasma concentrations
In vitro propranolol ‘internal’ concentrations after uptake (A:B)
from the concentration–response study were compared to pre-
dicted in silico and actual in vivo plasma concentrations of
propranolol in Oncorhynchus mykiss.  The predicted partition of
propranolol between blood and water can be determined by
[plasma] = 0.87 [water] as described by Owen et al. (2009). This
was calculated using the mammalian ﬁsh leverage model, whereby
the predicted plasma concentration can be described by multi-
plying the environmental concentration by the blood to water
partitioning coefﬁcient (Huggett et al., 2004) using the Fitzsim-
mons model for the partitioning of compounds between blood and
water (Fitzsimmons et al., 2001). Actual plasma concentrations of
propranolol in O. mykiss were obtained from Owen et al. (2009).
In vitro propranolol concentrations at 6 h (n = 3–6 from 3 biolog-
ical replicates) were tested for correlation to in silico and in vivo
plasma concentrations by ordinary least squares linear regression



























Resistance  (k Ω cm2)
Fig. 1. The relationship between 14C-mannitol permeability (after 24 h) and
transepithelial electrical resistance (TER) in 37 cultured rainbow trout gill epithelia
derived from four biological replicates. 14C-mannitol was applied to the apical com-
partment in freshwater, with L-15 medium in the basal compartment. Each data
point represents one DSI epithelium (n = 37) from four biological replicates.
3. Results
3.1. Epithelium membrane characteristics
DSI epithelial development was  monitored through daily mea-
surements of TER in symmetrical conditions, which after 8 days
reached 18.1 ± 1.3 k cm2 (n = 24). After apical freshwater appli-
cation TEP became increasingly negative from −0.9 ± 0.15 mV
to −12.9 ± 2.9 mV  (n = 8). The permeability of the paracellu-
lar marker 14C-mannitol produces a measure of the rate of
paracellular transport for compounds with similar molecular
weights via this route. Mannitol ﬂux in cell free inserts with
a TER of 0  cm2 (blanked) was  3.6 ± 0.2 × 10−6 cm s−1 (n = 4,
Fig. 1). DSI gill epithelia with TER of 200–1000  cm2 exhib-
ited a mannitol permeability of 1.1 ± 1.1 × 10−6 cm s−1, whilst
those >2 k cm2 showed the lowest mannitol permeability of
0.1 ± 0.01 × 10−6 cm s−1, with little variation between epithelia
(Fig. 1).
3.2. Apparent permeability coefﬁcients and transport ratios
In symmetrical conditions with L-15 medium on both sides of
the gill cell epithelium no signiﬁcant differences between Papp A:B
and Papp B:A for all 7 pharmaceuticals was observed (Fig. 2A), yet
all permeabilities were higher than that of the paracellular marker
mannitol (except for atenolol; Papp A:B: 0.1 ± 0.03 × 10−6 cm s−1
and Papp B:A: 0.1 ± 0.02 × 10−6 cm s−1 compared to mannitol;
Papp A:B: 0.1 ± 0.01 × 10−6 cm s−1). In asymmetrical conditions
with freshwater at the apical surface of the gill epithelium,
Papp A:B was signiﬁcantly higher than Papp B:A (P < 0.001) for
propranolol and imipramine, whilst no signiﬁcant differences
existed between uptake and efﬂux Papp of the remaining ﬁve
drugs metoprolol, atenolol, formoterol, terbutaline and ranitidine
(Fig. 2B). For propranolol, the Papp A:B increased signiﬁcantly from
1.7 ± 0.2 × 10−6 cm s−1 in symmetrical to 2.7 ± 0.2 × 10−6 cm s−1 in
asymmetrical conditions (P < 0.05) and Papp B:A decreased signiﬁ-
cantly from 1.1 ± 0.02 to 0.8 ± 0.1 × 10−6 cm s−1 (P < 0.05) (Fig. 2A
and B). Similarly for imipramine a signiﬁcant increase in Papp
A:B from symmetrical (1.9 ± 0.2 × 10−6 cm s−1) to asymmetrical
(3.0 ± 0.1 × 10−6 cm s−1; P < 0.05) and a signiﬁcant decrease in Papp
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Table  2
The uptake and efﬂux transport ratios (TR) of seven drugs in symmetrical and asym-
metrical conditions.
Uptake TR Efﬂux TR
Symmetrical Asymmetrical Symmetrical Asymmetrical
Propranolol 1.52* 3.21* 0.66 0.31
Metoprolol 0.56 1.32 1.78* 0.76
Atenolol 0.74 0.60 1.34 1.67*
Formoterol 1.08 0.97 0.93 1.03
Terbutaline 0.92 0.89 1.09 1.13
Ranitidine 1.21 0.88 0.83 1.14
Imipramine 0.84 1.83* 1.19 0.55
* represents TR ≥ 1.5.
B:A (2.2 ± 0.04 to 1.6 ± 0.1 × 10−6 cm s−1; P < 0.05) (Fig. 2A and B)
was observed.
Propranolol showed uptake TR values greater than 1.5
in both symmetrical and asymmetrical conditions, whilst for
imipramine; this was only observed in asymmetrical conditions.
Both metoprolol and atenolol had efﬂux TR values greater than
1.5 in symmetrical and asymmetrical conditions, respectively
(Table 2).
3.3. Bidirectional transport assays
In symmetrical conditions with L-15 medium on both sides
of the epithelium, ranitidine and imipramine exhibited greater
efﬂux transport from the basal to the apical compartments at 24 h
(P < 0.05) and at 30 and 48 h (P < 0.05) respectively. In asymmetri-
cal conditions involving the application of freshwater at the apical
surface, more propranolol, ranitidine and imipramine were taken
up across the gill cell surface than efﬂuxed after 48 h. This was sig-
niﬁcantly more so at 6 h (P < 0.001) and 24, 30 and 48 h (P < 0.01)
















































Fig. 2. The apparent permeability coefﬁcients (Papp) for uptake (Papp A:B, white bars)
and efﬂux (Papp B:A, gray bars) of seven pharmaceuticals (1 g L−1) across the DSI gill
cell epithelium at 6 h in symmetrical conditions (A) and asymmetrical conditions (B).
Signiﬁcant differences between the Papp A:B and Papp B:A for a drug within a condition
(symmetrical or asymmetrical) are indicated by asterisk (independent samples t-
test; ***P < 0.001). Signiﬁcant differences between symmetrical and asymmetrical
Papp A:B or Papp B:A for each drug are indicated by hash tag in (B) (independent samples
t-test; #P < 0.05). All experiments were performed in triplicate or more (n = 3–5) from
at  least one biological replicate and values are shown as means ± SEM.
points (6, 24, 30 and 48 h) for imipramine (P < 0.001). Metopro-
lol, formoterol and terbutaline showed slightly greater uptake than
efﬂux after 48 h, and this was signiﬁcantly more so for formoterol
at 48 h (P < 0.05).
3.4. Concentration-equilibrated transport assays
In symmetrical conditions with L-15 media and test drug on
both sides of the epithelium no signiﬁcant differences between
percentage of the initial drug concentrations in the apical and
basal compartments were observed for metoprolol, terbutaline
and ranitidine at any time point (Fig. 3B). The percentage of the
initial concentration of formoterol was more in the apical than
basal but only signiﬁcantly so at 24 h (P < 0.05). The percentage
of the initial concentration of propranolol in the apical compart-
ment was  signiﬁcantly more than the basal at all sampling points
after 0 h (6 and 24 h P < 0.01 and 30 and 48 h P < 0.05). This was
also seen for imipramine, which showed the same increased basal
to apical facilitated transport (P < 0.001 at 6, 24 and 30 h and
P < 0.01 at 48 h). However, in asymmetrical conditions the situ-
ation was  reversed whereby increased apical to basal transport,
indicative of facilitated uptake, resulted in signiﬁcantly more pro-
pranolol and imipramine in the basal compartments (P < 0.01 at
24 h and P < 0.001 to 30 and 48 h for propranolol and P < 0.01
at 6, 24 and 30 h and P < 0.001 at 48 h for imipramine). The
same was  true for ranitidine in asymmetrical conditions but to
a lesser degree (P < 0.05 at 24, 30 and 48 h). Metoprolol, for-
moterol and terbutaline showed no signs of facilitated transport
across the epithelium as no signiﬁcant differences were observed
(Fig. 3B).
3.5. The pH-dependent transport of propranolol
A decrease in pH from 8 to 6 resulted in a signiﬁcant reduc-
tion in the uptake permeability (Papp A:B) of propranolol from
2.7 ± 0.2 × 10−6 to 0.4 ± 0.03 × 10−6 cm s−1 (P < 0.001) in asymmet-
rical conditions. The effect was  opposite for efﬂux permeability
(Papp B:A) with an increase from 0.8 ± 0.1 to 2.8 ± 0.1 × 10−6 cm s−1
(P < 0.001; Fig. 4). An increase in pH from 8 to 9.5 was without
signiﬁcant effect (Fig. 4).
3.6. The concentration-dependent uptake of propranolol
A positive linear correlation between concentration
(0.014–10,000 g L−1) and ﬂux of propranolol was  observed
with regression line representing the best ﬁt of [rate] = 0.052
[concentration] (n = 54, r2 = 0.974, Fig. 5A). However, at lower
propranolol concentrations (0.014–0.14 g L−1) a 2nd order poly-
nomial regression best described the concentration–response
relationship (n = 24, r2 = 0.927, Fig. 5B) rather than linear (n = 24,
r2 = 0.908) with line representing the best ﬁt of [rate] = 0.057
[concentration].
3.7. The inhibition of the uptake of propranolol
Amantadine and verapamil did not inhibit Papp A:B of propranolol
(Fig. 6A and F). Apical and basal cimetidine application signiﬁcantly
inhibited the transport of propranolol at all time points (apart
from basal at time 6 h) by approximately 40–61.4% ± 3.4 (apical
application) and 55.9% ± 1.3 (basal application) at 48 h (P < 0.001)
(Fig. 6B). Similarly, cyclosporine A showed a signiﬁcant inhibition
of propranolol transport after 48 h to 69.9% (±3.7) of that in the con-
trol (P < 0.01) for apical application andto 66.3% (±6.1) (P < 0.001)
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Fig. 3. The transport assays of six pharmaceuticals: propranolol, metoprolol, formoterol, terbutaline, ranitidine and imipramine, in the DSI rainbow trout primary gill cell
system over 48 h under (A) bidirectional transport assays (BTA) and (B) concentration equilibrium transport assays (CETA) conditions. For BTA (A) the drug is applied at a
concentration of 1 g L−1 to either the apical (–––) for apical to basal transport; uptake, A:B or basal compartment (– – –) for basal to apical transport; efﬂux, B:A in either
symmetrical (L-15 medium in both compartments) or asymmetrical (freshwater in the apical compartment and L-15 medium in the basal) conditions. For this assay, data
are  shown as a percentage of the initial drug concentration in the donor chamber versus time. For CETA (B), the drug is added to both the apical and basal compartments
at  the same concentration (1 g L−1) in both symmetrical and asymmetrical conditions. Data are shown as a percentage of the initial concentration in either the apical or
basal  versus time. For both assays, signiﬁcant differences between the two  compartments are indicated by asterisk (one-way ANOVA; *P < 0.05; **P < 0.01; ***P < 0.001). All
experiments were performed in triplicate or more (n = 3–6) from at least one biological replicate and values are shown as means ± SEM.
for basal one (Fig. 6C). Application of the inhibitors MK571 and
quinidine again caused a signiﬁcant decrease in propranolol per-
meability over time by approximately 40% compared to the control
at 48 h for both apical and basal applications (P < 0.001) (Fig. 6D
and E).
3.8. Comparison to predicted and actual propranolol plasma
concentrations
Predicted plasma concentrations were calculated using
[plasma] = 0.87 [water] and actual plasma concentrations from
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Table  3
Propranolol concentration in silico (predicted), in vivo and in vitro (measured at various external propranolol concentrations).
Nominal propranolol concentration in water (g L−1) In silico (ng mL−1) (Huggett et al., 2004) In vivo (ng mL−1) (Owen et al., 2009) In vitro (ng mL−1)
0.1 0.087 n/a 0.04 (±0.002)
1.0 0.87 0.94* (n/a) 0.10 (±0.001)
10  8.7 3.3 (±0.4) 0.72 (±0.02)
100  87 16 (±7) 7.5 (±0.3)
1000 870 280 (±116) 79.5 (±7.3)
10,000 8700 5200 (±1333) 812 (±158)
100,000 87,000 n/a 5545 (±313)




























Fig. 4. The pH-dependent uptake of propranolol. Shown are the apparent perme-
ability coefﬁcients (Papp) for uptake (Papp A:B, white bars) and efﬂux (Papp B:A, gray
bars) of propranolol (1 g L−1) across the DSI gill cell epithelium at 6 h in asymmetri-
cal conditions at three different pHs. Signiﬁcant differences between uptake Papp or
efﬂux Papp are indicated by asterisk (one-way ANOVA; ***P < 0.001). All experiments
were performed in triplicate or more (n = 3–5) from two  biological replicates and
values are shown as means ± SEM.
Owen et al. (2009) (Table 3). A linear correlation between pre-
dicted plasma concentration and in vitro basal concentrations was
obtained and described by [in vitro] = 0.063 [predicted] (n = 21,
r2 = 0.995, Fig. 7). Furthermore, a correlation between actual
plasma concentrations (Owen et al., 2009) and in vitro basal
concentrations was obtained and described by [in vitro] = 0.155
[actual] (n = 21, r2 = 0.966, Fig. 7).
4. Discussion
The development of suitable in vitro cellular models to replace,
reﬁne and reduce (3Rs) the numbers of ﬁsh used in ecotoxicological
studies is an important requirement in current regulatory testing
(Scholz et al., 2013). Pharmaceuticals in the environment are con-
taminants of emerging concern and their behavior in water affects
uptake into biological systems (Boxall et al., 2012). Log Kow is often
used to determine the bioconcentration potential of a compound
which may  not be relevant to ionizable compounds such as pharma-
ceuticals (Hermens et al., 2013). The pH-corrected log Dow is used
to account for the fraction of ionizable and nonionisable species of a
substance at a given pH, but this accounts for partitioning between
two liquid phases and does not include partitioning across a biolog-
ical membrane. The present study is the ﬁrst to demonstrate how a
primary rainbow trout gill cell culture system can be used to assess
pharmaceutical uptake from water across a biological membrane.
Therefore, this offers a potential alternative to replace whole organ-
ism pharmaceutical uptake studies at differing water chemistries,
such as different pHs, the presence of dissolved organic matter or
real water samples from the ﬁeld.
Once a tight epithelium (>5 k cm2) has formed, the gills
present a barrier for paracellular transport that is relatively imper-
meable to the paracellular permeability marker 14C-mannitol
(Fig. 1). All pharmaceuticals (except atenolol) were transported
across the epithelium in both directions at a rate greater than that of
14C-mannitol, indicating that their transport is via a transcellular or
carrier-mediated process, as all exhibit molecular weights greater
than that of the marker (Hubatsch et al., 2007; Schwab et al., 2003).
The application of apical freshwater resulted in signiﬁcantly dif-
ferent drug permeations for propranolol and imipramine where
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Fig. 5. The concentration dependent uptake of propranolol (uptake; A:B) at 6 h after exposure to (A) 17 propranolol concentrations ranging from 0.014 to 10,000 g L−1 with
the  line representing the ﬁt of [rate] = 0.052 [concentration] (n = 54, r2 = 0.974) (note at lower concentrations that multiple data points are stacked) and (B) low propranolol
concentrations (0.014–0.14 g L−1) with the line representing the ﬁt of [rate] = 0.057 [concentration] (n = 24, r2 = 0.927). The values represent mean ± SEM from ﬁve biological
replicates.
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Fig. 6. The inhibition of the uptake of 1 g L−1 (4 nM)  propranolol from apical (freshwater) to basal (L-15 medium) using 400 nM of the six inhibitors amantadine (A); cimetidine
(B);  cyclosporine A (C); MK571 (D); quinidine (E) and verapamil (F), applied either apically, AP (–––) or basally, BL (– – –). Data are shown as percentage of the mean control, CTL
(·  · ·· · ·) over time. Signiﬁcant differences between the apically applied inhibitor and the control are indicated by asterisk (one-way ANOVA; *P < 0.05; **P < 0.01; ***P < 0.001).
Signiﬁcant differences between the basally applied inhibitor and the control are indicated by hash tag (#P < 0.05; ##P < 0.01; ###P < 0.001). All experiments were performed in
triplicate or more (n = 3–6 from at least one biological replicate for inhibitor studies; n = 18 from six biological replicates for the inhibitor free controls) and values are shown
as  means ± SEM.
from the basolateral compartment (Table 2; Figs. 2B and 3A). The
uptake of ionizable chemicals such as pharmaceuticals depends on
pH and the acid base constant (pKa) (Lahti et al., 2011). Both pro-
pranolol and imipramine are weak bases with pKa values around
9.5. Using the Henderson–Hasselbalch equation, 99% of propranolol
and imipramine exist in their protonated ionized form at pH 7.4 in
symmetrical conditions, which then falls to only 98% in freshwa-
ter at pH 8. Here, at pH 8, more of the natural unionized forms
are lipid-soluble, and thus may  cross the membrane via passive
transcellular routes explaining the enhanced uptake. However, the
1% change in speciation is unlikely to fully account for the differ-
ence in uptake observed (Fig. 2) and other factors are likely to
play a role. For example, in symmetrical conditions TEP is posi-
tive (1.9 ± 0.2 mV)  and becomes negative after apical freshwater
application (−10.3 ± 0.2 mV,  Fletcher et al., 2000; −12.9 ± 2.9 mV,
data not shown), to a value similar to that observed in vivo (Potts,
1984). The change in membrane potential to basolateral negative
generates an electrical gradient that aids cation partitioning across
the membrane (Fletcher et al., 2000). Alternatively, the TR values
greater than 1.5 in asymmetrical conditions for propranolol and
imipramine in BTA conditions (Table 2) indicate that a proportion
of the transport is via an carrier-mediated process (Schwab et al.,
2003). This observation was substantiated by the concentration
equilibrium transport assay (CETA) that eliminates concentration-
dependent passive transport across the gill epithelium allowing
the observation of carrier-mediated processes that drive xenobio-
tic transport. In CETA the difference in partitioning of radioactivity
between the two compartments is not due to disproportional loss of
compound adhering to the plastic ware of the apical and basolateral
compartments, since in cell free blank insert experiments an equal
percentage of the initial concentration added was absorbed to each
compartment and an 80% recovery was obtained after 48 h (data
not shown). Thus, it is possible to conclude that for propranolol
and imipramine, facilitated transport makes up approximately 10%
of the total transport, and around 5% for ranitidine efﬂux (Fig. 3B).
Uptake rates are important for predicting potential internal con-
centrations and are used to predict effects based on the “read
across” hypothesis and Mode of Action (Rand-Weaver et al., 2013).
Much of the in vivo uptake work used for these predictions expose
ﬁsh to very high water concentrations and extrapolates back to
these lower environmentally relevant values. Propranolol uptake
is concentration-dependent over the whole range of concentra-
tions but in the low, ng L−1 range, uptake deviates from linearity
(0.014–0.14 g L−1, Fig. 5). A similar result was obtained for the
uptake at very low concentrations of iron across zebraﬁsh gills and
was attributable to proton-dependent metal transporters (Bury and
Grosell, 2003). The facilitated transport of propranolol that occurs
in these environmentally relevant concentrations (Kostich et al.,
2014) is of interest because it suggests that the predictive mod-
els for uptake using data derived for higher concentrations may
underestimate uptake.
The uptake of propranolol is pH dependent up to pH 8, after
which further increases do not cause signiﬁcant effects (Fig. 4). This
again could be attributed to the difference in composition of ion-
ized and unionized species at different pHs, with a caveat that a
proportion of transport is likely via a facilitated process. However, it
should be noted that the pH of the apical bulk compartment, and the
microclimate at the boundary layer, were not measured after the
6 h duration of the experiment, and variations in such may  account
for changes in drug uptake. pH-dependent uptake of propranolol
has been observed in other epithelia including retina (Kubo et al.,
2013), Caco-2 cells (Wang et al., 2010) and kidney MDCK cells
(Dudley et al., 2000). In contrast, efﬂux of propranolol is far greater
at pH 6 than uptake (Fig. 4). This may  suggest the export of pro-
pranolol or its metabolite is pH-dependent. Candidates for drug
export are the ABC transporters; however these are not directly
regulated by pH changes (Altenberg et al., 1993; Neuhoff et al.,
2003). The internal pH of the cells is constant against external pH
changes and thus intracellular speciation of the drug is unlikely to
explain potential increase in efﬂux. It is likely that there are other
propranolol parent and/or metabolite exporters present on the
gill.
Propranolol uptake from water was inhibited by cimetidine,
cyclosporine A, MK571 and quinidine. These are inhibitors of a
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Fig. 7. Propranolol concentrations in the basal compartment of the primary gill cell model after 6 h apical exposure to propranolol in asymmetrical conditions plotted against
(A)  predicted (see text) Oncorhynchus mykiss propranolol plasma concentrations (0.1–100,000 g L−1) with regression line representing the ﬁt of [in vitro] = 0.063 [predicted]
(n  = 21, r2 = 0.995) or (B) actual in vivo plasma concentrations (1–10,000 g L−1) after 40 days exposure (Owen et al., 2009) with the regression line representing the ﬁt of [in
vitro]  = 0.155 [actual] (n = 21, r2 = 0.966) (Table 3). Basal in vitro concentrations were performed in triplicate or more (n = 3–5) and represent mean ± SEM from three biological
replicates.
number solute carrier and ABC transporters. A number of human
SLCs implicated in drug transport (SLC15s, SLCOs, SLC22s and
SLC47s [Dobson and Kell, 2008; Giacomini et al., 2010]) are homol-
ogous to SLCs found in teleost ﬁsh (Verri et al., 2012). Similarly,
ATP-binding cassette (ABC) transporters involved in the cellular
efﬂux of toxicants such as ABCBs, ABCCs and ABCG2 (Deeley et al.,
2006) are considered highly conserved amongst vertebrates (Dean
and Annilo, 2005) and have been documented in rainbow trout
cells both in vivo and in vitro (Fischer et al., 2011; Loncˇar et al.,
2010) but not fully characterized. Recent microarray studies using
the primary gill cell culture system have indentiﬁed the presence
of transcripts for genes encoding a number of SLCs, ABCs as well
as biotransformation enzymes (Schnell, Bury, Kille and Hogstrand,
unpublished data). But, the identiﬁcation of active proteins requires
further work.
The application of cimetidine and quinidine, which both interact
with organic cation transporter OCT2 (SLC22A2) (Giacomini et al.,
2010; Koepsell, 2013) signiﬁcantly reduce propranolol uptake. Pro-
pranolol transport via OCT2 was observed in renal LLC-PK1 cells
transiently transfected with hOCT2-V5, more speciﬁcally in the
active uptake of its cationic form across the apical membrane
(Dudley et al., 2000). Cimetidine is also used as a blocker of cisplatin
transport by OCT2 in zebraﬁsh lateral line hair cells (Thomas et al.,
2013) and the presence of OCT2-like proteins have been suggested
in other teleost ﬁsh gill epithelia (Verri et al., 2012). MK571 is an
inhibitor of the multidrug resistance protein (MRP) efﬂux pumps
(Deeley et al., 2006) and signiﬁcantly inhibited propranolol uptake.
The main MRP  expressed in the gill is MRP3 (ABCC3) (Loncˇar et al.,
2010). P-glycoprotein (Pgp; ABCB1) is implicated in propranolol
transport in rabbit conjunctivial epithelial cells (Yang et al., 2000)
and Caco-2 cells (Wang et al., 2010) and is present in rainbow trout
tissues but at low levels in the gill (Loncˇar et al., 2010). Whether
Pgp is involved in propranolol transport in the gill cell culture sys-
tem is unclear. In addition to inhibiting OCT2, quinidine also acts as
Pgp inhibitor (Giacomini et al., 2010) and cyclosporine A, another
Pgp inhibitor, also blocked propranolol transport but this may  be
via MRP  inhibition instead. Application of the Pgp inhibitor vera-
pamil, however, did not affect propranolol transport (Fig. 6F). Taken
together these observations would suggest that OCT2 and MRP3
may  be candidates for propranolol transport across the teleost gill
epithelium, but the location (apical or basolateral membrane) of
these transporters, and others, needs further assessment.
Owen et al. (2009) showed that predicted plasma concentra-
tions (Fitzsimmons et al., 2001) were good indicators of propranolol
uptake over a range of high concentrations. Our data also correlates
well with predicted (Fig. 7A) and measured plasma concentrations
(Fig. 7B). However, in vitro propranolol concentrations in the baso-
lateral compartment were an average 6% of the predicted and 16% of
actual plasma concentrations, whilst actual plasma concentrations
were only 59% of predicted (Owen et al., 2009). In vivo bioconcen-
tration studies can involve an uptake phase of 60 days until a steady
state is reached (OECD305; OECD, 2012). Owen et al. (2009) used a
40-day exposure period, and both procedures use a ﬂow through
system with a steady-state endpoint. Our in vitro assay took place
over 6 h in a static system, which could account for reduced propra-
nolol uptake. Furthermore, actual plasma concentrations may  be
lower than predicted as a proportion of the drug may  bind to pro-
teins or be metabolized by the gill (as suggested by Bartram et al.,
2011), which prediction models fail to take into account. Neverthe-
less, the relationships between this in vitro system to predicted and
actual propranolol plasma concentrations suggest its applicability
as a suitable in vitro model to investigate the uptake of xenobi-
otics and when combined with elimination rates, may supplement
in vivo bioconcentration ﬁsh studies. These model pharmaceuticals
used do not bioaccumulate; however, they may  be taken into a
ﬁsh, and or excreted. This functional primary gill model facilitates
our better understanding of these processes. Currently legislation
requires assessment for compounds of log Kow higher than 3. This
is an arbitrary value and we suspect that this value may  be con-
servative with little prospect of signiﬁcant bioaccumulation for
compounds lower than log Kow 4. This model provides a rapid
and ethically acceptable tool with which to perform a preliminary
assessment of compounds of low log Kow, and as such ideal for large
numbers of pharmaceuticals that typically have a lower propensity
to bioaccumulate.
The study shows that as well as the passive uptake and efﬂux
of neutral forms of pharmaceuticals, water enhances drug uptake
of ionizable pharmaceuticals via both passive transcellular and car-
rier mediated processes. Hence, the ability of this system to tolerate
freshwater is fundamental if we are to simulate in vivo drug uptake
across the gill. In addition, the facilitated uptake of propranolol
was more evident at low concentrations that are more environ-
mentally relevant; suggesting that in certain situations uptake may
be under predicted. Indeed there is signiﬁcant variation (ﬁve-fold)
recorded in plasma concentrations of individual ﬁsh exposed to
pharmaceuticals in vivo (Owen et al., 2009), and it could be that
individual difference in transporter expression may be a mechanis-
tic explanation for this variance. The use of this system provides an
opportunity to reduce the numbers of ﬁsh used in regulatory eco-
toxicological testing as the primary gill cells cultured from two  ﬁsh
136 L.C. Stott et al. / Aquatic Toxicology 159 (2015) 127–137
may  provide up to 72 individual gill cell cultures, and this method
bypasses in vivo drug exposures and uses much less test compound,
thus offering reﬁnement through improved animal welfare meth-
ods.
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IntroDuctIon
The freshwater fish gill is a multifunctional organ, and it is the 
site of gas exchange, osmoregulation, trace metal transport, 
nitrogenous waste excretion and xenobiotic uptake1–4. Fish are 
commonly used as indicator species to identify environmental 
hazards and, as their gills are constantly in contact with water, 
the gill epithelium is a focal point for countless studies that seek 
to understand deleterious effects of environmental toxicants2. 
Whole-animal studies can use millions of fish worldwide each 
year, and efforts are focusing on refining, reducing and replacing 
(3Rs) these numbers5. Alternative animal-free methods used in 
fish toxicology include the use of immortalized cell lines, as well 
as primary cultures of cells from fish organs. In the present article, 
we describe a protocol for the primary culture of a freshwater 
rainbow trout gill epithelium on a flat permeable membrane, via 
a repeated gill cell seeding protocol. This double-seeded insert 
(DSI) technique produces a heterogeneous epithelium similar to 
that found in vivo, and it was first described in Fletcher et al.6. 
We have used the DSI for studies investigating gill physiology and 
environmental monitoring7–20.
Development of the DSI technique
Primary culture of a rainbow trout gill epithelium was pioneered 
by Pärt et al.21. Wood and Pärt22 subsequently developed the 
single-seeded insert (SSI technique), in which isolated gill cells were 
cultured on permeable membrane inserts for the first time. This 
provided a two-chamber system that allowed the cells to grow into 
a polarized epithelium with an apical (water-facing) and basolateral 
(blood- or medium-facing) surface. The preparation exhibited bar-
rier properties that were similar to those of the gill epithelium, and 
it tolerated apical water exposure for limited time periods. However, 
the epithelium comprised only a cell population of pavement cells 
(PVCs), which are the respiratory cells of the gill epithelium.
This technique was further developed into the DSI technique6 
whereby primary cells are seeded on inserts over 2 d, producing a gill 
epithelium of multiple cell layers and types that includes PVCs and 
mitochondrion-rich cells (MRCs); the latter is associated with the 
transport of a number of ions and compounds across the fish gill1. 
The DSI procedure produces tight epithelia with transepithe-
lial resistance (TER) values of up to 34,000 Ω cm2, which are 
much higher than that of SSI (typically 1,000–5,000 Ω cm2)23. 
The preparation expresses tight junction (TJ) proteins such as 
occludin, claudins, zonula occludens7,8,24 and tricellulin9. The 
preparation also exhibits ion movement between the apical and 
basolateral compartments10–12. Active Ca2+ transport in the cell 
culture system resembles that of the intact fish10,12, although so 
far it has not been possible to produce the net uptake of Na+ and 
Cl− ions present in freshwater fish in cell culture.
Applications of the protocol
Primary cultured gill epithelia have been used to assess how 
hormones and environmental conditions influence TJ protein 
expression and regulate epithelial permeability7,8. Further 
applications of the gill cell culture technique include studies on 
cytochrome P450 activity14, lipid metabolism15, ammonia trans-
port16, cytotoxicity25 and metal-binding characteristics17. A recent 
study also used the DSI preparation to analyze the transport 
of pharmaceuticals across the gill, and found that, for some, 
facilitated transport processes may have a role at environmentally 
relevant concentrations18. It has also been used as an environ-
mental water monitoring tool of urban streams13 and in metal- 
polluted rivers19. However, these monitoring studies are restricted 
to a limited time frame, because the cultures can only withstand 
water exposure of up to 48 h. Thus, there is scope for future devel-
opment of the cell culture technique to improve both active ion 
transport characteristics and extended water tolerance.
Generation of reliable in vitro cell assay results as an alternative 
to whole-animal tests for hydrophobic and volatile compounds has 
been proven to be difficult. This is because these compounds adhere 
to the plastic and/or are volatized, which results in exposure con-
centrations in the small volumes used in in vitro assays that deviate 
substantially from the nominal concentrations. In addition, these 
hydrophobic compounds do not readily dissolve in medium, and to 
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this protocol describes how to reconstruct and culture the freshwater rainbow trout gill epithelium on flat permeable membrane 
supports within cell culture inserts. the protocol describes gill cell isolation, cultured gill epithelium formation, maintenance, 
monitoring and preparation for use in experimental procedures. to produce a heterogeneous gill epithelium, as seen in vivo, 
seeding of isolated gill cells twice over a 2-d period is required. as a consequence, this is termed the double-seeded insert 
technique. approximately 5–12 d after cell isolation and seeding, preparations develop electrically tight gill epithelia that can 
withstand freshwater on the apical cell surface. the system can be used to study freshwater gill physiology, and it is a humane 
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increase solubility they are administered with co-solvents that may 
also exert a cellular response in the assay system. Kramer et al.26 
described a solvent-free dosing system for hydrophobic compounds 
in which the immortalized rainbow trout gill cell line RTgill-W1 was 
grown on the underside of the membrane of an insert. This allows 
a polydimethylsiloxane membrane preloaded with test compound 
to be placed on the bottom of the wells in close proximity to but 
not touching the cells, which in turn allows for a constant dos-
ing concentration26. This technique is termed the double-seeded 
inverted insert (DSII) technique, and it can therefore be used in 
the development of a partition-controlled dosing system for hydro-
phobic compounds. We describe a modification to the method used 
by Kramer et al.26 in which primary gill cells are cultured on an 
inverted insert. Characterization of the resulting primary gill epithe-
lium growing in the DSII configuration is shown in Supplementary 
Figure 1 and was carried out as described in the Supplementary 
Methods. The advantage of the DSII system is that the cultured 
epithelia resembles that of the intact gill (Supplementary Fig. 1), 
and it can be used in a similar way to the RTgill-W1 cell line when 
grown on inverted inserts for solvent-free dosing of hydrophobic 
compounds. However, given that we have only obtained preliminary 
data to date using the primary cultured epithelium in the DSII con-
figuration, this method may require further optimization to ensure 
that it is optimally set up as required for specific experiments.
Comparison with other techniques
Bols et al.27 described the isolation of the RTgill-W1 rainbow 
trout gill cell line. The main difference between using the cell line 
and the primary gill cell culture is that when using the primary 
gill cell culture, both the DSI and DSII contain the different cell 
types present in the in vivo gill. The epithelium is polarized and 
electrically tight, with TER values of >20 kΩ cm2 compared with 
TER values in the range of ~200 Ω cm2 when RTgill W1 cells 
are used. Importantly, the DSI and DSII tolerate the application 
of freshwater on the apical surface, which means that these 
primary cell cultures are better suited for gill physiology and 
functional studies than the cell line. However, the RTgill-W1 cell 
line viability28 and cell growth29 have been shown to correlate, in 
most cases, to both whole fish mortality and growth on exposure 
to pollutants. Thus, the RTgill-W1 cell line shows promise as a 
replacement for fish in toxicity testing.
In a number of countries, fish are used in whole effluent 
toxicity testing as part of environmental monitoring programs. 
The DSI can be used to assist in environmental monitoring 
because in addition to tolerating the application of freshwater in 
the laboratory, the DSI also tolerates the application of river water, 
as shown in two studies13,19. In one of these studies19, we used 
the knowledge that the DSI responds to metals (assessed via the 
a
b
Figure 1 | Diagram of the primary cultured rainbow trout epithelium.  
(a,b) Reconstructed as DSI (a) or DSII (b) preparations. The epithelium 
attaches to the permeable membrane supports and polarizes so as to have 
an apical and basolateral cell surface (right). Epithelia are bathed on both 
sides with cell culture medium supplemented with FBS and antibiotics 
during development (left). For experimental purposes, freshwater can 
replace cell culture medium on the apical surface, whereas the basolateral 
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Figure 2 | Summarized flow diagram of rainbow trout gill cell isolation and 
seeding procedures. The reagents are prepared (see Reagent Setup) before 
excision of the gills; the filaments are teased apart and washed in PBS 
(PROCEDURE Steps 1–10). The filaments are centrifuged and washed before 
being treated with a trypsin solution to isolate cells (PROCEDURE Steps 11–16).  
The isolated cells are passed through a 100-µm strainer into a stop solution 
(see Reagent Setup; PROCEDURE Steps 17–21). The cell suspension is 
centrifuged and resuspended in cell culture medium containing FBS and 
antibiotics, and the cell density is determined (PROCEDURE Steps 18–25). 
The cells are seeded onto inserts for the double-seeded insert protocol 
(PROCEDURE Step 26A(i)) or onto inverted inserts for the double-seeded 
inverted insert protocol (PROCEDURE Step 26B(i)); this is termed day 0.  
The gill cell isolation procedure is repeated on day 1, and the inserts from 
the first seeding are washed with PBS before a second seed is placed on top 
(PROCEDURE Step 26A(ii–viii), 26B(ii–vii)). On day 2, the cells are washed  
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measurement of an increase in expression of the metal-responsive 
gene encoding metallothionein), mimics the physiological effect 
of metals on whole organisms in the laboratory20 and conducted a 
trial whereby the DSI were exposed to natural metal contaminated 
water in the field19. The field trial study indicated that the DSI 
responded to metals in this complex matrix (river water), thereby 
showing that it is able to detect bioreactive metals. However, fur-
ther experiments are required to assess the response of the DSI 
to other contaminants in more complex contaminant mixtures13 
and to determine its versatility for environmental monitoring.
Experimental design
The gill cells from two (~80 g) fish provide ~40 individual culture 
inserts, but this can increase to 72 depending on the success of the 
cell isolation, and thus this technique has the potential to reduce 
the number of organisms used in experiments. Therefore, at a 
practical level, in order to allow the comparison of toxicologi-
cal data from different aquatic ecotoxicology and physiological 
studies, a standardized procedure for DSI and DSII production is 
required. Here we present the most current and readily available 
standardized DSI technique (Fig. 1a), as well as the development 
of a DSII (Fig. 1b) technique. The protocols for the DSI and DSII 
techniques are summarized in a flow diagram (Fig. 2), and typi-
cal characteristics of the cultured epithelia are described in the 
ANTICIPATED RESULTS section. The controls for an experiment 
using DSI and DSII will depend on their intended use. For a typi-
cal experiment in which the cells are to be exposed to a compound 
in water13,18–20, a set of control inserts that are exposed to either 
medium or water without the test compound should be set up. 
By comparing results, such as expression of a gene of interest, 
between the test and controls, it is possible to determine whether 
the response is due to the effect of exposure to water, or to water 
and the test compound. To perform experiments that provide 
statistical rigor, it is recommended that the experiment include 




Juvenile rainbow trout (<100 g) should be acclimatized for at least  
2 weeks and maintained according to relevant governmental and  
institutional guidelines at 13–14 °C in good-quality water with constant  
14-h light and 10-h dark photoperiods  crItIcal The fish must be  
kept in optimum conditions. The water must be well aerated and  
of good quality, and fish should eat well and not show signs of stress.  
! cautIon Experiments must conform to relevant institutional and  
governmental regulations.
Leibovitz’s L-15 medium, no phenol red, with l-glutamine (Invitrogen,  
cat. no. 21083-027)  crItIcal We recommend using Leibovitz’s L-15 
medium without phenol red, because there has been reports that phenol  
red may contain estrogenic activity that may influence physiological  
or toxicological responses30.
FBS (Sigma-Aldrich, cat. no. F7524)
Penicillin-streptomycin (5,000 units ml−1 penicillin and 5 mg ml−1  
streptomycin; Invitrogen, cat. no. 15070063)
Gentamicin solution (10 mg ml−1; Invitrogen, cat. no. 15710049)
Fungizone (100 mg; Sigma-Aldrich, cat. no. A9528)
Trypsin-EDTA, 0.5% (wt/vol), ×10 (Invitrogen, cat. no. 15400054)
PBS (used as prewash solution)
Ethanol (VWR International, cat. no. 20821.321)
Calcium chloride dihydrate (Sigma-Aldrich, cat. no. 223506)
Magnesium sulfate heptahydrate (Sigma-Aldrich, cat. no. 230391)
Sodium bicarbonate (Sigma-Aldrich, cat. no. S6014)
Potassium chloride (Sigma-Aldrich, cat. no. P9333)
EQUIPMENT
Laminar flow hood, model no. M51424/2 (Microflow biological  
safety cabinet)
Centrifuge, refrigerated, 5810R, rotor A-4-62 (Eppendorf)
Vortex, F20220176 (VELP Scientifica)
Dissecting equipment; large sharp knife, forceps (SLS, cat. no. INS4291;  
00:SA), scissors (VWR International, cat. no. INS4808; INS4854) and  
scalpels (Swann-Morton, cat. no. 0501)  crItIcal All equipment must  
be autoclaved or sterilized using 70% (vol/vol) ethanol.
Portable gyratory shaker, model IKA-VIBRAX-VXR
Adjustable pipettes: P-20 (Gilson, cat. no. FA10003M), P-200 (Gilson,  
cat. no. FA10005M) and P-1000 (Gilson, cat. no. F123602)
Pipette tips: 20 µl (Starlab, cat. no. S1120-1810), 200 µl (Starlab,  
cat. no. S1120-8810) and 1,000 µl (Starlab, cat. no. S1122-1830)
Tissue culture pipettes: 5 ml (Corning, cat. no. CORN4051), 10 ml  
(Corning, cat. no. CORN4101) and 25 ml (Corning, cat. no. CORN4250)
Inverted phase-contrast microscope, TE200, Nikon Eclipse



























EVOM epithelial voltohmmeter modified by the manufacturer to read  
TER up to 100,000 Ω cm−2 (World Precision Instruments)
EVOM ‘chopstick’ electrodes, no. STX-2 (World Precision Instruments)
Inserts, 12-well, 0.4 µm, 0.9 cm2 effective growth area, polyethylene  
terephthalate (PET) membrane (BD Falcon, cat. no. 353180)
Companion cell culture plates, 12-well with low evaporation lid, notched 
(BD Falcon, cat. no. 353503)
Sterile tip box with damp cotton wool and glass slides inside
Sterile syringe filter, 0.2 µm (VWR International, cat. no. 194-2520)
Cell strainers, 100 µm, Nylon (BD Falcon, cat. no. 352360)
Falcon 50-ml conical tubes (BD Falcon, cat. no. 352070)
Sterile Petri dishes (VWR International, cat. no. 25382-166)
REAGENT SETUP
PBS PBS is 137 mM sodium chloride (Sigma-Aldrich, cat. no. 746398), 2.7 mM 
potassium chloride (Sigma-Aldrich, cat. no. P9333), 10 mM disodium hydro-
gen phosphate (Sigma-Aldrich, cat. no. 255793) and 1.8 mM potassium dihy-
drogen phosphate (Sigma-Aldrich, cat. no. P0662). It is prepared in dH2O and 
autoclaved. This can be stored for 1 month at room temperature (~20 °C).   
Before use, place it on ice.
Ethanol, 70% Prepare a 70% (vol/vol) solution of ethanol in dH2O.
Fungizone Prepare a 10 mg ml−1 solution and store it in 1-ml aliquots at 
−20 °C until further use.
Wash solution Add 1.2 ml of penicillin-streptomycin, 1.2 ml of gentamicin 
and 90 µl of Fungizone solution to a final volume of 30 ml of PBS. Prepare 
the solution at room temperature in sterile conditions in a tissue culture 
hood on the day of cell isolation. Before use, place it on ice.
Trypsin solution Dilute 0.5% (wt/vol) trypsin-EDTA to 0.05% by pipetting 
650 µl into a conical centrifuge tube and by bringing the volume up to 6.5 ml 
with PBS. Prepare the solution at room temperature in sterile conditions in a 
tissue culture hood on the day of cell isolation. 
Stop solution Pipette 2 ml of FBS into a conical centrifuge tube with 18 ml 
of PBS. Prepare it at room temperature in sterile conditions in a tissue culture 
hood on the day of cell isolation. Before use, place it on ice.
Rinse solution Add 0.5 ml of FBS in a tube, and make up the final volume to 19.5 ml  
with PBS. Prepare this solution at room temperature in sterile conditions in a 
tissue culture hood on the day of cell isolation. Before use, place it on ice.
Cell culture medium with antibiotics and FBS (medium A) Pipette 27 ml 
of FBS, 11 ml of penicillin-streptomycin and 11 ml of gentamicin, all sterile 
filtered, to 500 ml of L-15 medium. This can be made in advance and stored 
at 4 °C for up to 1 month.
Cell culture medium with FBS (medium B) Pipette 27 ml of FBS, sterile 
filtered, to 500 ml of L-15 medium. This can be made in advance and stored 
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Exposure cell culture medium L-15 without any supplementation can be 
stored at 4 °C for up to 1 month.
Artificial freshwater Freshwater is defined as water prepared to the  
standard used for maintaining fish, such as that recommended by the  
Organisation for Economic Co-operation and Development (OECD) and the 
International Organization for Standardization (ISO). To make up OECD 
freshwater, prepare the following four solutions (40× stocks). Solution 1:  
dissolve 11.76 g of CaCl2.2H2O in dH2O, and adjust the volume to 1 liter 
with dH2O (0.08 M). Solution 2: dissolve 4.93 g of MgSO4.7H2O in dH2O, 
and adjust the volume to 1 liter with dH2O (0.02 M). Solution 3: dissolve  
2.59 g of NaHCO3 in dH2O, and adjust the volume to 1 liter with dH2O  
(0.03 M). Solution 4: dissolve 0.23 g of KCl in dH2O, and adjust the volume 
to 1 liter (0.003 M). Once all the solutions are prepared, mix 25 ml of  
each solution, and the total volume is made up to 1 liter with dH2O.  
Aerate the dilution water until oxygen saturation is achieved, and then  
store it for about 2 d with further aeration before use23.
Natural freshwater Filter natural freshwater samples using a 0.2-µm sterile 
syringe filter before exposure to the cell culture.
proceDure
preparation of solutions and culture inserts ● tIMInG 1 h, plus 1.5 h of incubation to condition the membrane
 crItIcal The recommended volumes in this section are appropriate for one cell isolation procedure.
1| Prepare the two types of cell culture media with antibiotics (medium A) and without antibiotics (medium B;  
see Reagent Setup). Take a 50-ml aliquot of each and keep them on ice.
2| Prepare the prewash solution (18 ml), wash solution, trypsin solution, stop solution and rinse solution, and keep them on ice.
3| In the cell culture hood, remove the permeable membrane inserts and companion cell culture plates from their  
packaging. For the DSI technique, place inserts in the wells of cell culture plates and place the lid on top. For DSII,  
turn the inserts upside down in a humidified chamber. To generate the humidified chamber, we use a sterile pipette tip box 
with damp sterile cotton wool.
 crItIcal step For DSI, the flanges of the inserts rest between the notches of the well to minimize medium wicking  
and to assure the proper fitting of the plate with the lid.
 crItIcal step For DSII, microscope slides can be placed on top of the cotton wool in the tip box to create a stable and flat 
surface on which to place the upside-down inserts. This prevents the medium from spilling over the edge of the inverted insert.
4| Condition permeable membrane inserts by applying cell culture medium with FBS and antibiotics (A) to the surface of 
the insert on which the cells will be seeded. For DSI preparations, add 200 µl of cell culture medium with FBS and antibiotics 
(A) in the upper compartment. For DSII, add 200 µl of cell culture medium with FBS and antibiotics (A) onto the top of the 
upside-down insert. Close the systems and keep them at 18 °C in a cell culture incubator for at least 1.5 h.
rainbow trout dissection and gill cell isolation ● tIMInG 3 h
5| Euthanize one rainbow trout.
! cautIon Euthanize rainbow trout according to national and institutional guidelines. We follow UK Home Office Schedule 1 
procedures in which the fish is euthanized via the destruction of the brain, which is achieved by a blow to the cranium and 
the use of a sharp probe.
6| Remove the head behind the operculum with a sharp knife.
 crItIcal step It is important to perform this procedure quickly so as to reduce the extent of gill hemorrhaging and to 
avoid excessive bleeding and clotting on the filaments, which will reduce the quality of the gill cells obtained.
7| With dissecting scissors and forceps, remove the operculum (Fig. 3a) and excise out the intact gill arches by cutting the 
dorsal and ventral cartilage of each gill arch. Place the gill arches into 10 ml of prewash solution in a Petri dish (Fig. 3b).
 crItIcal step Avoid damage to the filaments by holding the cartilage of the arch and not the filaments.
8| Remove mucus by carefully blotting each gill arch onto tissue paper, and then cut the filaments from the arches and 
place the filaments into 10 ml of wash solution (prepared in Reagent Setup) in a Petri dish.
 crItIcal step Do not cut the filaments too close to the cartilage of the gill arch, as this will contaminate the cell  
culture with fibroblasts.
9| Tease the filaments apart using forceps, and cut them with a scalpel. This should result in filaments separated in  
bundles of 1–5. This increases the surface areas, which facilitates the action of the trypsin solution later.
10| Pour away this wash solution, and add the filaments to a 10-ml aliquot of wash solution in a 50-ml conical centrifuge 
tube, and place the tube on ice. Incubate the tube for 10 min.
 crItIcal step From this step onward, sterile culture technique must be used, and the procedures should therefore take 
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11| Centrifuge the tube for 4 min at 250g at 4 °C to collect 
the filaments. Aspirate and discard the supernatant.
12| Add the last remaining 10 ml of wash solution and 
moderately mix to dislodge the filaments. Incubate the tube 
on ice for a further 10 min.
13| Centrifuge again for 4 min at 250g at 4 °C, and then 
aspirate and discard the supernatant.
14| Add 500 µl of trypsin solution to the pelleted  
filaments, and agitate to remove any remaining wash  
solution. Centrifuge the tube for 4 min at 250g at 4 °C,  
and then aspirate and discard the supernatant.
15| Add 3 ml of trypsin solution to begin tryptic digestion, and shake for 12 min at 200 r.p.m. at room temperature.
16| To mechanically agitate the cut gill filaments and to improve cell yield, pass the filaments in trypsin solution repeatedly 
through a wide-bore pipette tip immediately after the 12-min trypsinization period. A wide-bore pipette tip can be prepared 
by removing the tip of a 1,000-µl pipette tip, so that the bore of the pipette aperture is ~2 mm. Sterilize by storing the cut 
pipette tip in 70% (vol/vol) ethanol. Before use, blot the wide-bore tip on tissue to remove residual ethanol, and pass the 
filaments/trypsin solution up and down at least 50 times.
17| Place the 100-µm cell strainer onto the 50-ml conical centrifuge tube containing 20 ml of stop solution (prepared in 
Reagent Setup) on ice. Pipette the filament/trypsin solution into the strainer, and agitate it to facilitate the collection of 
gill cells as a single-cell suspension in stop solution.
 crItIcal step After collection of cells, gently invert the conical centrifuge tube to mix the gill cells with the stop solution.
18| Remove the filaments from the strainer and replace them back into their original conical centrifuge tube. Repeat tryptic  
digestion by adding the remaining 3 ml of trypsin solution and by shaking for a further 12 min at 200 r.p.m. at room temperature.
19| Place a new 100-µm cell strainer onto the same 50-ml conical centrifuge tube containing the stop solution and the 
previously trypsinized cells, and repeat the gill cell isolation as in Step 13.
20| Centrifuge the cell suspension for 10 min at 250g at 4 °C. A red pellet should be obtained (Fig. 3c). Aspirate and  
discard the supernatant.
? trouBlesHootInG
21| Resuspend the red pellet in 2 ml of rinse solution (prepared in Reagent Setup), and then add the remaining 18 ml;  
agitate the mixture briefly and centrifuge it for 10 min at 250g at 4 °C. This should result in another red-colored pellet  
(Fig. 3d). Aspirate and discard the supernatant.
22| Resuspend the red pellet initially in 2 ml of cell culture medium with FBS and antibiotics (medium A), and flick the  
tube to dislodge the pellet many times; next, resuspend in 8 ml (for a total of 10 ml) and mix it well.
23| Add 10 µl of cell suspension to 90 µl of trypan blue solution in a 0.5-ml bullet centrifuge tube, and mix thoroughly using a vortex.
24| Count the viable cells using a hemocytometer on the basis of the trypan blue exclusion criterion.
 crItIcal step Exclude blood cells from the cell count. These appear as ellipsoidal cells, which are smaller than the gill cells.
a b
c d
Figure 3 | Dissection of the gills and isolation of the cells. (a) Four gill 
arches are located underneath each operculum on the lateral sides of the 
rainbow trout head. Scale bar, 0.5 cm. (b) Gill arches are excised by cutting 
the cartilage of the arch, and these are placed into 20 ml of prewash 
solution (PBS). Scale bar, 1 cm. (c,d) The gill cell pellet is obtained after 
centrifugation in Step 21 (c) and Step 22 (d). Trapped red blood cells give 
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25| Determine the concentration of cells and adjust cell counts of cell suspension from Step 21 to required seeding density 
detailed in the following steps.
? trouBlesHootInG
 pause poInt Cells can be left up to 2 h on ice.
cell seeding
26| Follow option A to seed the cells for a DSI experiment, and follow option B to seed cells for a DSII experiment.
(a) DsI cell seeding ● tIMInG 30 min
 (i)  Aspirate the medium conditioning the cell culture inserts (from Step 4) before cell seeding. Seed 1.2 × 106 cells  
in 800 µl of cell culture medium with FBS and antibiotics (medium A) per insert. In addition, set up three blank  
inserts (no cells) for TER measurements. Place 1 ml of cell culture medium with FBS and antibiotics (medium A)  
into the basolateral compartment. This is termed ‘day 0’. 
 crItIcal step It is recommended that when establishing the protocol an insert seeding density gradient be  
performed to determine the optimum seeding density for producing inserts with consistently tight epithelia10.
 (ii) Incubate the cells at 18 °C overnight.
 (iii) After the overnight incubation, begin a new gill cell preparation using another fish, by repeating Steps 5–25.
 (iv)  To prepare the previously seeded inserts (‘day 0’) for double-seeding (from Step 26A(i)), aspirate the medium first  
from the lower compartment and then carefully from the upper compartment. Wash the surface of the inserts by  
slowly applying 200 µl of PBS down the side of the insert (not directly onto the attached cells to avoid disruption), 
and tap the edge of the insert gently at this wash stage to dislodge dead cells and mucus. 
 crItIcal step When you are removing or changing the medium, always aspirate the lower compartment first,  
and then the upper one. This maintains the hydrostatic pressure onto the cells and it prevents them from lifting off.
 (v)  Repeat the wash as described in Step 26A(iv), with 200 µl of PBS. 
? trouBlesHootInG
 (vi)  Carefully apply the new gill cell preparation (obtained in Step 26A(iii)) directly on top of the previously seeded  
cells. Seed 1.2 × 106 cells in 800 µl of cell culture medium with FBS and antibiotics (medium A), and add 1 ml in  
the lower compartment afterward. Also apply medium to your blank insert controls. This is termed ‘day 1’. Incubate the 
cells at 18 °C.
 (vii)  After 24 h, wash the inserts again, as described in Step 26A(iv,v).
 (viii)  Add maintenance volumes of culture medium; 1.5-ml cell culture medium with FBS and antibiotics (medium A) in the 
upper compartment and then 2.0 ml in the lower compartment. This is termed ‘day 2’. Incubate the cells at 18 °C.
(B) DsII cell seeding ● tIMInG 30 min
 (i)  Aspirate the conditioning medium from the inverted cell culture inserts (from Step 4) before seeding. Seed 1.2 × 106 
cells in 200 µl of cell culture medium with FBS and antibiotics (medium A) per inverted insert, and leave them at 18 °C  
in the sterile tip box. Also set up three blank inserts (no cells) for blank TER measurements. This is termed day 0. 
 crItIcal step It is recommended that when establishing the protocol an insert seeding density gradient be  
performed to determine the optimum seeding density to produce inserts with consistently tight epithelia10.
 (ii)  Incubate the cells at 18 °C overnight.
 (iii)  After the overnight incubation and 24 h after Step 26B(i), begin a new gill cell preparation using another fish,  
by repeating Steps 5–25.
 (iv)  To prepare the previously seeded inserts (‘day 0’) for double-seeding, wash the inverted inserts by aspirating the  
medium and by carefully and slowly applying 200 µl of PBS.
 (v)  Repeat another 200-µl PBS wash. 
? trouBlesHootInG
 (vi)  Carefully apply the new gill cell preparation (obtained in Step 26B(iii)) directly on top of the previously seeded cells. 
Seed 1.2 × 106 cells in 200 µl of cell culture medium with FBS and antibiotics (medium A), and leave them in the 
sterile pipette tip box overnight at 18 °C. This is termed ‘day 1’.
 (vii)  Twenty-four hours later, wash the inserts again, as described in Step 26B(iv,v). The inserts can now be placed the  
right way up in companion wells. Replace it with maintenance volumes of culture medium: 1.5 ml of cell culture 
medium with FBS and antibiotics (medium A) in the upper compartment and then 2.0 ml in the lower compartment. 
Incubate the inserts at 18 °C. This is termed ‘day 2’.
Maintenance ● tIMInG 5–12 d
27| Incubate the inserts until day 4. On day 4, remove the medium and replace it with cell culture medium with FBS  
(medium B) without antibiotics. Continue to incubate cells at 18 °C, replacing the medium every 48 h. Monitor appropriate 
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check for (bacterial) contamination. Any contaminated cell 
culture inserts should be immediately removed, and the 
associated plate well should be rinsed with 70% (vol/vol) 
ethanol. From day 4 onward, TER can be monitored daily  
if desired, as described in the following section.
 crItIcal step Careful and thorough observation of  
culture preparations should take place before measuring TER 
(see following section) or changing the medium. Therefore, 
if one insert is found to be contaminated, it can be removed 
without cross-contaminating other epithelia.
Monitoring ter ● tIMInG 10 min
 crItIcal From day 4 onward, a daily measurement of TER can be made using a custom-modified (see Equipment)  
epithelial tissue voltohmmeter fitted with chopstick electrodes, as described in this section.
28| Sterilize the electrodes in 70% (vol/vol) ethanol and rinse them in PBS.
29| Confirm that the cells are not contaminated. If the cells are showing no signs of contamination, insert the electrode 
over the gill cell epithelium of each insert, such that the shorter arm of the electrode is in the upper compartment and the 
longer is in the lower compartment (Fig. 5a), and measure TER.
30| Calculate the net TER by subtracting the average TER of the blank insert (no cells; Step 26A(i) for DSI and Step 26B(i) 
for DSII) from the experimental value. Obtain final resistance-area values (Ω cm2) by multiplying the net TER by the  
effective growth area (0.9 cm2 for 12-well inserts). During days 7–14, DSI and DSII inserts should show TER values of 
~5,000–30,000 Ω cm2 (Fig. 5b and supplementary Fig. 1a). Once a TER value of 5,000 Ω cm2 or above is obtained,  
if desired you can proceed to assaying freshwater, as described in the next section.
? trouBlesHootInG
 pause poInt Epithelia can be stored with medium A in both the apical and basolateral compartments for later use by 
maintaining them at 4 °C for up to 2 weeks31.
experimental assay ● tIMInG 30 min
31| Remove the medium from the lower compartment, followed by the upper compartment.
32| To wash and remove traces of FBS, apply 800 µl of PBS in the upper compartment, and then apply 1,000 µl to the  
lower compartment.
33| Aspirate the lower compartment and wash a further two times before the final aspiration.
a b
c d
Figure 4 | Images of the double-seeded insert epithelium. (a) Phase-contrast 
micrograph of DSI gill epithelial cells. Scale bar, 100 µm. (b) Transmission 
electron micrograph of DSI gill epithelia showing the characteristic 
microridges on the apical surface. Scale bar, 200 nm. (c,d) Confocal 
microscope images of DSI epithelia in which 24 h before cell fixing, epithelia 
were exposed to symmetrical conditions with L-15 medium on both sides of 
the epithelium (c) or asymmetrical conditions with freshwater in the upper 
compartment and L-15 medium in the companion well (d), and cell nuclei 
were stained with 5 µM Hoechst (blue) and tight junctions with zonula 
occludens 1 antibody (green). Scale bars, 50 µm. (See supplementary 
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Figure 5 | Membrane development can be monitored by daily TER 
measurements. (a) A custom-modified epithelial tissue voltohmmeter is 
fitted with chopstick electrodes. The electrode arms are inserted above 
and below the gill cell epithelium of each insert, such that one arm of 
the electrode is in the upper compartment and the other arm is in the 
lower (bottom) compartment. (b) Measurements of TER in developing 
DSI. Freshwater (blue points) was added (after the dotted line) to the 
companion well compartment (the apical cell surface, while the insert 
contained L-15 medium) on day 4, resulting in an increase in TER still 
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34| Apply the solution of interest, e.g., freshwater, to the test compartment. For DSI, apply 1.5 ml of freshwater into the 
upper compartment, while leaving the lower compartment in 2.0 ml of L-15 medium. Depending on the experimental design, 
FBS can be removed from the medium. For DSII, apply 1.5 ml of L-15 medium without FBS into the upper compartment;  
2.0 ml of freshwater can now be applied to the lower compartment. The volume in the upper compartment can be reduced  
if required. Application of freshwater should cause a rise in TER (supplementary Fig. 1a). After freshwater application, 
inserts around 5,000 Ω cm2 may rise to 30,000 Ω cm2, whereas those already around 25,000–30,000 Ω cm2 may not rise by 
as much. After freshwater application, TER values should remain above 5,000 Ω cm2 for up to 48 h.
? trouBlesHootInG
Troubleshooting advice can be found in table 1.
● tIMInG 
Steps 1–4, preparation of solutions and cell culture inserts: 1 h; inserts also need to be left to condition for at least 1.5 h
Steps 5–25, rainbow trout dissection and gill cell isolation: 3 h
Step 26, DSI/DSII cell seeding: 30 min
Steps 27–30, maintenance and monitoring: this will depend on the number of inserts, and it can take between 30 min  
and 2 h on the day of medium changes; cell preparation reaches maturity over 5–12 d
Steps 31–34, experimental assay: 30 min
antIcIpateD results
The epithelia should have distinct apical and basolateral surface consisting of irregularly shaped epithelial (pavement) cells 
with microridges and plasma membranes (Fig. 4b and supplementary Fig. 1c,d) interspersed with MRCs (supplementary 
Fig. 1e) typically from day 5 onward while growing in both the DSI and DSII configurations. Both preparations should 
develop an electrically tight epithelium showing the presence of the TJ proteins, such as zonula occludens (Fig. 4c,d and 
supplementary Fig. 1f,g), typically from day 5 onward. The DSI can withstand water applied to the apical surface, but it 
does not tolerate water when exposed via the basolateral compartment31, and these traits are also evident in the DSII prepa-
rations (supplementary Fig. 1b). On the basis of rhodamine 123 staining6, the epithelium should consist of between 10 and 
15% MRCs, which is consistent with observations of the intact fish gill epithelium; however, PVCs make up the bulk of the 
epithelium, as is also seen in vivo1.
taBle 1 | Troubleshooting table.
step problem possible reason solution
20 Pellet is not red Excessive trypsinization  
Trypsin digestion has not 
stopped
Check the trypsin concentration and batch, and reduce the  
trypsinization time 
Check the FBS, and if it is out of date, remake the stop solution
25 Low cell viability Excessive trypsinization Decrease the trypsinization time
Low donor quality Check the health of stock fish
Low cell number Slow work pace Perform the procedure faster
Low EDTA concentra-
tions in trypsin solution 
(Reagent Setup)
Increase EDTA concentration to 5 mM in the trypsin solution 
(Reagent Setup)
26A(v), 26B(v) Extra mucus on cells Fish health–related problem Perform an additional PBS wash
30 Low TER Contamination Discard the cells
Seeding density Perform a seeding-density assay
Fish health–related problem Check the health of stock fish and water quality of the fish tank
Slow development Keep monitoring, and discard it if TER is <5,000 Ω cm2 by day 14
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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